table_name,column_name,primary_key,ordinal_position,type,discontinued,description
UB_AUTHORIZATION_TYPE,CLAIM_PRINT_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the claim print record. The unique identifier (.1 item) for the claim print record.
UB_AUTHORIZATION_TYPE,GROUP_LINE,N,2,INTEGER,No,The line number for the information associated with this record. The line number for the information associated with this record.
UB_AUTHORIZATION_TYPE,VALUE_LINE,N,3,INTEGER,No,The line number of one of the multiple values associated with a specific group of data within this record. The line number of one of the multiple values associated with a specific group of data within this record.
UB_AUTHORIZATION_TYPE,UB_AUTHORIZATION_TYPE_C_NAME,N,4,VARCHAR,No,"The authorization type category ID identifying whether the auth number on the row is a referral number or prior authorization number.
May contain organization-specific values: No
Category Entries:
Referral Number
Prior Authorization Number The authorization type category ID identifying whether the auth number on the row is a referral number or prior authorization number. May contain organization-specific values: No Category Entries: Referral Number Prior Authorization Number"
UB_AUTH_FULL_REFERRAL,CLAIM_PRINT_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the claim print record. The unique identifier (.1 item) for the claim print record.
UB_AUTH_FULL_REFERRAL,GROUP_LINE,N,2,INTEGER,No,The line number for the information associated with this record. The line number for the information associated with this record.
UB_AUTH_FULL_REFERRAL,VALUE_LINE,N,3,INTEGER,No,The line number of one of the multiple values associated with a specific group of data within this record. The line number of one of the multiple values associated with a specific group of data within this record.
UB_AUTH_FULL_REFERRAL,UB_AUTH_NUM_FULL_REFERRAL_ID,N,4,NUMERIC,No,"The unique ID of each referral or auth/cert record considered in the prior authorization number lookup, whether we read the prior authorization number from the record or not. The unique ID of each referral or auth/cert record considered in the prior authorization number lookup, whether we read the prior authorization number from the record or not."
UB_AUTH_NUM_SOURCE,CLAIM_PRINT_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the claim print record. The unique identifier (.1 item) for the claim print record.
UB_AUTH_NUM_SOURCE,GROUP_LINE,N,2,INTEGER,No,The line number for the information associated with this record. The line number for the information associated with this record.
UB_AUTH_NUM_SOURCE,VALUE_LINE,N,3,INTEGER,No,The line number of one of the multiple values associated with a specific group of data within this record. The line number of one of the multiple values associated with a specific group of data within this record.
UB_AUTH_NUM_SOURCE,UB_AUTH_NUM_SOURCE_C_NAME,N,4,VARCHAR,No,"The auth number search precedence category ID identifying where the authorization number was found.
May contain organization-specific values: No
Category Entries:
None
Claim Info - Authorization Number (PB:CLM-341; HB:HAR-7053)
Referral - Effective Coverages Authorization Number (RFL-18062)
Referral - Default Authorization Number (RFL-60)
Referral - Effective Coverages Pre-Certification Number (RFL-18064)
Referral - Default Pre-Certification Number (RFL-18010)
Episode Authorization Code
Bed Days Table - Authorization Number (RFL-8513/8527)
Dental Plan - Authorization Number (DTP-302)
Referral - SAR/TAR (RFL-210/250/269)
Referral - Service Level Auths (ETR-118; AUT-18062) The auth number search precedence category ID identifying where the authorization number was found. May contain organization-specific values: No Category Entries: None Claim Info - Authorization Number (PB:CLM-341; HB:HAR-7053) Referral - Effective Coverages Authorization Number (RFL-18062) Referral - Default Authorization Number (RFL-60) Referral - Effective Coverages Pre-Certification Number (RFL-18064) Referral - Default Pre-Certification Number (RFL-18010) Episode Authorization Code Bed Days Table - Authorization Number (RFL-8513/8527) Dental Plan - Authorization Number (DTP-302) Referral - SAR/TAR (RFL-210/250/269) Referral - Service Level Auths (ETR-118; AUT-18062)"
UB_HB_RFL_RECORD_SOURCE,CLAIM_PRINT_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the claim print record. The unique identifier (.1 item) for the claim print record.
UB_HB_RFL_RECORD_SOURCE,GROUP_LINE,N,2,INTEGER,No,The line number for the information associated with this record. The line number for the information associated with this record.
UB_HB_RFL_RECORD_SOURCE,VALUE_LINE,N,3,INTEGER,No,The line number of one of the multiple values associated with a specific group of data within this record. The line number of one of the multiple values associated with a specific group of data within this record.
UB_HB_RFL_RECORD_SOURCE,UB_HB_RFL_RECORD_SOURCE_C_NAME,N,4,VARCHAR,No,"The Hospital Billing referral source search precedence category ID identifying where the source referral or auth/cert record was found.
May contain organization-specific values: No
Category Entries:
Hospital account (HAR 130)
Authorization assigned to the charge (AUT 105)
Order associated with the charge (ORD 3300)
Authorization associated with the encounter of the charge (EPT 23017)
Technical referral associated with the encounter of the charge (EPT 23019)
Primary referral associated with the encounter of the charge (EPT 23015)
Authorization associated with the primary contact on the hospital account (EPT 23017)
Technical referral associated with the primary contact on the hospital account (EPT 23019)
Primary referral associated with the primary contact on the hospital account (EPT 23015) The Hospital Billing referral source search precedence category ID identifying where the source referral or auth/cert record was found. May contain organization-specific values: No Category Entries: Hospital account (HAR 130) Authorization assigned to the charge (AUT 105) Order associated with the charge (ORD 3300) Authorization associated with the encounter of the charge (EPT 23017) Technical referral associated with the encounter of the charge (EPT 23019) Primary referral associated with the encounter of the charge (EPT 23015) Authorization associated with the primary contact on the hospital account (EPT 23017) Technical referral associated with the primary contact on the hospital account (EPT 23019) Primary referral associated with the primary contact on the hospital account (EPT 23015)"
UB_PB_RFL_RECORD_SOURCE,CLAIM_PRINT_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the claim print record. The unique identifier (.1 item) for the claim print record.
UB_PB_RFL_RECORD_SOURCE,GROUP_LINE,N,2,INTEGER,No,The line number for the information associated with this record. The line number for the information associated with this record.
UB_PB_RFL_RECORD_SOURCE,VALUE_LINE,N,3,INTEGER,No,The line number of one of the multiple values associated with a specific group of data within this record. The line number of one of the multiple values associated with a specific group of data within this record.
UB_PB_RFL_RECORD_SOURCE,UB_PB_RFL_RECORD_SOURCE_C_NAME,N,4,VARCHAR,No,"The Professional Billing referral source search precedence category ID identifying where the source referral or auth/cert record was found.
May contain organization-specific values: No
Category Entries:
Referral assigned to the charge (ETR 116)
Authorization assigned to the charge (AUT 105)
Order associated with the charge (ORD 3300)
Encounter associated with the charge (EPT 23015) The Professional Billing referral source search precedence category ID identifying where the source referral or auth/cert record was found. May contain organization-specific values: No Category Entries: Referral assigned to the charge (ETR 116) Authorization assigned to the charge (AUT 105) Order associated with the charge (ORD 3300) Encounter associated with the charge (EPT 23015)"
UB_REF_FULL_REFERRAL,CLAIM_PRINT_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the claim print record. The unique identifier (.1 item) for the claim print record.
UB_REF_FULL_REFERRAL,GROUP_LINE,N,2,INTEGER,No,The line number for the information associated with this record. The line number for the information associated with this record.
UB_REF_FULL_REFERRAL,VALUE_LINE,N,3,INTEGER,No,The line number of one of the multiple values associated with a specific group of data within this record. The line number of one of the multiple values associated with a specific group of data within this record.
UB_REF_FULL_REFERRAL,UB_REF_NUM_FULL_REFERRAL_ID,N,4,NUMERIC,No,"The unique ID of each referral or auth/cert record considered in the referral number lookup, whether we read the referral number from the record or not. The unique ID of each referral or auth/cert record considered in the referral number lookup, whether we read the referral number from the record or not."
UB_SOURCE_AUTH,CLAIM_PRINT_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the claim print record. The unique identifier (.1 item) for the claim print record.
UB_SOURCE_AUTH,GROUP_LINE,N,2,INTEGER,No,The line number for the information associated with this record. The line number for the information associated with this record.
UB_SOURCE_AUTH,VALUE_LINE,N,3,INTEGER,No,The line number of one of the multiple values associated with a specific group of data within this record. The line number of one of the multiple values associated with a specific group of data within this record.
UB_SOURCE_AUTH,UB_SOURCE_AUTH_ID,N,4,NUMERIC,No,The unique ID of the service level authorization record when the authorization number on the row was found in the authorization record. The unique ID of the service level authorization record when the authorization number on the row was found in the authorization record.
UB_SOURCE_CLAIM_INFO,CLAIM_PRINT_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the claim print record. The unique identifier (.1 item) for the claim print record.
UB_SOURCE_CLAIM_INFO,GROUP_LINE,N,2,INTEGER,No,The line number for the information associated with this record. The line number for the information associated with this record.
UB_SOURCE_CLAIM_INFO,VALUE_LINE,N,3,INTEGER,No,The line number of one of the multiple values associated with a specific group of data within this record. The line number of one of the multiple values associated with a specific group of data within this record.
UB_SOURCE_CLAIM_INFO,UB_SOURCE_CLAIM_ID,N,4,NUMERIC,No,The unique ID of the claim information record when the authorization number on the row was found in the claim info record. The unique ID of the claim information record when the authorization number on the row was found in the claim info record.
UB_SOURCE_HSP_ACCT,CLAIM_PRINT_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the claim print record. The unique identifier (.1 item) for the claim print record.
UB_SOURCE_HSP_ACCT,GROUP_LINE,N,2,INTEGER,No,The line number for the information associated with this record. The line number for the information associated with this record.
UB_SOURCE_HSP_ACCT,VALUE_LINE,N,3,INTEGER,No,The line number of one of the multiple values associated with a specific group of data within this record. The line number of one of the multiple values associated with a specific group of data within this record.
UB_SOURCE_HSP_ACCT,UB_SOURCE_HSP_ACCOUNT_ID,N,4,NUMERIC,No,The unique ID of the hospital account when the authorization number on the row was found in the account. The unique ID of the hospital account when the authorization number on the row was found in the account.
UB_SOURCE_REFERRAL,CLAIM_PRINT_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the claim print record. The unique identifier (.1 item) for the claim print record.
UB_SOURCE_REFERRAL,GROUP_LINE,N,2,INTEGER,No,The line number for the information associated with this record. The line number for the information associated with this record.
UB_SOURCE_REFERRAL,VALUE_LINE,N,3,INTEGER,No,The line number of one of the multiple values associated with a specific group of data within this record. The line number of one of the multiple values associated with a specific group of data within this record.
UB_SOURCE_REFERRAL,UB_SOURCE_REFERRAL_ID,N,4,NUMERIC,No,The unique ID of the referral or auth/cert record when the authorization number on the row was found in the referral or auth/cert. The unique ID of the referral or auth/cert record when the authorization number on the row was found in the referral or auth/cert.
UB_SOURCE_TREAT_PLAN,CLAIM_PRINT_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the claim print record. The unique identifier (.1 item) for the claim print record.
UB_SOURCE_TREAT_PLAN,GROUP_LINE,N,2,INTEGER,No,The line number for the information associated with this record. The line number for the information associated with this record.
UB_SOURCE_TREAT_PLAN,VALUE_LINE,N,3,INTEGER,No,The line number of one of the multiple values associated with a specific group of data within this record. The line number of one of the multiple values associated with a specific group of data within this record.
UB_SOURCE_TREAT_PLAN,UB_SOURCE_TREATMENT_PLAN_ID,N,4,VARCHAR,No,The unique ID of the dental treatment plan record when the authorization number on the row was found in the treatment plan. The unique ID of the dental treatment plan record when the authorization number on the row was found in the treatment plan.
UCL_AMBRX_COVERAGE,UCL_ID,N,1,VARCHAR,No,The unique ID associated with the charge record. The unique ID associated with the charge record.
UCL_AMBRX_COVERAGE,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UCL_AMBRX_COVERAGE,AMBRX_COVERAGE_ID,N,3,NUMERIC,No,Stores the coverage for an Ambulatory Pharmacy charge. Stores the coverage for an Ambulatory Pharmacy charge.
UCL_AMBRX_COVERAGE,AMBRX_PROMISED_PMT,N,4,NUMERIC,No,Stores the payment amount promised to the organization by the payor specified in the coverage. Stores the payment amount promised to the organization by the payor specified in the coverage.
UCL_AMBRX_COVERAGE,PAT_DUE_AMT,N,5,NUMERIC,No,Stores the payment amount due to the organization from the patient for a pharmacy charge. Stores the payment amount due to the organization from the patient for a pharmacy charge.
UCL_AMBRX_COVERAGE,WRITE_OFF_AMT,N,6,NUMERIC,No,Stores the amount to be written off by the organization for a pharmacy charge. Stores the amount to be written off by the organization for a pharmacy charge.
UCL_ANES_EXCLUSION,UCL_ID,N,1,VARCHAR,No,The unique ID associated with the charge record. The unique ID associated with the charge record.
UCL_ANES_EXCLUSION,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UCL_ANES_EXCLUSION,ANES_EXCL_ST_DT_TM,N,3,DATETIME (Local),No,The starting date and time of the period exclusion for the anesthesia. The starting date and time of the period exclusion for the anesthesia.
UCL_ANES_EXCLUSION,ANES_EXCL_ED_DT_TM,N,4,DATETIME (Local),No,The end date and time of the period exclusion for the anesthesia. The end date and time of the period exclusion for the anesthesia.
UCL_ANES_EXCLUSION,ANES_EXCL_COMMENT,N,5,VARCHAR,No,The comment of the period exclusion for the anesthesia. The comment of the period exclusion for the anesthesia.
UCL_ANES_PERIOD,UCL_ID,N,1,VARCHAR,No,The unique ID associated with the charge record. The unique ID associated with the charge record.
UCL_ANES_PERIOD,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UCL_ANES_PERIOD,ANES_PRD_ST_DT_TM,N,3,DATETIME (Local),No,The start date and time of the anesthesia procedure. The start date and time of the anesthesia procedure.
UCL_ANES_PERIOD,ANES_PRD_ED_DT_TM,N,4,DATETIME (Local),No,The end date and time of the anesthesia procedure. The end date and time of the anesthesia procedure.
UCL_BUNDLED_EPISODE,UCL_ID,N,1,VARCHAR,No,The unique identifier for the charge line record. The unique identifier for the charge line record.
UCL_BUNDLED_EPISODE,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UCL_BUNDLED_EPISODE,LAST_UPDT_INST_UTC_DTTM,N,3,DATETIME (UTC),No,Stores the instant the bundled episode was updated on this charge line. Stores the instant the bundled episode was updated on this charge line.
UCL_BUNDLED_EPISODE,EPISODE_ID,N,4,NUMERIC,No,The bundled episode whose link is defined on this line The bundled episode whose link is defined on this line
UCL_BUNDLED_EPISODE,LINK_STATUS_C_NAME,N,5,VARCHAR,No,"This indicates whether this episode is linked to the universal charge line.
May contain organization-specific values: No
Category Entries:
Link
Unlink This indicates whether this episode is linked to the universal charge line. May contain organization-specific values: No Category Entries: Link Unlink"
UCL_BUNDLED_EPISODE,LINK_SOURCE_C_NAME,N,6,VARCHAR,No,"Indicates whether it's a user-override or something different that set the link.
May contain organization-specific values: No
Category Entries:
User
Visit Association
Auto Link
Auto Creation
Auto Link Via Transform
Auto Link Via Association
Auto Removal Indicates whether it's a user-override or something different that set the link. May contain organization-specific values: No Category Entries: User Visit Association Auto Link Auto Creation Auto Link Via Transform Auto Link Via Association Auto Removal"
UCL_BUNDLED_EPISODE,LINK_USER_ID,N,7,VARCHAR,No,Indicates the user who set the episode status for the charge line. Indicates the user who set the episode status for the charge line.
UCL_BUNDLED_EPISODE,LINK_USER_ID_NAME,N,8,VARCHAR,No,The name of the user record. This name may be hidden. The name of the user record. This name may be hidden.
UCL_CRC,UCL_ID,N,1,VARCHAR,No,The unique ID associated with the charge record. The unique ID associated with the charge record.
UCL_CRC,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UCL_CRC,CRC_CONDITION_C_NAME,N,3,VARCHAR,No,"CRC condition for the charge
May contain organization-specific values: Yes
Category Entries:
L1 - General Standard of 20 Degree or .5 Diopter Sphere or Cylinder Change Met
L2 - Replacement Due to Loss or Theft
L3 - Replacement Due to Breakage or Damage
L4 - Replacement Due to Patient Preference
L5 - Replacement Due to Medical Reason CRC condition for the charge May contain organization-specific values: Yes Category Entries: L1 - General Standard of 20 Degree or .5 Diopter Sphere or Cylinder Change Met L2 - Replacement Due to Loss or Theft L3 - Replacement Due to Breakage or Damage L4 - Replacement Due to Patient Preference L5 - Replacement Due to Medical Reason"
UCL_DOC_PROVIDER,UCL_ID,N,1,VARCHAR,No,The unique ID associated with the charge record. The unique ID associated with the charge record.
UCL_DOC_PROVIDER,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UCL_DOC_PROVIDER,DOC_PROV_ID_PROV_NAME,N,3,VARCHAR,No,The name of the service provider. This item may be hidden in a public view of the CLARITY_SER table. The name of the service provider. This item may be hidden in a public view of the CLARITY_SER table.
UCL_DOC_PROVIDER,DOC_PROV_FUNC_C_NAME,N,4,VARCHAR,No,"The documentation provider's function for this procedure.
May contain organization-specific values: Yes
Category Entries:
Supervised
Performed
Assisted
Observed
Billing Provider
Surrogate Provider
Ordering Provider The documentation provider's function for this procedure. May contain organization-specific values: Yes Category Entries: Supervised Performed Assisted Observed Billing Provider Surrogate Provider Ordering Provider"
UCL_DOC_PROVIDER,DOC_PROV_ST_DT_TM,N,5,DATETIME (Local),No,The start date and time for the documentation provider for this procedure. The start date and time for the documentation provider for this procedure.
UCL_DOC_PROVIDER,DOC_PROV_ED_DT_TM,N,6,DATETIME (Local),No,The end date and time for the documentation provider for this procedure. The end date and time for the documentation provider for this procedure.
UCL_MEA,UCL_ID,N,1,VARCHAR,No,The unique ID associated with the charge record. The unique ID associated with the charge record.
UCL_MEA,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UCL_MEA,MEA_TEST_C_NAME,N,3,VARCHAR,No,"MEA test for the charge
May contain organization-specific values: Yes
Category Entries:
Concentration
Gas Test Rate
Height
Hemoglobin
Hematocrit
Epoetin Starting Dosage
Creatinine
Oxygen
Last Kt/V Result MEA test for the charge May contain organization-specific values: Yes Category Entries: Concentration Gas Test Rate Height Hemoglobin Hematocrit Epoetin Starting Dosage Creatinine Oxygen Last Kt/V Result"
UCL_MEA,MEA_RESULT,N,4,NUMERIC,No,MEA test result for the charge MEA test result for the charge
UCL_MEA,MEA_PERFORMED_DATE,N,5,DATETIME,No,The date that the test was performed. The date that the test was performed.
UCL_NDC_CODES,UCL_ID,N,1,VARCHAR,No,The unique ID associated with the charge record. The unique ID associated with the charge record.
UCL_NDC_CODES,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UCL_NDC_CODES,NDC_CODE_ID,N,3,VARCHAR,No,The medication national drug codes associated with the charge. The medication national drug codes associated with the charge.
UCL_NDC_CODES,NDC_CODE_ID_NDC_CODE,N,4,VARCHAR,No,The external code for the National Drug Code (NDC). An NDC represents packages of medications. The external code for the National Drug Code (NDC). An NDC represents packages of medications.
UCL_NDC_CODES,NDC_CODE_ADMIN_AMT,N,5,NUMERIC,No,Administered amount for associated national drug code. Administered amount for associated national drug code.
UCL_NDC_CODES,NDC_CODE_UNIT_C_NAME,N,6,VARCHAR,No,"Unit associated with NDC administered amount.
May contain organization-specific values: No
Category Entries:
Milliliters
Milligrams
Grams
International Units
Units Unit associated with NDC administered amount. May contain organization-specific values: No Category Entries: Milliliters Milligrams Grams International Units Units"
UCL_PAT_VST_PROG,UCL_ID,N,1,VARCHAR,No,patient visit program for the charge patient visit program for the charge
UCL_PAT_VST_PROG,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UCL_PAT_VST_PROG,VISIT_PROGRAM_C_NAME,N,3,VARCHAR,No,"patient visit program category number
May contain organization-specific values: Yes patient visit program category number May contain organization-specific values: Yes"
UCL_TOOTH,UCL_ID,N,1,VARCHAR,No,The unique identifier for the charge line record. The unique identifier for the charge line record.
UCL_TOOTH,TOOTH_LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UCL_TOOTH,TOOTH_NUM_C_NAME,N,3,VARCHAR,No,"The tooth number category ID for the universal charge line.
May contain organization-specific values: No
Category Entries:
Tooth 1
Tooth 2
Tooth 3
Tooth 4
Tooth 5
Tooth 6
Tooth 7
Tooth 8
Tooth 9
Tooth 10
Tooth 11
Tooth 12
Tooth 13
Tooth 14
Tooth 15
Tooth 16
Tooth 17
Tooth 18
Tooth 19
Tooth 20
Tooth 21
Tooth 22
Tooth 23
Tooth 24
Tooth 25
Tooth 26
Tooth 27
Tooth 28
Tooth 29
Tooth 30
Tooth 31
Tooth 32
Tooth A
Tooth B
Tooth C
Tooth D
Tooth E
Tooth F
Tooth G
Tooth H
Tooth I
Tooth J
Tooth K
Tooth L
Tooth M
Tooth N
Tooth O
Tooth P
Tooth Q
Tooth R
Tooth S
Tooth T
Tooth 18 (FDI)
Tooth 17 (FDI)
Tooth 16 (FDI)
Tooth 15 (FDI)
Tooth 14 (FDI)
Tooth 13 (FDI)
Tooth 12 (FDI)
Tooth 11 (FDI)
Tooth 21 (FDI)
Tooth 22 (FDI)
Tooth 23 (FDI)
Tooth 24 (FDI)
Tooth 25 (FDI)
Tooth 26 (FDI)
Tooth 27 (FDI)
Tooth 28 (FDI)
Tooth 38 (FDI)
Tooth 37 (FDI)
Tooth 36 (FDI)
Tooth 35 (FDI)
Tooth 34 (FDI)
Tooth 33 (FDI)
Tooth 32 (FDI)
Tooth 31 (FDI)
Tooth 41 (FDI)
Tooth 42 (FDI)
Tooth 43 (FDI)
Tooth 44 (FDI)
Tooth 45 (FDI)
Tooth 46 (FDI)
Tooth 47 (FDI)
Tooth 48 (FDI)
Tooth 55 (FDI)
Tooth 54 (FDI)
Tooth 53 (FDI)
Tooth 52 (FDI)
Tooth 51 (FDI)
Tooth 61 (FDI)
Tooth 62 (FDI)
Tooth 63 (FDI)
Tooth 64 (FDI)
Tooth 65 (FDI)
Tooth 75 (FDI)
Tooth 74 (FDI)
Tooth 73 (FDI)
Tooth 72 (FDI)
Tooth 71 (FDI)
Tooth 81 (FDI)
Tooth 82 (FDI)
Tooth 83 (FDI)
Tooth 84 (FDI)
Tooth 85 (FDI)
Tooth UR8 (Palmer)
Tooth UR7 (Palmer)
Tooth UR6 (Palmer)
Tooth UR5 (Palmer)
Tooth UR4 (Palmer)
Tooth UR3 (Palmer)
Tooth UR2 (Palmer)
Tooth UR1 (Palmer)
Tooth UL1 (Palmer)
Tooth UL2 (Palmer)
Tooth UL3 (Palmer)
Tooth UL4 (Palmer)
Tooth UL5 (Palmer)
Tooth UL6 (Palmer)
Tooth UL7 (Palmer)
Tooth UL8 (Palmer)
Tooth LL8 (Palmer)
Tooth LL7 (Palmer)
Tooth LL6 (Palmer)
Tooth LL5 (Palmer)
Tooth LL4 (Palmer)
Tooth LL3 (Palmer)
Tooth LL2 (Palmer)
Tooth LL1 (Palmer)
Tooth LR1 (Palmer)
Tooth LR2 (Palmer)
Tooth LR3 (Palmer)
Tooth LR4 (Palmer)
Tooth LR5 (Palmer)
Tooth LR6 (Palmer)
Tooth LR7 (Palmer)
Tooth LR8 (Palmer)
Tooth URE (Palmer)
Tooth URD (Palmer)
Tooth URC (Palmer)
Tooth URB (Palmer)
Tooth URA (Palmer)
Tooth ULA (Palmer)
Tooth ULB (Palmer)
Tooth ULC (Palmer)
Tooth ULD (Palmer)
Tooth ULE (Palmer)
Tooth LLE (Palmer)
Tooth LLD (Palmer)
Tooth LLC (Palmer)
Tooth LLB (Palmer)
Tooth LLA (Palmer)
Tooth LRA (Palmer)
Tooth LRB (Palmer)
Tooth LRC (Palmer)
Tooth LRD (Palmer)
Tooth LRE (Palmer) The tooth number category ID for the universal charge line. May contain organization-specific values: No Category Entries: Tooth 1 Tooth 2 Tooth 3 Tooth 4 Tooth 5 Tooth 6 Tooth 7 Tooth 8 Tooth 9 Tooth 10 Tooth 11 Tooth 12 Tooth 13 Tooth 14 Tooth 15 Tooth 16 Tooth 17 Tooth 18 Tooth 19 Tooth 20 Tooth 21 Tooth 22 Tooth 23 Tooth 24 Tooth 25 Tooth 26 Tooth 27 Tooth 28 Tooth 29 Tooth 30 Tooth 31 Tooth 32 Tooth A Tooth B Tooth C Tooth D Tooth E Tooth F Tooth G Tooth H Tooth I Tooth J Tooth K Tooth L Tooth M Tooth N Tooth O Tooth P Tooth Q Tooth R Tooth S Tooth T Tooth 18 (FDI) Tooth 17 (FDI) Tooth 16 (FDI) Tooth 15 (FDI) Tooth 14 (FDI) Tooth 13 (FDI) Tooth 12 (FDI) Tooth 11 (FDI) Tooth 21 (FDI) Tooth 22 (FDI) Tooth 23 (FDI) Tooth 24 (FDI) Tooth 25 (FDI) Tooth 26 (FDI) Tooth 27 (FDI) Tooth 28 (FDI) Tooth 38 (FDI) Tooth 37 (FDI) Tooth 36 (FDI) Tooth 35 (FDI) Tooth 34 (FDI) Tooth 33 (FDI) Tooth 32 (FDI) Tooth 31 (FDI) Tooth 41 (FDI) Tooth 42 (FDI) Tooth 43 (FDI) Tooth 44 (FDI) Tooth 45 (FDI) Tooth 46 (FDI) Tooth 47 (FDI) Tooth 48 (FDI) Tooth 55 (FDI) Tooth 54 (FDI) Tooth 53 (FDI) Tooth 52 (FDI) Tooth 51 (FDI) Tooth 61 (FDI) Tooth 62 (FDI) Tooth 63 (FDI) Tooth 64 (FDI) Tooth 65 (FDI) Tooth 75 (FDI) Tooth 74 (FDI) Tooth 73 (FDI) Tooth 72 (FDI) Tooth 71 (FDI) Tooth 81 (FDI) Tooth 82 (FDI) Tooth 83 (FDI) Tooth 84 (FDI) Tooth 85 (FDI) Tooth UR8 (Palmer) Tooth UR7 (Palmer) Tooth UR6 (Palmer) Tooth UR5 (Palmer) Tooth UR4 (Palmer) Tooth UR3 (Palmer) Tooth UR2 (Palmer) Tooth UR1 (Palmer) Tooth UL1 (Palmer) Tooth UL2 (Palmer) Tooth UL3 (Palmer) Tooth UL4 (Palmer) Tooth UL5 (Palmer) Tooth UL6 (Palmer) Tooth UL7 (Palmer) Tooth UL8 (Palmer) Tooth LL8 (Palmer) Tooth LL7 (Palmer) Tooth LL6 (Palmer) Tooth LL5 (Palmer) Tooth LL4 (Palmer) Tooth LL3 (Palmer) Tooth LL2 (Palmer) Tooth LL1 (Palmer) Tooth LR1 (Palmer) Tooth LR2 (Palmer) Tooth LR3 (Palmer) Tooth LR4 (Palmer) Tooth LR5 (Palmer) Tooth LR6 (Palmer) Tooth LR7 (Palmer) Tooth LR8 (Palmer) Tooth URE (Palmer) Tooth URD (Palmer) Tooth URC (Palmer) Tooth URB (Palmer) Tooth URA (Palmer) Tooth ULA (Palmer) Tooth ULB (Palmer) Tooth ULC (Palmer) Tooth ULD (Palmer) Tooth ULE (Palmer) Tooth LLE (Palmer) Tooth LLD (Palmer) Tooth LLC (Palmer) Tooth LLB (Palmer) Tooth LLA (Palmer) Tooth LRA (Palmer) Tooth LRB (Palmer) Tooth LRC (Palmer) Tooth LRD (Palmer) Tooth LRE (Palmer)"
UC_GROUP,UC_GROUP_ID_RECORD_NAME,N,1,VARCHAR,No,Record name Record name
UC_GROUP,RECORD_NAME,N,2,VARCHAR,No,Record name Record name
UC_GROUP,GROUP_DISPLAY_NAME,N,3,VARCHAR,No,"The name of the group, as it appears to end users. The name of the group, as it appears to end users."
UC_GROUP_CONTACT,UC_GROUP_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the unified communications group record. The unique identifier (.1 item) for the unified communications group record.
UC_GROUP_CONTACT,CONTACT_DATE_REAL,N,2,FLOAT,No,"A unique contact date in decimal format. The integer portion of the number indicates the date of contact. The digits after the decimal distinguish different contacts on the same date and are unique for each contact on that date. For example, .00 is the first/only contact, .01 is the second contact, etc. A unique contact date in decimal format. The integer portion of the number indicates the date of contact. The digits after the decimal distinguish different contacts on the same date and are unique for each contact on that date. For example, .00 is the first/only contact, .01 is the second contact, etc."
UC_GROUP_CONTACT,NAME_HX,N,3,VARCHAR,No,Stores the history of the record name Stores the history of the record name
UNCONFIRMED_PAT_STAT_HX,PAT_ID,N,1,VARCHAR,No,The unique ID of the patient record for this row. This column is frequently used to link to the PATIENT table. The unique ID of the patient record for this row. This column is frequently used to link to the PATIENT table.
UNCONFIRMED_PAT_STAT_HX,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNCONFIRMED_PAT_STAT_HX,UNCNFRM_HX_STAT_C_NAME,N,3,VARCHAR,No,"Holds the historical information regarding the patient unconfirmed status (EPT 2023).
May contain organization-specific values: Yes
Category Entries:
Duplicate Review Needed
Identity Verification Needed
Patient Creation in Progress
Flagged as Suspicious Holds the historical information regarding the patient unconfirmed status (EPT 2023). May contain organization-specific values: Yes Category Entries: Duplicate Review Needed Identity Verification Needed Patient Creation in Progress Flagged as Suspicious"
UNCONFIRMED_PAT_STAT_HX,UNCNFRM_HX_STAT_SRC_C_NAME,N,4,VARCHAR,No,"Stores whether the patient status from EPT 2043 was added or removed.
May contain organization-specific values: No
Category Entries:
Added
Removed
Modified Stores whether the patient status from EPT 2043 was added or removed. May contain organization-specific values: No Category Entries: Added Removed Modified"
UNCONFIRMED_PAT_STAT_HX,UNCNFRM_HX_WKFW_C_NAME,N,5,VARCHAR,No,"Holds historical information regarding the unconfirmed patient source workflow in EPT 2044.
May contain organization-specific values: Yes
Category Entries:
MyChart - On My Way
MyChart - Unverified Proxy Video Visit
Welcome
MyChart - Self-Signup
MyChart - Open Scheduling
MyChart - Symptom Checker
Unconfirmed Identity Activity
Web Service
MyChart - SAML Login
MyChart - Guest Proxy
MyChart - Provider Finder
Cheers - Call Management
Patient Merge Holds historical information regarding the unconfirmed patient source workflow in EPT 2044. May contain organization-specific values: Yes Category Entries: MyChart - On My Way MyChart - Unverified Proxy Video Visit Welcome MyChart - Self-Signup MyChart - Open Scheduling MyChart - Symptom Checker Unconfirmed Identity Activity Web Service MyChart - SAML Login MyChart - Guest Proxy MyChart - Provider Finder Cheers - Call Management Patient Merge"
UNCONFIRMED_PAT_STAT_HX,UNCNFRM_HX_UTC_DTTM,N,6,DATETIME (UTC),No,Historical information regarding the instant the patient unconfirmed status changed. Historical information regarding the instant the patient unconfirmed status changed.
UNCONFIRMED_PAT_STAT_HX,UNCNFRM_HX_CLI_DTTM,N,7,DATETIME (Attached),No,Historical information regarding the client instant of the patient's unconfirmed status. Historical information regarding the client instant of the patient's unconfirmed status.
UNCONFIRMED_PAT_STAT_HX,UNCNFRM_HX_DTTM,N,8,DATETIME (Local),No,Historical information regarding the server instant of the patient's unconfirmed status. Historical information regarding the server instant of the patient's unconfirmed status.
UNCONFIRMED_PAT_STAT_HX,UNCNFRM_HX_MYPT_ID,N,9,VARCHAR,No,Holds historical information regarding the patient's unconfirmed status. This item holds the MyChart user linked to the patient's unconfirmed status change. Holds historical information regarding the patient's unconfirmed status. This item holds the MyChart user linked to the patient's unconfirmed status change.
UNCONFIRMED_PAT_STAT_HX,UNCNFRM_HX_USER_ID,N,10,VARCHAR,No,Holds historical information regarding the patient's unconfirmed status. This item holds the Hyperspace user linked to the patient's unconfirmed status change. Holds historical information regarding the patient's unconfirmed status. This item holds the Hyperspace user linked to the patient's unconfirmed status change.
UNCONFIRMED_PAT_STAT_HX,UNCNFRM_HX_USER_ID_NAME,N,11,VARCHAR,No,The name of the user record. This name may be hidden. The name of the user record. This name may be hidden.
UNCONFIRMED_PAT_STAT_HX,UNCNFRM_HX_RSN_C_NAME,N,12,VARCHAR,No,"Holds historical information regarding the patient's unconfirmed status. This item holds the reason linked to the patient's unconfirmed status change.
May contain organization-specific values: Yes
Category Entries:
Fake Demographics
Identity Theft
No Identification
Patient Not Present
Patient Cannot Communicate
Other Holds historical information regarding the patient's unconfirmed status. This item holds the reason linked to the patient's unconfirmed status change. May contain organization-specific values: Yes Category Entries: Fake Demographics Identity Theft No Identification Patient Not Present Patient Cannot Communicate Other"
UNCONFRM_PAT_INFO,PAT_ID,N,1,VARCHAR,No,The unique ID of the patient record for this row. This column is frequently used to link to the PATIENT table. The unique ID of the patient record for this row. This column is frequently used to link to the PATIENT table.
UNCONFRM_PAT_INFO,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNCONFRM_PAT_INFO,UNCONFRM_PAT_STAT_C_NAME,N,3,VARCHAR,No,"The unconfirmed patient status category ID for the patient.
May contain organization-specific values: Yes
Category Entries:
Duplicate Review Needed
Identity Verification Needed
Patient Creation in Progress
Flagged as Suspicious The unconfirmed patient status category ID for the patient. May contain organization-specific values: Yes Category Entries: Duplicate Review Needed Identity Verification Needed Patient Creation in Progress Flagged as Suspicious"
UNCONFRM_PAT_INFO,UNCONFRM_PAT_SRC_C_NAME,N,4,VARCHAR,No,"The unconfirmed patient workflow source category ID for the patient.
May contain organization-specific values: Yes
Category Entries:
MyChart - On My Way
MyChart - Unverified Proxy Video Visit
Welcome
MyChart - Self-Signup
MyChart - Open Scheduling
MyChart - Symptom Checker
Unconfirmed Identity Activity
Web Service
MyChart - SAML Login
MyChart - Guest Proxy
MyChart - Provider Finder
Cheers - Call Management
Patient Merge The unconfirmed patient workflow source category ID for the patient. May contain organization-specific values: Yes Category Entries: MyChart - On My Way MyChart - Unverified Proxy Video Visit Welcome MyChart - Self-Signup MyChart - Open Scheduling MyChart - Symptom Checker Unconfirmed Identity Activity Web Service MyChart - SAML Login MyChart - Guest Proxy MyChart - Provider Finder Cheers - Call Management Patient Merge"
UNCONFRM_PAT_INFO,UNCONFRM_PAT_RSN_C_NAME,N,5,VARCHAR,No,"The unconfirmed patient status reason category ID for the patient.
May contain organization-specific values: Yes
Category Entries:
Fake Demographics
Identity Theft
No Identification
Patient Not Present
Patient Cannot Communicate
Other The unconfirmed patient status reason category ID for the patient. May contain organization-specific values: Yes Category Entries: Fake Demographics Identity Theft No Identification Patient Not Present Patient Cannot Communicate Other"
UNIT_OF_MEASURE,UNIT_ID,N,1,NUMERIC,No,The unique identifier for the unit record. The unique identifier for the unit record.
UNIT_OF_MEASURE,UNIT_ID_UNIT_NAME,N,2,VARCHAR,No,Record name Record name
UNIT_OF_MEASURE,UNIT_NAME,N,3,VARCHAR,No,Record name Record name
UNIV_CHG_LN_DX,UCL_ID,N,1,VARCHAR,No,The unique ID associated with the charge record. The unique ID associated with the charge record.
UNIV_CHG_LN_DX,LINE,N,2,INTEGER,No,Each charge line (UCL) can have multiple diagnoses associated with it. The combination of UCL_ID and LINE make up a unique identifier for this diagnosis. Each charge line (UCL) can have multiple diagnoses associated with it. The combination of UCL_ID and LINE make up a unique identifier for this diagnosis.
UNIV_CHG_LN_DX,DIAGNOSIS_ID_DX_NAME,N,3,VARCHAR,No,The name of the diagnosis. The name of the diagnosis.
UNIV_CHG_LN_DX,DIAGNOSIS_QUAL_C_NAME,N,4,VARCHAR,No,"The qualifier for the diagnosis.
May contain organization-specific values: Yes The qualifier for the diagnosis. May contain organization-specific values: Yes"
UNIV_CHG_LN_MOD,UCL_ID,N,1,VARCHAR,No,The unique ID assigned to the charge line record. The unique ID assigned to the charge line record.
UNIV_CHG_LN_MOD,LINE,N,2,INTEGER,No,Each Universal Charge Line can have multiple modifiers associated with it. The combination of UCL_ID and LINE make up a unique identifier for this modifier. Each Universal Charge Line can have multiple modifiers associated with it. The combination of UCL_ID and LINE make up a unique identifier for this modifier.
UNIV_CHG_LN_MOD,MODIFIER_ID,N,3,VARCHAR,No,The modifier associated with the Universal Charge Line. The modifier associated with the Universal Charge Line.
UNIV_CHG_LN_MOD,MODIFIER_ID_MODIFIER_NAME,N,4,VARCHAR,No,The name of the modifier record. The name of the modifier record.
UNIV_CHG_LN_MSG_HX,UCL_ID,N,1,VARCHAR,No,The unique ID assigned to the UCL record (UCL .1). The unique ID assigned to the UCL record (UCL .1).
UNIV_CHG_LN_MSG_HX,LINE,N,2,INTEGER,No,Each charge line (UCL) can have multiple messages (UCM) associated with it. The combination of UCL_ID and LINE make up a unique identifier for this message. Each charge line (UCL) can have multiple messages (UCM) associated with it. The combination of UCL_ID and LINE make up a unique identifier for this message.
UNIV_CHG_LN_MSG_HX,MESSAGE_ID,N,3,NUMERIC,No,A history of Universal Charge Messages (UCM) that have updated this charge. A history of Universal Charge Messages (UCM) that have updated this charge.
UNOS_BIO_ANTI_THRP,REGISTRY_DATA_ID,N,1,NUMERIC,No,The registry record ID. The registry record ID.
UNOS_BIO_ANTI_THRP,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_BIO_ANTI_THRP,UNOS_BIO_ANTI_VI_C_NAME,N,3,VARCHAR,No,"The specific biological or anti-viral therapies undergone by the patient during the last follow-up period.
May contain organization-specific values: No
Category Entries:
Acyclovir (Zovirax)
Cytogam (CMV)
Gamimune
Gammagard
Ganciclovir (Cytovene)
Valganciclovir (Valcyte)
HBIG (Hepatitis B Immune Globulin)
Flu vaccine (Influenza virus)
Lamivudine (Epivir) (for treatment of Hepatitis B)
Other, specify
Valacyclovir (Valtrex) The specific biological or anti-viral therapies undergone by the patient during the last follow-up period. May contain organization-specific values: No Category Entries: Acyclovir (Zovirax) Cytogam (CMV) Gamimune Gammagard Ganciclovir (Cytovene) Valganciclovir (Valcyte) HBIG (Hepatitis B Immune Globulin) Flu vaccine (Influenza virus) Lamivudine (Epivir) (for treatment of Hepatitis B) Other, specify Valacyclovir (Valtrex)"
UNOS_BKV_TREATMENT,REGISTRY_DATA_ID,N,1,NUMERIC,No,The registry record ID. The registry record ID.
UNOS_BKV_TREATMENT,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_BKV_TREATMENT,UNOS_BKV_TREAT_C_NAME,N,3,VARCHAR,No,"The treatments used to treat the patient for BK viral infections.
May contain organization-specific values: No
Category Entries:
Immunosuppression reduction
Cidofovir
IVIG
Unknown
Other, specify The treatments used to treat the patient for BK viral infections. May contain organization-specific values: No Category Entries: Immunosuppression reduction Cidofovir IVIG Unknown Other, specify"
UNOS_BLD_SGR_CTRL,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier for the registry data record. The unique identifier for the registry data record.
UNOS_BLD_SGR_CTRL,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_BLD_SGR_CTRL,UNOS_BLD_SGR_CTRL_C_NAME,N,3,VARCHAR,No,"Indicates the method used to control the patient's blood sugar.
May contain organization-specific values: No
Category Entries:
Insulin
Oral Medication
Unknown, converted
Diet
No Treatment Indicates the method used to control the patient's blood sugar. May contain organization-specific values: No Category Entries: Insulin Oral Medication Unknown, converted Diet No Treatment"
UNOS_CARD_SURG_TYP,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the registry data record. The unique identifier (.1 item) for the registry data record.
UNOS_CARD_SURG_TYP,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_CARD_SURG_TYP,UNOS_CARD_SURG_TS_C_NAME,N,3,VARCHAR,No,"A list of the types of non-transplant cardiac surgery the patient has undergone prior to UNOS registration
May contain organization-specific values: No
Category Entries:
CABG
Valve Replacement/Repair
Congenital
Left Ventricular Remodeling
Other, Specify A list of the types of non-transplant cardiac surgery the patient has undergone prior to UNOS registration May contain organization-specific values: No Category Entries: CABG Valve Replacement/Repair Congenital Left Ventricular Remodeling Other, Specify"
UNOS_CLINICAL_INFO,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique ID of the registry record. The unique ID of the registry record.
UNOS_CLINICAL_INFO,UNOS_ORGAN_C_NAME,N,2,VARCHAR,No,"The type of organ transplanted.
May contain organization-specific values: No
Category Entries:
Lung
Pancreas
Liver
Kidney
Kidney/Pancreas
Intestine
Heart
Heart/Lung
Pancreas Islets The type of organ transplanted. May contain organization-specific values: No Category Entries: Lung Pancreas Liver Kidney Kidney/Pancreas Intestine Heart Heart/Lung Pancreas Islets"
UNOS_CLINICAL_INFO,UNOS_CARE_PROV_BY_C_NAME,N,3,VARCHAR,No,"The place or type of provider responsible for the patient's follow-up care.
May contain organization-specific values: No
Category Entries:
Transplant Center
Non-Transplant Center Specialty Physician
Primary Care Physician
Other, Specify The place or type of provider responsible for the patient's follow-up care. May contain organization-specific values: No Category Entries: Transplant Center Non-Transplant Center Specialty Physician Primary Care Physician Other, Specify"
UNOS_CLINICAL_INFO,UNOS_CARE_PROV_OTH,N,4,VARCHAR,No,"If different from common answers, the specified place or type of provider responsible for the patient's follow-up care. This clarifies the answer in the UNOS_CARE_PROV_BY_C column. If different from common answers, the specified place or type of provider responsible for the patient's follow-up care. This clarifies the answer in the UNOS_CARE_PROV_BY_C column."
UNOS_CLINICAL_INFO,UNOS_WAS_HOSP_C_NAME,N,5,VARCHAR,No,"Specifies whether the patient was hospitalized during the follow-up period.
May contain organization-specific values: No
Category Entries:
Yes
No
Unknown Specifies whether the patient was hospitalized during the follow-up period. May contain organization-specific values: No Category Entries: Yes No Unknown"
UNOS_CLINICAL_INFO,UNOS_NBR_HOSP_ADMIT,N,6,INTEGER,No,Specifies the number of hospitalizations during the follow-up period. Specifies the number of hospitalizations during the follow-up period.
UNOS_CLINICAL_INFO,UNOS_HOSP_STAT_C_NAME,N,7,VARCHAR,No,"If the number of hospitalizations is unspecified, this field indicates why.
May contain organization-specific values: No
Category Entries:
N/A
Not Done
Missing
Unknown If the number of hospitalizations is unspecified, this field indicates why. May contain organization-specific values: No Category Entries: N/A Not Done Missing Unknown"
UNOS_CLINICAL_INFO,UNOS_CLIN_RSCH_YN,N,8,VARCHAR,No,"Specifies whether the patient participated in any clinical research protocols for immunosuppressive medications.
May contain organization-specific values: No
Category Entries:
No
Yes Specifies whether the patient participated in any clinical research protocols for immunosuppressive medications. May contain organization-specific values: No Category Entries: No Yes"
UNOS_CLINICAL_INFO,UNOS_CLIN_RSCH_SPEC,N,9,VARCHAR,No,"If the patient participated in any protocols for immunosuppressive medications, this specifies which ones. If the patient participated in any protocols for immunosuppressive medications, this specifies which ones."
UNOS_CLINICAL_INFO,UNOS_DISEASE_RCR_C_NAME,N,10,VARCHAR,No,"Indicates the presence or absense of disease recurrence.
May contain organization-specific values: No
Category Entries:
No Recurrence
Suspected Recurrence
Biopsy Confirmed Recurrence
Unknown Indicates the presence or absense of disease recurrence. May contain organization-specific values: No Category Entries: No Recurrence Suspected Recurrence Biopsy Confirmed Recurrence Unknown"
UNOS_CLINICAL_INFO,UNOS_IMM_NONCOMP_C_NAME,N,11,VARCHAR,No,"Indicates whether there was evidence of patient non-compliance with immunosuppressive medications that could have compromised the patient's recovery.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether there was evidence of patient non-compliance with immunosuppressive medications that could have compromised the patient's recovery. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_MAINT_MEDS_C_NAME,N,12,VARCHAR,No,"Specifies whether maintenance immunosuppressive medications were given during the follow-up period.
May contain organization-specific values: No
Category Entries:
Yes, same as previous validated report
Yes, but different than previous validated report
None given
Yes, same as validated TRR form
Yes, but different than validated TRR form Specifies whether maintenance immunosuppressive medications were given during the follow-up period. May contain organization-specific values: No Category Entries: Yes, same as previous validated report Yes, but different than previous validated report None given Yes, same as validated TRR form Yes, but different than validated TRR form"
UNOS_CLINICAL_INFO,UNOS_IMM_DISC_YN,N,13,VARCHAR,No,"Indicates whether the physician discontinued all immunosuppressive medications.
The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN Indicates whether the physician discontinued all immunosuppressive medications. The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN"
UNOS_CLINICAL_INFO,UNOS_CREATININE,N,14,NUMERIC,No,The patient's most recent serum creatinine. The patient's most recent serum creatinine.
UNOS_CLINICAL_INFO,UNOS_CREAT_ST_C_NAME,N,15,VARCHAR,No,"The reason why the most recent serum creatinine is unspecified.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME The reason why the most recent serum creatinine is unspecified. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_ACUTE_REJ_C_NAME,N,16,VARCHAR,No,"Indicates whether there were any acute rejections during the last follow-up period.
May contain organization-specific values: No
Category Entries:
Yes, at least one episode treated with anti-rejection agent
Yes, none treated with additional anti-rejection agent
No
Unknown Indicates whether there were any acute rejections during the last follow-up period. May contain organization-specific values: No Category Entries: Yes, at least one episode treated with anti-rejection agent Yes, none treated with additional anti-rejection agent No Unknown"
UNOS_CLINICAL_INFO,UNOS_BX_CONFIRM_C_NAME,N,17,VARCHAR,No,"Indicates whether a biopsy was done to confirm acute rejection.
May contain organization-specific values: No
Category Entries:
Biopsy not done
Yes, rejection confirmed
Yes, rejection not confirmed
Unknown Indicates whether a biopsy was done to confirm acute rejection. May contain organization-specific values: No Category Entries: Biopsy not done Yes, rejection confirmed Yes, rejection not confirmed Unknown"
UNOS_CLINICAL_INFO,UNOS_MALG_POSTTXP_C_NAME,N,18,VARCHAR,No,"Indicates whether any post-transplant malignancies were found during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether any post-transplant malignancies were found during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_MALG_DNR_REL_C_NAME,N,19,VARCHAR,No,"Indicates whether discovered post-transplant malignancies were related to the donor.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether discovered post-transplant malignancies were related to the donor. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_MALG_PRETXP_C_NAME,N,20,VARCHAR,No,"Indicates whether discovered post-transplant malignancies were recurrences of a pre-transplant tumor.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether discovered post-transplant malignancies were recurrences of a pre-transplant tumor. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_MALG_NOVO_T_C_NAME,N,21,VARCHAR,No,"Indicates whether discovered post-transplant malignancies were new solid tumors.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether discovered post-transplant malignancies were new solid tumors. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_MALG_LYMPH_C_NAME,N,22,VARCHAR,No,"Indicates whether discovered post-transplant malignancies were new Lymphoproliferative disease and Lymphoma.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether discovered post-transplant malignancies were new Lymphoproliferative disease and Lymphoma. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_DIABETES_FP_C_NAME,N,23,VARCHAR,No,"Specifies whether the patient had an onset of diabetes during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Specifies whether the patient had an onset of diabetes during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_INSULIN_DEP_C_NAME,N,24,VARCHAR,No,"Indicates whether the patient is insulin dependent.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient is insulin dependent. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_CAD_C_NAME,N,25,VARCHAR,No,"Indicates whether the patient was diagnosed with coronary artery disease during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient was diagnosed with coronary artery disease during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_FRAC_PASTYR_C_NAME,N,26,VARCHAR,No,"Indicates whether the patient had any bone fractures either in the past year or since the last follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient had any bone fractures either in the past year or since the last follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_FRAC_SPINE_YN,N,27,VARCHAR,No,"Indicates whether the patient had any spine compression fractures either in the past year or since the last follow-up period.
The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN Indicates whether the patient had any spine compression fractures either in the past year or since the last follow-up period. The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN"
UNOS_CLINICAL_INFO,UNOS_FRAC_SPINE_NUM,N,28,INTEGER,No,The patient's number of spine compression fractures either in the past year or since the last follow-up period. The patient's number of spine compression fractures either in the past year or since the last follow-up period.
UNOS_CLINICAL_INFO,UNOS_FRAC_EXTRM_YN,N,29,VARCHAR,No,"Indicates whether the patient had any extremity fractures either in the past year or since the last follow-up period.
The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN Indicates whether the patient had any extremity fractures either in the past year or since the last follow-up period. The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN"
UNOS_CLINICAL_INFO,UNOS_FRAC_EXTRM_NUM,N,30,INTEGER,No,The patient's number of extremity fractures either in the past year or since the last follow-up period. The patient's number of extremity fractures either in the past year or since the last follow-up period.
UNOS_CLINICAL_INFO,UNOS_FRAC_OTHER_YN,N,31,VARCHAR,No,"Indicates whether the patient had any other fractures either in the past year or since the last follow-up period.
The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN Indicates whether the patient had any other fractures either in the past year or since the last follow-up period. The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN"
UNOS_CLINICAL_INFO,UNOS_FRAC_OTHER_NUM,N,32,INTEGER,No,The patient's number of other fractures either in the past year or since the last follow-up period. The patient's number of other fractures either in the past year or since the last follow-up period.
UNOS_CLINICAL_INFO,UNOS_AVN_C_NAME,N,33,VARCHAR,No,"Indicates whether the patient was diagnosed with Avascular Necrosis (AVN) during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient was diagnosed with Avascular Necrosis (AVN) during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PRI_DEATH_C_NAME,N,34,VARCHAR,No,"The patient's primary cause of death.
May contain organization-specific values: No
Category Entries:
Unknown
Other, Specify
Kidney Graft Failure: Primary Failure
Kidney Graft Failure: Rejection
Kidney Graft Failure: Technical
Kidney Graft Failure: Graft Infection
Kidney Graft Failure: Recurrent Disease
Kidney Graft Failure: Other, Specify
Infection: Bacterial Peritonitis
Infection: Bacterial Pneumonia
Infection: Bacterial Septicemia
Infection: Fungal
Infection: Mixed Other, Specify
Infection: Opportunistic Other, Specify
Infection: Urinary Tract
Infection: Viral
AIDS
Infection: Other, Specify
Cardiovascular: Myocardial Infarction
Cardiovascular: Arterial Embolism
Cardiovascular: Pulmonary Embolism
Cardiovascular: Other, Specify
Cerebrovascular: Stroke
Cerebrovascular: Other, Specify
Hemorrhage: Gastrointestinal
Hemorrhage: Intraoperative
Hemorrhage: Other, Specify
Malignancy: Metastatic Other, Specify
Malignancy: Primary Other, Specify
Malignancy: Post-Txp Lymphoproliferative
Malignancy: Other, Specify
Trauma: Motor Vehicle
Trauma: Other, Specify
Diabetes Mellitus
Intraoperative: Not Hemorrhage Other, Specify
Pancreatitis
Renal Failure
Respiratory Failure
Suicide
Non-Compliance
Liver Failure
Multiple Organ System Failure
Fluid/Electrolyte Disorder
Acid/Base Disorder
Immunosuppressive Drug Related Hematologic
Immunosuppressive Drug Related Non-Hematologic
Non-Immunosuppressive Drug Related Hematologic
Non-Immunosuppressive Non-Hematologic, Specify Drug
Kidney Graft Failure: Primary Non-Function (Graft Never Functioned Post-Transplant)
Infection: Viral COVID-19
Infection: Viral Other, Specify The patient's primary cause of death. May contain organization-specific values: No Category Entries: Unknown Other, Specify Kidney Graft Failure: Primary Failure Kidney Graft Failure: Rejection Kidney Graft Failure: Technical Kidney Graft Failure: Graft Infection Kidney Graft Failure: Recurrent Disease Kidney Graft Failure: Other, Specify Infection: Bacterial Peritonitis Infection: Bacterial Pneumonia Infection: Bacterial Septicemia Infection: Fungal Infection: Mixed Other, Specify Infection: Opportunistic Other, Specify Infection: Urinary Tract Infection: Viral AIDS Infection: Other, Specify Cardiovascular: Myocardial Infarction Cardiovascular: Arterial Embolism Cardiovascular: Pulmonary Embolism Cardiovascular: Other, Specify Cerebrovascular: Stroke Cerebrovascular: Other, Specify Hemorrhage: Gastrointestinal Hemorrhage: Intraoperative Hemorrhage: Other, Specify Malignancy: Metastatic Other, Specify Malignancy: Primary Other, Specify Malignancy: Post-Txp Lymphoproliferative Malignancy: Other, Specify Trauma: Motor Vehicle Trauma: Other, Specify Diabetes Mellitus Intraoperative: Not Hemorrhage Other, Specify Pancreatitis Renal Failure Respiratory Failure Suicide Non-Compliance Liver Failure Multiple Organ System Failure Fluid/Electrolyte Disorder Acid/Base Disorder Immunosuppressive Drug Related Hematologic Immunosuppressive Drug Related Non-Hematologic Non-Immunosuppressive Drug Related Hematologic Non-Immunosuppressive Non-Hematologic, Specify Drug Kidney Graft Failure: Primary Non-Function (Graft Never Functioned Post-Transplant) Infection: Viral COVID-19 Infection: Viral Other, Specify"
UNOS_CLINICAL_INFO,UNOS_PRI_DEATH_OTH,N,35,VARCHAR,No,Specifies the primary cause of death for the kidney graft recipient if that cause of death was not picked from a list. Specifies the primary cause of death for the kidney graft recipient if that cause of death was not picked from a list.
UNOS_CLINICAL_INFO,UNOS_SEC_DEATH_C_NAME,N,36,VARCHAR,No,"The patient's contributory cause of death.
The category values for this column were already listed for column: UNOS_PRI_DEATH_C_NAME The patient's contributory cause of death. The category values for this column were already listed for column: UNOS_PRI_DEATH_C_NAME"
UNOS_CLINICAL_INFO,UNOS_SEC_DEATH_OTH1,N,37,VARCHAR,No,The free-text description of the patient's contributory cause of death. The free-text description of the patient's contributory cause of death.
UNOS_CLINICAL_INFO,UNOS_SEC_DEATH2_C_NAME,N,38,VARCHAR,No,"The patient's second contributory cause of death.
The category values for this column were already listed for column: UNOS_PRI_DEATH_C_NAME The patient's second contributory cause of death. The category values for this column were already listed for column: UNOS_PRI_DEATH_C_NAME"
UNOS_CLINICAL_INFO,UNOS_SEC_DEATH_OTH2,N,39,VARCHAR,No,The free-text description of the patient's second contributory cause of death. The free-text description of the patient's second contributory cause of death.
UNOS_CLINICAL_INFO,UNOS_DIALYSIS_C_NAME,N,40,VARCHAR,No,"Indicates whether the patient has had dialysis since the last follow-up period.
May contain organization-specific values: No
Category Entries:
No
Yes, Resumed maintenance dialysis
Yes, No maintenance resumption
Yes, Maintenance resumption unknown
Yes, returned to chronic maintenance dialysis (ESRD)
Yes, returned to (or continued on) temporary dialysis
Unknown Indicates whether the patient has had dialysis since the last follow-up period. May contain organization-specific values: No Category Entries: No Yes, Resumed maintenance dialysis Yes, No maintenance resumption Yes, Maintenance resumption unknown Yes, returned to chronic maintenance dialysis (ESRD) Yes, returned to (or continued on) temporary dialysis Unknown"
UNOS_CLINICAL_INFO,UNOS_DLYS_DT,N,41,DATETIME,No,The date on which the patient resumed maintenance dialysis. The date on which the patient resumed maintenance dialysis.
UNOS_CLINICAL_INFO,UNOS_DLYS_PROV_ID,N,42,VARCHAR,No,The provider number for the center at which the patient receives dialysis. The provider number for the center at which the patient receives dialysis.
UNOS_CLINICAL_INFO,UNOS_DLYS_PROV_NAME,N,43,VARCHAR,No,The name of the center at which the patient receives dialysis. The name of the center at which the patient receives dialysis.
UNOS_CLINICAL_INFO,UNOS_BIO_ANTIV_C_NAME,N,44,VARCHAR,No,"Indicates whether the patient has had biological or anti-viral therapy in the last follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient has had biological or anti-viral therapy in the last follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_BIO_ANTIV_OTH1,N,45,VARCHAR,No,The patient's first other biological or anti-viral therapy during the last follow-up period. The patient's first other biological or anti-viral therapy during the last follow-up period.
UNOS_CLINICAL_INFO,UNOS_BIO_ANTIV_OTH2,N,46,VARCHAR,No,The patient's second other biological or anti-viral therapy during the last follow-up period. The patient's second other biological or anti-viral therapy during the last follow-up period.
UNOS_CLINICAL_INFO,UNOS_OTHER_THERP_YN,N,47,VARCHAR,No,"Indicates whether the patient had any other therapies during the follow-up period.
The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN Indicates whether the patient had any other therapies during the follow-up period. The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN"
UNOS_CLINICAL_INFO,UNOS_GRWTH_THERP_C_NAME,N,48,VARCHAR,No,"Indicates whether the patient had growth hormone therapy.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient had growth hormone therapy. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_BKV_TREAT_YN,N,49,VARCHAR,No,"Indicates whether the patient was treated for BK (Polyoma) Virus.
The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN Indicates whether the patient was treated for BK (Polyoma) Virus. The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN"
UNOS_CLINICAL_INFO,UNOS_BKV_TREAT_OTH,N,50,VARCHAR,No,The other specified treatments the patient had for BK (polyoma) viral infections. The other specified treatments the patient had for BK (polyoma) viral infections.
UNOS_CLINICAL_INFO,UNOS_URINE_PROT_C_NAME,N,51,VARCHAR,No,"Indicates whether urine protein was found by any method.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether urine protein was found by any method. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_CMV_IGG_C_NAME,N,52,VARCHAR,No,"The last CMV IgG result for the patient.
May contain organization-specific values: No
Category Entries:
Positive
Negative
Not Done
Unknown/Cannot Disclose The last CMV IgG result for the patient. May contain organization-specific values: No Category Entries: Positive Negative Not Done Unknown/Cannot Disclose"
UNOS_CLINICAL_INFO,UNOS_CMV_IGM_C_NAME,N,53,VARCHAR,No,"The last CMV IgM result for the patient.
The category values for this column were already listed for column: UNOS_CMV_IGG_C_NAME The last CMV IgM result for the patient. The category values for this column were already listed for column: UNOS_CMV_IGG_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KI_FL_PRI_C_NAME,N,54,VARCHAR,No,"The reason for kidney failure. This column pulls data from Transplant Recipient Follow-up forms.
May contain organization-specific values: No
Category Entries:
Hyperacute Rejection
Acute Rejection
Primary Failure
Graft Thrombosis
Infection
Surgical Complications
Urological Complications
Recurrent Disease
Chronic Rejection
BK (Polyoma) Virus
Primary Non-Function (Graft Never Functioned Post-Transplant)
Other, Specify The reason for kidney failure. This column pulls data from Transplant Recipient Follow-up forms. May contain organization-specific values: No Category Entries: Hyperacute Rejection Acute Rejection Primary Failure Graft Thrombosis Infection Surgical Complications Urological Complications Recurrent Disease Chronic Rejection BK (Polyoma) Virus Primary Non-Function (Graft Never Functioned Post-Transplant) Other, Specify"
UNOS_CLINICAL_INFO,UNOS_KI_FL_OTH,N,55,VARCHAR,No,The free-text reason for primary graft failure. The free-text reason for primary graft failure.
UNOS_CLINICAL_INFO,UNOS_KI_FL_ACUTE_C_NAME,N,56,VARCHAR,No,"Indicates whether acute rejection was a contributory cause of graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether acute rejection was a contributory cause of graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KI_FL_CHRON_C_NAME,N,57,VARCHAR,No,"Indicates whether chronic rejection was a contributory cause of graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether chronic rejection was a contributory cause of graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KI_FL_INFECT_C_NAME,N,58,VARCHAR,No,"Indicates whether infection was a contributory cause of graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether infection was a contributory cause of graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KI_FL_PT_NON_C_NAME,N,59,VARCHAR,No,"Indicates whether patient non-compliance was a contributory cause of graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether patient non-compliance was a contributory cause of graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KI_FL_RECUR_C_NAME,N,60,VARCHAR,No,"Indicates whether recurrent disease was a contributory cause of graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether recurrent disease was a contributory cause of graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KI_FL_CNTB_OTH,N,61,VARCHAR,No,A free-text contributory cause of graft failure. A free-text contributory cause of graft failure.
UNOS_CLINICAL_INFO,UNOS_KI_FL_THROMB_C_NAME,N,62,VARCHAR,No,"Indicates whether graft thrombosis was a contributory cause of graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether graft thrombosis was a contributory cause of graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KI_FL_BKV_C_NAME,N,63,VARCHAR,No,"Indicates whether BK (polyoma) virus was a contributory cause of graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether BK (polyoma) virus was a contributory cause of graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KI_FL_UROLOG_C_NAME,N,64,VARCHAR,No,"Indicates whether urological complications were a contributory cause of graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether urological complications were a contributory cause of graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_LVR_FAIL_C_NAME,N,65,VARCHAR,No,"Indicates whether primary graft failure was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether primary graft failure was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_BILIARY_C_NAME,N,66,VARCHAR,No,"Indicates whether biliary tract complication was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether biliary tract complication was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_HEP_DENOVO_C_NAME,N,67,VARCHAR,No,"Indicates whether DeNovo hepatitis was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether DeNovo hepatitis was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_VASC_THROMB_C_NAME,N,68,VARCHAR,No,"Indicates whether vascular thrombosis was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether vascular thrombosis was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_HEP_RECUR_C_NAME,N,69,VARCHAR,No,"Indicates whether recurrent hepatitis was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether recurrent hepatitis was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_HEP_ARTTHRM_C_NAME,N,70,VARCHAR,No,"Indicates whether hepatic arterial thrombosis was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether hepatic arterial thrombosis was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_HEP_OBSTRUCT_C_NAME,N,71,VARCHAR,No,"Indicates whether hepatic outflow obstruction was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether hepatic outflow obstruction was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PORT_VNTHRM_C_NAME,N,72,VARCHAR,No,"Indicates whether portal vein thrombosis was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether portal vein thrombosis was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_DIS_LAB_DT,N,73,DATETIME,No,Indicates the patient's discharge lab date. Indicates the patient's discharge lab date.
UNOS_CLINICAL_INFO,UNOS_DIS_BILI,N,74,NUMERIC,No,Indicates the patient's total bilirubin at discharge. Indicates the patient's total bilirubin at discharge.
UNOS_CLINICAL_INFO,UNOS_DIS_BILI_ST_C_NAME,N,75,VARCHAR,No,"Indicates the patient's discharge bilirubin status.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME Indicates the patient's discharge bilirubin status. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_DIS_SGPT,N,76,NUMERIC,No,Indicates the patient's SGPT ALT at discharge. Indicates the patient's SGPT ALT at discharge.
UNOS_CLINICAL_INFO,UNOS_DIS_SGPT_ST_C_NAME,N,77,VARCHAR,No,"Indicates the patient's discharge SGPT ALT status.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME Indicates the patient's discharge SGPT ALT status. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_DIS_ALBUM,N,78,NUMERIC,No,Indicates the patient's serum albumin at discharge. Indicates the patient's serum albumin at discharge.
UNOS_CLINICAL_INFO,UNOS_DIS_ALBUM_ST_C_NAME,N,79,VARCHAR,No,"Indicates the patient's discharge serum albumin status.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME Indicates the patient's discharge serum albumin status. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_DIS_CREAT,N,80,NUMERIC,No,Indicates the patient's serum creatinine at discharge. Indicates the patient's serum creatinine at discharge.
UNOS_CLINICAL_INFO,UNOS_DIS_CREAT_ST_C_NAME,N,81,VARCHAR,No,"Indicates the patient's discharge serum creatinine status.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME Indicates the patient's discharge serum creatinine status. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_DIS_INR,N,82,NUMERIC,No,Indicates the patient's INR at discharge. Indicates the patient's INR at discharge.
UNOS_CLINICAL_INFO,UNOS_DIS_INR_ST_C_NAME,N,83,VARCHAR,No,"Indications the patient's discharge INR status.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME Indications the patient's discharge INR status. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_LVR_REC_DIS_C_NAME,N,84,VARCHAR,No,"Indicates whether recurrent disease was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether recurrent disease was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_LVR_ACT_REJ_C_NAME,N,85,VARCHAR,No,"Indicates whether acute rejection was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether acute rejection was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_LVR_CHN_REJ_C_NAME,N,86,VARCHAR,No,"Indicates whether chronic rejection was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether chronic rejection was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_LVR_INFECT_C_NAME,N,87,VARCHAR,No,"Indicates whether infection was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether infection was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_LVR_PAT_NCM_C_NAME,N,88,VARCHAR,No,"Indicates whether patient noncompliance was a contributory cause for liver graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether patient noncompliance was a contributory cause for liver graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_LVR_OTHR_SPEC,N,89,VARCHAR,No,The free text description of other specified contributory reasons for the patient's liver graft failure. The free text description of other specified contributory reasons for the patient's liver graft failure.
UNOS_CLINICAL_INFO,UNOS_PAN_INS_RSM_DT,N,90,DATETIME,No,Indicates the date the patient resumed insulin/medication. Indicates the date the patient resumed insulin/medication.
UNOS_CLINICAL_INFO,UNOS_PAN_FAIL_DT,N,91,DATETIME,No,Indicates the patient's pancreas graft failure date. Indicates the patient's pancreas graft failure date.
UNOS_CLINICAL_INFO,UNOS_PAN_GRF_RMV_C_NAME,N,92,VARCHAR,No,"Indicates whether the patient's pancreas graft was removed.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient's pancreas graft was removed. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_GRF_RMV_DT,N,93,DATETIME,No,Indicates the patient's pancreas graft removal date. Indicates the patient's pancreas graft removal date.
UNOS_CLINICAL_INFO,UNOS_PAN_PRM_FAIL_C_NAME,N,94,VARCHAR,No,"Indicates the patient's primary cause of pancreas graft failure.
May contain organization-specific values: No
Category Entries:
Graft/Vascular Thrombosis
Infection
Bleeding
Anastomotic Leak
Primary Non-Function (Graft Never Functioned Post-Transplant)
Acute Rejection
Chronic Rejection
Hyperacute Rejection
Biopsy Proven Isletitis
Pancreatitis
Other Specify Indicates the patient's primary cause of pancreas graft failure. May contain organization-specific values: No Category Entries: Graft/Vascular Thrombosis Infection Bleeding Anastomotic Leak Primary Non-Function (Graft Never Functioned Post-Transplant) Acute Rejection Chronic Rejection Hyperacute Rejection Biopsy Proven Isletitis Pancreatitis Other Specify"
UNOS_CLINICAL_INFO,UNOS_PAN_OTHR_FAIL,N,95,VARCHAR,No,The free text description of other specified primary reasons for the patient's pancreas graft failure. The free text description of other specified primary reasons for the patient's pancreas graft failure.
UNOS_CLINICAL_INFO,UNOS_PAN_GV_THRMB_C_NAME,N,96,VARCHAR,No,"Indicates whether graft/vascular thrombosis was a contributory cause of pancreas graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether graft/vascular thrombosis was a contributory cause of pancreas graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_INFECT_C_NAME,N,97,VARCHAR,No,"Indicates whether infection was a contributory cause of pancreas graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether infection was a contributory cause of pancreas graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_BLEED_C_NAME,N,98,VARCHAR,No,"Indicates whether bleeding was a contributory cause of pancreas graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether bleeding was a contributory cause of pancreas graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_ANM_LK_C_NAME,N,99,VARCHAR,No,"Indicates whether anastomotic leak was a contributory cause of pancreas graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether anastomotic leak was a contributory cause of pancreas graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_ACT_REJ_C_NAME,N,100,VARCHAR,No,"Indicates whether acute rejection was a contributory cause of pancreas graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether acute rejection was a contributory cause of pancreas graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_CHN_REJ_C_NAME,N,101,VARCHAR,No,"Indicates whether chronic rejection was a contributory cause of pancreas graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether chronic rejection was a contributory cause of pancreas graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_BPSY_ISL_C_NAME,N,102,VARCHAR,No,"Indicates whether biopsy proven isletitis was a contributory cause of pancreas graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether biopsy proven isletitis was a contributory cause of pancreas graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_PAT_NCM_C_NAME,N,103,VARCHAR,No,"Indicates whether patient noncompliance was a contributory cause of pancreas graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether patient noncompliance was a contributory cause of pancreas graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_N_PNCRTS_C_NAME,N,104,VARCHAR,No,"Indicates whether pancreatitis was a complication that did not lead to pancreas graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether pancreatitis was a complication that did not lead to pancreas graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_NON_LK_C_NAME,N,105,VARCHAR,No,"Indicates whether anastomotic leak was a complication that did not lead to pancreas graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether anastomotic leak was a complication that did not lead to pancreas graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_NON_INF_C_NAME,N,106,VARCHAR,No,"Indicates whether abcess or local infection was a complication that did not lead to pancreas graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether abcess or local infection was a complication that did not lead to pancreas graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_NON_OTHR,N,107,VARCHAR,No,The free text description of other specified complications not leading to the patient's pancreas graft failure. The free text description of other specified complications not leading to the patient's pancreas graft failure.
UNOS_CLINICAL_INFO,UNOS_REC_LAB_DT,N,108,DATETIME,No,Indicates the patient's most recent lab date. Indicates the patient's most recent lab date.
UNOS_CLINICAL_INFO,UNOS_BILIRUBIN,N,109,NUMERIC,No,Indicates the patient's most recent total bilirubin. Indicates the patient's most recent total bilirubin.
UNOS_CLINICAL_INFO,UNOS_BILIRUBIN_ST_C_NAME,N,110,VARCHAR,No,"Indicates the patient's total bilirubin status.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME Indicates the patient's total bilirubin status. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_SGPT_ALT,N,111,NUMERIC,No,Indicates the patient's most recent SGPT ALT. Indicates the patient's most recent SGPT ALT.
UNOS_CLINICAL_INFO,UNOS_SGPT_ALT_ST_C_NAME,N,112,VARCHAR,No,"Indicates the patient's SGPT ALT status.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME Indicates the patient's SGPT ALT status. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_SERUM_ALBUMIN,N,113,NUMERIC,No,Indicates the patient's most recent serum albumin. Indicates the patient's most recent serum albumin.
UNOS_CLINICAL_INFO,UNOS_SERUM_ALB_ST_C_NAME,N,114,VARCHAR,No,"Indicates the patient's serum albumin status.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME Indicates the patient's serum albumin status. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_INR,N,115,NUMERIC,No,Indicates the patient's most recent INR. Indicates the patient's most recent INR.
UNOS_CLINICAL_INFO,UNOS_INR_ST_C_NAME,N,116,VARCHAR,No,"Indicates the patient's recent INR status.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME Indicates the patient's recent INR status. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_OTHR_SPEC,N,117,VARCHAR,No,The free text description of other specified contributory reasons for the patient's pancreas graft failure. The free text description of other specified contributory reasons for the patient's pancreas graft failure.
UNOS_CLINICAL_INFO,UNOS_SERUM_AMYLASE,N,118,NUMERIC,No,Indicates the patient's serum amylase value. Indicates the patient's serum amylase value.
UNOS_CLINICAL_INFO,UNOS_SERUM_AMY_ST_C_NAME,N,119,VARCHAR,No,"Indicates the patient's serum amylase status.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME Indicates the patient's serum amylase status. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_PANCRTS_C_NAME,N,120,VARCHAR,No,"Indicates whether pancreatitis was a contributory cause of pancreas graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether pancreatitis was a contributory cause of pancreas graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_BLDR_ENTDRN_DT,N,121,DATETIME,No,Indicates the patient's enteric drainage date. Indicates the patient's enteric drainage date.
UNOS_CLINICAL_INFO,UNOS_PAN_GRF_ST_C_NAME,N,122,VARCHAR,No,"Indicates the patient's current pancreas graft status.
May contain organization-specific values: No
Category Entries:
Functioning
Failed
Partial Function Indicates the patient's current pancreas graft status. May contain organization-specific values: No Category Entries: Functioning Failed Partial Function"
UNOS_CLINICAL_INFO,UNOS_BLDR_ENTDRN_C_NAME,N,123,VARCHAR,No,"Indicates whether conversion from bladder to enteric drain was performed.
May contain organization-specific values: No
Category Entries:
Yes
No
N/A
Unknown Indicates whether conversion from bladder to enteric drain was performed. May contain organization-specific values: No Category Entries: Yes No N/A Unknown"
UNOS_CLINICAL_INFO,UNOS_SEC_ACT_REJ_C_NAME,N,124,VARCHAR,No,"Indicates whether the patient had any acute rejections during the last follow-up for the second organ in a multi-organ form.
The category values for this column were already listed for column: UNOS_ACUTE_REJ_C_NAME Indicates whether the patient had any acute rejections during the last follow-up for the second organ in a multi-organ form. The category values for this column were already listed for column: UNOS_ACUTE_REJ_C_NAME"
UNOS_CLINICAL_INFO,UNOS_SEC_ACT_ST_C_NAME,N,125,VARCHAR,No,"In a multi-organ form, indicates whether a biopsy was done to confirm acute rejection of the second organ.
The category values for this column were already listed for column: UNOS_BX_CONFIRM_C_NAME In a multi-organ form, indicates whether a biopsy was done to confirm acute rejection of the second organ. The category values for this column were already listed for column: UNOS_BX_CONFIRM_C_NAME"
UNOS_CLINICAL_INFO,UNOS_RE_TXP_ORG_C_NAME,N,126,VARCHAR,No,"If a patient was retransplanted, inicates which organs were involved.
May contain organization-specific values: No
Category Entries:
Kidney
Pancreas
Kidney/Pancreas If a patient was retransplanted, inicates which organs were involved. May contain organization-specific values: No Category Entries: Kidney Pancreas Kidney/Pancreas"
UNOS_CLINICAL_INFO,UNOS_LVR_SC_DTH1_SP,N,127,VARCHAR,No,Specifies the first contributory cause of death for the liver graft recipient. Specifies the first contributory cause of death for the liver graft recipient.
UNOS_CLINICAL_INFO,UNOS_LVR_SC_DTH1_C_NAME,N,128,VARCHAR,No,"Indicates the first contributory cause of death for the liver graft recipient.
May contain organization-specific values: No
Category Entries:
Unknown
Other, Specify
Cardiovascular: Arterial Embolism
Cardiovascular: Pulmonary Embolism
Liver Graft Failure: Primary Failure
Liver Graft Failure: Vascular Thrombosis
Liver Graft Failure: Biliary Tract Complication
Liver Graft Failure: Hepatitis
Liver Graft Failure: Recurrent Disease (Non-Hepatitis)
Liver Graft Failure: Rejection
Liver Graft Failure: Infection (Non-Hepatitis)
Liver Graft Failure: Other, Specify
Graft vs. Host Disease
Cardiovascular: Arrhythmia
Cardiovascular: Arterial or Pulmonary Embolism
Cardiovascular: Hyperkalemic Arrest
Cardiovascular: Congestive Failure (CHF)
Cardiovascular: Myocardial Infarction
Cardiovascular: Other, Specify
Cardiovascular: Cardiac Arrest
Cerebrovascular: Embolic Stroke
Cerebrovascular: Hemorrhagic Stroke
Cerebrovascular: Other, Specify
Pulmonary Insuff or Edema (Exc Pneumonia)
Respiratory Failure: Other, Specify
Renal Failure
Multiple Organ System Failure
Hemorrhage: Lower Gastrointestinal
Hemorrhage: Neurological (Brain)
Hemorrhage: Variceal
Hemorrhage: Disseminated Intravascular Coagulation (DIC)
Hemorrhage: Other, Specify
Hemorrhage
Infection: Bacterial Peritonitis
Infection: Pneumonia Legionella Pneumocystosis
Infection: Generalized Sepsis
Infection: Fungal Aspergillus Cryptococcal
Infection: Mixed Other, Specify
Infection: Opportunistic
Infection: Viral
Infection: Other, Specify
Infection
Malignancy: Primary Other, Specify
Malignancy: Metastatic Other, Specify
Malignancy: Other, Specify
Malignancy
Post-Txp Lymphoproliferative Disorder
Operative: Other, Specify
Brain Dead: Never Recovered From Surgery
Suicide: Attempted Suicide Died Later
Trauma: Motor Vehicle
Trauma: Other, Specify
Diabetes Mellitus
Fluid/Electrolyte Disorder
Acid/Base Disorder
Acute Pancreatitis
AIDS
Immunosuppressive Drug Related Hematologic
Immunosuppressive Drug Related Non-Hematologic
Non-Immunosuppressive Drug Related Hematologic
Non-Immunosuppressive Non-Hematologic, Specify Drug
Liver Graft Failure: Primary Non-Function
Liver Graft Failure: Hepatic Artery Thrombosis
Liver Graft Failure: Other Vascular Thrombosis
Liver Graft Failure: Diffuse Cholangiopathy
Infection: Viral COVID-19
Infection: Viral Other, Specify Indicates the first contributory cause of death for the liver graft recipient. May contain organization-specific values: No Category Entries: Unknown Other, Specify Cardiovascular: Arterial Embolism Cardiovascular: Pulmonary Embolism Liver Graft Failure: Primary Failure Liver Graft Failure: Vascular Thrombosis Liver Graft Failure: Biliary Tract Complication Liver Graft Failure: Hepatitis Liver Graft Failure: Recurrent Disease (Non-Hepatitis) Liver Graft Failure: Rejection Liver Graft Failure: Infection (Non-Hepatitis) Liver Graft Failure: Other, Specify Graft vs. Host Disease Cardiovascular: Arrhythmia Cardiovascular: Arterial or Pulmonary Embolism Cardiovascular: Hyperkalemic Arrest Cardiovascular: Congestive Failure (CHF) Cardiovascular: Myocardial Infarction Cardiovascular: Other, Specify Cardiovascular: Cardiac Arrest Cerebrovascular: Embolic Stroke Cerebrovascular: Hemorrhagic Stroke Cerebrovascular: Other, Specify Pulmonary Insuff or Edema (Exc Pneumonia) Respiratory Failure: Other, Specify Renal Failure Multiple Organ System Failure Hemorrhage: Lower Gastrointestinal Hemorrhage: Neurological (Brain) Hemorrhage: Variceal Hemorrhage: Disseminated Intravascular Coagulation (DIC) Hemorrhage: Other, Specify Hemorrhage Infection: Bacterial Peritonitis Infection: Pneumonia Legionella Pneumocystosis Infection: Generalized Sepsis Infection: Fungal Aspergillus Cryptococcal Infection: Mixed Other, Specify Infection: Opportunistic Infection: Viral Infection: Other, Specify Infection Malignancy: Primary Other, Specify Malignancy: Metastatic Other, Specify Malignancy: Other, Specify Malignancy Post-Txp Lymphoproliferative Disorder Operative: Other, Specify Brain Dead: Never Recovered From Surgery Suicide: Attempted Suicide Died Later Trauma: Motor Vehicle Trauma: Other, Specify Diabetes Mellitus Fluid/Electrolyte Disorder Acid/Base Disorder Acute Pancreatitis AIDS Immunosuppressive Drug Related Hematologic Immunosuppressive Drug Related Non-Hematologic Non-Immunosuppressive Drug Related Hematologic Non-Immunosuppressive Non-Hematologic, Specify Drug Liver Graft Failure: Primary Non-Function Liver Graft Failure: Hepatic Artery Thrombosis Liver Graft Failure: Other Vascular Thrombosis Liver Graft Failure: Diffuse Cholangiopathy Infection: Viral COVID-19 Infection: Viral Other, Specify"
UNOS_CLINICAL_INFO,UNOS_LVR_SC_DTH2_C_NAME,N,129,VARCHAR,No,"Indicates the second contributory cause of death for the liver graft recipient.
The category values for this column were already listed for column: UNOS_LVR_SC_DTH1_C_NAME Indicates the second contributory cause of death for the liver graft recipient. The category values for this column were already listed for column: UNOS_LVR_SC_DTH1_C_NAME"
UNOS_CLINICAL_INFO,UNOS_LVR_SC_DTH2_SP,N,130,VARCHAR,No,Specifies the second contributory cause of death for the liver graft recipient. Specifies the second contributory cause of death for the liver graft recipient.
UNOS_CLINICAL_INFO,UNOS_KPF_SC_DTH1_C_NAME,N,131,VARCHAR,No,"Indicates the first contributory cause of death for the kidney and pancreas graft recipient.
May contain organization-specific values: No
Category Entries:
Unknown
Other, Specify
Infection: Bacterial Peritonitis
Infection: Bacterial Pneumonia
Infection: Bacterial Septicemia
Infection: Fungal Peritonitis
Infection: Fungal Pneumonia
Infection: Fungal Septicemia
Infection: Mixed Other, Specify
Infection: Opportunistic Other, Specify
Infection: Urinary Tract
Infection: Viral Cytomegalovirus (CMV)
Infection: Viral Non-CMV
AIDS
Infection: Other, Specify
Cardiovascular: Myocardial Infarction
Cardiovascular: Arterial Embolism
Cardiovascular: Vascular Embolism
Cardiovascular: Other, Specify
Cerebrovascular: Stroke
Cerebrovascular: Other, Specify
Hemorrhage: Gastrointestinal
Hemorrhage: Intraoperative
Hemorrhage: Other, Specify
Malignancy: Metastatic Other, Specify
Malignancy: Primary Other, Specify
Malignancy: Post-Txp Lymphoproliferative
Malignancy: Other, Specify
Trauma: Motor Vehicle
Trauma: Other, Specify
Diabetes Mellitus
Intraoperative: Not Hemorrhage Other, Specify
Pancreatitis (Graft)
Pancreatitis (Native)
Liver Failure
ARDS
Intraoperative: Other, Specify
Renal Failure
Respiratory Failure
Suicide
Multiple Organ System Failure
Non-Compliance
Cardiovascular: Pulmonary Embolism
Fluid/Electrolyte Disorder
Acid/Base Disorder
Immunosuppressive Drug Related Hematologic
Immunosuppressive Drug Related Non-Hematologic
Non-Immunosuppressive Drug Related Hematologic
Non-Immunosuppressive Non-Hematologic, Specify Drug
Infection: Viral COVID-19
Infection: Viral Other, Specify Indicates the first contributory cause of death for the kidney and pancreas graft recipient. May contain organization-specific values: No Category Entries: Unknown Other, Specify Infection: Bacterial Peritonitis Infection: Bacterial Pneumonia Infection: Bacterial Septicemia Infection: Fungal Peritonitis Infection: Fungal Pneumonia Infection: Fungal Septicemia Infection: Mixed Other, Specify Infection: Opportunistic Other, Specify Infection: Urinary Tract Infection: Viral Cytomegalovirus (CMV) Infection: Viral Non-CMV AIDS Infection: Other, Specify Cardiovascular: Myocardial Infarction Cardiovascular: Arterial Embolism Cardiovascular: Vascular Embolism Cardiovascular: Other, Specify Cerebrovascular: Stroke Cerebrovascular: Other, Specify Hemorrhage: Gastrointestinal Hemorrhage: Intraoperative Hemorrhage: Other, Specify Malignancy: Metastatic Other, Specify Malignancy: Primary Other, Specify Malignancy: Post-Txp Lymphoproliferative Malignancy: Other, Specify Trauma: Motor Vehicle Trauma: Other, Specify Diabetes Mellitus Intraoperative: Not Hemorrhage Other, Specify Pancreatitis (Graft) Pancreatitis (Native) Liver Failure ARDS Intraoperative: Other, Specify Renal Failure Respiratory Failure Suicide Multiple Organ System Failure Non-Compliance Cardiovascular: Pulmonary Embolism Fluid/Electrolyte Disorder Acid/Base Disorder Immunosuppressive Drug Related Hematologic Immunosuppressive Drug Related Non-Hematologic Non-Immunosuppressive Drug Related Hematologic Non-Immunosuppressive Non-Hematologic, Specify Drug Infection: Viral COVID-19 Infection: Viral Other, Specify"
UNOS_CLINICAL_INFO,UNOS_KPF_SC_DTH1_SP,N,132,VARCHAR,No,Specifies the first contributory cause of death for the kidney and pancreas graft recipient. Specifies the first contributory cause of death for the kidney and pancreas graft recipient.
UNOS_CLINICAL_INFO,UNOS_KPF_SC_DTH2_C_NAME,N,133,VARCHAR,No,"Indicates the second contributory cause of death for the kidney and pancreas graft recipient.
The category values for this column were already listed for column: UNOS_KPF_SC_DTH1_C_NAME Indicates the second contributory cause of death for the kidney and pancreas graft recipient. The category values for this column were already listed for column: UNOS_KPF_SC_DTH1_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KPF_SC_DTH2_SP,N,134,VARCHAR,No,Specifies the second contributory cause of death for the kidney and pancreas graft recipient. Specifies the second contributory cause of death for the kidney and pancreas graft recipient.
UNOS_CLINICAL_INFO,UNOS_PAN_SC_DTH1_C_NAME,N,135,VARCHAR,No,"Indicates the first contributory cause of death for the pancreas graft recipient.
May contain organization-specific values: No
Category Entries:
Unknown
Other, Specify
Infection: Bacterial Peritonitis
Infection: Bacterial Pneumonia
Infection: Bacterial Septicemia
Infection: Fungal Peritonitis
Infection: Fungal Pneumonia
Infection: Fungal Septicemia
Infection: Mixed Other, Specify
Infection: Opportunistic Other, Specify
Infection: Urinary Tract
Infection: Viral Cytomegalovirus (CMV)
Infection: Viral Non-CMV
AIDS
Infection: Other, Specify
Cardiovascular: MF/CHF
Cardiovascular: Vascular Embolism
Cardiovascular: Pulmonary Embolism
Cardiovascular: Other, Specify
Cerebrovascular: Stroke
Cerebrovascular: Other, Specify
Hemorrhage: Gastrointestinal
Hemorrhage: Intraoperative
Hemorrhage: Other, Specify
Malignancy: Metastatic Other, Specify
Malignancy: Primary Other, Specify
Malignancy: Post-Txp Lymphoproliferative
Malignancy: Other, Specify
Trauma: Motor Vehicle
Trauma: Other, Specify
Diabetes Mellitus Complications
Intraoperative: Not Hemorrhage Other, Specify
Pancreatitis (Graft)
Pancreatitis (Native)
Liver Failure
Renal Failure
Respiratory Failure (Non-Pneumonia)
ARDS
Suicide
Multiple Organ System Failure
Fluid/Electrolyte Disorder
Acid/Base Disorder
Immunosuppressive Drug Related Hematologic
Immunosuppressive Drug Related Non-Hematologic
Non-Immunosuppressive Drug Related Hematologic
Non-Immunosuppressive Non-Hematologic, Specify Drug
Infection: Viral COVID-19
Infection: Viral Other, Specify Indicates the first contributory cause of death for the pancreas graft recipient. May contain organization-specific values: No Category Entries: Unknown Other, Specify Infection: Bacterial Peritonitis Infection: Bacterial Pneumonia Infection: Bacterial Septicemia Infection: Fungal Peritonitis Infection: Fungal Pneumonia Infection: Fungal Septicemia Infection: Mixed Other, Specify Infection: Opportunistic Other, Specify Infection: Urinary Tract Infection: Viral Cytomegalovirus (CMV) Infection: Viral Non-CMV AIDS Infection: Other, Specify Cardiovascular: MF/CHF Cardiovascular: Vascular Embolism Cardiovascular: Pulmonary Embolism Cardiovascular: Other, Specify Cerebrovascular: Stroke Cerebrovascular: Other, Specify Hemorrhage: Gastrointestinal Hemorrhage: Intraoperative Hemorrhage: Other, Specify Malignancy: Metastatic Other, Specify Malignancy: Primary Other, Specify Malignancy: Post-Txp Lymphoproliferative Malignancy: Other, Specify Trauma: Motor Vehicle Trauma: Other, Specify Diabetes Mellitus Complications Intraoperative: Not Hemorrhage Other, Specify Pancreatitis (Graft) Pancreatitis (Native) Liver Failure Renal Failure Respiratory Failure (Non-Pneumonia) ARDS Suicide Multiple Organ System Failure Fluid/Electrolyte Disorder Acid/Base Disorder Immunosuppressive Drug Related Hematologic Immunosuppressive Drug Related Non-Hematologic Non-Immunosuppressive Drug Related Hematologic Non-Immunosuppressive Non-Hematologic, Specify Drug Infection: Viral COVID-19 Infection: Viral Other, Specify"
UNOS_CLINICAL_INFO,UNOS_PAN_SC_DTH1_SP,N,136,VARCHAR,No,Specifies the first contributory cause of death for the pancreas graft recipient. Specifies the first contributory cause of death for the pancreas graft recipient.
UNOS_CLINICAL_INFO,UNOS_DIS_LVR_DX_C_NAME,N,137,VARCHAR,No,"Indicates the pathology confirmed liver diagnosis at hospital discharge.
May contain organization-specific values: Yes
Category Entries:
Allergic Bronchopulmonary Aspergillosis
Bronchopulmonary Dysplasia
Ciliary Dyskinesis Syndrome
Constrictive Bronchiolitis
Dysmotile Cilia Syndrome
Granulomatous Lung Disease
Kartagener's Syndrome
Obstructive Lung Disease
Primary Ciliary Dyskinesia
Tuberous Sclerosis
Congenital Malformation
Peripheral Pulm Artery Stenosis and Second Degree Pulm Htn
Portopulmonary Hypertension
Pulmonary AV Malformation Congenital Heart Disease
Pulmonary Thromboembolic Disease
Pulmonary Veno-Occlusive Disease
Pulmonic Stenosis
Right Hypoplastic Lung
Thromboembolic Pulmonary Hypertension
Wegener's Granuloma - Restrictive
Wegener's Granuloma - Bronchiectasis
Crest - Restrictive
Crest - Pulmonary Hypertension
Pulmonary Telangiectasia - Restrictive
Pulmonary Telangiectasia - Pulmonary Hypertension
Scleroderma - Restrictive
Scleroderma - Pulmonary Hypertension
Common Variable Immune Deficiency
Fibrocavitary Lung Disease
Hypogammaglobulinemia
Shwachman-Diamond Syndrome
Alveolar Proteinosis
Amyloidosis
ARDS/Pneumonia
IIP: BOOP/COP
Bronchoalveolar Carcinoma (BAC)
Carcinoid Tumorlets
Chronic Pneumonitis of Infancy
Collagen Vascular Diseases
Connective Tissue Disease
Crest
Cutis Laxa
Desquamative Interstitial Pneumonitis (DIP)
Ehlers-Danlos Syndrome
Eosinophilic Granuloma
Eosinophilic Granulomatosis
Eosinophilic Pneumonial Chronic Granulomatosis
Fibrosing Mediastinitis
Graft-Vs-Host Disease (GVHD)
Hermansky Pudlak Syndrome
Histiocytosis X
Hypersensitivity Pneumonitis
Idiopathic Pulmonary Hemosiderosis
Interstitial Pneumonitis
IIP: Lymphocytic Interstitial Pneumonia
Lupus
Macleod Syndrome
Mixed Connective Tissue Disease
Paraneoplastic Pemphigus Associated Castleman's Disease
Polymyositis
Pulmonary Hyalinizing Granuloma
Pulmonary Langerhans Cell Granulomatosis
Pulmonary Telangiectasia
Restrictive Lung Disease
Scleroderma
Sjogren's Syndrome
Silicosis
Surfactant Protein B Deficiency
Swyer James Syndrome
Teratoma
Tracheopathia Osteoplastica
Usual Interstitial Pneumonitis
Wegener's Granuloma
Other, Specify
Dilated Myopathy: Idiopathic
Dilated Myopathy: Adriamycin
Dilated Myopathy: Post Partum
Dilated Myopathy: Familial
Dilated Myopathy: Myocarditis
Dilated Myopathy: Alcoholic
Dilated Myopathy: Viral
Dilated Myopathy: Ischemic
Dilated Myopathy: Viral (Not COVID-19)
COVID-19: Dilated Myopathy: Active Myocarditis
COVID-19: Dilated Myopathy: History of Myocarditis
Dilated Myopathy: Other, Specify
Restrictive Myopathy: Idiopathic
Restrictive Myopathy: Amyloidosis
Restrictive Myopathy: Endocardial Fibros
Restrictive Myopathy: Sarcoidosis
Restrictive Myopathy: Sec to Radiat/Chem
Restrictive Myopathy: Other, Specify
Heart Re-Tx/Gf: Hyperacute Rejection
Heart Re-Tx/Gf: Acute Rejection
Heart Re-Tx/Gf: Coronary Artery Disease
Heart Re-Tx/Gf: Non-Specific
Heart Re-Tx/Gf: Restrictive/Constrictive
Heart Re-Tx/Gf: Chronic Rejection
Heart Re-Tx/Gf: Primary Failure
Heart Re-Tx/Gf: Other Specify
Coronary Artery Disease
Hypertrophic Cardiomyopathy
Valvular Heart Disease
Congenital Heart Defect - Prior Surgery Unknown
Cancer
Congenital Heart Defect - Hypoplastic Left Heart Syndrome - Unoperated
Congenital Heart Defect - Without Surgery
Congenital Heart Defect - With Surgery
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Muscular Dystrophy: Other, Specify
Cardiac Disease: Other Specify
Heart: Other Specify
Eisenmenger's Syn: Atrial Septal Defect
Eisenmenger's Syn: VSD
Eisenmenger's Syn: PDA
Pulmonary Capillary Hemangiomatosis
ABCA3 Transporter Mutation
Secondary Pulmonary Fibrosis: Specify Cause
Surfactant Protein C Deficiency
IIP: Nonspecific Interstitial Pneumonia
IIP: Respiratory Bronchiolitis
IIP: Desquamative Interstitial Pneumonia
IIP: Acute Interstitial Pneumonia
Pulmonary Lymphangiectasia
Eisenmenger's Syn: Multi Congenital Anomalies
Eisenmenger's Syn: Other, Specify
Lung Re-Tx/Gf: Non-Specific
Lung Re-Tx/Gf: Obliterative Bronchiolitis
Lung Re-Tx/Gf: Restrictive
Lung Re-Tx/Gf: Acute Rejection
Lung Re-Tx/Gf: Obstructive
Lung Re-Tx/Gf: Primary Graft Failure
Lung Re-Tx/Gf: Obliterative Bronchiolitis-Restrictive
Lung Re-Tx/Gf: Obliterative Bronchiolitis-Obstructive
Lung Re-Tx/Gf: Other Specify
Congenital: Other Specify
Pulmonary Hypertension/Pulmonary Arterial Hypertension
Cystic Fibrosis
Inhalation Burns/Trauma
IIP: Idiopathic Pulmonary Fibrosis (IPF)
Sarcoidosis
Alpha - 1 - Antitrypsin Deficiency
COPD/Emphysema
Bronchiectasis
Rheumatoid Disease
Occupational Lung Disease Other, Specify
Lymphangioleiomyomatosis
Obliterative Bronchiolitis (Non-retransplant)
Pulmonary Fibrosis Other, Specify Cause
Pulmonary Vascular Disease
Secondary Pulmonary Hypertension
COVID-19: ARDS
COVID-19: Pulmonary Fibrosis
Combined Pulmonary Fibrosis and Emphysema (CPFE)
Heart/Lung Re-Tx/Gf: Primary Failure
Lung Disease: Other Specify
Idiopathic and Post-infectious Crescentic Glomerulonephritis
Membranous Glomerulonephritis
Mesangio-capillary Glomerulonephritis - Type I
Mesangio-capillary Glomerulonephritis Type II
IgA Nephropathy
Anti-GBM
Focal Glomerular Sclerosis (Focal Segmental - FSG)
Chronic Pyelonephritis (Reflux Nephropathy)
Polycystic Kidneys
Nephritis
Nephronophthisis
Diabetes - Type I Insulin Dep/Juvenile Onset
Diabetes - Type II Non-Insulin Dep/ Adult Onset
Oxalate Nephropathy (Includes Hereditary Oxalosis)
Cystinosis
Fabry's Disease
Amyloidosis - Kidney
Gout
Systemic Lupus Erythematosus
Progressive Systemic Sclerosis
Wilms' Tumor
Renal Cell Carcinoma
Incidental Carcinoma
Myeloma
Hemolytic Uremic Syndrome
Hypoplasia/Dysplasia/Dysgenesis/Agenesis
Cortical Necrosis
Acute Tubular Necrosis
Medullary Cystic Disease
Sickle Cell Anemia
Acquired Obstructive Nephropathy
Alport's Syndrome
Familial Nephropathy
Goodpasture's Syndrome
Malignant Hypertension
Henoch-Schonlein Purpura
Prune Belly Syndrome
Retransplant/Graft Failure Kidney
Diabetes - Type I Non-Insulin Dep/ Juvenile Onset
Diabetes - Type II Insulin Dep/Adult Onset
Hypertensive Nephrosclerosis
Chronic Glomerulonephritis - Unspecified
Membranous Nephropathy
Chronic Glomerulosclerosis - Unspecified
Analgesic Nephropathy
Radiation Nephritis
Antibiotic-Induced Nephritis
Cancer Chemotherapy Induced Nephritis
Calcineurin Inhibitor Nephrotoxicity
Heroin Nephrotoxicity
Renal Artery Thrombosis
Chronic Nephrosclerosis - Unspecified
Congenital Obstructive Uropathy
Scleroderma - Kidney
Wegener's Granulomatosis
Polyarteritis
Rheumatoid Arthritis
Sarcoidosis - Kidney
Lymphoma
Nephrolithiasis
Urolithiasis
Dysplasia
Pre-BMTransplantation Total Body Irradiation
Drug Related Interstitial Nephritis
Thin Basement Membrane Disease
Hereditary Oxalosis
Cholesterol Embolization
Focal Segmental Glomerulosclerosis
Rapid Progressive Glomerulonephritis (RPGN)
Diabetes Mellitus - Type I
Diabetes Mellitus - Type II
Diabetes Mellitus - Type Other / Unknown
Hepatorenal Syndrome
Lithium Toxicity
HIV Nephropathy
Acute Hepatic Necrosis (AHN): Drug, Specify
AHN: Type A
AHN: Type B, HBsAG+
AHN: Non A, Non B
AHN: Type C
AHN: Type D
AHN: Type B and C
AHN: Type B and D
AHN: Etiology Unknown
AHN: Other, Specify
Cirrhosis: Drug or Industrial Exposure, Specify
Cirrhosis: Type A
Cirrhosis: Type B-, HBsAG+
Cirrhosis: Non A, Non B
Cirrhosis: Type C
Cirrhosis: Type D
Cirrhosis: Type B and C
Cirrhosis: Type B and D
Cirrhosis: Cryptogenic-Idiopathic
Cirrhosis: Chronic Active Hepatitis: Etiology Unknown
Cirrhosis: Other, Specify
Cirrhosis: Autoimmune
Cirrhosis: Cryptogenic (Idiopathic)
Cirrhosis: Fatty Liver (NASH)
Alcoholic Cirrhosis
Alcoholic Cirrhosis with Hepatitis C
Acute Alcoholic Hepatitis
Acute Alcohol-Associated Hepatitis With or Without Cirrhosis
Alcohol-Associated Cirrhosis Without Acute Alcohol-Associated Hepatitis
Primary Biliary Cirrhosis (PBC)
Cirrhosis: Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Cirrhosis: Metabolic Dysfunction and Alcohol-Related/Associated Liver Disease (MetALD)
Secondary Biliary Cirrhosis: Caroli's Disease
Secondary Biliary Cirrhosis: Choledochal Cyst
Secondary Biliary Cirrhosis: Other, Specify
Primary Sclerosing Cholangitis (PSC): Crohn's Disease
Primary Sclerosing Cholangitis: Ulcerative Colitis
Primary Sclerosing Cholangitis: No Bowel Disease
Primary Sclerosing Cholangitis: Other, Specify
Familial Cholestasis: Byler's Disease
Familial Cholestasis: Other, Specify
Cholestatic Liver Disease: Other, Specify
Neonatal Cholestatic Liver Disease
Neonatal Hepatitis, Specify
Biliary Atresia: Extrahepatic
Biliary Hypoplasia: Nonsyndromic Paucity of Intrahepatic Bile Duct
Biliary Hypoplasia: Alagille Syndrome (Paucity of Intrahepatic Bile Duct)
Biliary Atresia or Hypoplasia: Other, Specify
Congenital Hepatic Fibrosis
Cystic Fibrosis - Liver
Budd-Chiari Syndrome
Metabolic Disease (METDIS): Alpha-1-Antitrypsin Deficiency (A-1-A)
METDIS: Wilson's Disease, Other Copper Metabolism Disorder
METDIS: Hemochromatosis - Hemosiderosis
METDIS: Glycogen Storage Disease Type I (GSD-I)
METDIS: Glycogen Storage Disease Type IV (GSD-IV)
METDIS: Hyperlipidemia-II, Homozygous Hypercholesterolemia
METDIS: Tyrosinemia
METDIS: Primary Oxalosis/Oxaluria, Hyperoxaluria
METDIS: Maple Syrup Urine Disease
METDIS: Other, Specify
Primary Liver Malignancy: Hepatoma, Hepatocellular Carcinoma (HCC)
Primary Liver Malignancy: Hepatoma (HCC) and Cirrhosis
Primary Liver Malignancy: Fibrolamellar (FL-HC)
Primary Liver Malignancy: Cholangiocarcinoma (CH-CA)
Primary Liver Malignancy: Hepatoblastoma (HBL)
Primary Liver Malignancy: Hemangioendothelioma, Hemangiosarcoma, Angiosarcoma
Primary Liver Malignancy: Other, Specify
Bile Duct Cancer (Cholangioma, Biliary Tract Carcinoma)
Secondary Hepatic Malignancy: Specify
Benign Tumor: Hepatic Adenoma
Benign Tumor: Polycystic Liver Disease
Benign Tumor: Other, Specify
Total Parenteral Nutrition (TPN)/Hyperalimentation Induced Liver Disease
Graft vs. Host Disease Secondary to Non-Liver Transplant
Trauma, Specify
Hepatitis B: Chronic or Acute
Hepatitis C: Chronic or Acute
NA: Non-hd Followups Only
Graft Failure
Retransplant/Graft Failure Pancreas
Diabetes Mellitus - Type I (Pancreas)
Diabetes Mellitus - Type II (Pancreas)
Diabetes Secondary to Chronic Pancreatitis without Pancreatectomy
Diabetes Secondary to Cystic Fibrosis without Pancreatectomy
Pancreatic Cancer
Bile Duct Cancer
Other Cancers
Pancreatectomy Prior to Pancreas Transplant
Diabetes Mellitus - Type Other/Unknown (Pancreas)
SGS: Intestinal Atresia
SGS: Necrotizing Enterocolitis
SGS: Intestinal Volvulus Secondary to Malrotation
SGS: Intestinal Volvulus Secondary to Adhesions
SGS: Intestinal Volvulus Secondary to Persistent Omphalomesenteric Duct
SGS: Gastroschisis
SGS: Mass Resect Sec to Inflammatory Bowel Disease-Crohns
SGS: Mass Resect Sec to Tumor
SGS: Mass Resect Sec to Mesenteric Arterial Thrombosis or Embolus
SGS: Mass Resect Sec to Mesenteric Venous Thrombosis
SGS: Other Specify
SGS: Unspecified
FBP: Hirschsprung's Disease
FBP: Neuronal Intestinal Dysplasia
FBP: Pseudo-obstruction-Neuropathic
FBP: Pseudo-obstruction-Myopathic
FBP: Protein-losing Enteropathy
FBP: Microvillous Inclusion Disease
FBP: Other Specify
FBP: Unspecified
Graft Failure
Retransplant
Other Intestinal Disease, Specify
Trauma
Infection
Burn/explosion
Ischemia
Congenital
Malignancy
Metabolic Indicates the pathology confirmed liver diagnosis at hospital discharge. May contain organization-specific values: Yes Category Entries: Allergic Bronchopulmonary Aspergillosis Bronchopulmonary Dysplasia Ciliary Dyskinesis Syndrome Constrictive Bronchiolitis Dysmotile Cilia Syndrome Granulomatous Lung Disease Kartagener's Syndrome Obstructive Lung Disease Primary Ciliary Dyskinesia Tuberous Sclerosis Congenital Malformation Peripheral Pulm Artery Stenosis and Second Degree Pulm Htn Portopulmonary Hypertension Pulmonary AV Malformation Congenital Heart Disease Pulmonary Thromboembolic Disease Pulmonary Veno-Occlusive Disease Pulmonic Stenosis Right Hypoplastic Lung Thromboembolic Pulmonary Hypertension Wegener's Granuloma - Restrictive Wegener's Granuloma - Bronchiectasis Crest - Restrictive Crest - Pulmonary Hypertension Pulmonary Telangiectasia - Restrictive Pulmonary Telangiectasia - Pulmonary Hypertension Scleroderma - Restrictive Scleroderma - Pulmonary Hypertension Common Variable Immune Deficiency Fibrocavitary Lung Disease Hypogammaglobulinemia Shwachman-Diamond Syndrome Alveolar Proteinosis Amyloidosis ARDS/Pneumonia IIP: BOOP/COP Bronchoalveolar Carcinoma (BAC) Carcinoid Tumorlets Chronic Pneumonitis of Infancy Collagen Vascular Diseases Connective Tissue Disease Crest Cutis Laxa Desquamative Interstitial Pneumonitis (DIP) Ehlers-Danlos Syndrome Eosinophilic Granuloma Eosinophilic Granulomatosis Eosinophilic Pneumonial Chronic Granulomatosis Fibrosing Mediastinitis Graft-Vs-Host Disease (GVHD) Hermansky Pudlak Syndrome Histiocytosis X Hypersensitivity Pneumonitis Idiopathic Pulmonary Hemosiderosis Interstitial Pneumonitis IIP: Lymphocytic Interstitial Pneumonia Lupus Macleod Syndrome Mixed Connective Tissue Disease Paraneoplastic Pemphigus Associated Castleman's Disease Polymyositis Pulmonary Hyalinizing Granuloma Pulmonary Langerhans Cell Granulomatosis Pulmonary Telangiectasia Restrictive Lung Disease Scleroderma Sjogren's Syndrome Silicosis Surfactant Protein B Deficiency Swyer James Syndrome Teratoma Tracheopathia Osteoplastica Usual Interstitial Pneumonitis Wegener's Granuloma Other, Specify Dilated Myopathy: Idiopathic Dilated Myopathy: Adriamycin Dilated Myopathy: Post Partum Dilated Myopathy: Familial Dilated Myopathy: Myocarditis Dilated Myopathy: Alcoholic Dilated Myopathy: Viral Dilated Myopathy: Ischemic Dilated Myopathy: Viral (Not COVID-19) COVID-19: Dilated Myopathy: Active Myocarditis COVID-19: Dilated Myopathy: History of Myocarditis Dilated Myopathy: Other, Specify Restrictive Myopathy: Idiopathic Restrictive Myopathy: Amyloidosis Restrictive Myopathy: Endocardial Fibros Restrictive Myopathy: Sarcoidosis Restrictive Myopathy: Sec to Radiat/Chem Restrictive Myopathy: Other, Specify Heart Re-Tx/Gf: Hyperacute Rejection Heart Re-Tx/Gf: Acute Rejection Heart Re-Tx/Gf: Coronary Artery Disease Heart Re-Tx/Gf: Non-Specific Heart Re-Tx/Gf: Restrictive/Constrictive Heart Re-Tx/Gf: Chronic Rejection Heart Re-Tx/Gf: Primary Failure Heart Re-Tx/Gf: Other Specify Coronary Artery Disease Hypertrophic Cardiomyopathy Valvular Heart Disease Congenital Heart Defect - Prior Surgery Unknown Cancer Congenital Heart Defect - Hypoplastic Left Heart Syndrome - Unoperated Congenital Heart Defect - Without Surgery Congenital Heart Defect - With Surgery Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Muscular Dystrophy: Other, Specify Cardiac Disease: Other Specify Heart: Other Specify Eisenmenger's Syn: Atrial Septal Defect Eisenmenger's Syn: VSD Eisenmenger's Syn: PDA Pulmonary Capillary Hemangiomatosis ABCA3 Transporter Mutation Secondary Pulmonary Fibrosis: Specify Cause Surfactant Protein C Deficiency IIP: Nonspecific Interstitial Pneumonia IIP: Respiratory Bronchiolitis IIP: Desquamative Interstitial Pneumonia IIP: Acute Interstitial Pneumonia Pulmonary Lymphangiectasia Eisenmenger's Syn: Multi Congenital Anomalies Eisenmenger's Syn: Other, Specify Lung Re-Tx/Gf: Non-Specific Lung Re-Tx/Gf: Obliterative Bronchiolitis Lung Re-Tx/Gf: Restrictive Lung Re-Tx/Gf: Acute Rejection Lung Re-Tx/Gf: Obstructive Lung Re-Tx/Gf: Primary Graft Failure Lung Re-Tx/Gf: Obliterative Bronchiolitis-Restrictive Lung Re-Tx/Gf: Obliterative Bronchiolitis-Obstructive Lung Re-Tx/Gf: Other Specify Congenital: Other Specify Pulmonary Hypertension/Pulmonary Arterial Hypertension Cystic Fibrosis Inhalation Burns/Trauma IIP: Idiopathic Pulmonary Fibrosis (IPF) Sarcoidosis Alpha - 1 - Antitrypsin Deficiency COPD/Emphysema Bronchiectasis Rheumatoid Disease Occupational Lung Disease Other, Specify Lymphangioleiomyomatosis Obliterative Bronchiolitis (Non-retransplant) Pulmonary Fibrosis Other, Specify Cause Pulmonary Vascular Disease Secondary Pulmonary Hypertension COVID-19: ARDS COVID-19: Pulmonary Fibrosis Combined Pulmonary Fibrosis and Emphysema (CPFE) Heart/Lung Re-Tx/Gf: Primary Failure Lung Disease: Other Specify Idiopathic and Post-infectious Crescentic Glomerulonephritis Membranous Glomerulonephritis Mesangio-capillary Glomerulonephritis - Type I Mesangio-capillary Glomerulonephritis Type II IgA Nephropathy Anti-GBM Focal Glomerular Sclerosis (Focal Segmental - FSG) Chronic Pyelonephritis (Reflux Nephropathy) Polycystic Kidneys Nephritis Nephronophthisis Diabetes - Type I Insulin Dep/Juvenile Onset Diabetes - Type II Non-Insulin Dep/ Adult Onset Oxalate Nephropathy (Includes Hereditary Oxalosis) Cystinosis Fabry's Disease Amyloidosis - Kidney Gout Systemic Lupus Erythematosus Progressive Systemic Sclerosis Wilms' Tumor Renal Cell Carcinoma Incidental Carcinoma Myeloma Hemolytic Uremic Syndrome Hypoplasia/Dysplasia/Dysgenesis/Agenesis Cortical Necrosis Acute Tubular Necrosis Medullary Cystic Disease Sickle Cell Anemia Acquired Obstructive Nephropathy Alport's Syndrome Familial Nephropathy Goodpasture's Syndrome Malignant Hypertension Henoch-Schonlein Purpura Prune Belly Syndrome Retransplant/Graft Failure Kidney Diabetes - Type I Non-Insulin Dep/ Juvenile Onset Diabetes - Type II Insulin Dep/Adult Onset Hypertensive Nephrosclerosis Chronic Glomerulonephritis - Unspecified Membranous Nephropathy Chronic Glomerulosclerosis - Unspecified Analgesic Nephropathy Radiation Nephritis Antibiotic-Induced Nephritis Cancer Chemotherapy Induced Nephritis Calcineurin Inhibitor Nephrotoxicity Heroin Nephrotoxicity Renal Artery Thrombosis Chronic Nephrosclerosis - Unspecified Congenital Obstructive Uropathy Scleroderma - Kidney Wegener's Granulomatosis Polyarteritis Rheumatoid Arthritis Sarcoidosis - Kidney Lymphoma Nephrolithiasis Urolithiasis Dysplasia Pre-BMTransplantation Total Body Irradiation Drug Related Interstitial Nephritis Thin Basement Membrane Disease Hereditary Oxalosis Cholesterol Embolization Focal Segmental Glomerulosclerosis Rapid Progressive Glomerulonephritis (RPGN) Diabetes Mellitus - Type I Diabetes Mellitus - Type II Diabetes Mellitus - Type Other / Unknown Hepatorenal Syndrome Lithium Toxicity HIV Nephropathy Acute Hepatic Necrosis (AHN): Drug, Specify AHN: Type A AHN: Type B, HBsAG+ AHN: Non A, Non B AHN: Type C AHN: Type D AHN: Type B and C AHN: Type B and D AHN: Etiology Unknown AHN: Other, Specify Cirrhosis: Drug or Industrial Exposure, Specify Cirrhosis: Type A Cirrhosis: Type B-, HBsAG+ Cirrhosis: Non A, Non B Cirrhosis: Type C Cirrhosis: Type D Cirrhosis: Type B and C Cirrhosis: Type B and D Cirrhosis: Cryptogenic-Idiopathic Cirrhosis: Chronic Active Hepatitis: Etiology Unknown Cirrhosis: Other, Specify Cirrhosis: Autoimmune Cirrhosis: Cryptogenic (Idiopathic) Cirrhosis: Fatty Liver (NASH) Alcoholic Cirrhosis Alcoholic Cirrhosis with Hepatitis C Acute Alcoholic Hepatitis Acute Alcohol-Associated Hepatitis With or Without Cirrhosis Alcohol-Associated Cirrhosis Without Acute Alcohol-Associated Hepatitis Primary Biliary Cirrhosis (PBC) Cirrhosis: Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis: Metabolic Dysfunction and Alcohol-Related/Associated Liver Disease (MetALD) Secondary Biliary Cirrhosis: Caroli's Disease Secondary Biliary Cirrhosis: Choledochal Cyst Secondary Biliary Cirrhosis: Other, Specify Primary Sclerosing Cholangitis (PSC): Crohn's Disease Primary Sclerosing Cholangitis: Ulcerative Colitis Primary Sclerosing Cholangitis: No Bowel Disease Primary Sclerosing Cholangitis: Other, Specify Familial Cholestasis: Byler's Disease Familial Cholestasis: Other, Specify Cholestatic Liver Disease: Other, Specify Neonatal Cholestatic Liver Disease Neonatal Hepatitis, Specify Biliary Atresia: Extrahepatic Biliary Hypoplasia: Nonsyndromic Paucity of Intrahepatic Bile Duct Biliary Hypoplasia: Alagille Syndrome (Paucity of Intrahepatic Bile Duct) Biliary Atresia or Hypoplasia: Other, Specify Congenital Hepatic Fibrosis Cystic Fibrosis - Liver Budd-Chiari Syndrome Metabolic Disease (METDIS): Alpha-1-Antitrypsin Deficiency (A-1-A) METDIS: Wilson's Disease, Other Copper Metabolism Disorder METDIS: Hemochromatosis - Hemosiderosis METDIS: Glycogen Storage Disease Type I (GSD-I) METDIS: Glycogen Storage Disease Type IV (GSD-IV) METDIS: Hyperlipidemia-II, Homozygous Hypercholesterolemia METDIS: Tyrosinemia METDIS: Primary Oxalosis/Oxaluria, Hyperoxaluria METDIS: Maple Syrup Urine Disease METDIS: Other, Specify Primary Liver Malignancy: Hepatoma, Hepatocellular Carcinoma (HCC) Primary Liver Malignancy: Hepatoma (HCC) and Cirrhosis Primary Liver Malignancy: Fibrolamellar (FL-HC) Primary Liver Malignancy: Cholangiocarcinoma (CH-CA) Primary Liver Malignancy: Hepatoblastoma (HBL) Primary Liver Malignancy: Hemangioendothelioma, Hemangiosarcoma, Angiosarcoma Primary Liver Malignancy: Other, Specify Bile Duct Cancer (Cholangioma, Biliary Tract Carcinoma) Secondary Hepatic Malignancy: Specify Benign Tumor: Hepatic Adenoma Benign Tumor: Polycystic Liver Disease Benign Tumor: Other, Specify Total Parenteral Nutrition (TPN)/Hyperalimentation Induced Liver Disease Graft vs. Host Disease Secondary to Non-Liver Transplant Trauma, Specify Hepatitis B: Chronic or Acute Hepatitis C: Chronic or Acute NA: Non-hd Followups Only Graft Failure Retransplant/Graft Failure Pancreas Diabetes Mellitus - Type I (Pancreas) Diabetes Mellitus - Type II (Pancreas) Diabetes Secondary to Chronic Pancreatitis without Pancreatectomy Diabetes Secondary to Cystic Fibrosis without Pancreatectomy Pancreatic Cancer Bile Duct Cancer Other Cancers Pancreatectomy Prior to Pancreas Transplant Diabetes Mellitus - Type Other/Unknown (Pancreas) SGS: Intestinal Atresia SGS: Necrotizing Enterocolitis SGS: Intestinal Volvulus Secondary to Malrotation SGS: Intestinal Volvulus Secondary to Adhesions SGS: Intestinal Volvulus Secondary to Persistent Omphalomesenteric Duct SGS: Gastroschisis SGS: Mass Resect Sec to Inflammatory Bowel Disease-Crohns SGS: Mass Resect Sec to Tumor SGS: Mass Resect Sec to Mesenteric Arterial Thrombosis or Embolus SGS: Mass Resect Sec to Mesenteric Venous Thrombosis SGS: Other Specify SGS: Unspecified FBP: Hirschsprung's Disease FBP: Neuronal Intestinal Dysplasia FBP: Pseudo-obstruction-Neuropathic FBP: Pseudo-obstruction-Myopathic FBP: Protein-losing Enteropathy FBP: Microvillous Inclusion Disease FBP: Other Specify FBP: Unspecified Graft Failure Retransplant Other Intestinal Disease, Specify Trauma Infection Burn/explosion Ischemia Congenital Malignancy Metabolic"
UNOS_CLINICAL_INFO,UNOS_DIS_LVR_DX_SP,N,138,VARCHAR,No,Specified pathology confirmed liver diagnosis at hospital discharge. Specified pathology confirmed liver diagnosis at hospital discharge.
UNOS_CLINICAL_INFO,UNOS_LVR_PM_DTH_C_NAME,N,139,VARCHAR,No,"Specifies the primary cause of death for the liver graft recipient if that cause of death was not picked from a list.
The category values for this column were already listed for column: UNOS_LVR_SC_DTH1_C_NAME Specifies the primary cause of death for the liver graft recipient if that cause of death was not picked from a list. The category values for this column were already listed for column: UNOS_LVR_SC_DTH1_C_NAME"
UNOS_CLINICAL_INFO,UNOS_LVR_PM_DTH_SP,N,140,VARCHAR,No,Specifies the primary cause of death for the liver graft recipient. Specifies the primary cause of death for the liver graft recipient.
UNOS_CLINICAL_INFO,UNOS_KPF_PM_DTH_C_NAME,N,141,VARCHAR,No,"Indicates the primary cause of death for the kidney and pancreas graft recipient.
The category values for this column were already listed for column: UNOS_KPF_SC_DTH1_C_NAME Indicates the primary cause of death for the kidney and pancreas graft recipient. The category values for this column were already listed for column: UNOS_KPF_SC_DTH1_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KPF_PM_DTH_SP,N,142,VARCHAR,No,Specifies the primary cause of death for the kidney and pancreas graft recipient if that cause of death was not picked from a list. Specifies the primary cause of death for the kidney and pancreas graft recipient if that cause of death was not picked from a list.
UNOS_CLINICAL_INFO,UNOS_PAN_PM_DTH_C_NAME,N,143,VARCHAR,No,"Indicates the primary cause of death for the pancreas graft recipient.
The category values for this column were already listed for column: UNOS_PAN_SC_DTH1_C_NAME Indicates the primary cause of death for the pancreas graft recipient. The category values for this column were already listed for column: UNOS_PAN_SC_DTH1_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_PM_DTH_SP,N,144,VARCHAR,No,Specifies the primary cause of death for the pancreas graft recipient if that cause of death was not picked from a list. Specifies the primary cause of death for the pancreas graft recipient if that cause of death was not picked from a list.
UNOS_CLINICAL_INFO,UNOS_PAN_SC_DTH2_C_NAME,N,145,VARCHAR,No,"Indicates the second contributory cause of death for the pancreas graft recipient.
The category values for this column were already listed for column: UNOS_PAN_SC_DTH1_C_NAME Indicates the second contributory cause of death for the pancreas graft recipient. The category values for this column were already listed for column: UNOS_PAN_SC_DTH1_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAN_SC_DTH2_SP,N,146,VARCHAR,No,Specifies the second contributory cause of death for the pancreas graft recipient. Specifies the second contributory cause of death for the pancreas graft recipient.
UNOS_CLINICAL_INFO,UNOS_PREV_ORG1_C_NAME,N,147,VARCHAR,No,"The organ transplanted at the most recent transplant.
The category values for this column were already listed for column: UNOS_ORGAN_C_NAME The organ transplanted at the most recent transplant. The category values for this column were already listed for column: UNOS_ORGAN_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PREV_TXP1_DT,N,148,DATETIME,No,The date of the most recent transplant. The date of the most recent transplant.
UNOS_CLINICAL_INFO,UNOS_PREV_FAIL1_DT,N,149,DATETIME,No,The graft failure date of the most recent transplant. The graft failure date of the most recent transplant.
UNOS_CLINICAL_INFO,UNOS_PREV_ORG2_C_NAME,N,150,VARCHAR,No,"The organ transplanted at the second most recent transplant.
The category values for this column were already listed for column: UNOS_ORGAN_C_NAME The organ transplanted at the second most recent transplant. The category values for this column were already listed for column: UNOS_ORGAN_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PREV_TXP2_DT,N,151,DATETIME,No,The date of the second most recent transplant. The date of the second most recent transplant.
UNOS_CLINICAL_INFO,UNOS_PREV_FAIL2_DT,N,152,DATETIME,No,The graft failure date of the second most recent transplant. The graft failure date of the second most recent transplant.
UNOS_CLINICAL_INFO,UNOS_PREV_ORG3_C_NAME,N,153,VARCHAR,No,"The organ transplanted at the third most recent transplant.
The category values for this column were already listed for column: UNOS_ORGAN_C_NAME The organ transplanted at the third most recent transplant. The category values for this column were already listed for column: UNOS_ORGAN_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PREV_TXP3_DT,N,154,DATETIME,No,The date of the third most recent transplant. The date of the third most recent transplant.
UNOS_CLINICAL_INFO,UNOS_PREV_FAIL3_DT,N,155,DATETIME,No,The graft failure date of the third most recent transplant. The graft failure date of the third most recent transplant.
UNOS_CLINICAL_INFO,UNOS_PREV_PAN_IST_C_NAME,N,156,VARCHAR,No,"Indicates whether the patient previously received a pancreas islet infusion.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient previously received a pancreas islet infusion. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_ABO_BLD_GRP_C_NAME,N,157,VARCHAR,No,"The patient's blood type.
May contain organization-specific values: No
Category Entries:
A
A1
A1B
A2
A2B
AB
B
O
Z (In Utero Only) The patient's blood type. May contain organization-specific values: No Category Entries: A A1 A1B A2 A2B AB B O Z (In Utero Only)"
UNOS_CLINICAL_INFO,UNOS_PRIM_DX_C_NAME,N,158,VARCHAR,No,"The patient's primary diagnosis.
May contain organization-specific values: No
Category Entries:
Allergic Bronchopulmonary Aspergillosis
Bronchopulmonary Dysplasia
Ciliary Dyskinesis Syndrome
Constrictive Bronchiolitis
Dysmotile Cilia Syndrome
Granulomatous Lung Disease
Kartagener's Syndrome
Obstructive Lung Disease
Primary Ciliary Dyskinesia
Tuberous Sclerosis
Congenital Malformation
Peripheral Pulm Artery Stenosis
Portopulmonary Hypertension
Pulmonary AV Malformation Congenital Heart Disease
Pulmonary Thromboembolic Disease
Pulmonary Veno-Occlusive Disease
Pulmonic Stenosis
Right Hypoplastic Lung
Thromboembolic Pulmonary Hypertension
Wegener's Granuloma - Restrictive
Wegener's Granuloma - Bronchiectasis
Crest - Restrictive
Crest - Pulmonary Hypertension
Pulmonary Telengectasia - Restrictive
Pulmonary Telengectasia - Pulmonary Hypertension
Scleroderma - Restrictive
Scleroderma - Pulmonary Hypertension
Common Variable Immune Deficiency
Fibrocavitary Lung Disease
Hypogammaglobulinemia
Shwachman-Diamond Syndrome
Alveolar Proteinosis
Amyloidosis
ARDS/Pnuemonia
IIP: BOOP/COP
Bronchoalveolar Carcinoma (BAC)
Carcinoid Tumorlets
Chronic Pneumonitis of Infancy
Collagen Vascular Diseases
Connective Tissue Disease
Crest
Cutis Laxa
Desquamative Interstitial Pneumonitis (DIP)
Ehlers-Danlos Syndrome
Eosinophilic Granuloma
Eosinophilic Granulomatosis
Eosinophilic Pneumonial Chronic Granulomatosis
Fibrosing Mediastinitis
Graft-vs-Host Disease (GVHD)
Hermansky Pudlak Syndrome
Histiocytosis X
Hypersensitivity Pneumonitis
Idiopathic Pulmonary Hemosiderosis
Interstitial Pneumonitis
IIP: Lymphocytic Interstitial Pneumonia
Lupus
Macleod Syndrome
Mixed Connective Tissue Disease
Paraneoplastic Pemphigus Associated Castleman's Disease
Polymyositis
Pulmonary Hyalinizing Granuloma
Pulmonary Langerhans Cell Granulomatosis
Pulmonary Telengectasia
Restrictive Lung Disease
Sjogren's Syndrome
Silicosis
Surfactant Protein B Deficiency
Swyer James Syndrome
Teratoma
Tracheopathia Osteoplastica
Usual Interstitial Pneumonitis
Wegener's Granuloma
Other, Specify
Dilated Myopathy: Idiopathic
Dilated Myopathy: Adriamycin
Dilated Myopathy: Post Partum
Dilated Myopathy: Familial
Dilated Myopathy: Myocarditis
Dilated Myopathy: Alcoholic
Dilated Myopathy: Viral
Dilated Myopathy: Ischemic
Dilated Myopathy: Viral (Not COVID-19)
COVID-19: Dilated Myopathy: Active Myocarditis
COVID-19: Dilated Myopathy: History of Myocarditis
Dilated Myopathy: Other, Specify
Restrictive Myopathy: Idiopathic
Restrictive Myopathy: Amyloidosis
Restrictive Myopathy: Endocardial Fibros
Restrictive Myopathy: Sarcoidosis
Restrictive Myopathy: Sec to Radiat/Chem
Restrictive Myopathy: Other, Specify
Heart Re-TX/GF: Hyperacute Rejection
Heart Re-TX/GF: Acute Rejection
Heart Re-TX/GF: Coronary Artery Disease
Heart Re-TX/GF: Non-Specific
Heart Re-TX/GF: Restrictive/Constrictive
Heart Re-TX/GF: Chronic Rejection
Heart Re-TX/GF: Primary Failure
Heart Re-TX/GF: Other, Specify
Coronary Artery Disease
Hypertrophic Cardiomyopathy
Valvular Heart Disease
Congenital Heart Defect - Prior Surgery Unknown
Cancer
Congenital Heart Defect - Hypoplastic Left Heart Syndrome - Unoperated
Congenital Heart Defect - Without Surgery
Congenital Heart Defect - With Surgery
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Muscular Dystrophy: Other Specify
Eisenmenger's Syn: Atrial Septal Defec
Eisenmenger's Syn: VSD
Eisenmenger's Syn: PDA
Pulmonary Capillary Hemangiomatosis
ABCA3 Transporter Mutation
Secondary Pulmonary Fibrosis: Specify Cause
Surfactant Protein C Deficiency
IIP: Nonspecific Interstitial Pneumonia
IIP: Respiratory Bronchiolitis
IIP: Desquamative Interstitial Pneumonia
IIP: Acute Interstitial Pneumonia
Pulmonary Lymphangiectasia
Eisenmenger's Syn: Multi Congenital Anomalies
Eisenmenger's Syn: Other Specify
Lung Re-TX/GF: Non-Specific
Lung Re-TX/GF: Obliterative Bronchioliti
Lung Re-TX/GF: Restrictive
Lung Re-TX/GF: Acute Rejection
Lung Re-TX/GF: Obstructive
Lung Re-TX/GF: Primary Graft Failure
Lung Re-Tx/GF: Obliterative Bronchiolitis-Restrictive
Lung Re-Tx/GF: Obliterative Bronchiolits-Obstructive
Lung Re-TX/GF: Other Specify
Pulmonary Hypertension/Pulmonary Arterial Hypertension
Cystic Fibrosis
Inhalation Burns/Trauma
IIP: Idiopathic Pulmonary Fibrosis
Sarcoidosis
Alpha - 1 - Antitrypsin Deficiency
COPD/Emphysema
Bronchiectasis
Rheumatoid Disease
Occupational Lung Disease: Other, Specify
Lymphangioleiomyomatosis
Obliterative Bronchiolitis (Non-Retransplant)
Pulmonary Fibrosis: Other Specify Cause
Pulmonary Vascular Disease
Secondary Pulmonary Hypertension
COVID-19: ARDS
COVID-19: Pulmonary Fibrosis
Combined Pulmonary Fibrosis and Emphysema (CPFE)
Heart/Lung Re-TX/GF: Primary Failure
Idio/Post-Infection Crescentic Glomerulonephri
Membranous Glomerulonephritis
Mesangio-Capillary 1 Glomerulonephritis
Mesangio-Capillary 2 Glomerulonephritis
IGA Nephropathy
Anti-GBM
Focal Glomerular Sclerosis (Focal Segmental - FGS)
Chronic Pyelonephritis/Reflux Nephropath
Polycystic Kidneys
Nephritis
Nephronophthisis
Diabetes - Type I Insulin Dep/Juv Onset
Diabetes - Type II Non-Insulin Dep/Adult
Oxalate Nephropathy (Includes Hereditary Oxalosis)
Cystinosis
Fabry's Disease
Amyloidosis
Gout
Systemic Lupus Erythematosus
Progressive Systemic Sclerosis
Wilms' Tumor
Renal Cell Carcinoma
Incidental Carcinoma
Myeloma
Hemolytic Uremic Syndrome
Hypoplasia/Dysplasia/Dysgensis/Agenesis
Cortical Necrosis
Acute Tubular Necrosis
Medullary Cystic Disease
Sickle Cell Anemia
Acquired Obstructive Nephropathy
Alport's Syndrome
Familial Nephropathy
Goodpasture's Syndrome
Malignant Hypertension
Henoch-Schoenlein Purpura
Prune Belly Syndrome
Retransplant/Graft Failure
Diabetes - Type I Non-Insulin Dep/Juv On
Diabetes - Type II Insulin Dep/Adult Ons
Hypertensive Nephrosclerosis
Chronic Glomerulonephritis Unspecified
Membranous Nephropathy
Chronic Glomerulosclerosis Unspecified
Analgesic Nephropathy
Radiation Nephritis
Antibiotic-Induced Nephritis
Cancer Chemotherapy Induced Nephritis
Calcineurin Inhibitor Nephrotoxicity
Heroin Nephrotoxicity
Renal Artery Thrombosis
Chronic Nephrosclerosis-Unspecified
Congenital Obstructive Uropathy
Scleroderma
Wegeners Granulomatosis
Polyarteritis
Rheumatoid Arthritis
Sarcoidosis
Lymphoma
Nephrolithiasis
Urolithiasis
Pre-BMT Total Body Irradiation
Drug Related Interstitial Nephritis
Thin Basement Membrane Disease
Cholesterol Embolization
Rapid Progressive Glomerulonephritis (Rpgn)
Diabetes Mellitus - Type I
Diabetes Mellitus - Type II
Diabetes Mellitus - Type Other / Unknown
Hepatorenal Syndrome
Lithium Toxicity
HIV Nephropathy
AHN: Drug Other, Specify
AHN: Type A
AHN: Type B- Hbsag+
AHN: Type C
AHN: Type D
AHN: Type B and C
AHN: Type B and D
AHN: Etiology Unknown
AHN: Other, Specify (e.g., Acute Viral Infection, Autoimmune Hepatitis - Fulminant)
Cirrhosis: Drug/Indust Exposure Other, Specify
Cirrhosis: Type A
Cirrhosis: Type B- Hbsag+
Cirrhosis: Type C
Cirrhosis: Type D
Cirrhosis: Type B and C
Cirrhosis: Type B and D
Cirrhosis: Cryptogenic- Idiopathic
Cirrhosis: Chronic Active Hepatitis: Etiology Unknown
Cirrhosis: Other, Specify (e.g., Histiocytosis, Sarcoidosis, Granulomatous)
Cirrhosis: Autoimmune
Cirrhosis: Cryptogenic (Idiopathic)
Cirrhosis: Fatty Liver (NASH)
Alcoholic Cirrhosis
Alcoholic Cirrhosis w/ Hepatitis C
Acute Alcoholic Hepatitis
Acute Alcohol-Associated Hepatitis With or Without Cirrhosis
Alcohol-Associated Cirrhosis Without Acute Alcohol-Associated Hepatitis
Primary Biliary Cirrhosis (PBC)
Cirrhosis: Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Cirrhosis: Metabolic Dysfunction and Alcohol-Related/Associated Liver Disease (MetALD)
Sec Biliary Cirrhosis: Caroli's Disease
Sec Biliary Cirrhosis: Choledochol Cyst
Sec Biliary Cirrhosis: Other, Specify
PSC: Crohn's Disease
PSC: Ulcerative Colitis
PSC: No Bowel Disease
PSC: Other, Specify
Familial Cholestasis: Byler's Disease
Familial Cholestasis: Other, Specify
Choles Liver Disease: Other, Specify
Neonatal Cholestatic Liver Disease
Neonatal Hepatitis Other, Specify
Biliary Atresia: Extrahepatic
Biliary Hypoplasia: Nonsyndromic Paucity of Intrahepatic Bile Duct
Biliary Hypoplasia: Alagille's Syndrome (Paucity of Intrahepatic Bile Duct)
Biliary Atresia or Hypoplasia: Other, Specify
Congenital Hepatic Fibrosis
Cystic Fibrosis
Budd-Chiari Syndrome
Metdis: Alpha-1-Antitrypsin Defic A-1-A
Metdis: Wilson's Disease, Other Copper Metabolism Disorder
Metdis: Hemochromatosis - Hemosiderosis
Metdis: Glyc Stor Dis Type I (GSD-I)
Metdis: Glyc Stor Dis Type IV (GSD-IV)
Metdis: Hyperlipidemia-II, Homozygous Hypercholesterolemia
Metdis: Tyrosinemia
Metdis: Primary Oxalosis/Oxaluria, Hyperoxaluria
Metdis: Maple Syrup Urine Disease
Metdis: Other, Specify
PLM: Hepatoma - Hepatocellular Carcinoma
PLM: Hepatoma (HCC) and Cirrhosis
PLM: Fibrolamellar (FL-HC)
PLM: Cholangiocarcinoma (CH-CA)
PLM: Hepatoblastoma (HBL)
PLM: Hemangioendothelioma, Hemangiosarcoma, Angiosarcoma
PLM: Other, Specify (i.e., Klatzkin Tumor, Leiomysarcoma)
Bile Duct Cancer: (Cholangioma, Biliary Tract Carcinoma)
Secondary Hepatic Malignancy Other, Specify
Benign Tumor: Hepatic Adenoma
Benign Tumor: Polycystic Liver Disease
Benign Tumor: Other, Specify
TPN/Hyperalimentation Ind Liver Disease
Graft vs. Host Dis Sec to Non-Liver Txp
Trauma Other, Specify
Graft Failure
Retransplant/Graft Failure Pancreas
Diabetes Mellitus - Type I (Pancreas)
Diabetes Mellitus - Type II (Pancreas)
Diabetes Secondary to Chronic Pancreatitis without Pancreatectomy
Diabetes Secondary to Cystic Fibrosis without Pancreatectomy
Pancreatic Cancer
Bile Duct Cancer
Other Cancers
Pancreatectomy Prior to Pancreas Transplant
Diabetes Mellitus - Type Other/Unknown (Pancreas) The patient's primary diagnosis. May contain organization-specific values: No Category Entries: Allergic Bronchopulmonary Aspergillosis Bronchopulmonary Dysplasia Ciliary Dyskinesis Syndrome Constrictive Bronchiolitis Dysmotile Cilia Syndrome Granulomatous Lung Disease Kartagener's Syndrome Obstructive Lung Disease Primary Ciliary Dyskinesia Tuberous Sclerosis Congenital Malformation Peripheral Pulm Artery Stenosis Portopulmonary Hypertension Pulmonary AV Malformation Congenital Heart Disease Pulmonary Thromboembolic Disease Pulmonary Veno-Occlusive Disease Pulmonic Stenosis Right Hypoplastic Lung Thromboembolic Pulmonary Hypertension Wegener's Granuloma - Restrictive Wegener's Granuloma - Bronchiectasis Crest - Restrictive Crest - Pulmonary Hypertension Pulmonary Telengectasia - Restrictive Pulmonary Telengectasia - Pulmonary Hypertension Scleroderma - Restrictive Scleroderma - Pulmonary Hypertension Common Variable Immune Deficiency Fibrocavitary Lung Disease Hypogammaglobulinemia Shwachman-Diamond Syndrome Alveolar Proteinosis Amyloidosis ARDS/Pnuemonia IIP: BOOP/COP Bronchoalveolar Carcinoma (BAC) Carcinoid Tumorlets Chronic Pneumonitis of Infancy Collagen Vascular Diseases Connective Tissue Disease Crest Cutis Laxa Desquamative Interstitial Pneumonitis (DIP) Ehlers-Danlos Syndrome Eosinophilic Granuloma Eosinophilic Granulomatosis Eosinophilic Pneumonial Chronic Granulomatosis Fibrosing Mediastinitis Graft-vs-Host Disease (GVHD) Hermansky Pudlak Syndrome Histiocytosis X Hypersensitivity Pneumonitis Idiopathic Pulmonary Hemosiderosis Interstitial Pneumonitis IIP: Lymphocytic Interstitial Pneumonia Lupus Macleod Syndrome Mixed Connective Tissue Disease Paraneoplastic Pemphigus Associated Castleman's Disease Polymyositis Pulmonary Hyalinizing Granuloma Pulmonary Langerhans Cell Granulomatosis Pulmonary Telengectasia Restrictive Lung Disease Sjogren's Syndrome Silicosis Surfactant Protein B Deficiency Swyer James Syndrome Teratoma Tracheopathia Osteoplastica Usual Interstitial Pneumonitis Wegener's Granuloma Other, Specify Dilated Myopathy: Idiopathic Dilated Myopathy: Adriamycin Dilated Myopathy: Post Partum Dilated Myopathy: Familial Dilated Myopathy: Myocarditis Dilated Myopathy: Alcoholic Dilated Myopathy: Viral Dilated Myopathy: Ischemic Dilated Myopathy: Viral (Not COVID-19) COVID-19: Dilated Myopathy: Active Myocarditis COVID-19: Dilated Myopathy: History of Myocarditis Dilated Myopathy: Other, Specify Restrictive Myopathy: Idiopathic Restrictive Myopathy: Amyloidosis Restrictive Myopathy: Endocardial Fibros Restrictive Myopathy: Sarcoidosis Restrictive Myopathy: Sec to Radiat/Chem Restrictive Myopathy: Other, Specify Heart Re-TX/GF: Hyperacute Rejection Heart Re-TX/GF: Acute Rejection Heart Re-TX/GF: Coronary Artery Disease Heart Re-TX/GF: Non-Specific Heart Re-TX/GF: Restrictive/Constrictive Heart Re-TX/GF: Chronic Rejection Heart Re-TX/GF: Primary Failure Heart Re-TX/GF: Other, Specify Coronary Artery Disease Hypertrophic Cardiomyopathy Valvular Heart Disease Congenital Heart Defect - Prior Surgery Unknown Cancer Congenital Heart Defect - Hypoplastic Left Heart Syndrome - Unoperated Congenital Heart Defect - Without Surgery Congenital Heart Defect - With Surgery Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Muscular Dystrophy: Other Specify Eisenmenger's Syn: Atrial Septal Defec Eisenmenger's Syn: VSD Eisenmenger's Syn: PDA Pulmonary Capillary Hemangiomatosis ABCA3 Transporter Mutation Secondary Pulmonary Fibrosis: Specify Cause Surfactant Protein C Deficiency IIP: Nonspecific Interstitial Pneumonia IIP: Respiratory Bronchiolitis IIP: Desquamative Interstitial Pneumonia IIP: Acute Interstitial Pneumonia Pulmonary Lymphangiectasia Eisenmenger's Syn: Multi Congenital Anomalies Eisenmenger's Syn: Other Specify Lung Re-TX/GF: Non-Specific Lung Re-TX/GF: Obliterative Bronchioliti Lung Re-TX/GF: Restrictive Lung Re-TX/GF: Acute Rejection Lung Re-TX/GF: Obstructive Lung Re-TX/GF: Primary Graft Failure Lung Re-Tx/GF: Obliterative Bronchiolitis-Restrictive Lung Re-Tx/GF: Obliterative Bronchiolits-Obstructive Lung Re-TX/GF: Other Specify Pulmonary Hypertension/Pulmonary Arterial Hypertension Cystic Fibrosis Inhalation Burns/Trauma IIP: Idiopathic Pulmonary Fibrosis Sarcoidosis Alpha - 1 - Antitrypsin Deficiency COPD/Emphysema Bronchiectasis Rheumatoid Disease Occupational Lung Disease: Other, Specify Lymphangioleiomyomatosis Obliterative Bronchiolitis (Non-Retransplant) Pulmonary Fibrosis: Other Specify Cause Pulmonary Vascular Disease Secondary Pulmonary Hypertension COVID-19: ARDS COVID-19: Pulmonary Fibrosis Combined Pulmonary Fibrosis and Emphysema (CPFE) Heart/Lung Re-TX/GF: Primary Failure Idio/Post-Infection Crescentic Glomerulonephri Membranous Glomerulonephritis Mesangio-Capillary 1 Glomerulonephritis Mesangio-Capillary 2 Glomerulonephritis IGA Nephropathy Anti-GBM Focal Glomerular Sclerosis (Focal Segmental - FGS) Chronic Pyelonephritis/Reflux Nephropath Polycystic Kidneys Nephritis Nephronophthisis Diabetes - Type I Insulin Dep/Juv Onset Diabetes - Type II Non-Insulin Dep/Adult Oxalate Nephropathy (Includes Hereditary Oxalosis) Cystinosis Fabry's Disease Amyloidosis Gout Systemic Lupus Erythematosus Progressive Systemic Sclerosis Wilms' Tumor Renal Cell Carcinoma Incidental Carcinoma Myeloma Hemolytic Uremic Syndrome Hypoplasia/Dysplasia/Dysgensis/Agenesis Cortical Necrosis Acute Tubular Necrosis Medullary Cystic Disease Sickle Cell Anemia Acquired Obstructive Nephropathy Alport's Syndrome Familial Nephropathy Goodpasture's Syndrome Malignant Hypertension Henoch-Schoenlein Purpura Prune Belly Syndrome Retransplant/Graft Failure Diabetes - Type I Non-Insulin Dep/Juv On Diabetes - Type II Insulin Dep/Adult Ons Hypertensive Nephrosclerosis Chronic Glomerulonephritis Unspecified Membranous Nephropathy Chronic Glomerulosclerosis Unspecified Analgesic Nephropathy Radiation Nephritis Antibiotic-Induced Nephritis Cancer Chemotherapy Induced Nephritis Calcineurin Inhibitor Nephrotoxicity Heroin Nephrotoxicity Renal Artery Thrombosis Chronic Nephrosclerosis-Unspecified Congenital Obstructive Uropathy Scleroderma Wegeners Granulomatosis Polyarteritis Rheumatoid Arthritis Sarcoidosis Lymphoma Nephrolithiasis Urolithiasis Pre-BMT Total Body Irradiation Drug Related Interstitial Nephritis Thin Basement Membrane Disease Cholesterol Embolization Rapid Progressive Glomerulonephritis (Rpgn) Diabetes Mellitus - Type I Diabetes Mellitus - Type II Diabetes Mellitus - Type Other / Unknown Hepatorenal Syndrome Lithium Toxicity HIV Nephropathy AHN: Drug Other, Specify AHN: Type A AHN: Type B- Hbsag+ AHN: Type C AHN: Type D AHN: Type B and C AHN: Type B and D AHN: Etiology Unknown AHN: Other, Specify (e.g., Acute Viral Infection, Autoimmune Hepatitis - Fulminant) Cirrhosis: Drug/Indust Exposure Other, Specify Cirrhosis: Type A Cirrhosis: Type B- Hbsag+ Cirrhosis: Type C Cirrhosis: Type D Cirrhosis: Type B and C Cirrhosis: Type B and D Cirrhosis: Cryptogenic- Idiopathic Cirrhosis: Chronic Active Hepatitis: Etiology Unknown Cirrhosis: Other, Specify (e.g., Histiocytosis, Sarcoidosis, Granulomatous) Cirrhosis: Autoimmune Cirrhosis: Cryptogenic (Idiopathic) Cirrhosis: Fatty Liver (NASH) Alcoholic Cirrhosis Alcoholic Cirrhosis w/ Hepatitis C Acute Alcoholic Hepatitis Acute Alcohol-Associated Hepatitis With or Without Cirrhosis Alcohol-Associated Cirrhosis Without Acute Alcohol-Associated Hepatitis Primary Biliary Cirrhosis (PBC) Cirrhosis: Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis: Metabolic Dysfunction and Alcohol-Related/Associated Liver Disease (MetALD) Sec Biliary Cirrhosis: Caroli's Disease Sec Biliary Cirrhosis: Choledochol Cyst Sec Biliary Cirrhosis: Other, Specify PSC: Crohn's Disease PSC: Ulcerative Colitis PSC: No Bowel Disease PSC: Other, Specify Familial Cholestasis: Byler's Disease Familial Cholestasis: Other, Specify Choles Liver Disease: Other, Specify Neonatal Cholestatic Liver Disease Neonatal Hepatitis Other, Specify Biliary Atresia: Extrahepatic Biliary Hypoplasia: Nonsyndromic Paucity of Intrahepatic Bile Duct Biliary Hypoplasia: Alagille's Syndrome (Paucity of Intrahepatic Bile Duct) Biliary Atresia or Hypoplasia: Other, Specify Congenital Hepatic Fibrosis Cystic Fibrosis Budd-Chiari Syndrome Metdis: Alpha-1-Antitrypsin Defic A-1-A Metdis: Wilson's Disease, Other Copper Metabolism Disorder Metdis: Hemochromatosis - Hemosiderosis Metdis: Glyc Stor Dis Type I (GSD-I) Metdis: Glyc Stor Dis Type IV (GSD-IV) Metdis: Hyperlipidemia-II, Homozygous Hypercholesterolemia Metdis: Tyrosinemia Metdis: Primary Oxalosis/Oxaluria, Hyperoxaluria Metdis: Maple Syrup Urine Disease Metdis: Other, Specify PLM: Hepatoma - Hepatocellular Carcinoma PLM: Hepatoma (HCC) and Cirrhosis PLM: Fibrolamellar (FL-HC) PLM: Cholangiocarcinoma (CH-CA) PLM: Hepatoblastoma (HBL) PLM: Hemangioendothelioma, Hemangiosarcoma, Angiosarcoma PLM: Other, Specify (i.e., Klatzkin Tumor, Leiomysarcoma) Bile Duct Cancer: (Cholangioma, Biliary Tract Carcinoma) Secondary Hepatic Malignancy Other, Specify Benign Tumor: Hepatic Adenoma Benign Tumor: Polycystic Liver Disease Benign Tumor: Other, Specify TPN/Hyperalimentation Ind Liver Disease Graft vs. Host Dis Sec to Non-Liver Txp Trauma Other, Specify Graft Failure Retransplant/Graft Failure Pancreas Diabetes Mellitus - Type I (Pancreas) Diabetes Mellitus - Type II (Pancreas) Diabetes Secondary to Chronic Pancreatitis without Pancreatectomy Diabetes Secondary to Cystic Fibrosis without Pancreatectomy Pancreatic Cancer Bile Duct Cancer Other Cancers Pancreatectomy Prior to Pancreas Transplant Diabetes Mellitus - Type Other/Unknown (Pancreas)"
UNOS_CLINICAL_INFO,UNOS_PRIM_DX_SP,N,159,VARCHAR,No,"The primary diagnosis, if it is not one of the available options in column UNOS_PRI_DX_C. The primary diagnosis, if it is not one of the available options in column UNOS_PRI_DX_C."
UNOS_CLINICAL_INFO,UNOS_DIAB_TYPE_C_NAME,N,160,VARCHAR,No,"Indicates whether the patient has a history of diabetes and if so, the type of diabetes.
May contain organization-specific values: No
Category Entries:
No
Type I
Type II
Type Other
Type Unknown
Diabetes Status Unknown Indicates whether the patient has a history of diabetes and if so, the type of diabetes. May contain organization-specific values: No Category Entries: No Type I Type II Type Other Type Unknown Diabetes Status Unknown"
UNOS_CLINICAL_INFO,UNOS_DIAL_TYPE_C_NAME,N,161,VARCHAR,No,"Indicates whether the patient has a history of dialysis treatment.
May contain organization-specific values: No
Category Entries:
No Dialysis
Hemodialysis
Peritoneal Dialysis
CAVH: Continuous Arteriovenous Hemofiltration
CV VH: Continuous Venous/Venous Hemofiltration
Dialysis Status Unknown
Dialysis Unknown Type Was Performed Indicates whether the patient has a history of dialysis treatment. May contain organization-specific values: No Category Entries: No Dialysis Hemodialysis Peritoneal Dialysis CAVH: Continuous Arteriovenous Hemofiltration CV VH: Continuous Venous/Venous Hemofiltration Dialysis Status Unknown Dialysis Unknown Type Was Performed"
UNOS_CLINICAL_INFO,UNOS_PEPT_ULCR_C_NAME,N,162,VARCHAR,No,"Indicates whether the patient has a history of peptic ulcers.
May contain organization-specific values: No
Category Entries:
No
Yes, Active Within The Last Year
Yes, Not Active Within The Last Year
Yes, Activity Unknown
Unknown Indicates whether the patient has a history of peptic ulcers. May contain organization-specific values: No Category Entries: No Yes, Active Within The Last Year Yes, Not Active Within The Last Year Yes, Activity Unknown Unknown"
UNOS_CLINICAL_INFO,UNOS_ANGINA_C_NAME,N,163,VARCHAR,No,"Indicates whether the patient has a history of angina and coronary artery disease.
May contain organization-specific values: No
Category Entries:
No
Yes, And Documented Coronary Artery Disease
Yes, With No Documented Coronary Artery Disease
Yes, But Coronary Artery Disease Unknown
Status Unknown Indicates whether the patient has a history of angina and coronary artery disease. May contain organization-specific values: No Category Entries: No Yes, And Documented Coronary Artery Disease Yes, With No Documented Coronary Artery Disease Yes, But Coronary Artery Disease Unknown Status Unknown"
UNOS_CLINICAL_INFO,UNOS_DRG_TRT_HYP_C_NAME,N,164,VARCHAR,No,"Indicates whether the patient has a history of high blood pressure or of being treated with medications to lower blood pressure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient has a history of high blood pressure or of being treated with medications to lower blood pressure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_SYM_CER_VASC_C_NAME,N,165,VARCHAR,No,"Indicates whether the patient has a history of transient ischemic attacks or stroke.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient has a history of transient ischemic attacks or stroke. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_SYM_PER_VASC_C_NAME,N,166,VARCHAR,No,"Indicates whether the patient has a history of peripheral vascular disease, including intermittent claudication or diminished peripheral pulses.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient has a history of peripheral vascular disease, including intermittent claudication or diminished peripheral pulses. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_DRG_TRT_COPD_C_NAME,N,167,VARCHAR,No,"Indicates whether the patient has a history of Chronic Obstructive Pulmonary Disease (COPD) or of being treated with medications to control COPD.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient has a history of Chronic Obstructive Pulmonary Disease (COPD) or of being treated with medications to control COPD. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_MALIG_HX_C_NAME,N,168,VARCHAR,No,"Indicates whether the patient has a history of malignant cancer.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient has a history of malignant cancer. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_MALIG_HX_SP,N,169,VARCHAR,No,"If the patient has a history of malignant cancer, free text indicating the specific type of tumor. If the patient has a history of malignant cancer, free text indicating the specific type of tumor."
UNOS_CLINICAL_INFO,UNOS_EXH_VAS_ACC_C_NAME,N,170,VARCHAR,No,"Indicates whether the available sites to obtain vascular access for hemodialysis have been exhausted.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the available sites to obtain vascular access for hemodialysis have been exhausted. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_EXH_PER_ACC_C_NAME,N,171,VARCHAR,No,"Indicates whether all sites to obtain peritoneal access have been exhausted.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether all sites to obtain peritoneal access have been exhausted. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_AGE_DIAB_ONST,N,172,NUMERIC,No,The patient's age at the time of diabetes onset. The patient's age at the time of diabetes onset.
UNOS_CLINICAL_INFO,UNOS_AGE_DIAB_ST_C_NAME,N,173,VARCHAR,No,"If the patient's age at the time of diabetes onset is not available, the reason this information is not available.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME If the patient's age at the time of diabetes onset is not available, the reason this information is not available. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PAT_IN_HOSP_C_NAME,N,174,VARCHAR,No,"Indicates whether the recipient was hospitalized during the 90 days prior to transplant admission.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient was hospitalized during the 90 days prior to transplant admission. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_HBV_C_AB_C_NAME,N,175,VARCHAR,No,"The patient's HBV core antibody serology results.
The category values for this column were already listed for column: UNOS_CMV_IGG_C_NAME The patient's HBV core antibody serology results. The category values for this column were already listed for column: UNOS_CMV_IGG_C_NAME"
UNOS_CLINICAL_INFO,UNOS_HBV_S_AG_C_NAME,N,176,VARCHAR,No,"The patient's HBV surface antigen serology results.
The category values for this column were already listed for column: UNOS_CMV_IGG_C_NAME The patient's HBV surface antigen serology results. The category values for this column were already listed for column: UNOS_CMV_IGG_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KID_BIOPSY_YN,N,177,VARCHAR,No,"Indicates whether a pre-implantation kidney biopsy was performed.
The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN Indicates whether a pre-implantation kidney biopsy was performed. The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN"
UNOS_CLINICAL_INFO,UNOS_BLD_TRNFSN_C_NAME,N,178,VARCHAR,No,"Indicates whether any pre-transplant blood infusions were performed.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether any pre-transplant blood infusions were performed. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_TOL_IND_TECH_C_NAME,N,179,VARCHAR,No,"Indicates whether any tolerance induction techniques were used.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether any tolerance induction techniques were used. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PREV_PREG_C_NAME,N,180,VARCHAR,No,"The number of pregnancies the patient had prior to transplant.
May contain organization-specific values: No
Category Entries:
No Previous Pregnancy
1 Previous Pregnancy
2 Previous Pregnancies
3 Previous Pregnancies
4 Previous Pregnancies
5 Previous Pregnancies
More Than 5 Previous Pregnancies
Yes
No
Not Applicable: < 10 Years Old
Unknown The number of pregnancies the patient had prior to transplant. May contain organization-specific values: No Category Entries: No Previous Pregnancy 1 Previous Pregnancy 2 Previous Pregnancies 3 Previous Pregnancies 4 Previous Pregnancies 5 Previous Pregnancies More Than 5 Previous Pregnancies Yes No Not Applicable: < 10 Years Old Unknown"
UNOS_CLINICAL_INFO,UNOS_PROC_TYPE_C_NAME,N,181,VARCHAR,No,"The procedure used for the transplant.
May contain organization-specific values: No
Category Entries:
Left Kidney
Right Kidney
En-Bloc
Dual Kidney
Hemi-Renal
Pancreas Segment
Whole Pancreas With Duodenum
Whole Pancreas With Duodenal Patch
Whole Pancreas
Pancreas Segment / Kidney Right
Pancreas Segment / Kidney Left
Pancreas Segment / En-Bloc Kidney
Pancreas Segment / Dual Kidney
Pancreas Segment / Hemi-Renal Kidney
Whole Pancreas With Duodenum / Left Kidney
Whole Pancreas With Duodenum / Right Kidney
Whole Pancreas With Duodenum / En-Bloc Kidneys
Pancreas With Duodenum / Dual Kidney
Whole Pancreas With Duodenum / Hemi-Renal Kidney
Whole Pancreas With Duodenal Patch / Left Kidney
Whole Pancreas With Duodenal Patch / Right Kidney
Whole Pancreas With Duodenal Patch / En-Bloc Kidneys
Pancreas With Duodenal Patch / Dual Kidney
Whole Pancreas With Duodenal Patch / Hemi-Renal Kidney
Whole Pancreas / Left Kidney
Whole Pancreas / Right Kidney
Whole Pancreas / En-Bloc Kidneys
Whole Pancreas / Dual Kidney
Whole Pancreas / Hemi-Renal Kidney The procedure used for the transplant. May contain organization-specific values: No Category Entries: Left Kidney Right Kidney En-Bloc Dual Kidney Hemi-Renal Pancreas Segment Whole Pancreas With Duodenum Whole Pancreas With Duodenal Patch Whole Pancreas Pancreas Segment / Kidney Right Pancreas Segment / Kidney Left Pancreas Segment / En-Bloc Kidney Pancreas Segment / Dual Kidney Pancreas Segment / Hemi-Renal Kidney Whole Pancreas With Duodenum / Left Kidney Whole Pancreas With Duodenum / Right Kidney Whole Pancreas With Duodenum / En-Bloc Kidneys Pancreas With Duodenum / Dual Kidney Whole Pancreas With Duodenum / Hemi-Renal Kidney Whole Pancreas With Duodenal Patch / Left Kidney Whole Pancreas With Duodenal Patch / Right Kidney Whole Pancreas With Duodenal Patch / En-Bloc Kidneys Pancreas With Duodenal Patch / Dual Kidney Whole Pancreas With Duodenal Patch / Hemi-Renal Kidney Whole Pancreas / Left Kidney Whole Pancreas / Right Kidney Whole Pancreas / En-Bloc Kidneys Whole Pancreas / Dual Kidney Whole Pancreas / Hemi-Renal Kidney"
UNOS_CLINICAL_INFO,UNOS_TCI_R_KID,N,182,NUMERIC,No,"The total cold ischemia time for the right kidney or both kidneys, in hours. If a pump is used, this includes pump time. The total cold ischemia time for the right kidney or both kidneys, in hours. If a pump is used, this includes pump time."
UNOS_CLINICAL_INFO,UNOS_TCI_R_KID_ST_C_NAME,N,183,VARCHAR,No,"If the total cold ischemia time is unavailable for the right kidney or both kidneys, this indicates why the information is unavailable.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME If the total cold ischemia time is unavailable for the right kidney or both kidneys, this indicates why the information is unavailable. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_TWI_R_KID,N,184,NUMERIC,No,"The total warm ischemia time for the right kidney or both kidneys, in minutes. The total warm ischemia time for the right kidney or both kidneys, in minutes."
UNOS_CLINICAL_INFO,UNOS_TWI_R_KID_ST_C_NAME,N,185,VARCHAR,No,"If the total warm ischemia time is unavailable for the right kidney or both kidneys, this indicates why the information is unavailable.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME If the total warm ischemia time is unavailable for the right kidney or both kidneys, this indicates why the information is unavailable. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_TCI_L_KID,N,186,NUMERIC,No,"The total cold ischemia time for the left kidney, in hours. If a pump is used, this includes pump time. The total cold ischemia time for the left kidney, in hours. If a pump is used, this includes pump time."
UNOS_CLINICAL_INFO,UNOS_TCI_L_KID_ST_C_NAME,N,187,VARCHAR,No,"If the total cold ischemia time is unavailable for the left kidney, this indicates why the information is unavailable.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME If the total cold ischemia time is unavailable for the left kidney, this indicates why the information is unavailable. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_TWI_L_KID,N,188,NUMERIC,No,"The total warm ischemia time for the left kidney, in minutes. The total warm ischemia time for the left kidney, in minutes."
UNOS_CLINICAL_INFO,UNOS_TWI_L_KID_ST_C_NAME,N,189,VARCHAR,No,"If the total warm ischemia time is unavailable for the left kidney, this indicates why the information is unavailable.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME If the total warm ischemia time is unavailable for the left kidney, this indicates why the information is unavailable. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KID_REC_ON_C_NAME,N,190,VARCHAR,No,"Indicates whether the transplanted organs were received on ice or on a pump.
May contain organization-specific values: Yes
Category Entries:
Ice
Pump
Not Applicable Indicates whether the transplanted organs were received on ice or on a pump. May contain organization-specific values: Yes Category Entries: Ice Pump Not Applicable"
UNOS_CLINICAL_INFO,UNOS_REC_ON_ICE_C_NAME,N,191,VARCHAR,No,"If the transplanted organs were received on ice, indicates whether the organs stayed on ice or were put on a pump.
May contain organization-specific values: No
Category Entries:
Stayed on Ice
Put on Pump If the transplanted organs were received on ice, indicates whether the organs stayed on ice or were put on a pump. May contain organization-specific values: No Category Entries: Stayed on Ice Put on Pump"
UNOS_CLINICAL_INFO,UNOS_REC_ON_PMP_C_NAME,N,192,VARCHAR,No,"If the transplanted organs were received on a pump, indicates whether the organs stayed on a pump or were put on ice.
May contain organization-specific values: No
Category Entries:
Stayed on Pump
Put on Ice If the transplanted organs were received on a pump, indicates whether the organs stayed on a pump or were put on ice. May contain organization-specific values: No Category Entries: Stayed on Pump Put on Ice"
UNOS_CLINICAL_INFO,UNOS_FIN_TXP_RSTN,N,193,NUMERIC,No,"If a pump was used during eschemia time, indicates the final resistance. If a pump was used during eschemia time, indicates the final resistance."
UNOS_CLINICAL_INFO,UNOS_FIN_TXP_RSTN_C_NAME,N,194,VARCHAR,No,"If the final resistance level is unavailable, this indicates why the information is unavailable.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME If the final resistance level is unavailable, this indicates why the information is unavailable. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_FIN_FLOW_RATE,N,195,NUMERIC,No,"If a pump was used, the final flow rate. If a pump was used, the final flow rate."
UNOS_CLINICAL_INFO,UNOS_FIN_FLOW_RT_C_NAME,N,196,VARCHAR,No,"If the final flow rate is unavailable, this indicates why the information is unavailable.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME If the final flow rate is unavailable, this indicates why the information is unavailable. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_TXP_INC_TUM_C_NAME,N,197,VARCHAR,No,"Indicates whether an incidental tumor was found in an organ that was removed from the recipient at the time of transplant.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether an incidental tumor was found in an organ that was removed from the recipient at the time of transplant. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_TXP_TUM_TYP_C_NAME,N,198,VARCHAR,No,"The type of incidental tumor found at the time of transplant.
May contain organization-specific values: No
Category Entries:
Oncocytoma
Renal Cell Carcinoma
Carcinoid
Adenoma
Transitional Cell Carcinoma
Other Primary Kidney Tumor, Specify The type of incidental tumor found at the time of transplant. May contain organization-specific values: No Category Entries: Oncocytoma Renal Cell Carcinoma Carcinoid Adenoma Transitional Cell Carcinoma Other Primary Kidney Tumor, Specify"
UNOS_CLINICAL_INFO,UNOS_TXP_TUM_TYP_SP,N,199,VARCHAR,No,The free text type of tumor found at the time of transplant. The free text type of tumor found at the time of transplant.
UNOS_CLINICAL_INFO,UNOS_KID_URN_24H_YN,N,200,VARCHAR,No,"Indicates whether the kidney graft produced at least 40 ml of urine in the first 24 hours following the transplant.
The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN Indicates whether the kidney graft produced at least 40 ml of urine in the first 24 hours following the transplant. The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN"
UNOS_CLINICAL_INFO,UNOS_PAT_DIAL_1W_YN,N,201,VARCHAR,No,"Indicates whether the recipient required any dialysis within the first 7 days following the transplant.
The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN Indicates whether the recipient required any dialysis within the first 7 days following the transplant. The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN"
UNOS_CLINICAL_INFO,UNOS_CREAT_DECLN_YN,N,202,VARCHAR,No,"Indicates whether the recipient's creatinine value declined by 25% or more in the first 24 hours on two separate samples.
The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN Indicates whether the recipient's creatinine value declined by 25% or more in the first 24 hours on two separate samples. The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN"
UNOS_CLINICAL_INFO,UNOS_HIV_SEROS_C_NAME,N,203,VARCHAR,No,"The patient's HIV serology results.
The category values for this column were already listed for column: UNOS_CMV_IGG_C_NAME The patient's HIV serology results. The category values for this column were already listed for column: UNOS_CMV_IGG_C_NAME"
UNOS_CLINICAL_INFO,UNOS_HCV_SEROS_C_NAME,N,204,VARCHAR,No,"The patient's HCV serology results.
The category values for this column were already listed for column: UNOS_CMV_IGG_C_NAME The patient's HCV serology results. The category values for this column were already listed for column: UNOS_CMV_IGG_C_NAME"
UNOS_CLINICAL_INFO,UNOS_EBV_SEROS_C_NAME,N,205,VARCHAR,No,"The patient's EBV serology results.
The category values for this column were already listed for column: UNOS_CMV_IGG_C_NAME The patient's EBV serology results. The category values for this column were already listed for column: UNOS_CMV_IGG_C_NAME"
UNOS_CLINICAL_INFO,UNOS_KID_RECIP_YN,N,206,VARCHAR,No,"Indicates whether the patient received a kidney.
May contain organization-specific values: No
Category Entries:
False
True Indicates whether the patient received a kidney. May contain organization-specific values: No Category Entries: False True"
UNOS_CLINICAL_INFO,UNOS_PAN_RECIP_YN,N,207,VARCHAR,No,"Indicates whether the patient received a pancreas.
The category values for this column were already listed for column: UNOS_KID_RECIP_YN Indicates whether the patient received a pancreas. The category values for this column were already listed for column: UNOS_KID_RECIP_YN"
UNOS_CLINICAL_INFO,UNOS_LVR_RECIP_YN,N,208,VARCHAR,No,"Indicates whether the patient received a liver.
The category values for this column were already listed for column: UNOS_KID_RECIP_YN Indicates whether the patient received a liver. The category values for this column were already listed for column: UNOS_KID_RECIP_YN"
UNOS_CLINICAL_INFO,UNOS_INT_RECIP_YN,N,209,VARCHAR,No,"Indicates whether the patient received an intestine.
The category values for this column were already listed for column: UNOS_KID_RECIP_YN Indicates whether the patient received an intestine. The category values for this column were already listed for column: UNOS_KID_RECIP_YN"
UNOS_CLINICAL_INFO,UNOS_HRT_RECIP_YN,N,210,VARCHAR,No,"Indicates whether the patient received a heart.
The category values for this column were already listed for column: UNOS_KID_RECIP_YN Indicates whether the patient received a heart. The category values for this column were already listed for column: UNOS_KID_RECIP_YN"
UNOS_CLINICAL_INFO,UNOS_LNG_RECIP_YN,N,211,VARCHAR,No,"Indicates whether the patient received a lung.
The category values for this column were already listed for column: UNOS_KID_RECIP_YN Indicates whether the patient received a lung. The category values for this column were already listed for column: UNOS_KID_RECIP_YN"
UNOS_CLINICAL_INFO,UNOS_PIT_RECIP_YN,N,212,VARCHAR,No,"Indicates whether the patient received a pancreas islet.
The category values for this column were already listed for column: UNOS_KID_RECIP_YN Indicates whether the patient received a pancreas islet. The category values for this column were already listed for column: UNOS_KID_RECIP_YN"
UNOS_CLINICAL_INFO,UNOS_BMW_RECIP_YN,N,213,VARCHAR,No,"Indicates whether the patient received bone marrow.
The category values for this column were already listed for column: UNOS_KID_RECIP_YN Indicates whether the patient received bone marrow. The category values for this column were already listed for column: UNOS_KID_RECIP_YN"
UNOS_CLINICAL_INFO,UNOS_PRETXP_DIAL_C_NAME,N,214,VARCHAR,No,"Indicates whether the patient was on dialysis prior to transplant.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the patient was on dialysis prior to transplant. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PRETXP_DIAL_DT,N,215,DATETIME,No,The date the recipient first began pre-transplant dialysis. The date the recipient first began pre-transplant dialysis.
UNOS_CLINICAL_INFO,UNOS_PRETXP_DL_ST_C_NAME,N,216,VARCHAR,No,"The recipients's dialysis date status if the dialysis date field is not populated.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME The recipients's dialysis date status if the dialysis date field is not populated. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_SRM_CREAT,N,217,NUMERIC,No,The recipient's serum creatinine in mg/dl at the time of transplant. The recipient's serum creatinine in mg/dl at the time of transplant.
UNOS_CLINICAL_INFO,UNOS_SRM_CREAT_ST_C_NAME,N,218,VARCHAR,No,"If the recipient's serum creatinine at the time of transplant is unavailable, this indicates why the information is unavailable.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME If the recipient's serum creatinine at the time of transplant is unavailable, this indicates why the information is unavailable. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_RESM_DIAL_YN,N,219,VARCHAR,No,"Indicates whether the recipient returned to maintenance dialysis.
The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN Indicates whether the recipient returned to maintenance dialysis. The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN"
UNOS_CLINICAL_INFO,UNOS_SURG_COMP_C_NAME,N,220,VARCHAR,No,"Indicates whether surgical complication is the contributory cause of graft failure.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether surgical complication is the contributory cause of graft failure. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_MALIG_C_NAME,N,221,VARCHAR,No,"Indicates whether the recipient had any malignancies between listing and transplant.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient had any malignancies between listing and transplant. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_MALIG_TYPE_SP,N,222,VARCHAR,No,The free text type of malignancy the recipient had between listing and transplant. The free text type of malignancy the recipient had between listing and transplant.
UNOS_CLINICAL_INFO,UNOS_MED_ANTI_RE_YN,N,223,VARCHAR,No,"Indicates whether the patient is currently on any maintenance or anti-rejection medications.
The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN Indicates whether the patient is currently on any maintenance or anti-rejection medications. The category values for this column were already listed for column: UNOS_CLIN_RSCH_YN"
UNOS_CLINICAL_INFO,UNOS_MED_CND_C_NAME,N,224,VARCHAR,No,"Indicates the patient's condition and location prior to the transplant.
May contain organization-specific values: No
Category Entries:
In Intensive Care Unit
Hospitalized Not in ICU
Not Hospitalized Indicates the patient's condition and location prior to the transplant. May contain organization-specific values: No Category Entries: In Intensive Care Unit Hospitalized Not in ICU Not Hospitalized"
UNOS_CLINICAL_INFO,UNOS_THF_PM_DTH_C_NAME,N,225,VARCHAR,No,"Indicates the primary cause of death for the thoracic graft recipient.
May contain organization-specific values: No
Category Entries:
Unknown
Other, Specify
Thoracic Graft Failure: Primary Failure
Thoracic Graft Failure: Rejection Hyperacute
Thoracic Graft Failure: Rejection Acute
Thoracic Graft Failure: Rejection Chronic
Thoracic Graft Failure: Technical
Thoracic Graft Failure: Graft Infection
Thoracic Graft Failure: Recurrent Disease
Thoracic Graft Failure: Non-Specific
Infection: Bacterial Septicemia
Infection: Bacterial Pneumonia
Infection: Bacterial Other, Specify
Infection: Viral Cytomegalovirus (CMV)
Infection: Viral Hepatitis
Infection: Viral Septicemia
Infection: Viral Other, Specify
Infection: Fungal Aspergillus
Infection: Fungal Other, Specify
Infection: Protozoal
Infection: Mixed Other, Specify
Infection: Other, Specify
Cardiovascular: Myocardial Infarction
Cardiovascular: Cardiac Arrest
Cardiovascular: Arterial Embolism
Cardiovascular: Ventricular Failure
Cardiovascular: Coronary Artery Disease
Cardiovascular: Atherosclerosis
Cardiovascular: Rhythm Disorder
Cardiovascular: Carditis
Cardiovascular: Aortic Aneurysm
Cardiovascular: Cardiogenic Shock
Cardiovascular: Other, Specify
Pulmonary: Dehiscence
Pulmonary: Bronchiolitis
Primary Pulmonary Hypertension
Pulmonary Embolism
Pulmonary: Respiratory Failure
Pulmonary: Acute Respiratory Distress Disease
Pulmonary: Other, Specify
Cerebrovascular: Stroke
Cerebrovascular: Hemorrhage (Non-Stroke)
Cerebrovascular: Brain Anoxia
Cerebrovascular: Degenerative Brain Disease
Cerebrovascular: Other, Specify
Hemorrhage: Gastrointestinal
Hemorrhage: Intraoperative
Hemorrhage: Disseminated Intravascular Coagulation (DIC)
Hemorrhage: Post-Operative
Hemorrhage: Respiratory
Hemorrhage: Other, Specify
Malignancy: Metastatic Other, Specify
Malignancy: Primary Other, Specify
Malignancy: Post-Txp Lymphoproliferative
Malignancy: Lymphoma
Malignancy: Skin
Malignancy: Other, Specify
Diabetes Mellitus
Intraoperative: Not Hemorrhage Other, Specify
Pancreatitis
Renal Failure
Liver Failure
Multiple Organ System Failure
Fluid/Electrolyte Disorder
Acid/Base Disorder
Amyloidosis
Hematologic Other, Specify
Immunosuppressive Drug Related Hematologic
Immunosuppressive Drug Related Non-Hematologic
Non-Immunosuppressive Drug Related Hematologic
Non-Immunosuppressive Non-Hematologic, Specify Drug
Trauma: Motor Vehicle
Suicide
Non-Compliance
Trauma: Other, Specify
Infection: Viral COVID-19 Indicates the primary cause of death for the thoracic graft recipient. May contain organization-specific values: No Category Entries: Unknown Other, Specify Thoracic Graft Failure: Primary Failure Thoracic Graft Failure: Rejection Hyperacute Thoracic Graft Failure: Rejection Acute Thoracic Graft Failure: Rejection Chronic Thoracic Graft Failure: Technical Thoracic Graft Failure: Graft Infection Thoracic Graft Failure: Recurrent Disease Thoracic Graft Failure: Non-Specific Infection: Bacterial Septicemia Infection: Bacterial Pneumonia Infection: Bacterial Other, Specify Infection: Viral Cytomegalovirus (CMV) Infection: Viral Hepatitis Infection: Viral Septicemia Infection: Viral Other, Specify Infection: Fungal Aspergillus Infection: Fungal Other, Specify Infection: Protozoal Infection: Mixed Other, Specify Infection: Other, Specify Cardiovascular: Myocardial Infarction Cardiovascular: Cardiac Arrest Cardiovascular: Arterial Embolism Cardiovascular: Ventricular Failure Cardiovascular: Coronary Artery Disease Cardiovascular: Atherosclerosis Cardiovascular: Rhythm Disorder Cardiovascular: Carditis Cardiovascular: Aortic Aneurysm Cardiovascular: Cardiogenic Shock Cardiovascular: Other, Specify Pulmonary: Dehiscence Pulmonary: Bronchiolitis Primary Pulmonary Hypertension Pulmonary Embolism Pulmonary: Respiratory Failure Pulmonary: Acute Respiratory Distress Disease Pulmonary: Other, Specify Cerebrovascular: Stroke Cerebrovascular: Hemorrhage (Non-Stroke) Cerebrovascular: Brain Anoxia Cerebrovascular: Degenerative Brain Disease Cerebrovascular: Other, Specify Hemorrhage: Gastrointestinal Hemorrhage: Intraoperative Hemorrhage: Disseminated Intravascular Coagulation (DIC) Hemorrhage: Post-Operative Hemorrhage: Respiratory Hemorrhage: Other, Specify Malignancy: Metastatic Other, Specify Malignancy: Primary Other, Specify Malignancy: Post-Txp Lymphoproliferative Malignancy: Lymphoma Malignancy: Skin Malignancy: Other, Specify Diabetes Mellitus Intraoperative: Not Hemorrhage Other, Specify Pancreatitis Renal Failure Liver Failure Multiple Organ System Failure Fluid/Electrolyte Disorder Acid/Base Disorder Amyloidosis Hematologic Other, Specify Immunosuppressive Drug Related Hematologic Immunosuppressive Drug Related Non-Hematologic Non-Immunosuppressive Drug Related Hematologic Non-Immunosuppressive Non-Hematologic, Specify Drug Trauma: Motor Vehicle Suicide Non-Compliance Trauma: Other, Specify Infection: Viral COVID-19"
UNOS_CLINICAL_INFO,UNOS_THF_PM_DTH_SP,N,226,VARCHAR,No,"Specifies the primary cause of death for the thoracic graft recipient, if that cause of death was not selected from a list. Specifies the primary cause of death for the thoracic graft recipient, if that cause of death was not selected from a list."
UNOS_CLINICAL_INFO,UNOS_THF_SC_DTH1_C_NAME,N,227,VARCHAR,No,"Indicates the first contributory cause of death for the thoracic graft recipient.
The category values for this column were already listed for column: UNOS_THF_PM_DTH_C_NAME Indicates the first contributory cause of death for the thoracic graft recipient. The category values for this column were already listed for column: UNOS_THF_PM_DTH_C_NAME"
UNOS_CLINICAL_INFO,UNOS_THF_SC_DTH1_SP,N,228,VARCHAR,No,Specifies the first contributory cause of death for the thoracic graft recipient. Specifies the first contributory cause of death for the thoracic graft recipient.
UNOS_CLINICAL_INFO,UNOS_THF_SC_DTH2_C_NAME,N,229,VARCHAR,No,"Indicates the second contributory cause of death for the thoracic graft recipient.
The category values for this column were already listed for column: UNOS_THF_PM_DTH_C_NAME Indicates the second contributory cause of death for the thoracic graft recipient. The category values for this column were already listed for column: UNOS_THF_PM_DTH_C_NAME"
UNOS_CLINICAL_INFO,UNOS_THF_SC_DTH2_SP,N,230,VARCHAR,No,Specifies the second contributory cause of death for the thoracic graft recipient. Specifies the second contributory cause of death for the thoracic graft recipient.
UNOS_CLINICAL_INFO,UNOS_HOSP_REJ_C_NAME,N,231,VARCHAR,No,"Indicates whether the recipient was hospitalized for rejection during this follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient was hospitalized for rejection during this follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_HOSP_INF_C_NAME,N,232,VARCHAR,No,"Indicates whether the recipient was hospitalized for infection during this follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient was hospitalized for infection during this follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_THF_FAIL_C_NAME,N,233,VARCHAR,No,"Indicates the primary cause of graft failure for the thoracic graft recipient.
May contain organization-specific values: No
Category Entries:
Primary Non-Function
Acute Rejection
Chronic Rejection/Atherosclerosis
Other, Specify Indicates the primary cause of graft failure for the thoracic graft recipient. May contain organization-specific values: No Category Entries: Primary Non-Function Acute Rejection Chronic Rejection/Atherosclerosis Other, Specify"
UNOS_CLINICAL_INFO,UNOS_EJ_FRAC,N,234,NUMERIC,No,Indicates the most recent ejection fraction available for the thoracic graft recipient. Indicates the most recent ejection fraction available for the thoracic graft recipient.
UNOS_CLINICAL_INFO,UNOS_EJ_FRAC_ST_C_NAME,N,235,VARCHAR,No,"The most recent ejection fraction status.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME The most recent ejection fraction status. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_SH_FRAC,N,236,NUMERIC,No,Indicates the most recent shortening fraction available for the thoracic graft recipient. Indicates the most recent shortening fraction available for the thoracic graft recipient.
UNOS_CLINICAL_INFO,UNOS_SH_FRAC_ST_C_NAME,N,237,VARCHAR,No,"The most recent shortening fraction status.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME The most recent shortening fraction status. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_PACE_C_NAME,N,238,VARCHAR,No,"Indicates whether the recipient has had a permanent pacemaker inserted during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient has had a permanent pacemaker inserted during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_CLIN_EVENT_C_NAME,N,239,VARCHAR,No,"Indicates whether the recipient has exhibited clinically significant events related to coronary artery disease.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient has exhibited clinically significant events related to coronary artery disease. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_FEV1,N,240,NUMERIC,No,Indicates the most recent value available for forced expiratory volume at one second. Indicates the most recent value available for forced expiratory volume at one second.
UNOS_CLINICAL_INFO,UNOS_FEV1_ST_C_NAME,N,241,VARCHAR,No,"The status of the most recent value available for forced expiratory volume at one second.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME The status of the most recent value available for forced expiratory volume at one second. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_O2_REQ,N,242,NUMERIC,No,The recipient's oxygen requirement at rest at the time of follow-up. The recipient's oxygen requirement at rest at the time of follow-up.
UNOS_CLINICAL_INFO,UNOS_O2_REQ_ST_C_NAME,N,243,VARCHAR,No,"The status of the recipient's oxygen requirement at rest at the time of follow-up.
The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME The status of the recipient's oxygen requirement at rest at the time of follow-up. The category values for this column were already listed for column: UNOS_HOSP_STAT_C_NAME"
UNOS_CLINICAL_INFO,UNOS_BR_OBLIT_C_NAME,N,244,VARCHAR,No,"Indicates whether the recipient has been diagnosed with a bronchial obliterans syndrome during the follow-up period.
May contain organization-specific values: No
Category Entries:
No BOS
Yes, Grade OP
Yes, Grade 1
Yes, Grade 2
Yes, Grade 3
Yes, Grade UNK
Unknown Indicates whether the recipient has been diagnosed with a bronchial obliterans syndrome during the follow-up period. May contain organization-specific values: No Category Entries: No BOS Yes, Grade OP Yes, Grade 1 Yes, Grade 2 Yes, Grade 3 Yes, Grade UNK Unknown"
UNOS_CLINICAL_INFO,UNOS_BR_STRIC_C_NAME,N,245,VARCHAR,No,"Indicates whether the recipient was diagnosed with a bronchial stricture during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient was diagnosed with a bronchial stricture during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_STENT_C_NAME,N,246,VARCHAR,No,"If the patient was diagnosed with a bronchial stricture, this indicates whether a stent was inserted.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME If the patient was diagnosed with a bronchial stricture, this indicates whether a stent was inserted. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_BONE_DISEAS_C_NAME,N,247,VARCHAR,No,"Indicates whether the recipient has exhibited new signs and symptoms of bone disease during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient has exhibited new signs and symptoms of bone disease during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_LVR_DISEASE_C_NAME,N,248,VARCHAR,No,"Indicates whether the recipient has exhibited new signs and symptoms of chronic liver disease during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient has exhibited new signs and symptoms of chronic liver disease during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_CATARACT_C_NAME,N,249,VARCHAR,No,"Indicates whether the recipient was newly diagnosed with cataracts during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient was newly diagnosed with cataracts during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_RENAL_DYS_C_NAME,N,250,VARCHAR,No,"Indicates whether the recipient was newly diagnosed with or developed signs and symptoms of renal dysfunction during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient was newly diagnosed with or developed signs and symptoms of renal dysfunction during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_CREAT25_C_NAME,N,251,VARCHAR,No,"Indicates whether the recipient's creatinine level was greater than 2.5 mg/dl during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient's creatinine level was greater than 2.5 mg/dl during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_CHRON_DIAL_C_NAME,N,252,VARCHAR,No,"Indicates whether the recipient had chronic peritoneal or hemodialysis during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient had chronic peritoneal or hemodialysis during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_RENAL_TXP_C_NAME,N,253,VARCHAR,No,"Indicates whether the recipient received a renal transplant during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient received a renal transplant during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_STROKE_C_NAME,N,254,VARCHAR,No,"Indicates whether the recipient experienced a stroke (CVA) during the follow-up period.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient experienced a stroke (CVA) during the follow-up period. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_DRG_HYPLIP_C_NAME,N,255,VARCHAR,No,"Indicates whether the recipient had any medication newly prescribed for the purpose of lowering serum lipid levels.
The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME Indicates whether the recipient had any medication newly prescribed for the purpose of lowering serum lipid levels. The category values for this column were already listed for column: UNOS_WAS_HOSP_C_NAME"
UNOS_CLINICAL_INFO,UNOS_TITER_A_DT,N,256,DATETIME,No,The current A titer sample date. The current A titer sample date.
UNOS_CLINICAL_INFO,UNOS_TITER_B_DT,N,257,DATETIME,No,The current B titer sample date. The current B titer sample date.
UNOS_CLIN_INFO_2,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the registry data record. The unique identifier (.1 item) for the registry data record.
UNOS_CLIN_INFO_2,UNOS_SEC_DX_C_NAME,N,2,VARCHAR,No,"Transplant patient's secondary diagnosis.
May contain organization-specific values: No
Category Entries:
Other, Specify
AHN: Drug Other, Specify
AHN: Type A
AHN: Type B- Hbsag+
AHN: Type C
AHN: Type D
AHN: Type B and C
AHN: Type B and D
AHN: Etiology Unknown
AHN: Other, Specify (e.g., Acute Viral Infection, Autoimmune Hepatitis - Fulminant)
Cirrhosis: Drug/Indust Exposure Other, Specify
Cirrhosis: Type A
Cirrhosis: Type B- Hbsag+
Cirrhosis: Type C
Cirrhosis: Type D
Cirrhosis: Type B and C
Cirrhosis: Type B and D
Cirrhosis: Chronic Active Hepatitis: Etiology Unknown
Cirrhosis: Other, Specify (e.g., Histiocytosis, Sarcoidosis, Granulomatous)
Cirrhosis: Autoimmune
Cirrhosis: Cryptogenic (Idiopathic)
Cirrhosis: Fatty Liver (NASH)
Alcoholic Cirrhosis
Alcoholic Cirrhosis w/ Hepatitis C
Acute Alcoholic Hepatitis
Acute Alcohol-Associated Hepatitis With or Without Cirrhosis
Alcohol-Associated Cirrhosis Without Acute Alcohol-Associated Hepatitis
Primary Biliary Cirrhosis (PBC)
Cirrhosis: Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Cirrhosis: Metabolic Dysfunction and Alcohol-Related/Associated Liver Disease (MetALD)
Sec Biliary Cirrhosis: Caroli's Disease
Sec Biliary Cirrhosis: Choledochol Cyst
Sec Biliary Cirrhosis: Other, Specify
PSC: Crohn's Disease
PSC: Ulcerative Colitis
PSC: No Bowel Disease
PSC: Other, Specify
Familial Cholestasis: Byler's Disease
Familial Cholestasis: Other, Specify
Choles Liver Disease: Other, Specify
Neonatal Cholestatic Liver Disease
Neonatal Hepatitis Other, Specify
Biliary Atresia: Extrahepatic
Biliary Hypoplasia: Nonsyndromic Paucity of Intrahepatic Bile Duct
Biliary Hypoplasia: Alagille's Syndrome (Paucity of Intrahepatic Bile Duct)
Biliary Atresia or Hypoplasia: Other, Specify
Congenital Hepatic Fibrosis
Cystic Fibrosis
Budd-Chiari Syndrome
Metdis: Alpha-1-Antitrypsin Defic A-1-A
Metdis: Wilson's Disease, Other Copper Metabolism Disorder
Metdis: Hemochromatosis - Hemosiderosis
Metdis: Glyc Stor Dis Type I (GSD-I)
Metdis: Glyc Stor Dis Type IV (GSD-IV)
Metdis: Hyperlipidemia-II, Homozygous Hypercholesterolemia
Metdis: Tyrosinemia
Metdis: Primary Oxalosis/Oxaluria, Hyperoxaluria
Metdis: Maple Syrup Urine Disease
Metdis: Other, Specify
PLM: Hepatoma - Hepatocellular Carcinoma
PLM: Hepatoma (HCC) and Cirrhosis
PLM: Fibrolamellar (FL-HC)
PLM: Cholangiocarcinoma (CH-CA)
PLM: Hepatoblastoma (HBL)
PLM: Hemangioendothelioma, Hemangiosarcoma, Angiosarcoma
PLM: Other, Specify (i.e., Klatzkin Tumor, Leiomysarcoma)
Bile Duct Cancer: (Cholangioma, Biliary Tract Carcinoma)
Secondary Hepatic Malignancy Other, Specify
Benign Tumor: Hepatic Adenoma
Benign Tumor: Polycystic Liver Disease
Benign Tumor: Other, Specify
TPN/Hyperalimentation Ind Liver Disease
Graft vs. Host Dis Sec to Non-Liver Txp
Trauma Other, Specify
Graft Failure Transplant patient's secondary diagnosis. May contain organization-specific values: No Category Entries: Other, Specify AHN: Drug Other, Specify AHN: Type A AHN: Type B- Hbsag+ AHN: Type C AHN: Type D AHN: Type B and C AHN: Type B and D AHN: Etiology Unknown AHN: Other, Specify (e.g., Acute Viral Infection, Autoimmune Hepatitis - Fulminant) Cirrhosis: Drug/Indust Exposure Other, Specify Cirrhosis: Type A Cirrhosis: Type B- Hbsag+ Cirrhosis: Type C Cirrhosis: Type D Cirrhosis: Type B and C Cirrhosis: Type B and D Cirrhosis: Chronic Active Hepatitis: Etiology Unknown Cirrhosis: Other, Specify (e.g., Histiocytosis, Sarcoidosis, Granulomatous) Cirrhosis: Autoimmune Cirrhosis: Cryptogenic (Idiopathic) Cirrhosis: Fatty Liver (NASH) Alcoholic Cirrhosis Alcoholic Cirrhosis w/ Hepatitis C Acute Alcoholic Hepatitis Acute Alcohol-Associated Hepatitis With or Without Cirrhosis Alcohol-Associated Cirrhosis Without Acute Alcohol-Associated Hepatitis Primary Biliary Cirrhosis (PBC) Cirrhosis: Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis: Metabolic Dysfunction and Alcohol-Related/Associated Liver Disease (MetALD) Sec Biliary Cirrhosis: Caroli's Disease Sec Biliary Cirrhosis: Choledochol Cyst Sec Biliary Cirrhosis: Other, Specify PSC: Crohn's Disease PSC: Ulcerative Colitis PSC: No Bowel Disease PSC: Other, Specify Familial Cholestasis: Byler's Disease Familial Cholestasis: Other, Specify Choles Liver Disease: Other, Specify Neonatal Cholestatic Liver Disease Neonatal Hepatitis Other, Specify Biliary Atresia: Extrahepatic Biliary Hypoplasia: Nonsyndromic Paucity of Intrahepatic Bile Duct Biliary Hypoplasia: Alagille's Syndrome (Paucity of Intrahepatic Bile Duct) Biliary Atresia or Hypoplasia: Other, Specify Congenital Hepatic Fibrosis Cystic Fibrosis Budd-Chiari Syndrome Metdis: Alpha-1-Antitrypsin Defic A-1-A Metdis: Wilson's Disease, Other Copper Metabolism Disorder Metdis: Hemochromatosis - Hemosiderosis Metdis: Glyc Stor Dis Type I (GSD-I) Metdis: Glyc Stor Dis Type IV (GSD-IV) Metdis: Hyperlipidemia-II, Homozygous Hypercholesterolemia Metdis: Tyrosinemia Metdis: Primary Oxalosis/Oxaluria, Hyperoxaluria Metdis: Maple Syrup Urine Disease Metdis: Other, Specify PLM: Hepatoma - Hepatocellular Carcinoma PLM: Hepatoma (HCC) and Cirrhosis PLM: Fibrolamellar (FL-HC) PLM: Cholangiocarcinoma (CH-CA) PLM: Hepatoblastoma (HBL) PLM: Hemangioendothelioma, Hemangiosarcoma, Angiosarcoma PLM: Other, Specify (i.e., Klatzkin Tumor, Leiomysarcoma) Bile Duct Cancer: (Cholangioma, Biliary Tract Carcinoma) Secondary Hepatic Malignancy Other, Specify Benign Tumor: Hepatic Adenoma Benign Tumor: Polycystic Liver Disease Benign Tumor: Other, Specify TPN/Hyperalimentation Ind Liver Disease Graft vs. Host Dis Sec to Non-Liver Txp Trauma Other, Specify Graft Failure"
UNOS_CLIN_INFO_2,UNOS_SEC_DX_OTH,N,3,VARCHAR,No,Free text description of transplant patient's the secondary diagnosis. Free text description of transplant patient's the secondary diagnosis.
UNOS_CLIN_INFO_2,UNOS_PULM_EMB_C_NAME,N,4,VARCHAR,No,"Indicates whether the candidate was diagnosed with a pulmonary embolism within the past six months.
May contain organization-specific values: No
Category Entries:
Yes
No
Unknown Indicates whether the candidate was diagnosed with a pulmonary embolism within the past six months. May contain organization-specific values: No Category Entries: Yes No Unknown"
UNOS_CLIN_INFO_2,UNOS_VARICES_BLD_C_NAME,N,5,VARCHAR,No,"Indicates whether the candidate was experiencing bleeding from varices present in the esophagus and/or stomach within two weeks prior to listing.
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the candidate was experiencing bleeding from varices present in the esophagus and/or stomach within two weeks prior to listing. The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_LVR_SURG_PX_C_NAME,N,6,VARCHAR,No,"The surgical procedure type used for liver transplant.
May contain organization-specific values: No
Category Entries:
Orthotopic
Heterotopic The surgical procedure type used for liver transplant. May contain organization-specific values: No Category Entries: Orthotopic Heterotopic"
UNOS_CLIN_INFO_2,UNOS_LVR_PROC_TYP_C_NAME,N,7,VARCHAR,No,"The procedure used for liver transplant.
May contain organization-specific values: No
Category Entries:
Whole Liver
Partial Liver, Remainder Not TXP or Living Transplant
Split Liver
Whole Liver w/ Pancreas (Technical Reasons)
Partial Liver w/ Pancreas (Technical Reasons)
Split Liver w/ Pancreas (Technical Reasons) The procedure used for liver transplant. May contain organization-specific values: No Category Entries: Whole Liver Partial Liver, Remainder Not TXP or Living Transplant Split Liver Whole Liver w/ Pancreas (Technical Reasons) Partial Liver w/ Pancreas (Technical Reasons) Split Liver w/ Pancreas (Technical Reasons)"
UNOS_CLIN_INFO_2,UNOS_LVR_SPLT_TYP_C_NAME,N,8,VARCHAR,No,"The split type used for liver transplant.
May contain organization-specific values: No
Category Entries:
Right Lobe without Middle Hepatic Vein (seg 5,6,7,8)
Right Lobe with Middle Hepatic Vein (seg 4,5,6,7,8)
Left Lobe (seg 2,3,4)
Left Lateral Segment (seg 2,3)
PARTIAL LI RIGHT NOT INDICATED
Left Lobe in Situ (seg 2,3,4)
Left Lobe on the Bench (seg 2,3,4)
New Left Lobe with Caudate in Situ (seg 1,2,3,4)
New Left Lobe with Caudate on the Bench (seg 1,2,3,4)
Left Lateral Segment in Situ (seg 2,3)
Left Lateral Segment on the Bench (seg 2,3)
Right Lobe without Middle Hepatic Vein in Situ (seg 5,6,7,8)
Right Lobe without Middle Hepatic Vein on the Bench (seg 5,6,7,8)
Right Lobe with Middle Hepatic Vein in Situ (seg 4,5,6,7,8)
Right Lobe with Middle Hepatic Vein on the Bench (seg 4,5,6,7,8)
Left Trisegment (seg 1,2,3,4,5,8)
Right Trisegment with Middle Hepatic Vein (seg 1,4,5,6)
Left Lobe with Caudate in Situ (seg 1,2,3,4)
Left Lobe with Caudate on the Bench (seg 1,2,3,4) The split type used for liver transplant. May contain organization-specific values: No Category Entries: Right Lobe without Middle Hepatic Vein (seg 5,6,7,8) Right Lobe with Middle Hepatic Vein (seg 4,5,6,7,8) Left Lobe (seg 2,3,4) Left Lateral Segment (seg 2,3) PARTIAL LI RIGHT NOT INDICATED Left Lobe in Situ (seg 2,3,4) Left Lobe on the Bench (seg 2,3,4) New Left Lobe with Caudate in Situ (seg 1,2,3,4) New Left Lobe with Caudate on the Bench (seg 1,2,3,4) Left Lateral Segment in Situ (seg 2,3) Left Lateral Segment on the Bench (seg 2,3) Right Lobe without Middle Hepatic Vein in Situ (seg 5,6,7,8) Right Lobe without Middle Hepatic Vein on the Bench (seg 5,6,7,8) Right Lobe with Middle Hepatic Vein in Situ (seg 4,5,6,7,8) Right Lobe with Middle Hepatic Vein on the Bench (seg 4,5,6,7,8) Left Trisegment (seg 1,2,3,4,5,8) Right Trisegment with Middle Hepatic Vein (seg 1,4,5,6) Left Lobe with Caudate in Situ (seg 1,2,3,4) Left Lobe with Caudate on the Bench (seg 1,2,3,4)"
UNOS_CLIN_INFO_2,UNOS_LVR_5_PRBC_C_NAME,N,9,VARCHAR,No,"Indicates whether the recipient received five or more units of packed red blood cells within 48 hours prior to transplantation due to spontaneous hypertensive bleeding.
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the recipient received five or more units of packed red blood cells within 48 hours prior to transplantation due to spontaneous hypertensive bleeding. The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_LVR_BCTRL_PT_C_NAME,N,10,VARCHAR,No,"Indicates whether the recipient was experiencing bacterial peritonitis.
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the recipient was experiencing bacterial peritonitis. The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_LVR_ABDO_SUR_C_NAME,N,11,VARCHAR,No,"Indicates whether the recipient had abdominal surgery prior to transplant.
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the recipient had abdominal surgery prior to transplant. The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_LVR_PVT_C_NAME,N,12,VARCHAR,No,"Indicates whether the recipient experienced portal vein thrombosis prior to transplant.
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the recipient experienced portal vein thrombosis prior to transplant. The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_LVR_TIPSS_C_NAME,N,13,VARCHAR,No,"Indicates whether the recipient required TIPSS (transjugular intrahepatic portosystemic shunt) prior to transplant.
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the recipient required TIPSS (transjugular intrahepatic portosystemic shunt) prior to transplant. The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_LVR_TUM_TYP_C_NAME,N,14,VARCHAR,No,"The type of incidental tumor found at the time of transplant.
May contain organization-specific values: No
Category Entries:
Hepatocellular Adenoma
Hemangioma
Hemangioendothelioma
Angiomyolipoma
Bile Duct Cystadenocarcinoma
Cholangiocarcinoma
Hepatocellular Carcinoma
Hepatoblastoma
Angiosarcoma
Other, Specify The type of incidental tumor found at the time of transplant. May contain organization-specific values: No Category Entries: Hepatocellular Adenoma Hemangioma Hemangioendothelioma Angiomyolipoma Bile Duct Cystadenocarcinoma Cholangiocarcinoma Hepatocellular Carcinoma Hepatoblastoma Angiosarcoma Other, Specify"
UNOS_CLIN_INFO_2,UNOS_WARM_ISCH_TM,N,15,NUMERIC,No,"The total warm ischemia time for the liver, in minutes. The total warm ischemia time for the liver, in minutes."
UNOS_CLIN_INFO_2,UNOS_WARM_ISCH_ST_C_NAME,N,16,VARCHAR,No,"If the total warm ischemia time is unavailable for the liver, this indicates why the information is unavailable.
May contain organization-specific values: No
Category Entries:
N/A
Not Done
Missing
Unknown If the total warm ischemia time is unavailable for the liver, this indicates why the information is unavailable. May contain organization-specific values: No Category Entries: N/A Not Done Missing Unknown"
UNOS_CLIN_INFO_2,UNOS_COLD_ISCH_TM,N,17,NUMERIC,No,"The total cold ischemia time for the liver, in hours. If a pump is used, this includes pump time. The total cold ischemia time for the liver, in hours. If a pump is used, this includes pump time."
UNOS_CLIN_INFO_2,UNOS_COLD_ISCH_ST_C_NAME,N,18,VARCHAR,No,"If the total cold ischemia time is unavailable for the liver, this indicates why the information is unavailable.
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME If the total cold ischemia time is unavailable for the liver, this indicates why the information is unavailable. The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,UNOS_LF_SPT_ECMO_C_NAME,N,19,VARCHAR,No,"Indicates whether the patient was on an extracorporeal membrane oxygenation machine for life support at the time of UNOS registration
May contain organization-specific values: No
Category Entries:
False
True Indicates whether the patient was on an extracorporeal membrane oxygenation machine for life support at the time of UNOS registration May contain organization-specific values: No Category Entries: False True"
UNOS_CLIN_INFO_2,UNOS_LF_SPT_AORP_C_NAME,N,20,VARCHAR,No,"Indicates whether the patient was on an intra-aortic balloon pump device for life support at the time of UNOS registration
The category values for this column were already listed for column: UNOS_LF_SPT_ECMO_C_NAME Indicates whether the patient was on an intra-aortic balloon pump device for life support at the time of UNOS registration The category values for this column were already listed for column: UNOS_LF_SPT_ECMO_C_NAME"
UNOS_CLIN_INFO_2,UNOS_LF_SPT_PRINF_C_NAME,N,21,VARCHAR,No,"Indicates whether the patient is on a prostacyclin infusion for life support at the time of UNOS registration
The category values for this column were already listed for column: UNOS_LF_SPT_ECMO_C_NAME Indicates whether the patient is on a prostacyclin infusion for life support at the time of UNOS registration The category values for this column were already listed for column: UNOS_LF_SPT_ECMO_C_NAME"
UNOS_CLIN_INFO_2,UNOS_LF_SPT_PRINH_C_NAME,N,22,VARCHAR,No,"Indicates whether the patient is on a prostacyclin inhalation machine for life support at the time of UNOS registration
The category values for this column were already listed for column: UNOS_LF_SPT_ECMO_C_NAME Indicates whether the patient is on a prostacyclin inhalation machine for life support at the time of UNOS registration The category values for this column were already listed for column: UNOS_LF_SPT_ECMO_C_NAME"
UNOS_CLIN_INFO_2,UNOS_LF_SPT_INHNO_C_NAME,N,23,VARCHAR,No,"Indicates whether the patient is receiving inhaled nitric oxide for life support at the time of UNOS registration
The category values for this column were already listed for column: UNOS_LF_SPT_ECMO_C_NAME Indicates whether the patient is receiving inhaled nitric oxide for life support at the time of UNOS registration The category values for this column were already listed for column: UNOS_LF_SPT_ECMO_C_NAME"
UNOS_CLIN_INFO_2,UNOS_LF_SPT_VAD_C_NAME,N,24,VARCHAR,No,"Indicates whether the patient is using a ventricular assist device at the time of UNOS registration
May contain organization-specific values: No
Category Entries:
NONE
LVAD
RVAD
TAH
LVAD+RVAD
LVAD/RVAD/TAH Unspecified Indicates whether the patient is using a ventricular assist device at the time of UNOS registration May contain organization-specific values: No Category Entries: NONE LVAD RVAD TAH LVAD+RVAD LVAD/RVAD/TAH Unspecified"
UNOS_CLIN_INFO_2,UNOS_LF_SPT_VADB1_C_NAME,N,25,VARCHAR,No,"Indicates the brand of the first ventricular assist device used by the patient at the time of UNOS registration
May contain organization-specific values: No
Category Entries:
Abiomed BVS 5000
Arrow Lionheart
Berlin Heart
Biomedicus
HeartMate II
HeartMate IP
HeartMate VE
HeartMate XVE
Heartsaver VAD
Jarvik 2000
Medos
MicroMed DeBakey
Novacor PC
Novacor PCq
Cardiac Assist Tandem Heart
Thoratec
Thoratec IVAD
Toyobo
Type Unspecified
Abiomed AB5000
Berlin Heart EXCOR
Evaheart
Heartware HVAD
Impella Recover 2.5
Impella Recover 5.0
CentriMag (Thoratec/Levitronix)
Maquet Josta Rotaflow
MicroMed DeBakey - Child
Terumo DuraHeart
Thoratec PVAD
Ventracor VentrAssist
Worldheart Levacor
PediMag (Thoratec/Levitronix)
Cardiac Assist Protek Duo
HeartMate III
Impella CP
Impella RP
ReliantHeartAssist 5
ReliantHeart aVAD
Impella 5.5
Abiomed BVS 5000
Berlin Heart
Biomedicus
Medos
Thoratec
Thoratec IVAD
Toyobo
Abiomed AB5000
Berlin Heart EXCOR
Cardiac Assist Tandem Heart
Evaheart
HeartMate II
HeartMate XVE
Heartsaver VAD
Heartware HVAD
Impella Recover 2.5
Impella Recover 5.0
Jarvik 2000
CentriMag (Thoratec/Levitronix)
Maquet Josta Rotaflow
MicroMed DeBakey
MicroMed DeBakey - Child
Terumo DuraHeart
Thoratec PVAD
Ventracor VentrAssist
Worldheart Levacor
PediMag (Thoratec/Levitronix)
Cardiac Assist Protek Duo
HeartMate III
Impella CP
Impella RP
ReliantHeartAssist 5
ReliantHeart aVAD
AbioCor
SynCardia CardioWest
Other, Specify Indicates the brand of the first ventricular assist device used by the patient at the time of UNOS registration May contain organization-specific values: No Category Entries: Abiomed BVS 5000 Arrow Lionheart Berlin Heart Biomedicus HeartMate II HeartMate IP HeartMate VE HeartMate XVE Heartsaver VAD Jarvik 2000 Medos MicroMed DeBakey Novacor PC Novacor PCq Cardiac Assist Tandem Heart Thoratec Thoratec IVAD Toyobo Type Unspecified Abiomed AB5000 Berlin Heart EXCOR Evaheart Heartware HVAD Impella Recover 2.5 Impella Recover 5.0 CentriMag (Thoratec/Levitronix) Maquet Josta Rotaflow MicroMed DeBakey - Child Terumo DuraHeart Thoratec PVAD Ventracor VentrAssist Worldheart Levacor PediMag (Thoratec/Levitronix) Cardiac Assist Protek Duo HeartMate III Impella CP Impella RP ReliantHeartAssist 5 ReliantHeart aVAD Impella 5.5 Abiomed BVS 5000 Berlin Heart Biomedicus Medos Thoratec Thoratec IVAD Toyobo Abiomed AB5000 Berlin Heart EXCOR Cardiac Assist Tandem Heart Evaheart HeartMate II HeartMate XVE Heartsaver VAD Heartware HVAD Impella Recover 2.5 Impella Recover 5.0 Jarvik 2000 CentriMag (Thoratec/Levitronix) Maquet Josta Rotaflow MicroMed DeBakey MicroMed DeBakey - Child Terumo DuraHeart Thoratec PVAD Ventracor VentrAssist Worldheart Levacor PediMag (Thoratec/Levitronix) Cardiac Assist Protek Duo HeartMate III Impella CP Impella RP ReliantHeartAssist 5 ReliantHeart aVAD AbioCor SynCardia CardioWest Other, Specify"
UNOS_CLIN_INFO_2,UNOS_LF_SPT_VADB2_C_NAME,N,26,VARCHAR,No,"Indicates the brand of a second ventricular assist device used by the patient at the time of UNOS registration
May contain organization-specific values: No
Category Entries:
Abiomed BVS 5000
Berlin Heart
Biomedicus
Medos
Thoratec
Thoratec IVAD
Toyobo
Abiomed AB5000
Berlin Heart EXCOR
Cardiac Assist Tandem Heart
Evaheart
HeartMate II
HeartMate XVE
Heartsaver VAD
Heartware HVAD
Impella Recover 2.5
Impella Recover 5.0
Jarvik 2000
CentriMag (Thoratec/Levitronix)
Maquet Josta Rotaflow
MicroMed DeBakey
MicroMed DeBakey - Child
Terumo DuraHeart
Thoratec PVAD
Ventracor VentrAssist
Worldheart Levacor
PediMag (Thoratec/Levitronix)
Cardiac Assist Protek Duo
HeartMate III
Impella CP
Impella RP
ReliantHeartAssist 5
ReliantHeart aVAD
Other, Specify Indicates the brand of a second ventricular assist device used by the patient at the time of UNOS registration May contain organization-specific values: No Category Entries: Abiomed BVS 5000 Berlin Heart Biomedicus Medos Thoratec Thoratec IVAD Toyobo Abiomed AB5000 Berlin Heart EXCOR Cardiac Assist Tandem Heart Evaheart HeartMate II HeartMate XVE Heartsaver VAD Heartware HVAD Impella Recover 2.5 Impella Recover 5.0 Jarvik 2000 CentriMag (Thoratec/Levitronix) Maquet Josta Rotaflow MicroMed DeBakey MicroMed DeBakey - Child Terumo DuraHeart Thoratec PVAD Ventracor VentrAssist Worldheart Levacor PediMag (Thoratec/Levitronix) Cardiac Assist Protek Duo HeartMate III Impella CP Impella RP ReliantHeartAssist 5 ReliantHeart aVAD Other, Specify"
UNOS_CLIN_INFO_2,UNOS_LF_SPT_VAD1S,N,27,VARCHAR,No,The brand name of the first ventricular assist device being used if the brand is not in the UNOS-defined table The brand name of the first ventricular assist device being used if the brand is not in the UNOS-defined table
UNOS_CLIN_INFO_2,UNOS_LF_SPT_VAD2S,N,28,VARCHAR,No,The brand name of the second ventricular assist device being used if the brand is not in the UNOS-defined table The brand name of the second ventricular assist device being used if the brand is not in the UNOS-defined table
UNOS_CLIN_INFO_2,UNOS_ANG_THOR_C_NAME,N,29,VARCHAR,No,"Indicates the thoracic transplant patient's angina status at the time of UNOS registration
May contain organization-specific values: No
Category Entries:
No Angina
Stable Angina - Strenuous Activity Results in Angina
Stable Angina - Ordinary Physical Activity Results in Angina
Stable Angina - No Rest Angina; Does Have Angina with Less than Ordinary Activity
Stable Angina - Angina with Any Physical Activity or At Rest
Unstable Angina
Angina, Stability Unknown
Unknown If Angina Present Indicates the thoracic transplant patient's angina status at the time of UNOS registration May contain organization-specific values: No Category Entries: No Angina Stable Angina - Strenuous Activity Results in Angina Stable Angina - Ordinary Physical Activity Results in Angina Stable Angina - No Rest Angina; Does Have Angina with Less than Ordinary Activity Stable Angina - Angina with Any Physical Activity or At Rest Unstable Angina Angina, Stability Unknown Unknown If Angina Present"
UNOS_CLIN_INFO_2,UNOS_SDEATH_C_NAME,N,30,VARCHAR,No,"Indicates whether the patient is at risk of sudden death at the time of UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient is at risk of sudden death at the time of UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_AMIOD_C_NAME,N,31,VARCHAR,No,"Indicates whether the patient is on an amiodarone medication at the time of UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient is on an amiodarone medication at the time of UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_DEFIB_IMP_C_NAME,N,32,VARCHAR,No,"Indicates whether the patient has an implantable defibrillator at the time of UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient has an implantable defibrillator at the time of UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_IV_INFECT_C_NAME,N,33,VARCHAR,No,"Indicates whether the patient had an infection requiring IV drug therapy within the 2 weeks prior to the time of UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient had an infection requiring IV drug therapy within the 2 weeks prior to the time of UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_EX_O2,N,34,NUMERIC,No,The amount of oxygen consumed during exercise (ml/min/kg) at the time of UNOS registration The amount of oxygen consumed during exercise (ml/min/kg) at the time of UNOS registration
UNOS_CLIN_INFO_2,UNOS_EX_O2_ST_C_NAME,N,35,VARCHAR,No,"The reason there is no value for exercise oxygen consumption at the time of UNOS registration
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME The reason there is no value for exercise oxygen consumption at the time of UNOS registration The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,UNOS_FVC,N,36,NUMERIC,No,The patient's forced vital capacity (% predicted) at the time of UNOS registration The patient's forced vital capacity (% predicted) at the time of UNOS registration
UNOS_CLIN_INFO_2,UNOS_FVC_ST_C_NAME,N,37,VARCHAR,No,"The reason there is no value for forced vital capacity at the time of UNOS registration
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME The reason there is no value for forced vital capacity at the time of UNOS registration The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,UNOS_PCO2,N,38,NUMERIC,No,The patient's partial pressure of carbon dioxide (mm/Hg) at the time of UNOS registration The patient's partial pressure of carbon dioxide (mm/Hg) at the time of UNOS registration
UNOS_CLIN_INFO_2,UNOS_PCO2_ST_C_NAME,N,39,VARCHAR,No,"The reason there is no value for carbon dioxide partial pressure at the time of UNOS registration
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME The reason there is no value for carbon dioxide partial pressure at the time of UNOS registration The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,UNOS_PUL_SEPS_IV_C_NAME,N,40,VARCHAR,No,"Indicates whether the patient experienced at least two pulmonary sepsis episodes treated by IV medications at the time of UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient experienced at least two pulmonary sepsis episodes treated by IV medications at the time of UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_CORT_DEP_C_NAME,N,41,VARCHAR,No,"Indicates whether the patient is dependent on at least 5 mg/day of corticosteroids at the time of UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient is dependent on at least 5 mg/day of corticosteroids at the time of UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_SIX_MIN_WALK,N,42,NUMERIC,No,The number of feet the patient is able to walk in 6 minutes at the time of UNOS registration The number of feet the patient is able to walk in 6 minutes at the time of UNOS registration
UNOS_CLIN_INFO_2,UNOS_PNRES_LNG_BC_C_NAME,N,43,VARCHAR,No,"Indicates whether the patient suffers from a pan-resistant bacterial lung at the time of UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient suffers from a pan-resistant bacterial lung at the time of UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_CARD_SURG_C_NAME,N,44,VARCHAR,No,"Indicates whether the patient has undergone any non-transplant cardiac surgery prior to UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient has undergone any non-transplant cardiac surgery prior to UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_CARD_SURG_S,N,45,VARCHAR,No,Description of a cardiac surgery the patient has undergone prior to UNOS registration that is not on the UNOS-defined category list Description of a cardiac surgery the patient has undergone prior to UNOS registration that is not on the UNOS-defined category list
UNOS_CLIN_INFO_2,UNOS_LUNG_SURG_C_NAME,N,46,VARCHAR,No,"Indicates whether the patient has undergone any non-transplant lung surgery prior to UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient has undergone any non-transplant lung surgery prior to UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_LUNG_SURG_S,N,47,VARCHAR,No,Description of a lung surgery the patient has undergone prior to UNOS registration that is not on the UNOS-defined category list Description of a lung surgery the patient has undergone prior to UNOS registration that is not on the UNOS-defined category list
UNOS_CLIN_INFO_2,UNOS_IV_INOTROPES_C_NAME,N,48,VARCHAR,No,"Indicates whether the patient is on intravenous inotropes for life support at the time of UNOS registration
The category values for this column were already listed for column: UNOS_LF_SPT_ECMO_C_NAME Indicates whether the patient is on intravenous inotropes for life support at the time of UNOS registration The category values for this column were already listed for column: UNOS_LF_SPT_ECMO_C_NAME"
UNOS_CLIN_INFO_2,UNOS_THOR_SURG_C_NAME,N,49,VARCHAR,No,"Indicates whether the pediatric the patient has undergone any non-transplant thoracic surgery prior to UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the pediatric the patient has undergone any non-transplant thoracic surgery prior to UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_STERNO_C_NAME,N,50,VARCHAR,No,"The number of sternotomies the patient has undergone prior to UNOS registration
May contain organization-specific values: No
Category Entries:
Unknown If There Were Prior Sternotomies
Zero
One
Two
Three
Four
Five+
Unknown Number of Prior Sternotomies The number of sternotomies the patient has undergone prior to UNOS registration May contain organization-specific values: No Category Entries: Unknown If There Were Prior Sternotomies Zero One Two Three Four Five+ Unknown Number of Prior Sternotomies"
UNOS_CLIN_INFO_2,UNOS_THORAC_C_NAME,N,51,VARCHAR,No,"The number of thoracotomies the patient has undergone prior to UNOS registration
May contain organization-specific values: No
Category Entries:
Unknown If There Were Prior Thoracotomies
Zero
One
Two
Three
Four
Five+
Unknown Number of Prior Thoracotomies The number of thoracotomies the patient has undergone prior to UNOS registration May contain organization-specific values: No Category Entries: Unknown If There Were Prior Thoracotomies Zero One Two Three Four Five+ Unknown Number of Prior Thoracotomies"
UNOS_CLIN_INFO_2,UNOS_CONGEN_CARD_C_NAME,N,52,VARCHAR,No,"Indicates whether the patient has undergone surgery for a congenital cardiac condition prior to UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient has undergone surgery for a congenital cardiac condition prior to UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_PALLIA_SURG_C_NAME,N,53,VARCHAR,No,"Indicates whether the patient has undergone palliative surgery prior to UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient has undergone palliative surgery prior to UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_CORR_SURG_C_NAME,N,54,VARCHAR,No,"Indicates whether the patient has undergone corrective surgery prior to UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient has undergone corrective surgery prior to UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_SING_VENT_C_NAME,N,55,VARCHAR,No,"Indicates whether the patient has undergone surgery for a single ventricular prior to UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient has undergone surgery for a single ventricular prior to UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_FEV1FVC,N,56,NUMERIC,No,The ratio of forced expiratory volume in one second to forced vital capacity at the time of UNOS registration The ratio of forced expiratory volume in one second to forced vital capacity at the time of UNOS registration
UNOS_CLIN_INFO_2,UNOS_FEV1FVC_ST_C_NAME,N,57,VARCHAR,No,"The reason there is no value for the ratio of forced expiratory volume in one second to forced vital capacity at the time of UNOS registration
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME The reason there is no value for the ratio of forced expiratory volume in one second to forced vital capacity at the time of UNOS registration The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,UNOS_ANTI_ARRYTH_C_NAME,N,58,VARCHAR,No,"Indicates whether the patient is on an antiarrythmic agent at the time of UNOS registration
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates whether the patient is on an antiarrythmic agent at the time of UNOS registration The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_CRDO,N,59,NUMERIC,No,The cardiac output of the patient (L/min) at the time of UNOS registration The cardiac output of the patient (L/min) at the time of UNOS registration
UNOS_CLIN_INFO_2,UNOS_CRDO_ST_C_NAME,N,60,VARCHAR,No,"The reason there is no value for cardiac output at the time of UNOS registration
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME The reason there is no value for cardiac output at the time of UNOS registration The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,UNOS_CRDO_INOVAS_YN,N,61,VARCHAR,No,"Indicates whether the patient was on inotropes or vasodilators that affected the cardiac output reading
May contain organization-specific values: No
Category Entries:
No
Yes Indicates whether the patient was on inotropes or vasodilators that affected the cardiac output reading May contain organization-specific values: No Category Entries: No Yes"
UNOS_CLIN_INFO_2,UNOS_PCW_AVG,N,62,NUMERIC,No,The average pulmonary capillary wedge pressure (mm/Hg) at the time of UNOS registration The average pulmonary capillary wedge pressure (mm/Hg) at the time of UNOS registration
UNOS_CLIN_INFO_2,UNOS_PCW_AVG_ST_C_NAME,N,63,VARCHAR,No,"The reason there is no value for the average pulmonary capillary wedge pressure at the time of UNOS registration
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME The reason there is no value for the average pulmonary capillary wedge pressure at the time of UNOS registration The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,UNOS_PCW_AVG_INV_YN,N,64,VARCHAR,No,"Indicates whether the patient was on inotropes or vasodilators that affected the average pulmonary capillary wedge pressure reading
The category values for this column were already listed for column: UNOS_CRDO_INOVAS_YN Indicates whether the patient was on inotropes or vasodilators that affected the average pulmonary capillary wedge pressure reading The category values for this column were already listed for column: UNOS_CRDO_INOVAS_YN"
UNOS_CLIN_INFO_2,UNOS_PA_SYS,N,65,NUMERIC,No,The systolic blood pressure of the patient's pulmonary artery (mm/Hg) at the time of UNOS registration The systolic blood pressure of the patient's pulmonary artery (mm/Hg) at the time of UNOS registration
UNOS_CLIN_INFO_2,UNOS_PA_SYS_ST_C_NAME,N,66,VARCHAR,No,"The reason there is no value for the pulmonary artery systolic blood pressure at the time of UNOS registration
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME The reason there is no value for the pulmonary artery systolic blood pressure at the time of UNOS registration The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,UNOS_PA_SYS_INOV_YN,N,67,VARCHAR,No,"Indicates whether the patient was on inotropes or vasodilators that affected the pulmonary artery systolic blood pressure reading
The category values for this column were already listed for column: UNOS_CRDO_INOVAS_YN Indicates whether the patient was on inotropes or vasodilators that affected the pulmonary artery systolic blood pressure reading The category values for this column were already listed for column: UNOS_CRDO_INOVAS_YN"
UNOS_CLIN_INFO_2,UNOS_PA_DIA,N,68,NUMERIC,No,The diastolic blood pressure of the patient's pulmonary artery (mm/Hg) at the time of UNOS registration The diastolic blood pressure of the patient's pulmonary artery (mm/Hg) at the time of UNOS registration
UNOS_CLIN_INFO_2,UNOS_PA_DIA_ST_C_NAME,N,69,VARCHAR,No,"The reason there is no value for the pulmonary artery diastolic blood pressure at the time of UNOS registration
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME The reason there is no value for the pulmonary artery diastolic blood pressure at the time of UNOS registration The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,UNOS_PA_DIA_INOV_YN,N,70,VARCHAR,No,"Indicates whether the patient was on inotropes or vasodilators that affected the pulmonary artery diastolic blood pressure reading
The category values for this column were already listed for column: UNOS_CRDO_INOVAS_YN Indicates whether the patient was on inotropes or vasodilators that affected the pulmonary artery diastolic blood pressure reading The category values for this column were already listed for column: UNOS_CRDO_INOVAS_YN"
UNOS_CLIN_INFO_2,UNOS_PA_AVG,N,71,NUMERIC,No,The average blood pressure of the patient's pulmonary artery (mm/Hg) at the time of UNOS registration The average blood pressure of the patient's pulmonary artery (mm/Hg) at the time of UNOS registration
UNOS_CLIN_INFO_2,UNOS_PA_AVG_ST_C_NAME,N,72,VARCHAR,No,"The reason there is no value for the average pulmonary artery blood pressure at the time of UNOS registration
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME The reason there is no value for the average pulmonary artery blood pressure at the time of UNOS registration The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,UNOS_PA_AVG_INVS_YN,N,73,VARCHAR,No,"Indicates whether the patient was on inotropes or vasodilators that affected the average pulmonary artery blood pressure reading
The category values for this column were already listed for column: UNOS_CRDO_INOVAS_YN Indicates whether the patient was on inotropes or vasodilators that affected the average pulmonary artery blood pressure reading The category values for this column were already listed for column: UNOS_CRDO_INOVAS_YN"
UNOS_CLIN_INFO_2,UNOS_LF_SPT_PGLAN_C_NAME,N,74,VARCHAR,No,"Indicates whether the patient was on an prostaglandins for life support at the time of UNOS registration
The category values for this column were already listed for column: UNOS_LF_SPT_ECMO_C_NAME Indicates whether the patient was on an prostaglandins for life support at the time of UNOS registration The category values for this column were already listed for column: UNOS_LF_SPT_ECMO_C_NAME"
UNOS_CLIN_INFO_2,UNOS_TITER_A_C_NAME,N,75,VARCHAR,No,"The current A titer value If the recipient's ABO blood-type is B or O.
May contain organization-specific values: No
Category Entries:
1:0
1:1
1:2
1:4
1:8
1:16
1:32
1:64
1:128
1:256
Not Taken
Not Available The current A titer value If the recipient's ABO blood-type is B or O. May contain organization-specific values: No Category Entries: 1:0 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 Not Taken Not Available"
UNOS_CLIN_INFO_2,UNOS_TITER_B_C_NAME,N,76,VARCHAR,No,"The current B titer value If the recipient's ABO blood-type is A or O.
The category values for this column were already listed for column: UNOS_TITER_A_C_NAME The current B titer value If the recipient's ABO blood-type is A or O. The category values for this column were already listed for column: UNOS_TITER_A_C_NAME"
UNOS_CLIN_INFO_2,HX_OF_HCC_YN,N,77,VARCHAR,No,"Indicates whether the patient ever had a diagnosis of HCC.
May contain organization-specific values: No
Category Entries:
Yes
No Indicates whether the patient ever had a diagnosis of HCC. May contain organization-specific values: No Category Entries: Yes No"
UNOS_CLIN_INFO_2,NEOADJUVANT_YN,N,78,VARCHAR,No,"Indicates whether the patient received neoadjuvant therapy.
The category values for this column were already listed for column: UNOS_CRDO_INOVAS_YN Indicates whether the patient received neoadjuvant therapy. The category values for this column were already listed for column: UNOS_CRDO_INOVAS_YN"
UNOS_CLIN_INFO_2,CMV_STATUS_C_NAME,N,79,VARCHAR,No,"Stores the patient's CMV status.
May contain organization-specific values: No
Category Entries:
Positive
Negative
Not Done
Unknown/Cannot Disclose Stores the patient's CMV status. May contain organization-specific values: No Category Entries: Positive Negative Not Done Unknown/Cannot Disclose"
UNOS_CLIN_INFO_2,UNOS_HBV_SURFACE_C_NAME,N,80,VARCHAR,No,"The patient's HBV surface antibody total results.
The category values for this column were already listed for column: CMV_STATUS_C_NAME The patient's HBV surface antibody total results. The category values for this column were already listed for column: CMV_STATUS_C_NAME"
UNOS_CLIN_INFO_2,UNOS_OPO,N,81,VARCHAR,No,The OPO that recovered the organ. The OPO that recovered the organ.
UNOS_CLIN_INFO_2,UNOS_RIGHT_RESIST,N,82,NUMERIC,No,The final resistance at the time of transplant for the right kidney. The final resistance at the time of transplant for the right kidney.
UNOS_CLIN_INFO_2,UNOS_R_F_TXP_RSTN_C_NAME,N,83,VARCHAR,No,"If the final resistance level is unavailable, this indicates why the information is unavailable.
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME If the final resistance level is unavailable, this indicates why the information is unavailable. The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,UNOS_R_FIN_FLOW_RT,N,84,NUMERIC,No,"If a pump was used, the final flow rate for the right kidney. If a pump was used, the final flow rate for the right kidney."
UNOS_CLIN_INFO_2,UNOS_R_FN_FLOW_RT_C_NAME,N,85,VARCHAR,No,"If the final flow rate is unavailable, this indicates why the information is unavailable.
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME If the final flow rate is unavailable, this indicates why the information is unavailable. The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,UNOS_DIFF_CHOLANG_C_NAME,N,86,VARCHAR,No,"Indicates if the organ failed due to diffuse cholangiopathy.
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates if the organ failed due to diffuse cholangiopathy. The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,ER_URGENT_C_NAME,N,87,VARCHAR,No,"Indicates if the patient was admitted to the ER or Urgent care during the follow-up period related to the transplant.
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicates if the patient was admitted to the ER or Urgent care during the follow-up period related to the transplant. The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,CREAT_DT,N,88,DATETIME,No,Stores the date the patient's most recent creatinine test was drawn. Stores the date the patient's most recent creatinine test was drawn.
UNOS_CLIN_INFO_2,SYS_BP_DT,N,89,DATETIME,No,The date that the patient's systolic blood pressure was read. The date that the patient's systolic blood pressure was read.
UNOS_CLIN_INFO_2,DIA_BP_DT,N,90,DATETIME,No,The date that the patient's diastolic blood pressure was read. The date that the patient's diastolic blood pressure was read.
UNOS_CLIN_INFO_2,CNTRY_RESIDENCE_C_NAME,N,91,VARCHAR,No,"The patient's country of permanent residence.
May contain organization-specific values: No
Category Entries:
United States
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Azores
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei Darussalam
Bulgaria
Burkina
Burma (Myanmar)
Burundi
Cambodia
Cameroon
Canada
Canary Islands
Canton and Enderbury Islands
Cape Verde
Cayman Island
Central African Republic
Chad
Chile
China
Christmas Islands
Cocos (Keeling) Island
Colombia
Comoros
Congo
Democratic Republic of Congo
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
The Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
England
Equatorial Guinea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern and Antarctic
Gabon
The Gambia
Gaza Strip
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Johnston Atoll
Jordan
Democratic Kampuchea
Kazakhstan
Kenya
Kiribati
Korea
Kuwait
Kyrgyzstan
Lao Peoples' Democratic Republic
Latin America
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia (Skopje)
Madagascar
Madeira Island
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mexico
Federated States of Micronesia
Midway Islands
Moldova
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
Spain
Spanish Africa
Sri Lanka
St. Christopher
St. Helena
St. Kitts and Nevis
St. Pierre and Miquelon
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
United Republic of Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Island
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
USA Minor Outlying Islands
Uzbekistan
Vanuata
Vatican City
Venezuela
Vietnam
Virgin Islands of The USA
Republic of Yemen
Zambia
Zimbabwe
Unknown The patient's country of permanent residence. May contain organization-specific values: No Category Entries: United States Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Azores Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia-Herzegovina Botswana Brazil British Indian Ocean Territory British Virgin Islands Brunei Darussalam Bulgaria Burkina Burma (Myanmar) Burundi Cambodia Cameroon Canada Canary Islands Canton and Enderbury Islands Cape Verde Cayman Island Central African Republic Chad Chile China Christmas Islands Cocos (Keeling) Island Colombia Comoros Congo Democratic Republic of Congo Cook Islands Costa Rica Croatia Cuba Cyprus The Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador England Equatorial Guinea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern and Antarctic Gabon The Gambia Gaza Strip Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Ivory Coast Jamaica Japan Johnston Atoll Jordan Democratic Kampuchea Kazakhstan Kenya Kiribati Korea Kuwait Kyrgyzstan Lao Peoples' Democratic Republic Latin America Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Macedonia (Skopje) Madagascar Madeira Island Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mexico Federated States of Micronesia Midway Islands Moldova Monaco Mongolia Montserrat Morocco Mozambique Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Island Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia and Montenegro Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Spanish Africa Sri Lanka St. Christopher St. Helena St. Kitts and Nevis St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan United Republic of Tanzania Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Island Tuvalu Uganda Ukraine United Arab Emirates United Kingdom Uruguay USA Minor Outlying Islands Uzbekistan Vanuata Vatican City Venezuela Vietnam Virgin Islands of The USA Republic of Yemen Zambia Zimbabwe Unknown"
UNOS_CLIN_INFO_2,YR_OF_ENTRY_ST_C_NAME,N,92,VARCHAR,No,"Reason the year of entry to the US is missing.
The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME Reason the year of entry to the US is missing. The category values for this column were already listed for column: UNOS_WARM_ISCH_ST_C_NAME"
UNOS_CLIN_INFO_2,INSURANCE_LOSS_C_NAME,N,93,VARCHAR,No,"Indicates if the patient has lost insurance coverage due to the donation.
May contain organization-specific values: No
Category Entries:
No
Yes
No
Unknown Indicates if the patient has lost insurance coverage due to the donation. May contain organization-specific values: No Category Entries: No Yes No Unknown"
UNOS_CLIN_INFO_2,UNOS_HEIGHT_DATE,N,94,DATETIME,No,The date the patient's height was measured. The date the patient's height was measured.
UNOS_CLIN_INFO_2,UNOS_WEIGHT_DATE,N,95,DATETIME,No,The date the patient's weight was measured. The date the patient's weight was measured.
UNOS_CLIN_INFO_2,UNOS_HEP_B_C_NAME,N,96,VARCHAR,No,"Indicate if the patient receive a hepatitis B vaccine.
The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME Indicate if the patient receive a hepatitis B vaccine. The category values for this column were already listed for column: UNOS_PULM_EMB_C_NAME"
UNOS_CLIN_INFO_2,UNOS_NO_HEPB_RSN_C_NAME,N,97,VARCHAR,No,"Indicates the reason the patient has not received a hepatitis B vaccine.
May contain organization-specific values: No
Category Entries:
Prior Immunity
Medical Precaution
Time Constraints
Patient Objection
Product Out of Stock
Other, Specify Indicates the reason the patient has not received a hepatitis B vaccine. May contain organization-specific values: No Category Entries: Prior Immunity Medical Precaution Time Constraints Patient Objection Product Out of Stock Other, Specify"
UNOS_CLIN_INFO_2,UNOS_NO_HEPB_RSN_OTHR,N,98,VARCHAR,No,Indicates the free-text reason the patient has not received a hepatitis B vaccine. Indicates the free-text reason the patient has not received a hepatitis B vaccine.
UNOS_CLIN_INFO_3,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the registry data record. The unique identifier (.1 item) for the registry data record.
UNOS_CLIN_INFO_3,DNR_VIR_TESTED_YN,N,2,VARCHAR,No,"Indicates whether the donor was tested for HIV, CMV, HBV, HCV or EBV prior to the donation.
May contain organization-specific values: No
Category Entries:
No
Yes Indicates whether the donor was tested for HIV, CMV, HBV, HCV or EBV prior to the donation. May contain organization-specific values: No Category Entries: No Yes"
UNOS_CLIN_INFO_3,VIR_CMV_TESTED_YN,N,3,VARCHAR,No,"Indicates the presence of CMV.
The category values for this column were already listed for column: DNR_VIR_TESTED_YN Indicates the presence of CMV. The category values for this column were already listed for column: DNR_VIR_TESTED_YN"
UNOS_CLIN_INFO_3,VIR_CMV_DISEASE_C_NAME,N,4,VARCHAR,No,"Indicates whether the patient had any CMV related clinical disease.
May contain organization-specific values: No
Category Entries:
Yes
No
Unknown Indicates whether the patient had any CMV related clinical disease. May contain organization-specific values: No Category Entries: Yes No Unknown"
UNOS_CLIN_INFO_3,VIR_CMV_NUC_ACID_C_NAME,N,5,VARCHAR,No,"The patient's CMV nucleic acid test results.
May contain organization-specific values: No
Category Entries:
Positive
Negative
Not Done
Unknown/Cannot Disclose The patient's CMV nucleic acid test results. May contain organization-specific values: No Category Entries: Positive Negative Not Done Unknown/Cannot Disclose"
UNOS_CLIN_INFO_3,VIR_CMV_CULTURE_C_NAME,N,6,VARCHAR,No,"The patient's CMV culture test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's CMV culture test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_CMV_PREUNET_C_NAME,N,7,VARCHAR,No,"The patient's pre-UNet CMV data.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's pre-UNet CMV data. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_HIV_TESTED_YN,N,8,VARCHAR,No,"Indicates the presence of any of several retroviruses indicative of AIDS.
The category values for this column were already listed for column: DNR_VIR_TESTED_YN Indicates the presence of any of several retroviruses indicative of AIDS. The category values for this column were already listed for column: DNR_VIR_TESTED_YN"
UNOS_CLIN_INFO_3,VIR_HIV_SCREEN_C_NAME,N,9,VARCHAR,No,"The patient's HIV screening test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's HIV screening test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_HIV_CONFIRM_C_NAME,N,10,VARCHAR,No,"The patient's HIV confirmation test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's HIV confirmation test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_HIV_DISEASE_C_NAME,N,11,VARCHAR,No,"Indicates whether the patient had any HIV related clinical disease.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME Indicates whether the patient had any HIV related clinical disease. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,VIR_HIV_ANTIB_C_NAME,N,12,VARCHAR,No,"The patient's HIV antibody test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's HIV antibody test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_HIV_RNA_C_NAME,N,13,VARCHAR,No,"The patient's HIV RNA test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's HIV RNA test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_HBV_TESTED_YN,N,14,VARCHAR,No,"Indicates the presence of HBV or serum hepatitis.
The category values for this column were already listed for column: DNR_VIR_TESTED_YN Indicates the presence of HBV or serum hepatitis. The category values for this column were already listed for column: DNR_VIR_TESTED_YN"
UNOS_CLIN_INFO_3,VIR_HBV_DISEASE_C_NAME,N,15,VARCHAR,No,"Indicates whether the patient had any HBV related clinical disease.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME Indicates whether the patient had any HBV related clinical disease. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,VIR_HBV_LVR_HISTO_C_NAME,N,16,VARCHAR,No,"The patient's HBV liver histology test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's HBV liver histology test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_HBV_DNA_C_NAME,N,17,VARCHAR,No,"The patient's HBV DNA test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's HBV DNA test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_HBV_HDV_C_NAME,N,18,VARCHAR,No,"The patient's HBV HDV (Delta virus) test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's HBV HDV (Delta virus) test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_HCV_TESTED_YN,N,19,VARCHAR,No,"Indicates the presence of HCV.
The category values for this column were already listed for column: DNR_VIR_TESTED_YN Indicates the presence of HCV. The category values for this column were already listed for column: DNR_VIR_TESTED_YN"
UNOS_CLIN_INFO_3,VIR_HCV_DISEASE_C_NAME,N,20,VARCHAR,No,"Indicates whether the patient had any HCV related clinical disease.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME Indicates whether the patient had any HCV related clinical disease. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,VIR_HCV_LVR_HISTO_C_NAME,N,21,VARCHAR,No,"The patient's HCV liver histology test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's HCV liver histology test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_HCV_ANTIB_C_NAME,N,22,VARCHAR,No,"The patient's HCV antibody test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's HCV antibody test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_HCV_RIBA_C_NAME,N,23,VARCHAR,No,"The patient's HCV RIBA test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's HCV RIBA test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_HCV_RNA_C_NAME,N,24,VARCHAR,No,"The patient's HCV RNA test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's HCV RNA test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_EBV_TESTED_YN,N,25,VARCHAR,No,"Indicates the presence of EBV or EB virus.
The category values for this column were already listed for column: DNR_VIR_TESTED_YN Indicates the presence of EBV or EB virus. The category values for this column were already listed for column: DNR_VIR_TESTED_YN"
UNOS_CLIN_INFO_3,VIR_EBV_DISEASE_C_NAME,N,26,VARCHAR,No,"Indicates whether the patient had any EBV related clinical disease.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME Indicates whether the patient had any EBV related clinical disease. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,VIR_EBV_IGG_C_NAME,N,27,VARCHAR,No,"The patient's EBV IgG test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's EBV IgG test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_EBV_IGM_C_NAME,N,28,VARCHAR,No,"The patient's EBV IgM test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's EBV IgM test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,VIR_EBV_DNA_C_NAME,N,29,VARCHAR,No,"The patient's EBV DNA test results.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The patient's EBV DNA test results. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,UNOS_CANCER_HX_C_NAME,N,30,VARCHAR,No,"Indicates whether the donor had a history of cancer prior to the donation.
May contain organization-specific values: No
Category Entries:
No
Skin - Squamous, Basal Cell
Skin - Melanoma
CNS Tumor - Astrocytoma
CNS Tumor - Glioblastoma Multiforme
CNS Tumor - Medulloblastoma
CNS Tumor - Neuroblastoma
CNS Tumor - Angioblastoma
CNS Tumor - Meningioma
CNS Tumor - Other
Genitourinary - Bladder
Genitourinary - Uterine Cervix
Genitourinary - Uterine Body Endometrial
Genitourinary - Uterine Body Choriocarcinoma
Genitourinary - Vulva
Genitourinary - Ovarian
Genitourinary - Penis, Testicular
Genitourinary - Prostate
Genitourinary - Kidney
Genitourinary - Unknown
Gastrointestinal - Esophageal
Gastrointestinal - Stomach
Gastrointestinal - Small Intestine
Gastrointestinal - Colo-Rectal
Gastrointestinal - Liver & Biliary Tract
Gastrointestinal - Pancreas
Breast
Thyroid
Tongue/Throat
Larynx
Lung (Include Bronchial)
Leukemia/Lymphoma
Unknown
Other, Specify Indicates whether the donor had a history of cancer prior to the donation. May contain organization-specific values: No Category Entries: No Skin - Squamous, Basal Cell Skin - Melanoma CNS Tumor - Astrocytoma CNS Tumor - Glioblastoma Multiforme CNS Tumor - Medulloblastoma CNS Tumor - Neuroblastoma CNS Tumor - Angioblastoma CNS Tumor - Meningioma CNS Tumor - Other Genitourinary - Bladder Genitourinary - Uterine Cervix Genitourinary - Uterine Body Endometrial Genitourinary - Uterine Body Choriocarcinoma Genitourinary - Vulva Genitourinary - Ovarian Genitourinary - Penis, Testicular Genitourinary - Prostate Genitourinary - Kidney Genitourinary - Unknown Gastrointestinal - Esophageal Gastrointestinal - Stomach Gastrointestinal - Small Intestine Gastrointestinal - Colo-Rectal Gastrointestinal - Liver & Biliary Tract Gastrointestinal - Pancreas Breast Thyroid Tongue/Throat Larynx Lung (Include Bronchial) Leukemia/Lymphoma Unknown Other, Specify"
UNOS_CLIN_INFO_3,UNOS_CANCER_HX_SP,N,31,VARCHAR,No,The name of the cancer of which the donor had a history prior to the donation. The name of the cancer of which the donor had a history prior to the donation.
UNOS_CLIN_INFO_3,CANCER_FREE_INTERVL,N,32,INTEGER,No,"If the donor had a history of cancer, the number of years the donor was cancer-free prior to donation. If the donor had a history of cancer, the number of years the donor was cancer-free prior to donation."
UNOS_CLIN_INFO_3,CANCER_FREE_ST_C_NAME,N,33,VARCHAR,No,"Specifies the reason why the number of years the donor was free of the cancer is not available.
May contain organization-specific values: No
Category Entries:
N/A
Not Done
Missing
Unknown Specifies the reason why the number of years the donor was free of the cancer is not available. May contain organization-specific values: No Category Entries: N/A Not Done Missing Unknown"
UNOS_CLIN_INFO_3,UNOS_HX_HYPERTNSN_C_NAME,N,34,VARCHAR,No,"Indicates whether the donor had a history of hypertension prior to donation.
May contain organization-specific values: No
Category Entries:
No
Yes, 0-5 Years
Yes, 6-10 Years
Yes, >10 Years
Yes, Unknown Duration
Unknown Indicates whether the donor had a history of hypertension prior to donation. May contain organization-specific values: No Category Entries: No Yes, 0-5 Years Yes, 6-10 Years Yes, >10 Years Yes, Unknown Duration Unknown"
UNOS_CLIN_INFO_3,UNOS_HX_HYPT_DIET_C_NAME,N,35,VARCHAR,No,"If the donor had a history of hypertension, indicates whether diet was used as a treatment method.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME If the donor had a history of hypertension, indicates whether diet was used as a treatment method. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,UNOS_HX_HYPT_DIUR_C_NAME,N,36,VARCHAR,No,"If the donor had a history of hypertension, indicates whether diuretics were used as a treatment method.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME If the donor had a history of hypertension, indicates whether diuretics were used as a treatment method. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,UNOS_HX_HYPT_MED_C_NAME,N,37,VARCHAR,No,"If the donor had a history of hypertension, indicates whether medication was used as a treatment method.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME If the donor had a history of hypertension, indicates whether medication was used as a treatment method. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,PREOP_BP_SYSTOLIC,N,38,INTEGER,No,The living donor's systolic blood pressure prior to donation. The living donor's systolic blood pressure prior to donation.
UNOS_CLIN_INFO_3,PREOP_BP_SYST_ST_C_NAME,N,39,VARCHAR,No,"Specifies why the living donor's systolic blood pressure prior to donation is not available.
The category values for this column were already listed for column: CANCER_FREE_ST_C_NAME Specifies why the living donor's systolic blood pressure prior to donation is not available. The category values for this column were already listed for column: CANCER_FREE_ST_C_NAME"
UNOS_CLIN_INFO_3,PREOP_BP_DIASTOLIC,N,40,INTEGER,No,The living donor's diastolic blood pressure prior to donation. The living donor's diastolic blood pressure prior to donation.
UNOS_CLIN_INFO_3,PREOP_BP_DIAS_ST_C_NAME,N,41,VARCHAR,No,"Specifies why the living donor's diastolic blood pressure prior to donation is not available.
The category values for this column were already listed for column: CANCER_FREE_ST_C_NAME Specifies why the living donor's diastolic blood pressure prior to donation is not available. The category values for this column were already listed for column: CANCER_FREE_ST_C_NAME"
UNOS_CLIN_INFO_3,PREOP_URINE_RATIO,N,42,NUMERIC,No,The donor's urinalysis protein-creatinine ratio prior to donation. The donor's urinalysis protein-creatinine ratio prior to donation.
UNOS_CLIN_INFO_3,PREOP_URINE_PRTN_C_NAME,N,43,VARCHAR,No,"The living donor's urinalysis urine protein prior to donation.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The living donor's urinalysis urine protein prior to donation. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,UNOS_KI_GLOMERO_C_NAME,N,44,VARCHAR,No,"The living donor's glomerulosclerosis if the living donor had a kidney biopsy prior to donation.
May contain organization-specific values: No
Category Entries:
0-5
6-10
11-15
16-20
20+
Indeterminate The living donor's glomerulosclerosis if the living donor had a kidney biopsy prior to donation. May contain organization-specific values: No Category Entries: 0-5 6-10 11-15 16-20 20+ Indeterminate"
UNOS_CLIN_INFO_3,UNOS_KI_PROC_TYPE_C_NAME,N,45,VARCHAR,No,"The kidney intended procedure type.
May contain organization-specific values: No
Category Entries:
Transabdominal
Flank (retroperitoneal)
Laparoscopic Not Hand-Assisted
Laparoscopic Hand-Assisted
Natural Orifice
Robotic The kidney intended procedure type. May contain organization-specific values: No Category Entries: Transabdominal Flank (retroperitoneal) Laparoscopic Not Hand-Assisted Laparoscopic Hand-Assisted Natural Orifice Robotic"
UNOS_CLIN_INFO_3,CNV_LAPAROS_OPEN_YN,N,46,VARCHAR,No,"Indicates whether there was a conversion from laparoscopic to open procedure if laparoscopic was selected for intended procedure type.
The category values for this column were already listed for column: DNR_VIR_TESTED_YN Indicates whether there was a conversion from laparoscopic to open procedure if laparoscopic was selected for intended procedure type. The category values for this column were already listed for column: DNR_VIR_TESTED_YN"
UNOS_CLIN_INFO_3,CIGARETTE_HX_YN,N,47,VARCHAR,No,"Indicates whether the donor has a history of cigarette use.
The category values for this column were already listed for column: DNR_VIR_TESTED_YN Indicates whether the donor has a history of cigarette use. The category values for this column were already listed for column: DNR_VIR_TESTED_YN"
UNOS_CLIN_INFO_3,UNOS_CGR_PCK_YR_C_NAME,N,48,VARCHAR,No,"The number of packs of cigarettes the donor smoked per day multiplied by the number of years if the donor has a history of cigarette use.
May contain organization-specific values: No
Category Entries:
0-10
11-20
21-30
31-40
41-50
>50
Unknown Pack Years The number of packs of cigarettes the donor smoked per day multiplied by the number of years if the donor has a history of cigarette use. May contain organization-specific values: No Category Entries: 0-10 11-20 21-30 31-40 41-50 >50 Unknown Pack Years"
UNOS_CLIN_INFO_3,UNOS_ABSTINENCE_C_NAME,N,49,VARCHAR,No,"The number of months the donor has abstained from cigarettes if the donor has a history of cigarette use.
May contain organization-specific values: No
Category Entries:
0-2 Months
3-12 Months
13-24 Months
25-36 Months
37-48 Months
49-60 Months
>60 Months
Continues to Smoke
Unknown Duration The number of months the donor has abstained from cigarettes if the donor has a history of cigarette use. May contain organization-specific values: No Category Entries: 0-2 Months 3-12 Months 13-24 Months 25-36 Months 37-48 Months 49-60 Months >60 Months Continues to Smoke Unknown Duration"
UNOS_CLIN_INFO_3,UNOS_OTH_TOBACCO_C_NAME,N,50,VARCHAR,No,"Indicates whether the donor has a history of other tobacco use.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME Indicates whether the donor has a history of other tobacco use. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,UNOS_DNR_DEATH_C_NAME,N,51,VARCHAR,No,"The cause of death if the living donor died.
May contain organization-specific values: No
Category Entries:
Infection: Donation/Surgery Related
Infection: Not Donation/Surgery Related
Pulmonary Embolism
Malignancy
Domino Liver Donor Transplant Related Death (Liver donors only)
Cardiovascular
CVA
Hemorrhage: Donation/Surgery Related
Hemorrhage: Not Donation/Surgery Related
Homicide
Suicide
Accidental
Other, Specify The cause of death if the living donor died. May contain organization-specific values: No Category Entries: Infection: Donation/Surgery Related Infection: Not Donation/Surgery Related Pulmonary Embolism Malignancy Domino Liver Donor Transplant Related Death (Liver donors only) Cardiovascular CVA Hemorrhage: Donation/Surgery Related Hemorrhage: Not Donation/Surgery Related Homicide Suicide Accidental Other, Specify"
UNOS_CLIN_INFO_3,NONAUTOLOG_BLOOD_YN,N,52,VARCHAR,No,"Indicates whether non-autologous blood was administered to the donor.
The category values for this column were already listed for column: DNR_VIR_TESTED_YN Indicates whether non-autologous blood was administered to the donor. The category values for this column were already listed for column: DNR_VIR_TESTED_YN"
UNOS_CLIN_INFO_3,PRBC_UNIT_NUM,N,53,INTEGER,No,The number of units the donor received for PRBC if non-autologous blood was administered to the donor. The number of units the donor received for PRBC if non-autologous blood was administered to the donor.
UNOS_CLIN_INFO_3,PLATELETS_UNIT_NUM,N,54,INTEGER,No,The number of units the donor received for platelets if non-autologous blood was administered to the donor. The number of units the donor received for platelets if non-autologous blood was administered to the donor.
UNOS_CLIN_INFO_3,FFP_UNIT_NUM,N,55,INTEGER,No,The number of units the donor received for FFP if non-autologous blood was administered to the donor. The number of units the donor received for FFP if non-autologous blood was administered to the donor.
UNOS_CLIN_INFO_3,KI_VSC_COMP_C_NAME,N,56,VARCHAR,No,"Indicates whether the donor experienced vascular complications requiring intervention during the first 6 weeks after the donation.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME Indicates whether the donor experienced vascular complications requiring intervention during the first 6 weeks after the donation. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,KI_VSC_COMP_OTH,N,57,VARCHAR,No,Free text description of the kidney vascular complication(s) if the donor experienced vascular complications requiring intervention during the first 6 weeks after the donation. Free text description of the kidney vascular complication(s) if the donor experienced vascular complications requiring intervention during the first 6 weeks after the donation.
UNOS_CLIN_INFO_3,KI_OTH_COMP_C_NAME,N,58,VARCHAR,No,"Indicates whether the donor experienced other complication requiring intervention during the first 6 weeks after the donation.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME Indicates whether the donor experienced other complication requiring intervention during the first 6 weeks after the donation. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,KI_OTH_COMP_SP,N,59,VARCHAR,No,Free text description of the kidney other complication(s) if the donor experienced vascular complications requiring intervention during the first 6 weeks after the donation. Free text description of the kidney other complication(s) if the donor experienced vascular complications requiring intervention during the first 6 weeks after the donation.
UNOS_CLIN_INFO_3,KI_REOP_C_NAME,N,60,VARCHAR,No,"Indicates whether the donor required reoperation the first 6 weeks after the donation.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME Indicates whether the donor required reoperation the first 6 weeks after the donation. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,KI_REOP_BLEEDING_YN,N,61,VARCHAR,No,"Indicates whether bleeding is the reason for reoperation during first six weeks.
May contain organization-specific values: No
Category Entries:
False
True Indicates whether bleeding is the reason for reoperation during first six weeks. May contain organization-specific values: No Category Entries: False True"
UNOS_CLIN_INFO_3,KI_REOP_BLEEDING_DT,N,62,DATETIME,No,The reoperation date if bleeding is the reason for reoperation during first six weeks. The reoperation date if bleeding is the reason for reoperation during first six weeks.
UNOS_CLIN_INFO_3,KI_REOP_HERN_REP_YN,N,63,VARCHAR,No,"Indicates whether hernia repair is the reason for reoperation during first six weeks.
The category values for this column were already listed for column: KI_REOP_BLEEDING_YN Indicates whether hernia repair is the reason for reoperation during first six weeks. The category values for this column were already listed for column: KI_REOP_BLEEDING_YN"
UNOS_CLIN_INFO_3,KI_REOP_HERN_REP_DT,N,64,DATETIME,No,The reoperation date if hernia repair is the reason for reoperation during first six weeks. The reoperation date if hernia repair is the reason for reoperation during first six weeks.
UNOS_CLIN_INFO_3,KI_REOP_BOW_OBST_YN,N,65,VARCHAR,No,"Indicates whether bowel obstruction is the reason for reoperation during first six weeks.
The category values for this column were already listed for column: KI_REOP_BLEEDING_YN Indicates whether bowel obstruction is the reason for reoperation during first six weeks. The category values for this column were already listed for column: KI_REOP_BLEEDING_YN"
UNOS_CLIN_INFO_3,KI_REOP_BOW_OBST_DT,N,66,DATETIME,No,The reoperation date if bowel obstruction is the reason for reoperation during first six weeks. The reoperation date if bowel obstruction is the reason for reoperation during first six weeks.
UNOS_CLIN_INFO_3,KI_REOP_VSC_YN,N,67,VARCHAR,No,"Indicates whether vascular is the reason for reoperation during first six weeks.
The category values for this column were already listed for column: KI_REOP_BLEEDING_YN Indicates whether vascular is the reason for reoperation during first six weeks. The category values for this column were already listed for column: KI_REOP_BLEEDING_YN"
UNOS_CLIN_INFO_3,KI_REOP_VSC_DT,N,68,DATETIME,No,The reoperation date if vascular is the reason for reoperation during first six weeks. The reoperation date if vascular is the reason for reoperation during first six weeks.
UNOS_CLIN_INFO_3,KI_REOP_OTH_YN,N,69,VARCHAR,No,"Indicates whether there is a specific reason for reoperation during first six weeks.
The category values for this column were already listed for column: KI_REOP_BLEEDING_YN Indicates whether there is a specific reason for reoperation during first six weeks. The category values for this column were already listed for column: KI_REOP_BLEEDING_YN"
UNOS_CLIN_INFO_3,KI_REOP_OTH_SP,N,70,VARCHAR,No,Free text description of the reason for reoperation during first six weeks. Free text description of the reason for reoperation during first six weeks.
UNOS_CLIN_INFO_3,KI_REOP_OTH_DT,N,71,DATETIME,No,The reoperation date if there is a specific reason for reoperation during first six weeks. The reoperation date if there is a specific reason for reoperation during first six weeks.
UNOS_CLIN_INFO_3,READMISSION_C_NAME,N,72,VARCHAR,No,"Indicates whether the donor required any readmission after the initial discharge during the first 6 weeks after the donation.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME Indicates whether the donor required any readmission after the initial discharge during the first 6 weeks after the donation. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,READMISSION_SP,N,73,VARCHAR,No,Free text description of the reason why the donor required readmission after the initial discharge during the first 6 weeks after the donation. Free text description of the reason why the donor required readmission after the initial discharge during the first 6 weeks after the donation.
UNOS_CLIN_INFO_3,READMISSION_DT,N,74,DATETIME,No,The date of the first readmission. The date of the first readmission.
UNOS_CLIN_INFO_3,KI_OTH_PROC_C_NAME,N,75,VARCHAR,No,"Indicates whether the donor required other interventional procedures after the initial discharge during the first 6 weeks after the donation.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME Indicates whether the donor required other interventional procedures after the initial discharge during the first 6 weeks after the donation. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,KI_OTH_PROC_SP,N,76,VARCHAR,No,Free text description of the procedure(s) if the donor required other interventional procedures after the initial discharge during the first 6 weeks after the donation. Free text description of the procedure(s) if the donor required other interventional procedures after the initial discharge during the first 6 weeks after the donation.
UNOS_CLIN_INFO_3,KI_OTH_PROC_DT,N,77,DATETIME,No,The date of procedure if the donor required other interventional procedures after the initial discharge during the first 6 weeks after the donation. The date of procedure if the donor required other interventional procedures after the initial discharge during the first 6 weeks after the donation.
UNOS_CLIN_INFO_3,POSTOP_BP_SYSTOLIC,N,78,INTEGER,No,The donor's systolic blood pressure within 6 weeks after the donation. The donor's systolic blood pressure within 6 weeks after the donation.
UNOS_CLIN_INFO_3,POSTOP_BP_SYST_ST_C_NAME,N,79,VARCHAR,No,"The reason why the donor's systolic blood pressure is not available.
The category values for this column were already listed for column: CANCER_FREE_ST_C_NAME The reason why the donor's systolic blood pressure is not available. The category values for this column were already listed for column: CANCER_FREE_ST_C_NAME"
UNOS_CLIN_INFO_3,POSTOP_BP_DIASTOLIC,N,80,INTEGER,No,The donor's diastolic blood pressure within 6 weeks after the donation. The donor's diastolic blood pressure within 6 weeks after the donation.
UNOS_CLIN_INFO_3,POSTOP_BP_DIAS_ST_C_NAME,N,81,VARCHAR,No,"The reason why the donor's diastolic blood pressure is not available.
The category values for this column were already listed for column: CANCER_FREE_ST_C_NAME The reason why the donor's diastolic blood pressure is not available. The category values for this column were already listed for column: CANCER_FREE_ST_C_NAME"
UNOS_CLIN_INFO_3,POSTOP_URINE_RATIO,N,82,NUMERIC,No,The donor's urinalysis protein-creatinine ratio within 6 weeks after the donation. The donor's urinalysis protein-creatinine ratio within 6 weeks after the donation.
UNOS_CLIN_INFO_3,POSTOP_URINE_PRTN_C_NAME,N,83,VARCHAR,No,"The donor's urinalysis urine protein within 6 weeks after the donation.
The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME The donor's urinalysis urine protein within 6 weeks after the donation. The category values for this column were already listed for column: VIR_CMV_NUC_ACID_C_NAME"
UNOS_CLIN_INFO_3,DNR_HYPERTNSN_MED_C_NAME,N,84,VARCHAR,No,"Indicates whether donor developed hypertension requiring medication within 6 weeks after the donation.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME Indicates whether donor developed hypertension requiring medication within 6 weeks after the donation. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,ORGAN_RECOVERY_DT,N,85,DATETIME,No,Date of donor organ recovery. Date of donor organ recovery.
UNOS_CLIN_INFO_3,UNOS_CATSCAN_C_NAME,N,86,VARCHAR,No,"Indicates whether a CAT scan was performed for the patient.
May contain organization-specific values: No
Category Entries:
Not Done
Yes, Normal Results
Yes, Specify Results
Unknown Indicates whether a CAT scan was performed for the patient. May contain organization-specific values: No Category Entries: Not Done Yes, Normal Results Yes, Specify Results Unknown"
UNOS_CLIN_INFO_3,UNOS_CATSCAN_SP,N,87,VARCHAR,No,The patient's CAT scan result. The patient's CAT scan result.
UNOS_CLIN_INFO_3,UNOS_MRI_C_NAME,N,88,VARCHAR,No,"Indicates whether an MRI was performed for the patient.
The category values for this column were already listed for column: UNOS_CATSCAN_C_NAME Indicates whether an MRI was performed for the patient. The category values for this column were already listed for column: UNOS_CATSCAN_C_NAME"
UNOS_CLIN_INFO_3,UNOS_MRI_SP,N,89,VARCHAR,No,The patient's MRI result. The patient's MRI result.
UNOS_CLIN_INFO_3,UNOS_ULTRASND_C_NAME,N,90,VARCHAR,No,"Indicates whether an ultrasound was performed for the patient.
The category values for this column were already listed for column: UNOS_CATSCAN_C_NAME Indicates whether an ultrasound was performed for the patient. The category values for this column were already listed for column: UNOS_CATSCAN_C_NAME"
UNOS_CLIN_INFO_3,UNOS_ULTRASND_SP,N,91,VARCHAR,No,The patient's ultrasound result. The patient's ultrasound result.
UNOS_CLIN_INFO_3,READMISSION_DT_ST_C_NAME,N,92,VARCHAR,No,"The reason why the first readmission date is not available.
The category values for this column were already listed for column: CANCER_FREE_ST_C_NAME The reason why the first readmission date is not available. The category values for this column were already listed for column: CANCER_FREE_ST_C_NAME"
UNOS_CLIN_INFO_3,KI_COMP_C_NAME,N,93,VARCHAR,No,"Indicates whether the donor experienced kidney complications.
The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME Indicates whether the donor experienced kidney complications. The category values for this column were already listed for column: VIR_CMV_DISEASE_C_NAME"
UNOS_CLIN_INFO_3,KI_COMP_SP,N,94,VARCHAR,No,Free text description of the type of kidney complications. Free text description of the type of kidney complications.
UNOS_CLIN_INFO_3,UNOS_DNR_DEATH_SP,N,95,VARCHAR,No,Free text description of the cause of death if the living donor died. Free text description of the cause of death if the living donor died.
UNOS_CLIN_INFO_3,UNOS_RECOVR_ORG_C_NAME,N,96,VARCHAR,No,"The organ recovered from the donor that is being addressed by this form.
May contain organization-specific values: No
Category Entries:
Right Kidney
Left Kidney
Pancreas Segment
Liver Segment
Intestine Segment
Living Donor Heart Transplant
Right Single Lung
Left Single Lung
Left Lung Lobe
Right Lung Lobe
Domino Whole Liver The organ recovered from the donor that is being addressed by this form. May contain organization-specific values: No Category Entries: Right Kidney Left Kidney Pancreas Segment Liver Segment Intestine Segment Living Donor Heart Transplant Right Single Lung Left Single Lung Left Lung Lobe Right Lung Lobe Domino Whole Liver"
UNOS_CLIN_INFO_4,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the registry data record. The unique identifier (.1 item) for the registry data record.
UNOS_CLIN_INFO_4,C_PEPTIDE,N,2,NUMERIC,No,The patient's most recent C-peptide lab value The patient's most recent C-peptide lab value
UNOS_CLIN_INFO_4,C_PEPTIDE_ST_C_NAME,N,3,VARCHAR,No,"The status item for the C-peptide result
May contain organization-specific values: No
Category Entries:
N/A
Not Done
Missing
Unknown The status item for the C-peptide result May contain organization-specific values: No Category Entries: N/A Not Done Missing Unknown"
UNOS_CLIN_INFO_4,HBA1C,N,4,NUMERIC,No,The patient's HbA1c The patient's HbA1c
UNOS_CLIN_INFO_4,HBA1C_ST_C_NAME,N,5,VARCHAR,No,"The HbA1c status for the patient
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The HbA1c status for the patient The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,PAT_ON_INSULIN_C_NAME,N,6,VARCHAR,No,"Whether the patient is on insulin
May contain organization-specific values: No
Category Entries:
Yes
No
Unknown Whether the patient is on insulin May contain organization-specific values: No Category Entries: Yes No Unknown"
UNOS_CLIN_INFO_4,INSULIN_RES_DT_C_NAME,N,7,VARCHAR,No,"The status for the insulin resumed date
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The status for the insulin resumed date The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,INSULIN_DOSE,N,8,INTEGER,No,The patient's insulin dosage The patient's insulin dosage
UNOS_CLIN_INFO_4,INSULIN_DOSE_DT_ST_C_NAME,N,9,VARCHAR,No,"The insulin dosage status
May contain organization-specific values: No
Category Entries:
N/A
Not Done
Missing
Unknown
Sliding Scale The insulin dosage status May contain organization-specific values: No Category Entries: N/A Not Done Missing Unknown Sliding Scale"
UNOS_CLIN_INFO_4,BLOOD_SUGAR_CTL_C_NAME,N,10,VARCHAR,No,"Indicates if the patient is using blood sugar control
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates if the patient is using blood sugar control The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,ORAL_BLD_SGR_MED_C_NAME,N,11,VARCHAR,No,"Indicates whether the patient is on oral medications for blood sugar control
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether the patient is on oral medications for blood sugar control The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,ORAL_MED_RSM_DT,N,12,DATETIME,No,The date the patient resumed oral medication for blood sugar control The date the patient resumed oral medication for blood sugar control
UNOS_CLIN_INFO_4,ORAL_MED_RSM_DT_S_C_NAME,N,13,VARCHAR,No,"The reason there is no blood sugar resumed date
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason there is no blood sugar resumed date The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,ON_DIABETIC_DIET_C_NAME,N,14,VARCHAR,No,"Indicates whether the patient is on a diabetic diet
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether the patient is on a diabetic diet The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,INSULIN_DUR,N,15,INTEGER,No,The insulin duration The insulin duration
UNOS_CLIN_INFO_4,INSULIN_DUR_ST_C_NAME,N,16,VARCHAR,No,"The insulin duration status
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The insulin duration status The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PFT1_DATE,N,17,DATETIME,No,The date of the transplant patient's first set of pulmonary function tests during the follow-up period. The date of the transplant patient's first set of pulmonary function tests during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_PFT1_DATE_ST_C_NAME,N,18,VARCHAR,No,"The reason the Pulmonary Function Test (1): Date test performed field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Pulmonary Function Test (1): Date test performed field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PFT1_FEV1,N,19,NUMERIC,No,The transplant patient's FEV1 in L for the first set of pulmonary function tests during the follow-up period. The transplant patient's FEV1 in L for the first set of pulmonary function tests during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_PFT1_FEV1_ST_C_NAME,N,20,VARCHAR,No,"The reason the Pulmonary Function Test (1): FEV1 field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Pulmonary Function Test (1): FEV1 field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PFT1_FVC,N,21,NUMERIC,No,The transplant patient's FVC in L for the first set of pulmonary function tests during the follow-up period. The transplant patient's FVC in L for the first set of pulmonary function tests during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_PFT1_FVC_ST_C_NAME,N,22,VARCHAR,No,"The reason the Pulmonary Function Test (1): FVC field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Pulmonary Function Test (1): FVC field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PFT1_FEF2575,N,23,NUMERIC,No,The transplant patient's FEF 25-75 in L/sec for the first set of pulmonary function tests during the follow-up period. The transplant patient's FEF 25-75 in L/sec for the first set of pulmonary function tests during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_PFT1_FEF_ST_C_NAME,N,24,VARCHAR,No,"The reason the Pulmonary Function Test (1): FEF 25-75 field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Pulmonary Function Test (1): FEF 25-75 field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PFT2_DATE,N,25,DATETIME,No,The date of the transplant patient's second set of pulmonary function tests during the follow-up period. The date of the transplant patient's second set of pulmonary function tests during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_PFT2_DATE_ST_C_NAME,N,26,VARCHAR,No,"The reason the Pulmonary Function Test (2): Date test performed field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Pulmonary Function Test (2): Date test performed field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PFT2_FEV1,N,27,NUMERIC,No,The transplant patient's FEV1 in L for the second set of pulmonary function tests during the follow-up period. The transplant patient's FEV1 in L for the second set of pulmonary function tests during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_PFT2_FEV1_ST_C_NAME,N,28,VARCHAR,No,"The reason the Pulmonary Function Test (2): FEV1 field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Pulmonary Function Test (2): FEV1 field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PFT2_FVC,N,29,NUMERIC,No,The transplant patient's FVC in L for the second set of pulmonary function tests during the follow-up period. The transplant patient's FVC in L for the second set of pulmonary function tests during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_PFT2_FVC_ST_C_NAME,N,30,VARCHAR,No,"The reason the Pulmonary Function Test (2): FVC field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Pulmonary Function Test (2): FVC field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PFT2_FEF2575,N,31,NUMERIC,No,The transplant patient's FEF 25-75 in L/sec for the second set of pulmonary function tests during the follow-up period. The transplant patient's FEF 25-75 in L/sec for the second set of pulmonary function tests during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_PFT2_FEF_ST_C_NAME,N,32,VARCHAR,No,"The reason the Pulmonary Function Test (2): FEF 25-75 field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Pulmonary Function Test (2): FEF 25-75 field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PFT3_DATE,N,33,DATETIME,No,The date of the transplant patient's third set of pulmonary function tests during the follow-up period. The date of the transplant patient's third set of pulmonary function tests during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_PFT3_DATE_ST_C_NAME,N,34,VARCHAR,No,"The reason the Pulmonary Function Test (3): Date test performed field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Pulmonary Function Test (3): Date test performed field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PFT3_FEV1,N,35,NUMERIC,No,The transplant patient's FEV1 in L for the third set of pulmonary function tests during the follow-up period. The transplant patient's FEV1 in L for the third set of pulmonary function tests during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_PFT3_FEV1_ST_C_NAME,N,36,VARCHAR,No,"The reason the Pulmonary Function Test (3): FEV1 field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Pulmonary Function Test (3): FEV1 field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PFT3_FVC,N,37,NUMERIC,No,The transplant patient's FVC in L for the third set of pulmonary function tests during the follow-up period. The transplant patient's FVC in L for the third set of pulmonary function tests during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_PFT3_FVC_ST_C_NAME,N,38,VARCHAR,No,"The reason the Pulmonary Function Test (3): FVC field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Pulmonary Function Test (3): FVC field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PFT3_FEF2575,N,39,NUMERIC,No,The transplant patient's FEF 25-75 in L/sec for the third set of pulmonary function tests during the follow-up period. The transplant patient's FEF 25-75 in L/sec for the third set of pulmonary function tests during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_PFT3_FEF_ST_C_NAME,N,40,VARCHAR,No,"The reason the Pulmonary Function Test (3): FEF 25-75 field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Pulmonary Function Test (3): FEF 25-75 field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_SUPPO2_YN,N,41,VARCHAR,No,"Whether the transplant patient required supplemental oxygen during the follow-up period.
May contain organization-specific values: No
Category Entries:
Yes
No Whether the transplant patient required supplemental oxygen during the follow-up period. May contain organization-specific values: No Category Entries: Yes No"
UNOS_CLIN_INFO_4,UNOS_FIO2_REST,N,42,INTEGER,No,The transplant patient's percentage of inspired oxygen required at rest during the follow-up period. The transplant patient's percentage of inspired oxygen required at rest during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_FIO2_REST_ST_C_NAME,N,43,VARCHAR,No,"The reason the FiO2 at rest field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the FiO2 at rest field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_O2FLOW_REST,N,44,NUMERIC,No,The transplant patient's oxygen flow required at rest in L/min during the follow-up period. The transplant patient's oxygen flow required at rest in L/min during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_O2FLOW_REST_ST_C_NAME,N,45,VARCHAR,No,"The reason the Flow at rest field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Flow at rest field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_FIO2_EXERCISE,N,46,INTEGER,No,The transplant patient's percentage of inspired oxygen required with exercise during the follow-up period. The transplant patient's percentage of inspired oxygen required with exercise during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_FIO2_EXERCISE_ST_C_NAME,N,47,VARCHAR,No,"The reason the FiO2 with exercise field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the FiO2 with exercise field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_O2FLOW_EXERCISE,N,48,NUMERIC,No,The transplant patient's oxygen flow required with exercise in L/min during the follow-up period. The transplant patient's oxygen flow required with exercise in L/min during the follow-up period.
UNOS_CLIN_INFO_4,UNOS_O2FLOW_EXERCISE_ST_C_NAME,N,49,VARCHAR,No,"The reason the Flow with exercise field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the Flow with exercise field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_EPSD_VT_C_NAME,N,50,VARCHAR,No,"Indicates whether the transplant patient had ventilatory support.
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether the transplant patient had ventilatory support. The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,UNOS_EPSD_VT_TIME_C_NAME,N,51,VARCHAR,No,"The timeframe of the transplant patient’s ventilatory support.
May contain organization-specific values: No
Category Entries:
At time of transplant
Within 3 months of transplant
> 3 months prior to transplant The timeframe of the transplant patient’s ventilatory support. May contain organization-specific values: No Category Entries: At time of transplant Within 3 months of transplant > 3 months prior to transplant"
UNOS_CLIN_INFO_4,UNOS_TRACH_C_NAME,N,52,VARCHAR,No,"Indicates whether the transplant patient had a tracheostomy.
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether the transplant patient had a tracheostomy. The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,UNOS_HR_PROC_C_NAME,N,53,VARCHAR,No,"The heart procedure used for the transplant.
May contain organization-specific values: No
Category Entries:
Orthotopic Bicaval
Orthotopic Traditional
Orthotopic Total (Bicaval, PV)
Heterotopic The heart procedure used for the transplant. May contain organization-specific values: No Category Entries: Orthotopic Bicaval Orthotopic Traditional Orthotopic Total (Bicaval, PV) Heterotopic"
UNOS_CLIN_INFO_4,UNOS_HRHL_ISCH,N,54,INTEGER,No,The heart total ischemia time in minutes. The heart total ischemia time in minutes.
UNOS_CLIN_INFO_4,UNOS_HRHL_ISCH_ST_C_NAME,N,55,VARCHAR,No,"The reason why the heart total ischemia time field is empty.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason why the heart total ischemia time field is empty. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_LLU_ISCH,N,56,INTEGER,No,The left lung total ischemia time in minutes. Submitted to UNOS for field name lu_isch. The left lung total ischemia time in minutes. Submitted to UNOS for field name lu_isch.
UNOS_CLIN_INFO_4,UNOS_LLU_ISCH_ST_C_NAME,N,57,VARCHAR,No,"The reason why the left lung total ischemia time field is empty. Submitted to UNOS for field name lu_isch_i.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason why the left lung total ischemia time field is empty. Submitted to UNOS for field name lu_isch_i. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_RLU_ISCH,N,58,INTEGER,No,The right lung total ischemia time in minutes. Submitted to UNOS for field name lu2_isch. The right lung total ischemia time in minutes. Submitted to UNOS for field name lu2_isch.
UNOS_CLIN_INFO_4,UNOS_RLU_ISCH_ST_C_NAME,N,59,VARCHAR,No,"The reason why the right lung total ischemia time field is empty. Submitted to UNOS for field name lu2_isch_i.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason why the right lung total ischemia time field is empty. Submitted to UNOS for field name lu2_isch_i. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PST_STROKE_C_NAME,N,60,VARCHAR,No,"Indicates whether the transplant patient had a stroke post-transplant but prior to discharge.
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether the transplant patient had a stroke post-transplant but prior to discharge. The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PST_DIALYSIS_C_NAME,N,61,VARCHAR,No,"Indicates whether the transplant patient had dialysis post-transplant but prior to discharge.
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether the transplant patient had dialysis post-transplant but prior to discharge. The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PST_VENT_C_NAME,N,62,VARCHAR,No,"Indicates whether the transplant patient had ventilator support post-transplant but prior to discharge.
May contain organization-specific values: No
Category Entries:
No
Ventilator support for <= 48 hours
Ventilator support for > 48 hours but < 5 days
Ventilator support for >= 5 days
Ventilator support, duration unknown
Unknown status Indicates whether the transplant patient had ventilator support post-transplant but prior to discharge. May contain organization-specific values: No Category Entries: No Ventilator support for <= 48 hours Ventilator support for > 48 hours but < 5 days Ventilator support for >= 5 days Ventilator support, duration unknown Unknown status"
UNOS_CLIN_INFO_4,UNOS_PST_REINTUB_C_NAME,N,63,VARCHAR,No,"Indicates whether the transplant patient was reintubated post-transplant but prior to discharge.
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether the transplant patient was reintubated post-transplant but prior to discharge. The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PST_AIR_DEHI_C_NAME,N,64,VARCHAR,No,"Indicates whether the transplant patient had airway dehiscence post-transplant but prior to discharge.
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether the transplant patient had airway dehiscence post-transplant but prior to discharge. The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PRE_A_TITER_C_NAME,N,65,VARCHAR,No,"The transplant patient's most recent pre-transplant anti-A titer. This field only applies if the recipient's ABO blood type is B or O.
May contain organization-specific values: No
Category Entries:
1:0
1:1
1:2
1:4
1:8
1:16
1:32
1:64
1:128
1:256
Not Taken
Not Available The transplant patient's most recent pre-transplant anti-A titer. This field only applies if the recipient's ABO blood type is B or O. May contain organization-specific values: No Category Entries: 1:0 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 Not Taken Not Available"
UNOS_CLIN_INFO_4,UNOS_PRE_TITER_A_DT,N,66,DATETIME,No,The date of the transplant patient's most recent pre-transplant anti-A titer. The date of the transplant patient's most recent pre-transplant anti-A titer.
UNOS_CLIN_INFO_4,UNOS_PRE_B_TITER_C_NAME,N,67,VARCHAR,No,"The transplant patient's most recent pre-transplant anti-B titer. This field only applies if the recipient's ABO blood type is A or O.
The category values for this column were already listed for column: UNOS_PRE_A_TITER_C_NAME The transplant patient's most recent pre-transplant anti-B titer. This field only applies if the recipient's ABO blood type is A or O. The category values for this column were already listed for column: UNOS_PRE_A_TITER_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PRE_TITER_B_DT,N,68,DATETIME,No,The date of the transplant patient's most recent pre-transplant anti-B titer. The date of the transplant patient's most recent pre-transplant anti-B titer.
UNOS_CLIN_INFO_4,UNOS_CARDIAC_INDEX,N,69,INTEGER,No,The transplant patient's most recent cardiac index in L/min/m^2 during the reporting period. The transplant patient's most recent cardiac index in L/min/m^2 during the reporting period.
UNOS_CLIN_INFO_4,UNOS_INTUB_72HR_C_NAME,N,70,VARCHAR,No,"Indicates whether the transplant patient was intubated at 72 hours after transplant.
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether the transplant patient was intubated at 72 hours after transplant. The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PAO2_72HR,N,71,INTEGER,No,The transplant patient's PaO2 in mm/Hg at 72 hours after transplant. The transplant patient's PaO2 in mm/Hg at 72 hours after transplant.
UNOS_CLIN_INFO_4,UNOS_FIO2_72HR,N,72,INTEGER,No,The transplant patient's percentage of inspired oxygen required at 72 hours after transplant. The transplant patient's percentage of inspired oxygen required at 72 hours after transplant.
UNOS_CLIN_INFO_4,UNOS_EMCO_72HR_C_NAME,N,73,VARCHAR,No,"Indicates whether extracorporeal membrane oxygenation was used on the transplant patient at 72 hours after transplant.
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether extracorporeal membrane oxygenation was used on the transplant patient at 72 hours after transplant. The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,UNOS_NO_72HR_C_NAME,N,74,VARCHAR,No,"Indicates whether the transplant patient inhaled nitric oxide at 72 hours after transplant.
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether the transplant patient inhaled nitric oxide at 72 hours after transplant. The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PAO2_72HR_ST_C_NAME,N,75,VARCHAR,No,"The reason the PaO2 at 72 hours field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the PaO2 at 72 hours field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_FIO2_72HR_ST_C_NAME,N,76,VARCHAR,No,"The reason the FiO2 at 72 hours field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason the FiO2 at 72 hours field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_LU_PERFUSED_YN,N,77,VARCHAR,No,"Indicates whether the transplant organs were perfused prior to transplant.
May contain organization-specific values: No
Category Entries:
No
Yes Indicates whether the transplant organs were perfused prior to transplant. May contain organization-specific values: No Category Entries: No Yes"
UNOS_CLIN_INFO_4,UNOS_PERFSN_LOC_C_NAME,N,78,VARCHAR,No,"The location at which the transplant organs were perfused prior to transplant.
May contain organization-specific values: No
Category Entries:
Recovery Site (Donor Hospital)
OPO
Transplant Hospital - Transplant Site
Transplant Hospital - Not Transplant Site
External Perfusion Center The location at which the transplant organs were perfused prior to transplant. May contain organization-specific values: No Category Entries: Recovery Site (Donor Hospital) OPO Transplant Hospital - Transplant Site Transplant Hospital - Not Transplant Site External Perfusion Center"
UNOS_CLIN_INFO_4,UNOS_PERFSN_PERF_C_NAME,N,79,VARCHAR,No,"Who performed the perfusion on the transplant organs prior to transplant.
May contain organization-specific values: No
Category Entries:
OPO
Transplant program
External perfusion center Who performed the perfusion on the transplant organs prior to transplant. May contain organization-specific values: No Category Entries: OPO Transplant program External perfusion center"
UNOS_CLIN_INFO_4,UNOS_TIME_ON_PERFSN,N,80,INTEGER,No,The total time in minutes the transplant organs were on perfusion prior to transplant. The total time in minutes the transplant organs were on perfusion prior to transplant.
UNOS_CLIN_INFO_4,UNOS_TIME_PERF_ST_C_NAME,N,81,VARCHAR,No,"The reason why the total time on perfusion field is blank.
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The reason why the total time on perfusion field is blank. The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_LLU_RCD_C_NAME,N,82,VARCHAR,No,"How the left lung was received at the transplant center.
May contain organization-specific values: No
Category Entries:
On ice
On pump, stayed on pump
On pump, put on ice How the left lung was received at the transplant center. May contain organization-specific values: No Category Entries: On ice On pump, stayed on pump On pump, put on ice"
UNOS_CLIN_INFO_4,UNOS_RLU_RCD_C_NAME,N,83,VARCHAR,No,"How the right lung was received at the transplant center.
The category values for this column were already listed for column: UNOS_LLU_RCD_C_NAME How the right lung was received at the transplant center. The category values for this column were already listed for column: UNOS_LLU_RCD_C_NAME"
UNOS_CLIN_INFO_4,SURG_NAME,N,84,VARCHAR,No,The name of the surgeon who last saw the transplant patient. The name of the surgeon who last saw the transplant patient.
UNOS_CLIN_INFO_4,SURG_NPI,N,85,VARCHAR,No,The National Provider Identifier (NPI) of the surgeon who last saw the transplant patient. The National Provider Identifier (NPI) of the surgeon who last saw the transplant patient.
UNOS_CLIN_INFO_4,UNOS_STEROID_C_NAME,N,86,VARCHAR,No,"Indicates whether the transplant patient has a chronic steroid prescription.
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether the transplant patient has a chronic steroid prescription. The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,UNOS_TRNSFSNS_C_NAME,N,87,VARCHAR,No,"Indicates whether the transplant patient has undergone transfusions between listing and transplant.
The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME Indicates whether the transplant patient has undergone transfusions between listing and transplant. The category values for this column were already listed for column: PAT_ON_INSULIN_C_NAME"
UNOS_CLIN_INFO_4,UNOS_HL_PROC_TYP_C_NAME,N,88,VARCHAR,No,"The heart or lung procedure type used for the transplant.
May contain organization-specific values: No
Category Entries:
Heart
Heart Lung
Single Left Lung
Single Right Lung
Bilateral Sequential Lung
En-Bloc Double Lung
Right Lobe
Left Lobe The heart or lung procedure type used for the transplant. May contain organization-specific values: No Category Entries: Heart Heart Lung Single Left Lung Single Right Lung Bilateral Sequential Lung En-Bloc Double Lung Right Lobe Left Lobe"
UNOS_CLIN_INFO_4,UNOS_PA_PRIM_DX_C_NAME,N,89,VARCHAR,No,"UNOS pancreas primary diagnosis
May contain organization-specific values: No
Category Entries:
Allergic Bronchopulmonary Aspergillosis
Bronchopulmonary Dysplasia
Ciliary Dyskinesis Syndrome
Constrictive Bronchiolitis
Dysmotile Cilia Syndrome
Granulomatous Lung Disease
Kartagener's Syndrome
Obstructive Lung Disease
Primary Ciliary Dyskinesia
Tuberous Sclerosis
Congenital Malformation
Peripheral Pulm Artery Stenosis
Portopulmonary Hypertension
Pulmonary AV Malformation Congenital Heart Disease
Pulmonary Thromboembolic Disease
Pulmonary Veno-Occlusive Disease
Pulmonic Stenosis
Right Hypoplastic Lung
Thromboembolic Pulmonary Hypertension
Wegener's Granuloma - Restrictive
Wegener's Granuloma - Bronchiectasis
Crest - Restrictive
Crest - Pulmonary Hypertension
Pulmonary Telengectasia - Restrictive
Pulmonary Telengectasia - Pulmonary Hypertension
Scleroderma - Restrictive
Scleroderma - Pulmonary Hypertension
Common Variable Immune Deficiency
Fibrocavitary Lung Disease
Hypogammaglobulinemia
Shwachman-Diamond Syndrome
Alveolar Proteinosis
Amyloidosis
ARDS/Pnuemonia
IIP: BOOP/COP
Bronchoalveolar Carcinoma (BAC)
Carcinoid Tumorlets
Chronic Pneumonitis of Infancy
Collagen Vascular Diseases
Connective Tissue Disease
Crest
Cutis Laxa
Desquamative Interstitial Pneumonitis (DIP)
Ehlers-Danlos Syndrome
Eosinophilic Granuloma
Eosinophilic Granulomatosis
Eosinophilic Pneumonial Chronic Granulomatosis
Fibrosing Mediastinitis
Graft-vs-Host Disease (GVHD)
Hermansky Pudlak Syndrome
Histiocytosis X
Hypersensitivity Pneumonitis
Idiopathic Pulmonary Hemosiderosis
Interstitial Pneumonitis
IIP: Lymphocytic Interstitial Pneumonia
Lupus
Macleod Syndrome
Mixed Connective Tissue Disease
Paraneoplastic Pemphigus Associated Castleman's Disease
Polymyositis
Pulmonary Hyalinizing Granuloma
Pulmonary Langerhans Cell Granulomatosis
Pulmonary Telengectasia
Restrictive Lung Disease
Sjogren's Syndrome
Silicosis
Surfactant Protein B Deficiency
Swyer James Syndrome
Teratoma
Tracheopathia Osteoplastica
Usual Interstitial Pneumonitis
Wegener's Granuloma
Other, Specify
Dilated Myopathy: Idiopathic
Dilated Myopathy: Adriamycin
Dilated Myopathy: Post Partum
Dilated Myopathy: Familial
Dilated Myopathy: Myocarditis
Dilated Myopathy: Alcoholic
Dilated Myopathy: Viral
Dilated Myopathy: Ischemic
Dilated Myopathy: Viral (Not COVID-19)
COVID-19: Dilated Myopathy: Active Myocarditis
COVID-19: Dilated Myopathy: History of Myocarditis
Dilated Myopathy: Other, Specify
Restrictive Myopathy: Idiopathic
Restrictive Myopathy: Amyloidosis
Restrictive Myopathy: Endocardial Fibros
Restrictive Myopathy: Sarcoidosis
Restrictive Myopathy: Sec to Radiat/Chem
Restrictive Myopathy: Other, Specify
Heart Re-TX/GF: Hyperacute Rejection
Heart Re-TX/GF: Acute Rejection
Heart Re-TX/GF: Coronary Artery Disease
Heart Re-TX/GF: Non-Specific
Heart Re-TX/GF: Restrictive/Constrictive
Heart Re-TX/GF: Chronic Rejection
Heart Re-TX/GF: Primary Failure
Heart Re-TX/GF: Other, Specify
Coronary Artery Disease
Hypertrophic Cardiomyopathy
Valvular Heart Disease
Congenital Heart Defect - Prior Surgery Unknown
Cancer
Congenital Heart Defect - Hypoplastic Left Heart Syndrome - Unoperated
Congenital Heart Defect - Without Surgery
Congenital Heart Defect - With Surgery
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Muscular Dystrophy: Other Specify
Eisenmenger's Syn: Atrial Septal Defec
Eisenmenger's Syn: VSD
Eisenmenger's Syn: PDA
Pulmonary Capillary Hemangiomatosis
ABCA3 Transporter Mutation
Secondary Pulmonary Fibrosis: Specify Cause
Surfactant Protein C Deficiency
IIP: Nonspecific Interstitial Pneumonia
IIP: Respiratory Bronchiolitis
IIP: Desquamative Interstitial Pneumonia
IIP: Acute Interstitial Pneumonia
Pulmonary Lymphangiectasia
Eisenmenger's Syn: Multi Congenital Anomalies
Eisenmenger's Syn: Other Specify
Lung Re-TX/GF: Non-Specific
Lung Re-TX/GF: Obliterative Bronchioliti
Lung Re-TX/GF: Restrictive
Lung Re-TX/GF: Acute Rejection
Lung Re-TX/GF: Obstructive
Lung Re-TX/GF: Primary Graft Failure
Lung Re-Tx/GF: Obliterative Bronchiolitis-Restrictive
Lung Re-Tx/GF: Obliterative Bronchiolits-Obstructive
Lung Re-TX/GF: Other Specify
Pulmonary Hypertension/Pulmonary Arterial Hypertension
Cystic Fibrosis
Inhalation Burns/Trauma
IIP: Idiopathic Pulmonary Fibrosis
Sarcoidosis
Alpha - 1 - Antitrypsin Deficiency
COPD/Emphysema
Bronchiectasis
Rheumatoid Disease
Occupational Lung Disease: Other, Specify
Lymphangioleiomyomatosis
Obliterative Bronchiolitis (Non-Retransplant)
Pulmonary Fibrosis: Other Specify Cause
Pulmonary Vascular Disease
Secondary Pulmonary Hypertension
COVID-19: ARDS
COVID-19: Pulmonary Fibrosis
Combined Pulmonary Fibrosis and Emphysema (CPFE)
Heart/Lung Re-TX/GF: Primary Failure
Idio/Post-Infection Crescentic Glomerulonephri
Membranous Glomerulonephritis
Mesangio-Capillary 1 Glomerulonephritis
Mesangio-Capillary 2 Glomerulonephritis
IGA Nephropathy
Anti-GBM
Focal Glomerular Sclerosis (Focal Segmental - FGS)
Chronic Pyelonephritis/Reflux Nephropath
Polycystic Kidneys
Nephritis
Nephronophthisis
Diabetes - Type I Insulin Dep/Juv Onset
Diabetes - Type II Non-Insulin Dep/Adult
Oxalate Nephropathy (Includes Hereditary Oxalosis)
Cystinosis
Fabry's Disease
Amyloidosis
Gout
Systemic Lupus Erythematosus
Progressive Systemic Sclerosis
Wilms' Tumor
Renal Cell Carcinoma
Incidental Carcinoma
Myeloma
Hemolytic Uremic Syndrome
Hypoplasia/Dysplasia/Dysgensis/Agenesis
Cortical Necrosis
Acute Tubular Necrosis
Medullary Cystic Disease
Sickle Cell Anemia
Acquired Obstructive Nephropathy
Alport's Syndrome
Familial Nephropathy
Goodpasture's Syndrome
Malignant Hypertension
Henoch-Schoenlein Purpura
Prune Belly Syndrome
Retransplant/Graft Failure
Diabetes - Type I Non-Insulin Dep/Juv On
Diabetes - Type II Insulin Dep/Adult Ons
Hypertensive Nephrosclerosis
Chronic Glomerulonephritis Unspecified
Membranous Nephropathy
Chronic Glomerulosclerosis Unspecified
Analgesic Nephropathy
Radiation Nephritis
Antibiotic-Induced Nephritis
Cancer Chemotherapy Induced Nephritis
Calcineurin Inhibitor Nephrotoxicity
Heroin Nephrotoxicity
Renal Artery Thrombosis
Chronic Nephrosclerosis-Unspecified
Congenital Obstructive Uropathy
Scleroderma
Wegeners Granulomatosis
Polyarteritis
Rheumatoid Arthritis
Sarcoidosis
Lymphoma
Nephrolithiasis
Urolithiasis
Pre-BMT Total Body Irradiation
Drug Related Interstitial Nephritis
Thin Basement Membrane Disease
Cholesterol Embolization
Rapid Progressive Glomerulonephritis (Rpgn)
Diabetes Mellitus - Type I
Diabetes Mellitus - Type II
Diabetes Mellitus - Type Other / Unknown
Hepatorenal Syndrome
Lithium Toxicity
HIV Nephropathy
AHN: Drug Other, Specify
AHN: Type A
AHN: Type B- Hbsag+
AHN: Type C
AHN: Type D
AHN: Type B and C
AHN: Type B and D
AHN: Etiology Unknown
AHN: Other, Specify (e.g., Acute Viral Infection, Autoimmune Hepatitis - Fulminant)
Cirrhosis: Drug/Indust Exposure Other, Specify
Cirrhosis: Type A
Cirrhosis: Type B- Hbsag+
Cirrhosis: Type C
Cirrhosis: Type D
Cirrhosis: Type B and C
Cirrhosis: Type B and D
Cirrhosis: Cryptogenic- Idiopathic
Cirrhosis: Chronic Active Hepatitis: Etiology Unknown
Cirrhosis: Other, Specify (e.g., Histiocytosis, Sarcoidosis, Granulomatous)
Cirrhosis: Autoimmune
Cirrhosis: Cryptogenic (Idiopathic)
Cirrhosis: Fatty Liver (NASH)
Alcoholic Cirrhosis
Alcoholic Cirrhosis w/ Hepatitis C
Acute Alcoholic Hepatitis
Acute Alcohol-Associated Hepatitis With or Without Cirrhosis
Alcohol-Associated Cirrhosis Without Acute Alcohol-Associated Hepatitis
Primary Biliary Cirrhosis (PBC)
Cirrhosis: Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Cirrhosis: Metabolic Dysfunction and Alcohol-Related/Associated Liver Disease (MetALD)
Sec Biliary Cirrhosis: Caroli's Disease
Sec Biliary Cirrhosis: Choledochol Cyst
Sec Biliary Cirrhosis: Other, Specify
PSC: Crohn's Disease
PSC: Ulcerative Colitis
PSC: No Bowel Disease
PSC: Other, Specify
Familial Cholestasis: Byler's Disease
Familial Cholestasis: Other, Specify
Choles Liver Disease: Other, Specify
Neonatal Cholestatic Liver Disease
Neonatal Hepatitis Other, Specify
Biliary Atresia: Extrahepatic
Biliary Hypoplasia: Nonsyndromic Paucity of Intrahepatic Bile Duct
Biliary Hypoplasia: Alagille's Syndrome (Paucity of Intrahepatic Bile Duct)
Biliary Atresia or Hypoplasia: Other, Specify
Congenital Hepatic Fibrosis
Cystic Fibrosis
Budd-Chiari Syndrome
Metdis: Alpha-1-Antitrypsin Defic A-1-A
Metdis: Wilson's Disease, Other Copper Metabolism Disorder
Metdis: Hemochromatosis - Hemosiderosis
Metdis: Glyc Stor Dis Type I (GSD-I)
Metdis: Glyc Stor Dis Type IV (GSD-IV)
Metdis: Hyperlipidemia-II, Homozygous Hypercholesterolemia
Metdis: Tyrosinemia
Metdis: Primary Oxalosis/Oxaluria, Hyperoxaluria
Metdis: Maple Syrup Urine Disease
Metdis: Other, Specify
PLM: Hepatoma - Hepatocellular Carcinoma
PLM: Hepatoma (HCC) and Cirrhosis
PLM: Fibrolamellar (FL-HC)
PLM: Cholangiocarcinoma (CH-CA)
PLM: Hepatoblastoma (HBL)
PLM: Hemangioendothelioma, Hemangiosarcoma, Angiosarcoma
PLM: Other, Specify (i.e., Klatzkin Tumor, Leiomysarcoma)
Bile Duct Cancer: (Cholangioma, Biliary Tract Carcinoma)
Secondary Hepatic Malignancy Other, Specify
Benign Tumor: Hepatic Adenoma
Benign Tumor: Polycystic Liver Disease
Benign Tumor: Other, Specify
TPN/Hyperalimentation Ind Liver Disease
Graft vs. Host Dis Sec to Non-Liver Txp
Trauma Other, Specify
Graft Failure
Retransplant/Graft Failure Pancreas
Diabetes Mellitus - Type I (Pancreas)
Diabetes Mellitus - Type II (Pancreas)
Diabetes Secondary to Chronic Pancreatitis without Pancreatectomy
Diabetes Secondary to Cystic Fibrosis without Pancreatectomy
Pancreatic Cancer
Bile Duct Cancer
Other Cancers
Pancreatectomy Prior to Pancreas Transplant
Diabetes Mellitus - Type Other/Unknown (Pancreas) UNOS pancreas primary diagnosis May contain organization-specific values: No Category Entries: Allergic Bronchopulmonary Aspergillosis Bronchopulmonary Dysplasia Ciliary Dyskinesis Syndrome Constrictive Bronchiolitis Dysmotile Cilia Syndrome Granulomatous Lung Disease Kartagener's Syndrome Obstructive Lung Disease Primary Ciliary Dyskinesia Tuberous Sclerosis Congenital Malformation Peripheral Pulm Artery Stenosis Portopulmonary Hypertension Pulmonary AV Malformation Congenital Heart Disease Pulmonary Thromboembolic Disease Pulmonary Veno-Occlusive Disease Pulmonic Stenosis Right Hypoplastic Lung Thromboembolic Pulmonary Hypertension Wegener's Granuloma - Restrictive Wegener's Granuloma - Bronchiectasis Crest - Restrictive Crest - Pulmonary Hypertension Pulmonary Telengectasia - Restrictive Pulmonary Telengectasia - Pulmonary Hypertension Scleroderma - Restrictive Scleroderma - Pulmonary Hypertension Common Variable Immune Deficiency Fibrocavitary Lung Disease Hypogammaglobulinemia Shwachman-Diamond Syndrome Alveolar Proteinosis Amyloidosis ARDS/Pnuemonia IIP: BOOP/COP Bronchoalveolar Carcinoma (BAC) Carcinoid Tumorlets Chronic Pneumonitis of Infancy Collagen Vascular Diseases Connective Tissue Disease Crest Cutis Laxa Desquamative Interstitial Pneumonitis (DIP) Ehlers-Danlos Syndrome Eosinophilic Granuloma Eosinophilic Granulomatosis Eosinophilic Pneumonial Chronic Granulomatosis Fibrosing Mediastinitis Graft-vs-Host Disease (GVHD) Hermansky Pudlak Syndrome Histiocytosis X Hypersensitivity Pneumonitis Idiopathic Pulmonary Hemosiderosis Interstitial Pneumonitis IIP: Lymphocytic Interstitial Pneumonia Lupus Macleod Syndrome Mixed Connective Tissue Disease Paraneoplastic Pemphigus Associated Castleman's Disease Polymyositis Pulmonary Hyalinizing Granuloma Pulmonary Langerhans Cell Granulomatosis Pulmonary Telengectasia Restrictive Lung Disease Sjogren's Syndrome Silicosis Surfactant Protein B Deficiency Swyer James Syndrome Teratoma Tracheopathia Osteoplastica Usual Interstitial Pneumonitis Wegener's Granuloma Other, Specify Dilated Myopathy: Idiopathic Dilated Myopathy: Adriamycin Dilated Myopathy: Post Partum Dilated Myopathy: Familial Dilated Myopathy: Myocarditis Dilated Myopathy: Alcoholic Dilated Myopathy: Viral Dilated Myopathy: Ischemic Dilated Myopathy: Viral (Not COVID-19) COVID-19: Dilated Myopathy: Active Myocarditis COVID-19: Dilated Myopathy: History of Myocarditis Dilated Myopathy: Other, Specify Restrictive Myopathy: Idiopathic Restrictive Myopathy: Amyloidosis Restrictive Myopathy: Endocardial Fibros Restrictive Myopathy: Sarcoidosis Restrictive Myopathy: Sec to Radiat/Chem Restrictive Myopathy: Other, Specify Heart Re-TX/GF: Hyperacute Rejection Heart Re-TX/GF: Acute Rejection Heart Re-TX/GF: Coronary Artery Disease Heart Re-TX/GF: Non-Specific Heart Re-TX/GF: Restrictive/Constrictive Heart Re-TX/GF: Chronic Rejection Heart Re-TX/GF: Primary Failure Heart Re-TX/GF: Other, Specify Coronary Artery Disease Hypertrophic Cardiomyopathy Valvular Heart Disease Congenital Heart Defect - Prior Surgery Unknown Cancer Congenital Heart Defect - Hypoplastic Left Heart Syndrome - Unoperated Congenital Heart Defect - Without Surgery Congenital Heart Defect - With Surgery Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Muscular Dystrophy: Other Specify Eisenmenger's Syn: Atrial Septal Defec Eisenmenger's Syn: VSD Eisenmenger's Syn: PDA Pulmonary Capillary Hemangiomatosis ABCA3 Transporter Mutation Secondary Pulmonary Fibrosis: Specify Cause Surfactant Protein C Deficiency IIP: Nonspecific Interstitial Pneumonia IIP: Respiratory Bronchiolitis IIP: Desquamative Interstitial Pneumonia IIP: Acute Interstitial Pneumonia Pulmonary Lymphangiectasia Eisenmenger's Syn: Multi Congenital Anomalies Eisenmenger's Syn: Other Specify Lung Re-TX/GF: Non-Specific Lung Re-TX/GF: Obliterative Bronchioliti Lung Re-TX/GF: Restrictive Lung Re-TX/GF: Acute Rejection Lung Re-TX/GF: Obstructive Lung Re-TX/GF: Primary Graft Failure Lung Re-Tx/GF: Obliterative Bronchiolitis-Restrictive Lung Re-Tx/GF: Obliterative Bronchiolits-Obstructive Lung Re-TX/GF: Other Specify Pulmonary Hypertension/Pulmonary Arterial Hypertension Cystic Fibrosis Inhalation Burns/Trauma IIP: Idiopathic Pulmonary Fibrosis Sarcoidosis Alpha - 1 - Antitrypsin Deficiency COPD/Emphysema Bronchiectasis Rheumatoid Disease Occupational Lung Disease: Other, Specify Lymphangioleiomyomatosis Obliterative Bronchiolitis (Non-Retransplant) Pulmonary Fibrosis: Other Specify Cause Pulmonary Vascular Disease Secondary Pulmonary Hypertension COVID-19: ARDS COVID-19: Pulmonary Fibrosis Combined Pulmonary Fibrosis and Emphysema (CPFE) Heart/Lung Re-TX/GF: Primary Failure Idio/Post-Infection Crescentic Glomerulonephri Membranous Glomerulonephritis Mesangio-Capillary 1 Glomerulonephritis Mesangio-Capillary 2 Glomerulonephritis IGA Nephropathy Anti-GBM Focal Glomerular Sclerosis (Focal Segmental - FGS) Chronic Pyelonephritis/Reflux Nephropath Polycystic Kidneys Nephritis Nephronophthisis Diabetes - Type I Insulin Dep/Juv Onset Diabetes - Type II Non-Insulin Dep/Adult Oxalate Nephropathy (Includes Hereditary Oxalosis) Cystinosis Fabry's Disease Amyloidosis Gout Systemic Lupus Erythematosus Progressive Systemic Sclerosis Wilms' Tumor Renal Cell Carcinoma Incidental Carcinoma Myeloma Hemolytic Uremic Syndrome Hypoplasia/Dysplasia/Dysgensis/Agenesis Cortical Necrosis Acute Tubular Necrosis Medullary Cystic Disease Sickle Cell Anemia Acquired Obstructive Nephropathy Alport's Syndrome Familial Nephropathy Goodpasture's Syndrome Malignant Hypertension Henoch-Schoenlein Purpura Prune Belly Syndrome Retransplant/Graft Failure Diabetes - Type I Non-Insulin Dep/Juv On Diabetes - Type II Insulin Dep/Adult Ons Hypertensive Nephrosclerosis Chronic Glomerulonephritis Unspecified Membranous Nephropathy Chronic Glomerulosclerosis Unspecified Analgesic Nephropathy Radiation Nephritis Antibiotic-Induced Nephritis Cancer Chemotherapy Induced Nephritis Calcineurin Inhibitor Nephrotoxicity Heroin Nephrotoxicity Renal Artery Thrombosis Chronic Nephrosclerosis-Unspecified Congenital Obstructive Uropathy Scleroderma Wegeners Granulomatosis Polyarteritis Rheumatoid Arthritis Sarcoidosis Lymphoma Nephrolithiasis Urolithiasis Pre-BMT Total Body Irradiation Drug Related Interstitial Nephritis Thin Basement Membrane Disease Cholesterol Embolization Rapid Progressive Glomerulonephritis (Rpgn) Diabetes Mellitus - Type I Diabetes Mellitus - Type II Diabetes Mellitus - Type Other / Unknown Hepatorenal Syndrome Lithium Toxicity HIV Nephropathy AHN: Drug Other, Specify AHN: Type A AHN: Type B- Hbsag+ AHN: Type C AHN: Type D AHN: Type B and C AHN: Type B and D AHN: Etiology Unknown AHN: Other, Specify (e.g., Acute Viral Infection, Autoimmune Hepatitis - Fulminant) Cirrhosis: Drug/Indust Exposure Other, Specify Cirrhosis: Type A Cirrhosis: Type B- Hbsag+ Cirrhosis: Type C Cirrhosis: Type D Cirrhosis: Type B and C Cirrhosis: Type B and D Cirrhosis: Cryptogenic- Idiopathic Cirrhosis: Chronic Active Hepatitis: Etiology Unknown Cirrhosis: Other, Specify (e.g., Histiocytosis, Sarcoidosis, Granulomatous) Cirrhosis: Autoimmune Cirrhosis: Cryptogenic (Idiopathic) Cirrhosis: Fatty Liver (NASH) Alcoholic Cirrhosis Alcoholic Cirrhosis w/ Hepatitis C Acute Alcoholic Hepatitis Acute Alcohol-Associated Hepatitis With or Without Cirrhosis Alcohol-Associated Cirrhosis Without Acute Alcohol-Associated Hepatitis Primary Biliary Cirrhosis (PBC) Cirrhosis: Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis: Metabolic Dysfunction and Alcohol-Related/Associated Liver Disease (MetALD) Sec Biliary Cirrhosis: Caroli's Disease Sec Biliary Cirrhosis: Choledochol Cyst Sec Biliary Cirrhosis: Other, Specify PSC: Crohn's Disease PSC: Ulcerative Colitis PSC: No Bowel Disease PSC: Other, Specify Familial Cholestasis: Byler's Disease Familial Cholestasis: Other, Specify Choles Liver Disease: Other, Specify Neonatal Cholestatic Liver Disease Neonatal Hepatitis Other, Specify Biliary Atresia: Extrahepatic Biliary Hypoplasia: Nonsyndromic Paucity of Intrahepatic Bile Duct Biliary Hypoplasia: Alagille's Syndrome (Paucity of Intrahepatic Bile Duct) Biliary Atresia or Hypoplasia: Other, Specify Congenital Hepatic Fibrosis Cystic Fibrosis Budd-Chiari Syndrome Metdis: Alpha-1-Antitrypsin Defic A-1-A Metdis: Wilson's Disease, Other Copper Metabolism Disorder Metdis: Hemochromatosis - Hemosiderosis Metdis: Glyc Stor Dis Type I (GSD-I) Metdis: Glyc Stor Dis Type IV (GSD-IV) Metdis: Hyperlipidemia-II, Homozygous Hypercholesterolemia Metdis: Tyrosinemia Metdis: Primary Oxalosis/Oxaluria, Hyperoxaluria Metdis: Maple Syrup Urine Disease Metdis: Other, Specify PLM: Hepatoma - Hepatocellular Carcinoma PLM: Hepatoma (HCC) and Cirrhosis PLM: Fibrolamellar (FL-HC) PLM: Cholangiocarcinoma (CH-CA) PLM: Hepatoblastoma (HBL) PLM: Hemangioendothelioma, Hemangiosarcoma, Angiosarcoma PLM: Other, Specify (i.e., Klatzkin Tumor, Leiomysarcoma) Bile Duct Cancer: (Cholangioma, Biliary Tract Carcinoma) Secondary Hepatic Malignancy Other, Specify Benign Tumor: Hepatic Adenoma Benign Tumor: Polycystic Liver Disease Benign Tumor: Other, Specify TPN/Hyperalimentation Ind Liver Disease Graft vs. Host Dis Sec to Non-Liver Txp Trauma Other, Specify Graft Failure Retransplant/Graft Failure Pancreas Diabetes Mellitus - Type I (Pancreas) Diabetes Mellitus - Type II (Pancreas) Diabetes Secondary to Chronic Pancreatitis without Pancreatectomy Diabetes Secondary to Cystic Fibrosis without Pancreatectomy Pancreatic Cancer Bile Duct Cancer Other Cancers Pancreatectomy Prior to Pancreas Transplant Diabetes Mellitus - Type Other/Unknown (Pancreas)"
UNOS_CLIN_INFO_4,UNOS_PA_PRIM_DX_SP,N,90,VARCHAR,No,"UNOS pancreas primary diagnosis, specify UNOS pancreas primary diagnosis, specify"
UNOS_CLIN_INFO_4,UNOS_PA_GR_PLCMNT_C_NAME,N,91,VARCHAR,No,"UNOS pancreas graft placement
May contain organization-specific values: No
Category Entries:
Intra-Peritoneal
Retro-Peritoneal
Partial Intra/Retro-Peritoneal UNOS pancreas graft placement May contain organization-specific values: No Category Entries: Intra-Peritoneal Retro-Peritoneal Partial Intra/Retro-Peritoneal"
UNOS_CLIN_INFO_4,UNOS_PA_OP_TECH_C_NAME,N,92,VARCHAR,No,"UNOS pancreas operative technique
May contain organization-specific values: No
Category Entries:
Pancreas alone
Simultaneous kidney-pancreas
Pancreas after kidney
Cluster
Multi-organ non-cluster
Pancreas with kidney different donor UNOS pancreas operative technique May contain organization-specific values: No Category Entries: Pancreas alone Simultaneous kidney-pancreas Pancreas after kidney Cluster Multi-organ non-cluster Pancreas with kidney different donor"
UNOS_CLIN_INFO_4,UNOS_PA_DUCT_MGMT_C_NAME,N,93,VARCHAR,No,"UNOS pancreas duct management
May contain organization-specific values: No
Category Entries:
Enteric w/roux-en-y
Enteric w/o roux-en-y
Cystostomy
Duct injection immediate
Duct injection delayed
Other, specify UNOS pancreas duct management May contain organization-specific values: No Category Entries: Enteric w/roux-en-y Enteric w/o roux-en-y Cystostomy Duct injection immediate Duct injection delayed Other, specify"
UNOS_CLIN_INFO_4,UNOS_PA_DUCT_MGM_SP,N,94,VARCHAR,No,"UNOS pancreas duct management, specify UNOS pancreas duct management, specify"
UNOS_CLIN_INFO_4,UNOS_PA_VNS_MGMT_C_NAME,N,95,VARCHAR,No,"UNOS pancreas venous vascular management
May contain organization-specific values: No
Category Entries:
Systemic system (iliac:cava)
Portal system (portal or tributaries)
Not applicable/multi-organ cluster UNOS pancreas venous vascular management May contain organization-specific values: No Category Entries: Systemic system (iliac:cava) Portal system (portal or tributaries) Not applicable/multi-organ cluster"
UNOS_CLIN_INFO_4,UNOS_PA_ART_RCN_C_NAME,N,96,VARCHAR,No,"UNOS pancreas arterial reconstruction
May contain organization-specific values: No
Category Entries:
Celiac with Pancreas
Y-Graft to SPA and SMA
SPA to SMA Direct
SPA to SMA with Interposition
SPA Alone
Insertion of a donor iliac artery graft
Supraceliac aortic anastomosis to portion of donor thoracic aorta
Reanastomosis of donor thoracic aorta
Other UNOS pancreas arterial reconstruction May contain organization-specific values: No Category Entries: Celiac with Pancreas Y-Graft to SPA and SMA SPA to SMA Direct SPA to SMA with Interposition SPA Alone Insertion of a donor iliac artery graft Supraceliac aortic anastomosis to portion of donor thoracic aorta Reanastomosis of donor thoracic aorta Other"
UNOS_CLIN_INFO_4,UNOS_PA_ART_RCN_SP,N,97,VARCHAR,No,"UNOS pancreas arterial reconstruction, specify UNOS pancreas arterial reconstruction, specify"
UNOS_CLIN_INFO_4,UNOS_PA_VNS_EXT_YN,N,98,VARCHAR,No,"UNOS pancreas venous extension graft
The category values for this column were already listed for column: UNOS_SUPPO2_YN UNOS pancreas venous extension graft The category values for this column were already listed for column: UNOS_SUPPO2_YN"
UNOS_CLIN_INFO_4,UNOS_PA_TOT_PRES,N,99,NUMERIC,No,UNOS pancreas total preservation time (hours) UNOS pancreas total preservation time (hours)
UNOS_CLIN_INFO_4,UNOS_PA_TOT_PR_ST_C_NAME,N,100,VARCHAR,No,"UNOS pancreas total preservation time status
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME UNOS pancreas total preservation time status The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_PA_HYP_REJ_C_NAME,N,101,VARCHAR,No,"UNOS pancreas contributory cause of graft failure: hyperacute rejection
May contain organization-specific values: No
Category Entries:
Yes
No
Unknown UNOS pancreas contributory cause of graft failure: hyperacute rejection May contain organization-specific values: No Category Entries: Yes No Unknown"
UNOS_CLIN_INFO_4,UNOS_WT_POST_TX,N,102,NUMERIC,No,The patient's post-transplant weight The patient's post-transplant weight
UNOS_CLIN_INFO_4,UNOS_WT_POST_ST_C_NAME,N,103,VARCHAR,No,"The patient's post-transplant weight status
The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME The patient's post-transplant weight status The category values for this column were already listed for column: C_PEPTIDE_ST_C_NAME"
UNOS_CLIN_INFO_4,UNOS_INSLN_POST_TX,N,104,NUMERIC,No,UNOS average total insulin dosage per day post-transplant UNOS average total insulin dosage per day post-transplant
UNOS_CLIN_INFO_4,UNOS_INS_PST_ST_C_NAME,N,105,VARCHAR,No,"UNOS average total insulin dosage per day post-transplant status
May contain organization-specific values: No
Category Entries:
N/A
Not Done
Missing
Unknown
Sliding Scale UNOS average total insulin dosage per day post-transplant status May contain organization-specific values: No Category Entries: N/A Not Done Missing Unknown Sliding Scale"
UNOS_CLIN_INFO_5,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the registry data record. The unique identifier (.1 item) for the registry data record.
UNOS_CLIN_INFO_5,UNOS_TXP_TZ_C_NAME,N,2,VARCHAR,No,"The time zone in which the patient's transplant procedure took place.
May contain organization-specific values: No
Category Entries:
Atlantic Standard Time
Atlantic Daylight Time
Eastern Standard Time
Eastern Daylight Time
Central Standard Time
Central Daylight Time
Mountain Standard Time
Mountain Daylight Time
Pacific Standard Time
Pacific Daylight Time
Alaskan Standard Time
Alaskan Daylight Time
Hawaiian Standard Time
Hawaiian Daylight Time The time zone in which the patient's transplant procedure took place. May contain organization-specific values: No Category Entries: Atlantic Standard Time Atlantic Daylight Time Eastern Standard Time Eastern Daylight Time Central Standard Time Central Daylight Time Mountain Standard Time Mountain Daylight Time Pacific Standard Time Pacific Daylight Time Alaskan Standard Time Alaskan Daylight Time Hawaiian Standard Time Hawaiian Daylight Time"
UNOS_CLIN_INFO_5,UNOS_TXP_DTTM,N,3,DATETIME (Local),No,The instant the transplant procedure took place. The instant the transplant procedure took place.
UNOS_CLIN_INFO_5,UNOS_LK_CHKIN_DTTM,N,4,DATETIME (Local),No,The date and time the left kidney arrived at the transplant hospital. The date and time the left kidney arrived at the transplant hospital.
UNOS_CLIN_INFO_5,UNOS_LK_CHKIN_TZ_C_NAME,N,5,VARCHAR,No,"The time zone in which the left kidney arrived at the transplant hospital.
The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME The time zone in which the left kidney arrived at the transplant hospital. The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME"
UNOS_CLIN_INFO_5,UNOS_LK_CHKIN_ST_C_NAME,N,6,VARCHAR,No,"The reason the left kidney check-in date and time is blank.
May contain organization-specific values: No
Category Entries:
N/A
Not Done
Missing
Unknown The reason the left kidney check-in date and time is blank. May contain organization-specific values: No Category Entries: N/A Not Done Missing Unknown"
UNOS_CLIN_INFO_5,UNOS_RK_CHKIN_DTTM,N,7,DATETIME (Local),No,The date and time the right kidney arrived at the transplant hospital. The date and time the right kidney arrived at the transplant hospital.
UNOS_CLIN_INFO_5,UNOS_RK_CHKIN_TZ_C_NAME,N,8,VARCHAR,No,"The time zone in which the right kidney arrived at the transplant hospital.
The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME The time zone in which the right kidney arrived at the transplant hospital. The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME"
UNOS_CLIN_INFO_5,UNOS_RK_CHKIN_ST_C_NAME,N,9,VARCHAR,No,"The reason the right kidney check-in date and time is blank.
The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME The reason the right kidney check-in date and time is blank. The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME"
UNOS_CLIN_INFO_5,UNOS_BK_CHKIN_DTTM,N,10,DATETIME (Local),No,The date and time the en bloc kidneys arrived at the transplant hospital. The date and time the en bloc kidneys arrived at the transplant hospital.
UNOS_CLIN_INFO_5,UNOS_BK_CHKIN_TZ_C_NAME,N,11,VARCHAR,No,"The time zone in which the en bloc kidneys arrived at the transplant hospital.
The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME The time zone in which the en bloc kidneys arrived at the transplant hospital. The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME"
UNOS_CLIN_INFO_5,UNOS_BK_CHKIN_ST_C_NAME,N,12,VARCHAR,No,"The reason the en bloc kidneys check-in date and time is blank.
The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME The reason the en bloc kidneys check-in date and time is blank. The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME"
UNOS_CLIN_INFO_5,UNOS_P_CHKIN_DTTM,N,13,DATETIME (Local),No,The date and time the pancreas arrived at the transplant hospital. The date and time the pancreas arrived at the transplant hospital.
UNOS_CLIN_INFO_5,UNOS_P_CHKIN_TZ_C_NAME,N,14,VARCHAR,No,"The time zone in which the pancreas arrived at the transplant hospital.
The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME The time zone in which the pancreas arrived at the transplant hospital. The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME"
UNOS_CLIN_INFO_5,UNOS_P_CHKIN_ST_C_NAME,N,15,VARCHAR,No,"The reason the pancreas check-in date and time is blank.
The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME The reason the pancreas check-in date and time is blank. The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME"
UNOS_CLIN_INFO_5,UNOS_L_CHKIN_DTTM,N,16,DATETIME (Local),No,The date and time the liver arrived at the transplant hospital. The date and time the liver arrived at the transplant hospital.
UNOS_CLIN_INFO_5,UNOS_L_CHKIN_TZ_C_NAME,N,17,VARCHAR,No,"The time zone in which the liver arrived at the transplant hospital.
The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME The time zone in which the liver arrived at the transplant hospital. The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME"
UNOS_CLIN_INFO_5,UNOS_L_CHKIN_ST_C_NAME,N,18,VARCHAR,No,"The reason the liver check-in date and time is blank.
The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME The reason the liver check-in date and time is blank. The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME"
UNOS_CLIN_INFO_5,UNOS_H_CHKIN_DTTM,N,19,DATETIME (Local),No,The date and time the heart arrived at the transplant hospital. The date and time the heart arrived at the transplant hospital.
UNOS_CLIN_INFO_5,UNOS_H_CHKIN_TZ_C_NAME,N,20,VARCHAR,No,"The time zone in which the heart arrived at the transplant hospital.
The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME The time zone in which the heart arrived at the transplant hospital. The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME"
UNOS_CLIN_INFO_5,UNOS_H_CHKIN_ST_C_NAME,N,21,VARCHAR,No,"The reason the heart check-in date and time is blank.
The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME The reason the heart check-in date and time is blank. The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME"
UNOS_CLIN_INFO_5,UNOS_LL_CHKIN_DTTM,N,22,DATETIME (Local),No,The date and time the left lung arrived at the transplant hospital. The date and time the left lung arrived at the transplant hospital.
UNOS_CLIN_INFO_5,UNOS_LL_CHKIN_TZ_C_NAME,N,23,VARCHAR,No,"The time zone in which the left lung arrived at the transplant hospital.
The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME The time zone in which the left lung arrived at the transplant hospital. The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME"
UNOS_CLIN_INFO_5,UNOS_LL_CHKIN_ST_C_NAME,N,24,VARCHAR,No,"The reason the left lung check-in date and time is blank.
The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME The reason the left lung check-in date and time is blank. The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME"
UNOS_CLIN_INFO_5,UNOS_RL_CHKIN_DTTM,N,25,DATETIME (Local),No,The date and time the right lung arrived at the transplant hospital. The date and time the right lung arrived at the transplant hospital.
UNOS_CLIN_INFO_5,UNOS_RL_CHKIN_TZ_C_NAME,N,26,VARCHAR,No,"The time zone in which the right lung arrived at the transplant hospital.
The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME The time zone in which the right lung arrived at the transplant hospital. The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME"
UNOS_CLIN_INFO_5,UNOS_RL_CHKIN_ST_C_NAME,N,27,VARCHAR,No,"The reason the right lung check-in date and time is blank.
The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME The reason the right lung check-in date and time is blank. The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME"
UNOS_CLIN_INFO_5,UNOS_BL_CHKIN_DTTM,N,28,DATETIME (Local),No,The date and time the en bloc lungs arrived at the transplant hospital. The date and time the en bloc lungs arrived at the transplant hospital.
UNOS_CLIN_INFO_5,UNOS_BL_CHKIN_TZ_C_NAME,N,29,VARCHAR,No,"The time zone in which the en bloc lungs arrived at the transplant hospital.
The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME The time zone in which the en bloc lungs arrived at the transplant hospital. The category values for this column were already listed for column: UNOS_TXP_TZ_C_NAME"
UNOS_CLIN_INFO_5,UNOS_BL_CHKIN_ST_C_NAME,N,30,VARCHAR,No,"The reason the en bloc lungs check-in date and time is blank.
The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME The reason the en bloc lungs check-in date and time is blank. The category values for this column were already listed for column: UNOS_LK_CHKIN_ST_C_NAME"
UNOS_CLIN_INFO_5,UNOS_KI_FAIL_TRR_C_NAME,N,31,VARCHAR,No,"The primary reason for the transplant patient's kidney graft failure for TRFs. Submitted to UNOS for field name grf_fail_cause_ty.
May contain organization-specific values: No
Category Entries:
Hyperacute Rejection
Acute Rejection
Primary Failure
Graft Thrombosis
Infection
Surgical Complications
Urological Complications
Recurrent Disease
Primary Non-Function (Graft Never Functioned Post-Transplant)
Other, Specify The primary reason for the transplant patient's kidney graft failure for TRFs. Submitted to UNOS for field name grf_fail_cause_ty. May contain organization-specific values: No Category Entries: Hyperacute Rejection Acute Rejection Primary Failure Graft Thrombosis Infection Surgical Complications Urological Complications Recurrent Disease Primary Non-Function (Graft Never Functioned Post-Transplant) Other, Specify"
UNOS_DIAB_TREATMNT,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier for the registry data record. The unique identifier for the registry data record.
UNOS_DIAB_TREATMNT,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_DIAB_TREATMNT,UNOS_DIAB_TREAT_C_NAME,N,3,VARCHAR,No,"If the donor had diabetes prior to donation, the type of treatment the donor received.
May contain organization-specific values: No
Category Entries:
Insulin
Oral Hypoglycemic Agent
Diet If the donor had diabetes prior to donation, the type of treatment the donor received. May contain organization-specific values: No Category Entries: Insulin Oral Hypoglycemic Agent Diet"
UNOS_ETHNICITY,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier for the registry data record. The unique identifier for the registry data record.
UNOS_ETHNICITY,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_ETHNICITY,UNOS_ETHNICITY_C_NAME,N,3,VARCHAR,No,"The candidate's race.
May contain organization-specific values: No
Category Entries:
American Indian
Eskimo
Aleutian
Alaska Indian
American Indian or Alaska Native: Other origin
American Indian or Alaska Native: Origin not reported
Asian Indian/Indian Sub-Continent
Chinese
Filipino
Japanese
Korean
Vietnamese
Asian: Other origin
Asian: Origin not reported
African American
African (Continental)
West Indian
Haitian
Black or African American: Other origin
Black or African American: Origin not reported
Mexican
Puerto Rican (Mainland)
Puerto Rican (Island)
Cuban
Hispanic/Latino: Other
Hispanic/Latino: Not Specified/Unknown
Native Hawaiian
Guamanian or Chamorro
Samoan
Native Hawaiian or Other Pacific Islander: Other origin
Native Hawaiian or Other Pacific Islander: Origin not reported
European Descent
Arab or Middle Eastern
North African (Non-Black)
White: Other origin
White: Origin not reported
Unknown (For Donor Referral Only)
White
Black or African American
American Indian or Alaska Native
Asian
Native Hawaiian or Other Pacific Islander
Arab or Middle Eastern (Inactive)
Indian Sub-continent
Hispanic/Latino
Race not reported
Unknown (For Donor Referral Only) The candidate's race. May contain organization-specific values: No Category Entries: American Indian Eskimo Aleutian Alaska Indian American Indian or Alaska Native: Other origin American Indian or Alaska Native: Origin not reported Asian Indian/Indian Sub-Continent Chinese Filipino Japanese Korean Vietnamese Asian: Other origin Asian: Origin not reported African American African (Continental) West Indian Haitian Black or African American: Other origin Black or African American: Origin not reported Mexican Puerto Rican (Mainland) Puerto Rican (Island) Cuban Hispanic/Latino: Other Hispanic/Latino: Not Specified/Unknown Native Hawaiian Guamanian or Chamorro Samoan Native Hawaiian or Other Pacific Islander: Other origin Native Hawaiian or Other Pacific Islander: Origin not reported European Descent Arab or Middle Eastern North African (Non-Black) White: Other origin White: Origin not reported Unknown (For Donor Referral Only) White Black or African American American Indian or Alaska Native Asian Native Hawaiian or Other Pacific Islander Arab or Middle Eastern (Inactive) Indian Sub-continent Hispanic/Latino Race not reported Unknown (For Donor Referral Only)"
UNOS_IMMUNO_INFO,REGISTRY_DATA_ID,N,1,NUMERIC,No,Registry data record ID. Registry data record ID.
UNOS_IMMUNO_INFO,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_IMMUNO_INFO,IMMUNO_IDENTIFIER,N,3,INTEGER,No,The immunosuppression drug ID. The immunosuppression drug ID.
UNOS_IMMUNO_INFO,UNOS_DRUG_CODE_C_NAME,N,4,VARCHAR,No,"The immunosuppression drug code.
May contain organization-specific values: No
Category Entries:
Sandimmune
Neoral
Prograf (tacrolimus)
Rapamune (sirolimus)
Leflunomide (LFL)
Imuran (azathioprine, AZA)
CellCept (MMF)
Cytoxan (cyclophosphamide)
Methotrexate (Folex PFS, Mexate-AQ, Rheumatrex)
Atgam
NRATG / NRATS
OKT3 (Orthoclone, Muromonab)
T10B9 (Medimmune)
Thymoglobulin
Zenapax - Daclizumab
Simulect (basiliximab)
Gengraf
Zortress (everolimus)
EON (Generic Cyclosporine)
Myfortic (mycophenolic acid)
Generic Cyclosporine
Steroids (prednisone, methylprednisolone, Solumedrol, Medrol)
Campath (alemtuzumab)
FTY 720
Rituxan (rituximab)
Astagraf XL (extended release tacrolimus)
Generic Tacrolimus (generic Prograf)
Generic MMF (generic CellCept)
Nulojix (belatacept)
Generic Myfortic (generic mycophenolic acid)
Generic Sirolimus
Envarsus XR (tacrolimus XR)
Other Immunosuppressive Medication
Other Investigational Immunosuppressive Medication
ALG
Cyclosporin
OKT4 The immunosuppression drug code. May contain organization-specific values: No Category Entries: Sandimmune Neoral Prograf (tacrolimus) Rapamune (sirolimus) Leflunomide (LFL) Imuran (azathioprine, AZA) CellCept (MMF) Cytoxan (cyclophosphamide) Methotrexate (Folex PFS, Mexate-AQ, Rheumatrex) Atgam NRATG / NRATS OKT3 (Orthoclone, Muromonab) T10B9 (Medimmune) Thymoglobulin Zenapax - Daclizumab Simulect (basiliximab) Gengraf Zortress (everolimus) EON (Generic Cyclosporine) Myfortic (mycophenolic acid) Generic Cyclosporine Steroids (prednisone, methylprednisolone, Solumedrol, Medrol) Campath (alemtuzumab) FTY 720 Rituxan (rituximab) Astagraf XL (extended release tacrolimus) Generic Tacrolimus (generic Prograf) Generic MMF (generic CellCept) Nulojix (belatacept) Generic Myfortic (generic mycophenolic acid) Generic Sirolimus Envarsus XR (tacrolimus XR) Other Immunosuppressive Medication Other Investigational Immunosuppressive Medication ALG Cyclosporin OKT4"
UNOS_IMMUNO_INFO,IMM_PREV_MAINT_YN,N,5,VARCHAR,No,"Indicates whether the drug was used previously for maintenance.
May contain organization-specific values: No
Category Entries:
No
Yes Indicates whether the drug was used previously for maintenance. May contain organization-specific values: No Category Entries: No Yes"
UNOS_IMMUNO_INFO,IMM_CUR_MAINT_YN,N,6,VARCHAR,No,"Indicates whether the drug is currently being used in the follow-up period for maintenance.
The category values for this column were already listed for column: IMM_PREV_MAINT_YN Indicates whether the drug is currently being used in the follow-up period for maintenance. The category values for this column were already listed for column: IMM_PREV_MAINT_YN"
UNOS_IMMUNO_INFO,IMM_ANTI_REJECT_YN,N,7,VARCHAR,No,"Indicates whether the drug was used as an anti-rejection agent.
The category values for this column were already listed for column: IMM_PREV_MAINT_YN Indicates whether the drug was used as an anti-rejection agent. The category values for this column were already listed for column: IMM_PREV_MAINT_YN"
UNOS_IMMUNO_INFO,IMM_DRUG_CODE_OTHER,N,8,VARCHAR,No,"The drug code's description, if it is not one of the available options in column UNOS_DRUG_CODE_C. The drug code's description, if it is not one of the available options in column UNOS_DRUG_CODE_C."
UNOS_IMMUNO_INFO,UNOS_IMM_INDU_YN,N,9,VARCHAR,No,"Indicates whether this drug was used for induction.
The category values for this column were already listed for column: IMM_PREV_MAINT_YN Indicates whether this drug was used for induction. The category values for this column were already listed for column: IMM_PREV_MAINT_YN"
UNOS_IMMUNO_INFO,UNOS_IMM_INDU_DAYS,N,10,NUMERIC,No,The total number of days this drug was administered for induction if this drug was used for induction. The total number of days this drug was administered for induction if this drug was used for induction.
UNOS_IMMUNO_INFO,UNOS_IMM_INDU_ST_C_NAME,N,11,VARCHAR,No,"If this drug was used for induction, and the number of days used for induction is not available, this indicates why.
May contain organization-specific values: No
Category Entries:
N/A
Not Done
Missing
Unknown If this drug was used for induction, and the number of days used for induction is not available, this indicates why. May contain organization-specific values: No Category Entries: N/A Not Done Missing Unknown"
UNOS_INFO,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the registry data record. The unique identifier (.1 item) for the registry data record.
UNOS_INFO,UNOS_REC_KEY,N,2,VARCHAR,No,The unique record key given to the form by UNOS. The unique record key given to the form by UNOS.
UNOS_INFO,UNOS_ORGAN_C_NAME,N,3,VARCHAR,No,"The type of organ transplanted.
May contain organization-specific values: No
Category Entries:
Lung
Pancreas
Liver
Kidney
Kidney/Pancreas
Intestine
Heart
Heart/Lung
Pancreas Islets The type of organ transplanted. May contain organization-specific values: No Category Entries: Lung Pancreas Liver Kidney Kidney/Pancreas Intestine Heart Heart/Lung Pancreas Islets"
UNOS_INFO,UNOS_PAT_FIRST_NAME,N,4,VARCHAR,No,The patient's first name. The patient's first name.
UNOS_INFO,UNOS_PAT_LAST_NAME,N,5,VARCHAR,No,The patient's last name. The patient's last name.
UNOS_INFO,UNOS_PAT_MIDDLE_INI,N,6,VARCHAR,No,The patient's middle initial. The patient's middle initial.
UNOS_INFO,UNOS_HIC,N,7,VARCHAR,No,The patient's Health Insurance Commission Number. The patient's Health Insurance Commission Number.
UNOS_INFO,UNOS_DOB_DT,N,8,DATETIME,No,The patient's date of birth. The patient's date of birth.
UNOS_INFO,UNOS_SEX_C_NAME,N,9,VARCHAR,No,"The category number for the UNOS-imported sex assigned at birth. This is the same as the internal ID. If you use IntraConnect, this is the Community ID (CID).
May contain organization-specific values: No
Category Entries:
Male
Female The category number for the UNOS-imported sex assigned at birth. This is the same as the internal ID. If you use IntraConnect, this is the Community ID (CID). May contain organization-specific values: No Category Entries: Male Female"
UNOS_INFO,UNOS_PAT_KEY,N,10,INTEGER,No,The transplant center ID issued to the patient by UNOS. The transplant center ID issued to the patient by UNOS.
UNOS_INFO,UNOS_TXP_DT,N,11,DATETIME,No,The date of the patient's transplant operation. The date of the patient's transplant operation.
UNOS_INFO,UNOS_RCPT_CTR_CODE,N,12,VARCHAR,No,The code used by UNOS to identify the facility at which the transplant operation took place. The code used by UNOS to identify the facility at which the transplant operation took place.
UNOS_INFO,UNOS_RCPT_CTR_TYPE,N,13,VARCHAR,No,The type of facility at which the transplant operation took place. The type of facility at which the transplant operation took place.
UNOS_INFO,UNOS_FOL_CTR_CODE,N,14,VARCHAR,No,The code used by UNOS to identify the facility responsible for the patient's follow-up care. The code used by UNOS to identify the facility responsible for the patient's follow-up care.
UNOS_INFO,UNOS_FOL_CTR_TYPE,N,15,VARCHAR,No,The type of facility responsible for the patient's follow-up care. The type of facility responsible for the patient's follow-up care.
UNOS_INFO,UNOS_DONORID,N,16,VARCHAR,No,The transplant center ID issued to the donor by UNOS. The transplant center ID issued to the donor by UNOS.
UNOS_INFO,UNOS_DONOR_TYPE_C_NAME,N,17,VARCHAR,No,"The type of donor: living or deceased.
May contain organization-specific values: No
Category Entries:
Deceased
Living The type of donor: living or deceased. May contain organization-specific values: No Category Entries: Deceased Living"
UNOS_INFO,UNOS_TRR_KEY,N,18,INTEGER,No,The patient's Transplant Recipient Registration ID. The patient's Transplant Recipient Registration ID.
UNOS_INFO,UNOS_FORM_STATUS_C_NAME,N,19,VARCHAR,No,"The form status of the follow-up form sent to UNOS. It should be one of these values: ID Value 1 Amnesty 2 Expected 3 Returned 4 Received 5 Suspended 6 Validated
May contain organization-specific values: No
Category Entries:
Amnesty
Expected
Returned
Received
Suspended
Validated The form status of the follow-up form sent to UNOS. It should be one of these values: ID Value 1 Amnesty 2 Expected 3 Returned 4 Received 5 Suspended 6 Validated May contain organization-specific values: No Category Entries: Amnesty Expected Returned Received Suspended Validated"
UNOS_INFO,UNOS_ADD_DT,N,20,DATETIME,No,The date on which the UNOS follow-up form was created. The date on which the UNOS follow-up form was created.
UNOS_INFO,UNOS_CHANGE_DT,N,21,DATETIME,No,The date on which the UNOS follow-up form was changed. The date on which the UNOS follow-up form was changed.
UNOS_INFO,UNOS_FOL_PROV_NUM,N,22,VARCHAR,No,The NPI of the provider responsible for the patient's follow-up care. The NPI of the provider responsible for the patient's follow-up care.
UNOS_INFO,UNOS_GRAFT_STATUS_C_NAME,N,23,VARCHAR,No,"The graft's status: functioning or failed.
May contain organization-specific values: No
Category Entries:
Functioning
Failed The graft's status: functioning or failed. May contain organization-specific values: No Category Entries: Functioning Failed"
UNOS_INFO,UNOS_GRAFT_FAIL_DT,N,24,DATETIME,No,The date of the graft's failure. The date of the graft's failure.
UNOS_INFO,UNOS_FOL_UP_CODE_C_NAME,N,25,VARCHAR,No,"The follow-up code assigned to the encounter. Follow-up code indicates the period of time on which a form is reporting.
May contain organization-specific values: No
Category Entries:
3 month
6 month
1 year
2 year
3 year
4 year
5 year
6 year
7 year
8 year
9 year
10 year
11 year
12 year
13 year
14 year
15 year
16 year
17 year
18 year
19 year
20 year
21 year
22 year
23 year
24 year
25 year
26 year
27 year
28 year
29 year
30 year
31 year
32 year
33 year
34 year
35 year
36 year
37 year
38 year
39 year
40 year
41 year
42 year
43 year
44 year
45 year
46 year
47 year
48 year
49 year
50 year
51 year
52 year
53 year
54 year
55 year
56 year
57 year
58 year
59 year
60 year
61 year
62 year
63 year
64 year
65 year
66 year
67 year
68 year
69 year
70 year
71 year
72 year
73 year
74 year
75 year
76 year
77 year
78 year
79 year
Graft failure
1 year after graft failure
2 year after graft failure
3 year after graft failure
4 year after graft failure
5 year after graft failure
Lost to follow-up
Recipient death The follow-up code assigned to the encounter. Follow-up code indicates the period of time on which a form is reporting. May contain organization-specific values: No Category Entries: 3 month 6 month 1 year 2 year 3 year 4 year 5 year 6 year 7 year 8 year 9 year 10 year 11 year 12 year 13 year 14 year 15 year 16 year 17 year 18 year 19 year 20 year 21 year 22 year 23 year 24 year 25 year 26 year 27 year 28 year 29 year 30 year 31 year 32 year 33 year 34 year 35 year 36 year 37 year 38 year 39 year 40 year 41 year 42 year 43 year 44 year 45 year 46 year 47 year 48 year 49 year 50 year 51 year 52 year 53 year 54 year 55 year 56 year 57 year 58 year 59 year 60 year 61 year 62 year 63 year 64 year 65 year 66 year 67 year 68 year 69 year 70 year 71 year 72 year 73 year 74 year 75 year 76 year 77 year 78 year 79 year Graft failure 1 year after graft failure 2 year after graft failure 3 year after graft failure 4 year after graft failure 5 year after graft failure Lost to follow-up Recipient death"
UNOS_INFO,UNOS_TXP_DSCH_DT,N,26,DATETIME,No,The date on which the patient was discharged after the transplant operation. The date on which the patient was discharged after the transplant operation.
UNOS_INFO,PHYS_NAME,N,27,VARCHAR,No,The name of the physician who last saw the patient. The name of the physician who last saw the patient.
UNOS_INFO,NPI,N,28,VARCHAR,No,The NPI of the physician who last saw the patient. The NPI of the physician who last saw the patient.
UNOS_INFO,UNOS_HEIGHT,N,29,NUMERIC,No,The patient's height in centimeters. The patient's height in centimeters.
UNOS_INFO,UNOS_HEIGHT_STAT_C_NAME,N,30,VARCHAR,No,"The code specifying why the patient's height is empty.
May contain organization-specific values: No
Category Entries:
N/A
Not Done
Missing
Unknown The code specifying why the patient's height is empty. May contain organization-specific values: No Category Entries: N/A Not Done Missing Unknown"
UNOS_INFO,UNOS_WEIGHT,N,31,NUMERIC,No,The patient's weight in kilograms. The patient's weight in kilograms.
UNOS_INFO,UNOS_WEIGHT_STAT_C_NAME,N,32,VARCHAR,No,"The code specifying why the patient's weight is empty.
The category values for this column were already listed for column: UNOS_HEIGHT_STAT_C_NAME The code specifying why the patient's weight is empty. The category values for this column were already listed for column: UNOS_HEIGHT_STAT_C_NAME"
UNOS_INFO,PAT_STATUS_DT,N,33,DATETIME,No,"The date for the most recent of the following events: patient last seen, organ retransplanted, or patient's death. The date for the most recent of the following events: patient last seen, organ retransplanted, or patient's death."
UNOS_INFO,PAT_STATUS_C_NAME,N,34,VARCHAR,No,"The patient's status: living, dead, or retransplanted.
May contain organization-specific values: No
Category Entries:
Living
Dead
Not Seen
Retransplanted
Lost
Natural Disaster The patient's status: living, dead, or retransplanted. May contain organization-specific values: No Category Entries: Living Dead Not Seen Retransplanted Lost Natural Disaster"
UNOS_INFO,UNOS_FUNC_STATUS_C_NAME,N,35,VARCHAR,No,"The patient's functional status as reported to UNOS.
May contain organization-specific values: No
Category Entries:
Performs activities of daily living with NO assistance
Performs activities of daily living with SOME assistance
Performs activities of daily living with TOTAL assistance
Not Applicable (Patient Less Than 1 Year Old)
Unknown
10% - Moribund, Fatal Processes Progressing Rapidly
20% - Very Sick, Hospitalization Necessary: Active Treatment Necessary
30% - Severely Disabled: Hospitalization is Indicated, Death Not Imminent
40% - Disabled: Requires Special Care and Assistance
50% - Requires Considerable Assistance and Frequent Medical Care
60% - Requires Occasional Assistance but is Able to Care for Needs
70% - Cares for Self: Unable to Carry on Normal Activity or Active Work
80% - Normal Activity with Effort: Some Symptoms of Disease
90% - Able to Carry on Normal Activity: Minor Symptoms of Disease
100% - Normal, No Complaints, No Evidence of Disease
10% - No Play; Does Not Get out of Bed
20% - Often Sleeping; Play Entirely Limited to Very Passive Activities
30% - In Bed; Needs Assistance Even for Quiet Play
40% - Mostly in Bed, Participates in Quiet Activities
50% - Can Dress but Lies Around Much of Day; No Active Play; Quiet Play/Activities
60% - Up and Around, but Minimal Active Play; Keeps Busy with Quieter Activities
70% - Both Greater Restriction of and Less Time Spent in Play Activity
80% - Active, but Tires More Quickly
90% - Minor Restrictions in Physically Strenuous Activity
100% - Fully Active, Normal The patient's functional status as reported to UNOS. May contain organization-specific values: No Category Entries: Performs activities of daily living with NO assistance Performs activities of daily living with SOME assistance Performs activities of daily living with TOTAL assistance Not Applicable (Patient Less Than 1 Year Old) Unknown 10% - Moribund, Fatal Processes Progressing Rapidly 20% - Very Sick, Hospitalization Necessary: Active Treatment Necessary 30% - Severely Disabled: Hospitalization is Indicated, Death Not Imminent 40% - Disabled: Requires Special Care and Assistance 50% - Requires Considerable Assistance and Frequent Medical Care 60% - Requires Occasional Assistance but is Able to Care for Needs 70% - Cares for Self: Unable to Carry on Normal Activity or Active Work 80% - Normal Activity with Effort: Some Symptoms of Disease 90% - Able to Carry on Normal Activity: Minor Symptoms of Disease 100% - Normal, No Complaints, No Evidence of Disease 10% - No Play; Does Not Get out of Bed 20% - Often Sleeping; Play Entirely Limited to Very Passive Activities 30% - In Bed; Needs Assistance Even for Quiet Play 40% - Mostly in Bed, Participates in Quiet Activities 50% - Can Dress but Lies Around Much of Day; No Active Play; Quiet Play/Activities 60% - Up and Around, but Minimal Active Play; Keeps Busy with Quieter Activities 70% - Both Greater Restriction of and Less Time Spent in Play Activity 80% - Active, but Tires More Quickly 90% - Minor Restrictions in Physically Strenuous Activity 100% - Fully Active, Normal"
UNOS_INFO,UNOS_PHYSICAL_CAP_C_NAME,N,36,VARCHAR,No,"The patient's physical capacity as reported to UNOS.
May contain organization-specific values: No
Category Entries:
No Limitations
Limited Mobility
Wheelchair Bound or More Limited
Not Applicable (<1 Year Old or Hospitalized)
Unknown The patient's physical capacity as reported to UNOS. May contain organization-specific values: No Category Entries: No Limitations Limited Mobility Wheelchair Bound or More Limited Not Applicable (<1 Year Old or Hospitalized) Unknown"
UNOS_INFO,UNOS_WORK_C_NAME,N,37,VARCHAR,No,"Indicates whether the patient is working for income.
May contain organization-specific values: No
Category Entries:
Yes
No
Unknown Indicates whether the patient is working for income. May contain organization-specific values: No Category Entries: Yes No Unknown"
UNOS_INFO,UNOS_WORK_REASON_C_NAME,N,38,VARCHAR,No,"The reason why the patient is not working.
May contain organization-specific values: No
Category Entries:
Disability
Demands of Treatment
Insurance Conflict
Inability to Find Work
Patient Choice - Homemaker
Patient Choice - Student Full Time/Part Time
Patient Choice - Retired
Patient Choice - Other
Not Applicable - Hospitalized
Unknown The reason why the patient is not working. May contain organization-specific values: No Category Entries: Disability Demands of Treatment Insurance Conflict Inability to Find Work Patient Choice - Homemaker Patient Choice - Student Full Time/Part Time Patient Choice - Retired Patient Choice - Other Not Applicable - Hospitalized Unknown"
UNOS_INFO,UNOS_WORK_LEVEL_C_NAME,N,39,VARCHAR,No,"The level at which the patient is working, full time or part time, and why.
May contain organization-specific values: No
Category Entries:
Working Full Time
Working Part Time Due to Demands of Treatment
Working Part Time Due to Disability
Working Part Time Due to Insurance Conflict
Working Part Time Due to Inability to Find Full Time Work
Working Part Time Due to Patient Choice
Working Part Time Reason Unknown
Working, Part Time vs. Full Time Unknown The level at which the patient is working, full time or part time, and why. May contain organization-specific values: No Category Entries: Working Full Time Working Part Time Due to Demands of Treatment Working Part Time Due to Disability Working Part Time Due to Insurance Conflict Working Part Time Due to Inability to Find Full Time Work Working Part Time Due to Patient Choice Working Part Time Reason Unknown Working, Part Time vs. Full Time Unknown"
UNOS_INFO,UNOS_ACAD_PROG_C_NAME,N,40,VARCHAR,No,"The patient's academic progress.
May contain organization-specific values: No
Category Entries:
Within One Grade Level of Peers
Delayed Grade Level
Special Education
Not Applicable, too young for school/ High School graduate or GED
Unknown The patient's academic progress. May contain organization-specific values: No Category Entries: Within One Grade Level of Peers Delayed Grade Level Special Education Not Applicable, too young for school/ High School graduate or GED Unknown"
UNOS_INFO,UNOS_ACAD_LEVEL_C_NAME,N,41,VARCHAR,No,"The patient's academic activity level.
May contain organization-specific values: No
Category Entries:
Full Academic Load
Reduced Academic Load
Unable to Participate in Academics Due to Disease or Condition
Unable to Participate Regularly in Academics Due to Dialysis
Not Applicable, too young for school/ High School graduate or GED
Unknown The patient's academic activity level. May contain organization-specific values: No Category Entries: Full Academic Load Reduced Academic Load Unable to Participate in Academics Due to Disease or Condition Unable to Participate Regularly in Academics Due to Dialysis Not Applicable, too young for school/ High School graduate or GED Unknown"
UNOS_INFO,UNOS_INSUR_PRI_C_NAME,N,42,VARCHAR,No,"The patient's primary type of insurance during the follow-up period.
May contain organization-specific values: No
Category Entries:
Private Insurance
Public Insurance - Medicaid
Public Insurance - Medicare FFS (Fee for Service)
Public Insurance - Medicare & Choice
Public Insurance - CHIP (Children's Health Insurance Program)
Public Insurance - Department of VA
Public Insurance - Other Government
Self
Donation
Free Care
Pending
Foreign Government, Specify
Public insurance - Medicare Unspecified
US/State Govt Agency
Unknown The patient's primary type of insurance during the follow-up period. May contain organization-specific values: No Category Entries: Private Insurance Public Insurance - Medicaid Public Insurance - Medicare FFS (Fee for Service) Public Insurance - Medicare & Choice Public Insurance - CHIP (Children's Health Insurance Program) Public Insurance - Department of VA Public Insurance - Other Government Self Donation Free Care Pending Foreign Government, Specify Public insurance - Medicare Unspecified US/State Govt Agency Unknown"
UNOS_INFO,UNOS_INSUR_FRGN_C_NAME,N,43,VARCHAR,No,"The foreign government responsible for the patient's primary insurance.
May contain organization-specific values: No
Category Entries:
Andorra
Afghanistan
Antigua and Barbuda
Anguilla
Albania
Algeria
Armenia
Angola
Argentina
Aruba
American Samoa
Austria
Australia
Azerbaijan
Azores
Barbados
Brunei Darussalam
Belgium
Benin
Bermuda
Bangladesh
Bosnia-Herzegovina
Bahrain
Bahamas
Bhutan
British Indian Ocean Territory
Bulgaria
Bolivia
Brazil
Burundi
Burkina
Burma (Myanmar)
British Virgin Islands
Botswana
Belarus
Belize
Canary Islands
Cambodia
Canada
Central African Republic
Cocos (Keeling) Island
Canton and Enderbury Islands
Congo
Chad
China
Chile
Cook Islands
Cameroon
Comoros
Congo, Democratic Republic of
Colombia
Croatia
Costa Rica
Cuba
Cape Verde
Christmas Islands
Cayman Island
Cyprus
Czech Republic, The
Djibouti
Denmark
Dominica
Dominican Republic
Ecuador
Estonia
Equatorial Guinea
Egypt
England
El Salvador
Ethiopia
French Guiana
Finland
Fiji
Falkland Islands (Malvinas)
Faroe Islands
French Polynesia
France
French Southern and Antarctic
Gabon
Grenada
Guadeloupe
Georgia
Germany, Federal Republic of
Ghana
Gibraltar
Greenland
Gambia, The
Greece
Guatemala
Guinea-Bissau
Guam
Guinea
Guyana
Gaza Strip
Hong Kong
Heard Island and McDonald Islands
Honduras
Haiti
Hungary
Ivory Coast
Iceland
Indonesia
India
Ireland
Iran
Iraq
Israel
Italy
Jamaica
Jordan
Japan
Johnston Atoll
Kenya
Kyrgyzstan
Kiribati
Korea
Kampuchea, Democratic
Kuwait
Kazakhstan
Lao Peoples' Democratic Republic
Latin America
Libya
Liechtenstein
Lebanon
Liberia
Lesotho
Lithuania
Latvia
Luxembourg
Macau
Macedonia (Skopje)
Madagascar
Madeira Island
Moldova
Mexico
Micronesia, Federated States of
Marshall Islands
Maldives
Mali
Monaco
Mongolia
Morocco
Mauritania
Montserrat
Malta
Martinique
Mauritius
Malawi
Midway Islands
Malaysia
Mozambique
Namibia
Netherlands Antilles
New Caledonia
Netherlands
Norfolk Island
Nigeria
Nicaragua
Niger
North Korea
Norway
Northern Mariana Islands
Nepal
Nauru
Niue
New Zealand
Oman
Palau
Panama
Peru
Pitcairn Island
Philippines
Pakistan
Poland
Papua New Guinea
Puerto Rico
Paraguay
Portugal
Qatar
Reunion
Romania
Russia
Rwanda
South Africa
Samoa
Saudi Arabia
Seychelles
Sudan
Sweden
Singapore
Svalbard and Jan Mayen Islands
Slovakia
South Korea
Solomon Islands
Sri Lanka
Slovenia
San Marino
Senegal
Somalia
Spain
St. Pierre and Miquelon
Serbia and Montenegro
Sierra Leone
Suriname
Spanish Africa
St. Christopher
St. Helena
St. Kitts and Nevis
Saint Lucia
Sao Tome and Principe
Saint Vincent and the Grenadines
Switzerland
Syrian Arab Republic
Swaziland
Turks and Caicos Island
Trinidad and Tobago
Togo
Thailand
Tajikistan
Tokelau
Turkmenistan
Tunisia
Tonga
Turkey
Tuvalu
Taiwan
Tanzania, United Republic of
United Arab Emirates
Uganda
Ukraine
United Kingdom
USA Minor Outlying Islands
Uruguay
United States
Uzbekistan
Vatican City
Venezuela
Virgin Islands of the USA
Vietnam
Vanuata
Yemen, Republic of
Zambia
Zimbabwe
Unknown The foreign government responsible for the patient's primary insurance. May contain organization-specific values: No Category Entries: Andorra Afghanistan Antigua and Barbuda Anguilla Albania Algeria Armenia Angola Argentina Aruba American Samoa Austria Australia Azerbaijan Azores Barbados Brunei Darussalam Belgium Benin Bermuda Bangladesh Bosnia-Herzegovina Bahrain Bahamas Bhutan British Indian Ocean Territory Bulgaria Bolivia Brazil Burundi Burkina Burma (Myanmar) British Virgin Islands Botswana Belarus Belize Canary Islands Cambodia Canada Central African Republic Cocos (Keeling) Island Canton and Enderbury Islands Congo Chad China Chile Cook Islands Cameroon Comoros Congo, Democratic Republic of Colombia Croatia Costa Rica Cuba Cape Verde Christmas Islands Cayman Island Cyprus Czech Republic, The Djibouti Denmark Dominica Dominican Republic Ecuador Estonia Equatorial Guinea Egypt England El Salvador Ethiopia French Guiana Finland Fiji Falkland Islands (Malvinas) Faroe Islands French Polynesia France French Southern and Antarctic Gabon Grenada Guadeloupe Georgia Germany, Federal Republic of Ghana Gibraltar Greenland Gambia, The Greece Guatemala Guinea-Bissau Guam Guinea Guyana Gaza Strip Hong Kong Heard Island and McDonald Islands Honduras Haiti Hungary Ivory Coast Iceland Indonesia India Ireland Iran Iraq Israel Italy Jamaica Jordan Japan Johnston Atoll Kenya Kyrgyzstan Kiribati Korea Kampuchea, Democratic Kuwait Kazakhstan Lao Peoples' Democratic Republic Latin America Libya Liechtenstein Lebanon Liberia Lesotho Lithuania Latvia Luxembourg Macau Macedonia (Skopje) Madagascar Madeira Island Moldova Mexico Micronesia, Federated States of Marshall Islands Maldives Mali Monaco Mongolia Morocco Mauritania Montserrat Malta Martinique Mauritius Malawi Midway Islands Malaysia Mozambique Namibia Netherlands Antilles New Caledonia Netherlands Norfolk Island Nigeria Nicaragua Niger North Korea Norway Northern Mariana Islands Nepal Nauru Niue New Zealand Oman Palau Panama Peru Pitcairn Island Philippines Pakistan Poland Papua New Guinea Puerto Rico Paraguay Portugal Qatar Reunion Romania Russia Rwanda South Africa Samoa Saudi Arabia Seychelles Sudan Sweden Singapore Svalbard and Jan Mayen Islands Slovakia South Korea Solomon Islands Sri Lanka Slovenia San Marino Senegal Somalia Spain St. Pierre and Miquelon Serbia and Montenegro Sierra Leone Suriname Spanish Africa St. Christopher St. Helena St. Kitts and Nevis Saint Lucia Sao Tome and Principe Saint Vincent and the Grenadines Switzerland Syrian Arab Republic Swaziland Turks and Caicos Island Trinidad and Tobago Togo Thailand Tajikistan Tokelau Turkmenistan Tunisia Tonga Turkey Tuvalu Taiwan Tanzania, United Republic of United Arab Emirates Uganda Ukraine United Kingdom USA Minor Outlying Islands Uruguay United States Uzbekistan Vatican City Venezuela Virgin Islands of the USA Vietnam Vanuata Yemen, Republic of Zambia Zimbabwe Unknown"
UNOS_INFO,UNOS_COGNITIV_DEV_C_NAME,N,44,VARCHAR,No,"The patient's cognitive development level.
May contain organization-specific values: No
Category Entries:
Definite Cognitive Delay/Impairment
Probable Cognitive Delay/Impairment
Questionable Cognitive Delay/Impairment
No Cognitive Delay/Impairment
Not Assessed The patient's cognitive development level. May contain organization-specific values: No Category Entries: Definite Cognitive Delay/Impairment Probable Cognitive Delay/Impairment Questionable Cognitive Delay/Impairment No Cognitive Delay/Impairment Not Assessed"
UNOS_INFO,UNOS_MOTOR_DEV_C_NAME,N,45,VARCHAR,No,"The patient's motor development level.
May contain organization-specific values: No
Category Entries:
Definite Motor Delay/Impairment
Probable Motor Delay/Impairment
Questionable Motor Delay/Impairment
No Motor Delay/Impairment
Not Assessed The patient's motor development level. May contain organization-specific values: No Category Entries: Definite Motor Delay/Impairment Probable Motor Delay/Impairment Questionable Motor Delay/Impairment No Motor Delay/Impairment Not Assessed"
UNOS_INFO,UNOS_VITALS_DT,N,46,DATETIME,No,The date on which the patient's height and weight were measured. This field is specified for pediatric patients. The date on which the patient's height and weight were measured. This field is specified for pediatric patients.
UNOS_INFO,UNOS_STATE_C_NAME,N,47,VARCHAR,No,"The patient's state of permanent residency.
May contain organization-specific values: No
Category Entries:
Alaska
Alabama
Arkansas
Pago Pago
Arizona
California
Colorado
Connecticut
Dist. Of Columbia
Delaware
Florida
Georgia
Guam
Hawaii
Iowa
Idaho
Illinois
Indiana
Kansas
Kentucky
Louisiana
Massachusetts
Maryland
Maine
Michigan
Minnesota
Missouri
Saipan Mariana Islands
Mississippi
Montana
Foreign Country
North Carolina
North Dakota
Nebraska
New Hampshire
New Jersey
New Mexico
Nevada
New York
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
State
Tennessee
Texas
Utah
Virginia
Virgin Islands
Vermont
Washington
Wisconsin
West Virginia
Wyoming
Unknown The patient's state of permanent residency. May contain organization-specific values: No Category Entries: Alaska Alabama Arkansas Pago Pago Arizona California Colorado Connecticut Dist. Of Columbia Delaware Florida Georgia Guam Hawaii Iowa Idaho Illinois Indiana Kansas Kentucky Louisiana Massachusetts Maryland Maine Michigan Minnesota Missouri Saipan Mariana Islands Mississippi Montana Foreign Country North Carolina North Dakota Nebraska New Hampshire New Jersey New Mexico Nevada New York Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota State Tennessee Texas Utah Virginia Virgin Islands Vermont Washington Wisconsin West Virginia Wyoming Unknown"
UNOS_INFO,UNOS_ZIP,N,48,VARCHAR,No,The patient's ZIP Code. The patient's ZIP Code.
UNOS_INFO,VOID_REASON,N,49,VARCHAR,No,The reason for voiding the record. The reason for voiding the record.
UNOS_INFO,UNOS_PREV_SURNAME,N,50,VARCHAR,No,"Any surnames used by the patient, other than the surname recorded in the Name item. Any surnames used by the patient, other than the surname recorded in the Name item."
UNOS_INFO,UNOS_PAT_IN_ZIP_C_NAME,N,51,VARCHAR,No,"Indicates whether the patient is waiting in their permanent ZIP code.
The category values for this column were already listed for column: UNOS_WORK_C_NAME Indicates whether the patient is waiting in their permanent ZIP code. The category values for this column were already listed for column: UNOS_WORK_C_NAME"
UNOS_INFO,UNOS_CITIZEN_C_NAME,N,52,VARCHAR,No,"The candidate's citizenship status.
May contain organization-specific values: No
Category Entries:
US Citizen
Resident Alien
Non-Resident Alien, Year Entered US
Non-US Citizen/US Resident
Non-US Citizen/Non-US Resident, Traveled to US for Reason Other Than Transplant
Non-US Citizen/Non-US Resident, Traveled to US for Transplant The candidate's citizenship status. May contain organization-specific values: No Category Entries: US Citizen Resident Alien Non-Resident Alien, Year Entered US Non-US Citizen/US Resident Non-US Citizen/Non-US Resident, Traveled to US for Reason Other Than Transplant Non-US Citizen/Non-US Resident, Traveled to US for Transplant"
UNOS_INFO,UNOS_ENTRY_USA_DT,N,53,NUMERIC,No,"If the candidate is a Non-Resident Alien, the year the candidate entered the United States. If the candidate is a Non-Resident Alien, the year the candidate entered the United States."
UNOS_INFO,UNOS_EDU_LEVEL_C_NAME,N,54,VARCHAR,No,"The candidate's highest level of education.
May contain organization-specific values: No
Category Entries:
None
Grade School (0-8)
High School (9-12) or GED
Attended College/Technical School
Associate/Bachelor Degree
Post-College Graduate Degree
N/A (Less Than 5 Years Old)
Unknown The candidate's highest level of education. May contain organization-specific values: No Category Entries: None Grade School (0-8) High School (9-12) or GED Attended College/Technical School Associate/Bachelor Degree Post-College Graduate Degree N/A (Less Than 5 Years Old) Unknown"
UNOS_INFO,UNOS_SEC_PAY_C_NAME,N,55,VARCHAR,No,"The candidate's secondary source of payment.
May contain organization-specific values: No
Category Entries:
Private Insurance
Public Insurance - Medicaid
Public Insurance - Medicare FFS (Fee For Service)
Public Insurance - Medicare & Choice
Public Insurance - Chip (Children's Health Insurance Program)
Public Insurance - Other Government
Self
Donation
Free Care
None
Public insurance - Medicare Unspecified
US/State Govt Agency The candidate's secondary source of payment. May contain organization-specific values: No Category Entries: Private Insurance Public Insurance - Medicaid Public Insurance - Medicare FFS (Fee For Service) Public Insurance - Medicare & Choice Public Insurance - Chip (Children's Health Insurance Program) Public Insurance - Other Government Self Donation Free Care None Public insurance - Medicare Unspecified US/State Govt Agency"
UNOS_INFO,UNOS_OTIS_REGID,N,56,VARCHAR,No,"The candidate's registry ID in OTIS, as supplied by UNOS. The candidate's registry ID in OTIS, as supplied by UNOS."
UNOS_INFO,UNOS_LIST_ADD_DT,N,57,DATETIME,No,The date the candidate was listed or added to the waitlist. The date the candidate was listed or added to the waitlist.
UNOS_INFO,UNOS_TXP_ADMIT_DT,N,58,DATETIME,No,"The date the recipient was admitted to the transplant center. If the patient was admitted to the hospital before it was determined a transplant was needed, the date it was determined the patient needed a transplant. The date the recipient was admitted to the transplant center. If the patient was admitted to the hospital before it was determined a transplant was needed, the date it was determined the patient needed a transplant."
UNOS_INFO,UNOS_TRSFR_PROV_NUM,N,59,VARCHAR,No,UNOS transfer provider number. This information is downloaded from UNOS. UNOS transfer provider number. This information is downloaded from UNOS.
UNOS_INFO,UNOS_TRANSFER_DT,N,60,DATETIME,No,Transfer date. This information is downloaded from UNOS. Transfer date. This information is downloaded from UNOS.
UNOS_INFO,HOME_ADDRESS,N,61,VARCHAR,No,The patient's street address. The patient's street address.
UNOS_INFO,HOME_CITY,N,62,VARCHAR,No,The patient's home city. The patient's home city.
UNOS_INFO,HOME_PHONE,N,63,VARCHAR,No,The patient's home phone number. The patient's home phone number.
UNOS_INFO,WORK_PHONE,N,64,VARCHAR,No,The patient's work phone number. The patient's work phone number.
UNOS_INFO,EMAIL,N,65,VARCHAR,No,The patient's e-mail address. The patient's e-mail address.
UNOS_INFO,UNOS_MARITAL_ST_C_NAME,N,66,VARCHAR,No,"The patient's marital status.
May contain organization-specific values: No
Category Entries:
Single
Married
Divorced
Separated
Life Partner
Widowed
Unknown The patient's marital status. May contain organization-specific values: No Category Entries: Single Married Divorced Separated Life Partner Widowed Unknown"
UNOS_INFO,UNOS_LIV_DNR_TYP_C_NAME,N,67,VARCHAR,No,"The relationship between the living donor and the recipient.
May contain organization-specific values: No
Category Entries:
Biological, Blood Related Parent
Biological, Blood Related Child
Biological, Blood Related Identical Twin
Biological, Blood Related Full Sibling
Biological, Blood Related Half Sibling
Biological, Blood Related Other Relative: Specify
Non-Biological, Spouse
Non-Biological, Life Partner
Non-Biological, Unrelated: Paired Donation
Non-Biological, Unrelated: Non-Directed Donation (Anonymous)
Non-Biological, Living/Deceased Donation
Non-Biological, Unrelated: Domino
Biological, Blood Related: Domino
Biological, Blood Related: Non-Domino Therapeutic Donor
Non-Biological, Unrelated: Non-Domino Therapeutic Donor
Non-Biological, Other Unrelated Directed Donation: Specify The relationship between the living donor and the recipient. May contain organization-specific values: No Category Entries: Biological, Blood Related Parent Biological, Blood Related Child Biological, Blood Related Identical Twin Biological, Blood Related Full Sibling Biological, Blood Related Half Sibling Biological, Blood Related Other Relative: Specify Non-Biological, Spouse Non-Biological, Life Partner Non-Biological, Unrelated: Paired Donation Non-Biological, Unrelated: Non-Directed Donation (Anonymous) Non-Biological, Living/Deceased Donation Non-Biological, Unrelated: Domino Biological, Blood Related: Domino Biological, Blood Related: Non-Domino Therapeutic Donor Non-Biological, Unrelated: Non-Domino Therapeutic Donor Non-Biological, Other Unrelated Directed Donation: Specify"
UNOS_INFO,UNOS_LIV_DNR_TYP_SP,N,68,VARCHAR,No,Free text description of the relationship between the living donor and the recipient. Free text description of the relationship between the living donor and the recipient.
UNOS_INFO,DNR_INSURANCE_ST_C_NAME,N,69,VARCHAR,No,"Indicates whether the donor had health insurance at the time of donation.
The category values for this column were already listed for column: UNOS_WORK_C_NAME Indicates whether the donor had health insurance at the time of donation. The category values for this column were already listed for column: UNOS_WORK_C_NAME"
UNOS_INFO,DNR_RECIPIENT_LNAME,N,70,VARCHAR,No,The recipient's last name in the living donor form. The recipient's last name in the living donor form.
UNOS_INFO,DNR_RECIPIENT_FNAME,N,71,VARCHAR,No,The recipient's first name in the living donor form. The recipient's first name in the living donor form.
UNOS_INFO,DNR_RECOV_CNTR_CODE,N,72,VARCHAR,No,The donor recovery facility center code. The donor recovery facility center code.
UNOS_INFO,DNR_RECOV_CNTR_TYPE,N,73,VARCHAR,No,The donor recovery facility center type. The donor recovery facility center type.
UNOS_INFO,DNR_WRKUP_CNTR_CODE,N,74,VARCHAR,No,The donor workup facility center code. The donor workup facility center code.
UNOS_INFO,DNR_WRKUP_CNTR_TYPE,N,75,VARCHAR,No,The donor workup facility center type. The donor workup facility center type.
UNOS_INFO,ORG_RCV_TXP_SAME_YN,N,76,VARCHAR,No,"Indicates whether the organ recovery and transplant occurred at the same center.
May contain organization-specific values: No
Category Entries:
No
Yes Indicates whether the organ recovery and transplant occurred at the same center. May contain organization-specific values: No Category Entries: No Yes"
UNOS_INFO,PRE_DONATN_HEIGHT,N,77,NUMERIC,No,The living donor's height (in centimeters) prior to donation. The living donor's height (in centimeters) prior to donation.
UNOS_INFO,PRE_DONATN_HT_ST_C_NAME,N,78,VARCHAR,No,"Specifies why the height of the living donor prior to donation is not available.
The category values for this column were already listed for column: UNOS_HEIGHT_STAT_C_NAME Specifies why the height of the living donor prior to donation is not available. The category values for this column were already listed for column: UNOS_HEIGHT_STAT_C_NAME"
UNOS_INFO,PRE_DONATN_WEIGHT,N,79,NUMERIC,No,The living donor's weight (in kilograms) prior to donation. The living donor's weight (in kilograms) prior to donation.
UNOS_INFO,PRE_DONATN_WT_ST_C_NAME,N,80,VARCHAR,No,"Specifies why the weight of the living donor prior to donation is not available.
The category values for this column were already listed for column: UNOS_HEIGHT_STAT_C_NAME Specifies why the weight of the living donor prior to donation is not available. The category values for this column were already listed for column: UNOS_HEIGHT_STAT_C_NAME"
UNOS_INFO,UNOS_DNR_STATUS_C_NAME,N,81,VARCHAR,No,"The status of the donor.
May contain organization-specific values: No
Category Entries:
Living
Dead
Lost
Not Seen The status of the donor. May contain organization-specific values: No Category Entries: Living Dead Lost Not Seen"
UNOS_INFO,UNOS_DNR_ST_COLL,N,82,VARCHAR,No,The attempts to collect donor status if unable to contact donor. The attempts to collect donor status if unable to contact donor.
UNOS_INFO,UNOS_LIV_DNR_ST_C_NAME,N,83,VARCHAR,No,"The most recent donor status.
May contain organization-specific values: No
Category Entries:
Living: Donor Seen at Transplant Center
Living: Donor Status Update by Verbal or Written Communication
Living: Donor Status Update by Other Health Care Facility
Living: Donor Status Update via Other Source (Example: recipient)
Living: Donor Contacted, Declined Follow-up with Transplant Center
Dead
Lost: No Attempt to Contact Donor
Lost: Unable to Contact Donor
Not Seen The most recent donor status. May contain organization-specific values: No Category Entries: Living: Donor Seen at Transplant Center Living: Donor Status Update by Verbal or Written Communication Living: Donor Status Update by Other Health Care Facility Living: Donor Status Update via Other Source (Example: recipient) Living: Donor Contacted, Declined Follow-up with Transplant Center Dead Lost: No Attempt to Contact Donor Lost: Unable to Contact Donor Not Seen"
UNOS_INFO,UNOS_LF_SUPPORT_YN,N,84,VARCHAR,No,"Indicates whether the candidate was on life support.
The category values for this column were already listed for column: ORG_RCV_TXP_SAME_YN Indicates whether the candidate was on life support. The category values for this column were already listed for column: ORG_RCV_TXP_SAME_YN"
UNOS_INFO,UNOS_LF_SPT_VENT_YN,N,85,VARCHAR,No,"Indicates whether the candidate was on continuous invasive ventilation.
May contain organization-specific values: No
Category Entries:
False
True Indicates whether the candidate was on continuous invasive ventilation. May contain organization-specific values: No Category Entries: False True"
UNOS_INFO,UNOS_LF_SPT_LVR_YN,N,86,VARCHAR,No,"Indicates whether the candidate had an artificial liver.
The category values for this column were already listed for column: UNOS_LF_SPT_VENT_YN Indicates whether the candidate had an artificial liver. The category values for this column were already listed for column: UNOS_LF_SPT_VENT_YN"
UNOS_INFO,UNOS_LF_SPT_OTH_YN,N,87,VARCHAR,No,"Indicates whether the candidate was on other types of life support.
The category values for this column were already listed for column: UNOS_LF_SPT_VENT_YN Indicates whether the candidate was on other types of life support. The category values for this column were already listed for column: UNOS_LF_SPT_VENT_YN"
UNOS_INFO,UNOS_LF_SPT_OTH_SP,N,88,VARCHAR,No,Free text description of the type of life support. Free text description of the type of life support.
UNOS_INFO,UNOS_PA_PRIM_INS_C_NAME,N,89,VARCHAR,No,"UNOS pancreas primary source of payment
The category values for this column were already listed for column: UNOS_INSUR_PRI_C_NAME UNOS pancreas primary source of payment The category values for this column were already listed for column: UNOS_INSUR_PRI_C_NAME"
UNOS_INFO,UNOS_PA_FRN_GOV_C_NAME,N,90,VARCHAR,No,"UNOS pancreas foreign government, specify
The category values for this column were already listed for column: UNOS_INSUR_FRGN_C_NAME UNOS pancreas foreign government, specify The category values for this column were already listed for column: UNOS_INSUR_FRGN_C_NAME"
UNOS_INFO,UNOS_ETHNICITY_C_NAME,N,91,VARCHAR,No,"The patient's ethnicity.
May contain organization-specific values: No
Category Entries:
Hispanic or Latino
Not Hispanic or Latino
Ethnicity not reported The patient's ethnicity. May contain organization-specific values: No Category Entries: Hispanic or Latino Not Hispanic or Latino Ethnicity not reported"
UNOS_INS_LOSS_TYPE,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the registry data record. The unique identifier (.1 item) for the registry data record.
UNOS_INS_LOSS_TYPE,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_INS_LOSS_TYPE,INS_LOSS_TYPE_C_NAME,N,3,VARCHAR,No,"Indicates what type of insurance the patient has lost due to donation.
May contain organization-specific values: No
Category Entries:
Health Insurance
Life Insurance Indicates what type of insurance the patient has lost due to donation. May contain organization-specific values: No Category Entries: Health Insurance Life Insurance"
UNOS_KI_COMP_ST,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier for the registry data record. The unique identifier for the registry data record.
UNOS_KI_COMP_ST,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_KI_COMP_ST,UNOS_KI_COMP_ST_C_NAME,N,3,VARCHAR,No,"The status of kidney complications.
May contain organization-specific values: No
Category Entries:
Added to UNOS TX Candidate Waiting List
Other, Specify
Other, Specify The status of kidney complications. May contain organization-specific values: No Category Entries: Added to UNOS TX Candidate Waiting List Other, Specify Other, Specify"
UNOS_KI_OTH_COMP,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier for the registry data record. The unique identifier for the registry data record.
UNOS_KI_OTH_COMP,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_KI_OTH_COMP,UNOS_KI_OTH_COMP_C_NAME,N,3,VARCHAR,No,"The complication(s) if the donor experienced other complications requiring intervention during the first 6 weeks after the donation.
May contain organization-specific values: No
Category Entries:
Renal Insufficiency Requiring Dialysis
Ascites
Line or IV Complication
Pneumothorax
Pneumonia
Wound Complication
Brachial Nerve Injury
Other, Specify The complication(s) if the donor experienced other complications requiring intervention during the first 6 weeks after the donation. May contain organization-specific values: No Category Entries: Renal Insufficiency Requiring Dialysis Ascites Line or IV Complication Pneumothorax Pneumonia Wound Complication Brachial Nerve Injury Other, Specify"
UNOS_KI_VSC_COMP,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier for the registry data record. The unique identifier for the registry data record.
UNOS_KI_VSC_COMP,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_KI_VSC_COMP,UNOS_KI_VSC_COMP_C_NAME,N,3,VARCHAR,No,"The complication(s) if the donor experienced vascular complications requiring intervention during the first 6 weeks after the donation.
May contain organization-specific values: No
Category Entries:
Renal Vein
Renal Artery
Aorta
Vena Cava
Pulmonary Embolus
Deep Vein Thrombosis
Other, Specify The complication(s) if the donor experienced vascular complications requiring intervention during the first 6 weeks after the donation. May contain organization-specific values: No Category Entries: Renal Vein Renal Artery Aorta Vena Cava Pulmonary Embolus Deep Vein Thrombosis Other, Specify"
UNOS_LUNG_SURG_TYP,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the registry data record. The unique identifier (.1 item) for the registry data record.
UNOS_LUNG_SURG_TYP,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_LUNG_SURG_TYP,UNOS_LUNG_SURG_TS_C_NAME,N,3,VARCHAR,No,"A list of the types of non-transplant lung surgery the patient has undergone prior to UNOS registration
May contain organization-specific values: No
Category Entries:
Pneumoreduction
Pneumothorax Surgery-Nodule
Pneumothorax Decortication
Lobectomy
Pneumonectomy
Left Thoracotomy
Right Thoractomy
Other, Specify A list of the types of non-transplant lung surgery the patient has undergone prior to UNOS registration May contain organization-specific values: No Category Entries: Pneumoreduction Pneumothorax Surgery-Nodule Pneumothorax Decortication Lobectomy Pneumonectomy Left Thoracotomy Right Thoractomy Other, Specify"
UNOS_MALIG_HX_TYPE,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier for the registry data record. The unique identifier for the registry data record.
UNOS_MALIG_HX_TYPE,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_MALIG_HX_TYPE,UNOS_MALIG_HX_TY_C_NAME,N,3,VARCHAR,No,"If the patient has a history of malignant cancer, indicates the types of tumors.
May contain organization-specific values: No
Category Entries:
Skin Melanoma
Skin Non-Melanoma
CNS Tumor
Genitourinary
Breast
Thyroid
Tongue/Throat/Larynx
Lung
Leukemia/Lymphoma
Type Unknown
Other, Specify
Liver
Hepatocellular Carcinoma
Hepatoblastoma
Cholangiocarcinoma If the patient has a history of malignant cancer, indicates the types of tumors. May contain organization-specific values: No Category Entries: Skin Melanoma Skin Non-Melanoma CNS Tumor Genitourinary Breast Thyroid Tongue/Throat/Larynx Lung Leukemia/Lymphoma Type Unknown Other, Specify Liver Hepatocellular Carcinoma Hepatoblastoma Cholangiocarcinoma"
UNOS_MALIG_TYPE,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier for the registry data record. The unique identifier for the registry data record.
UNOS_MALIG_TYPE,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_MALIG_TYPE,UNOS_MALIG_TYPE_C_NAME,N,3,VARCHAR,No,"The types of malignancy the recipient had between listing and transplant.
May contain organization-specific values: No
Category Entries:
Skin Melanoma
Skin Non-Melanoma
CNS Tumor
Genitourinary
Breast
Thyroid
Tongue/Throat/Larynx
Lung
Leukemia/Lymphoma
Type Unknown
Other, Specify
Liver
Hepatocellular Carcinoma
Hepatoblastoma
Cholangiocarcinoma The types of malignancy the recipient had between listing and transplant. May contain organization-specific values: No Category Entries: Skin Melanoma Skin Non-Melanoma CNS Tumor Genitourinary Breast Thyroid Tongue/Throat/Larynx Lung Leukemia/Lymphoma Type Unknown Other, Specify Liver Hepatocellular Carcinoma Hepatoblastoma Cholangiocarcinoma"
UNOS_OTH_THERAPIES,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier for the registry data record. The unique identifier for the registry data record.
UNOS_OTH_THERAPIES,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_OTH_THERAPIES,UNOS_OTH_THERP_C_NAME,N,3,VARCHAR,No,"The specific other therapy undergone by the patient.
May contain organization-specific values: No
Category Entries:
Photopheresis
Plasmapheresis
Total Lymphoid Irradiation (TLI) The specific other therapy undergone by the patient. May contain organization-specific values: No Category Entries: Photopheresis Plasmapheresis Total Lymphoid Irradiation (TLI)"
UNOS_READM_RSN,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier for the registry data record. The unique identifier for the registry data record.
UNOS_READM_RSN,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
UNOS_READM_RSN,UNOS_READM_RSN_C_NAME,N,3,VARCHAR,No,"The reason why the donor required readmission after the initial discharge during the first 6 weeks after the donation.
May contain organization-specific values: No
Category Entries:
Wound Infection
Fever
Bowel Obstruction
Pleural Effusion
Vascular Complications
Other, Specify The reason why the donor required readmission after the initial discharge during the first 6 weeks after the donation. May contain organization-specific values: No Category Entries: Wound Infection Fever Bowel Obstruction Pleural Effusion Vascular Complications Other, Specify"
UNOS_THRR_DYSFUNCTION,REGISTRY_DATA_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the registry data record. The unique identifier (.1 item) for the registry data record.
UNOS_THRR_DYSFUNCTION,TXP24_PGD_C_NAME,N,2,VARCHAR,No,"Stores whether primary graft dysfunction (PGD) was present for the patient 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
Yes
No
Unknown Stores whether primary graft dysfunction (PGD) was present for the patient 24 hours after transplant. May contain organization-specific values: No Category Entries: Yes No Unknown"
UNOS_THRR_DYSFUNCTION,TXP24_PGD_LV_C_NAME,N,3,VARCHAR,No,"Stores whether primary graft dysfunction - left ventricular (PGD-LV) was present 24 hours after transplant.
The category values for this column were already listed for column: TXP24_PGD_C_NAME Stores whether primary graft dysfunction - left ventricular (PGD-LV) was present 24 hours after transplant. The category values for this column were already listed for column: TXP24_PGD_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_PGD_RV_C_NAME,N,4,VARCHAR,No,"Stores whether primary graft dysfunction - right ventricular (PGD-RV) was present 24 hours after transplant.
The category values for this column were already listed for column: TXP24_PGD_C_NAME Stores whether primary graft dysfunction - right ventricular (PGD-RV) was present 24 hours after transplant. The category values for this column were already listed for column: TXP24_PGD_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_LA_PRES,N,5,NUMERIC,No,Left atrial (LA) pressure 24 hours after transplant. Left atrial (LA) pressure 24 hours after transplant.
UNOS_THRR_DYSFUNCTION,TXP24_LA_PRES_ST_C_NAME,N,6,VARCHAR,No,"Left atrial (LA) Pressure status 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
N/A
Not Done
Missing
Unknown Left atrial (LA) Pressure status 24 hours after transplant. May contain organization-specific values: No Category Entries: N/A Not Done Missing Unknown"
UNOS_THRR_DYSFUNCTION,TXP24_PCWP,N,7,NUMERIC,No,Stores the Pulmonary Capillary Wedge Pressure (PCWP) for the patient 24 hours after transplant. Stores the Pulmonary Capillary Wedge Pressure (PCWP) for the patient 24 hours after transplant.
UNOS_THRR_DYSFUNCTION,TXP24_PCWP_ST_C_NAME,N,8,VARCHAR,No,"Pulmonary capillary wedge pressure (PCWP) status 24 hours after transplant.
The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME Pulmonary capillary wedge pressure (PCWP) status 24 hours after transplant. The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_RA_PRES,N,9,NUMERIC,No,Right atrial (RA) pressure 24 hours after transplant. Right atrial (RA) pressure 24 hours after transplant.
UNOS_THRR_DYSFUNCTION,TXP24_RA_PRES_ST_C_NAME,N,10,VARCHAR,No,"Right atrial (RA) pressure status 24 hours after transplant.
The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME Right atrial (RA) pressure status 24 hours after transplant. The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_PA_SYS_PRES,N,11,NUMERIC,No,Pulmonary Artery (PA) systolic pressure 24 hours after transplant. Pulmonary Artery (PA) systolic pressure 24 hours after transplant.
UNOS_THRR_DYSFUNCTION,TXP24_PASYSPRS_ST_C_NAME,N,12,VARCHAR,No,"Pulmonary artery (PA) systolic pressure status 24 hours after transplant.
The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME Pulmonary artery (PA) systolic pressure status 24 hours after transplant. The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_DIA_PRES,N,13,NUMERIC,No,Pulmonary artery (PA) diastolic pressure 24 hours after transplant. Pulmonary artery (PA) diastolic pressure 24 hours after transplant.
UNOS_THRR_DYSFUNCTION,TXP24_DIA_PRES_ST_C_NAME,N,14,VARCHAR,No,"Pulmonary artery (PA) diastolic pressure status 24 hours after transplant.
The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME Pulmonary artery (PA) diastolic pressure status 24 hours after transplant. The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_CO,N,15,NUMERIC,No,Cardiac Output (CO) 24 hours after transplant. Cardiac Output (CO) 24 hours after transplant.
UNOS_THRR_DYSFUNCTION,TXP24_CO_ST_C_NAME,N,16,VARCHAR,No,"Cardiac Output (CO) status 24 hours after transplant.
The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME Cardiac Output (CO) status 24 hours after transplant. The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_PAT_LIFESUP_YN,N,17,VARCHAR,No,"Stores whether the patient was on Life Support 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
No
Yes Stores whether the patient was on Life Support 24 hours after transplant. May contain organization-specific values: No Category Entries: No Yes"
UNOS_THRR_DYSFUNCTION,TXP24_ECMO_YN,N,18,VARCHAR,No,"Stores whether the patient was on an extracorporeal membrane oxygenation (ECMO) machine for life support 24 hours after transplant.
The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN Stores whether the patient was on an extracorporeal membrane oxygenation (ECMO) machine for life support 24 hours after transplant. The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN"
UNOS_THRR_DYSFUNCTION,TXP24_IA_BLON_PMP_YN,N,19,VARCHAR,No,"Stores whether the patient was on an intra-aortic balloon pump for life support 24 hours after transplant.
The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN Stores whether the patient was on an intra-aortic balloon pump for life support 24 hours after transplant. The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN"
UNOS_THRR_DYSFUNCTION,TXP24_INH_NO_YN,N,20,VARCHAR,No,"Stores whether the patient was receiving inhaled nitric oxide for life support 24 hours after transplant.
The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN Stores whether the patient was receiving inhaled nitric oxide for life support 24 hours after transplant. The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN"
UNOS_THRR_DYSFUNCTION,TXP24_PAT_ON_VAD_C_NAME,N,21,VARCHAR,No,"Stores whether the patient was on a ventricular assist device (VAD) 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
NONE
LVAD
RVAD
TAH
LVAD+RVAD
LVAD/RVAD/TAH Unspecified Stores whether the patient was on a ventricular assist device (VAD) 24 hours after transplant. May contain organization-specific values: No Category Entries: NONE LVAD RVAD TAH LVAD+RVAD LVAD/RVAD/TAH Unspecified"
UNOS_THRR_DYSFUNCTION,TXP24_VAD_BRAND1_C_NAME,N,22,VARCHAR,No,"Brand of the first ventricular assist device (VAD) used by the patient 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
Abiomed BVS 5000
Arrow Lionheart
Berlin Heart
Biomedicus
HeartMate II
HeartMate IP
HeartMate VE
HeartMate XVE
Heartsaver VAD
Jarvik 2000
Medos
MicroMed DeBakey
Novacor PC
Novacor PCq
Cardiac Assist Tandem Heart
Thoratec
Thoratec IVAD
Toyobo
Type Unspecified
Abiomed AB5000
Berlin Heart EXCOR
Evaheart
Heartware HVAD
Impella Recover 2.5
Impella Recover 5.0
CentriMag (Thoratec/Levitronix)
Maquet Josta Rotaflow
MicroMed DeBakey - Child
Terumo DuraHeart
Thoratec PVAD
Ventracor VentrAssist
Worldheart Levacor
PediMag (Thoratec/Levitronix)
Cardiac Assist Protek Duo
HeartMate III
Impella CP
Impella RP
ReliantHeartAssist 5
ReliantHeart aVAD
Impella 5.5
Abiomed BVS 5000
Berlin Heart
Biomedicus
Medos
Thoratec
Thoratec IVAD
Toyobo
Abiomed AB5000
Berlin Heart EXCOR
Cardiac Assist Tandem Heart
Evaheart
HeartMate II
HeartMate XVE
Heartsaver VAD
Heartware HVAD
Impella Recover 2.5
Impella Recover 5.0
Jarvik 2000
CentriMag (Thoratec/Levitronix)
Maquet Josta Rotaflow
MicroMed DeBakey
MicroMed DeBakey - Child
Terumo DuraHeart
Thoratec PVAD
Ventracor VentrAssist
Worldheart Levacor
PediMag (Thoratec/Levitronix)
Cardiac Assist Protek Duo
HeartMate III
Impella CP
Impella RP
ReliantHeartAssist 5
ReliantHeart aVAD
AbioCor
SynCardia CardioWest
Other, Specify Brand of the first ventricular assist device (VAD) used by the patient 24 hours after transplant. May contain organization-specific values: No Category Entries: Abiomed BVS 5000 Arrow Lionheart Berlin Heart Biomedicus HeartMate II HeartMate IP HeartMate VE HeartMate XVE Heartsaver VAD Jarvik 2000 Medos MicroMed DeBakey Novacor PC Novacor PCq Cardiac Assist Tandem Heart Thoratec Thoratec IVAD Toyobo Type Unspecified Abiomed AB5000 Berlin Heart EXCOR Evaheart Heartware HVAD Impella Recover 2.5 Impella Recover 5.0 CentriMag (Thoratec/Levitronix) Maquet Josta Rotaflow MicroMed DeBakey - Child Terumo DuraHeart Thoratec PVAD Ventracor VentrAssist Worldheart Levacor PediMag (Thoratec/Levitronix) Cardiac Assist Protek Duo HeartMate III Impella CP Impella RP ReliantHeartAssist 5 ReliantHeart aVAD Impella 5.5 Abiomed BVS 5000 Berlin Heart Biomedicus Medos Thoratec Thoratec IVAD Toyobo Abiomed AB5000 Berlin Heart EXCOR Cardiac Assist Tandem Heart Evaheart HeartMate II HeartMate XVE Heartsaver VAD Heartware HVAD Impella Recover 2.5 Impella Recover 5.0 Jarvik 2000 CentriMag (Thoratec/Levitronix) Maquet Josta Rotaflow MicroMed DeBakey MicroMed DeBakey - Child Terumo DuraHeart Thoratec PVAD Ventracor VentrAssist Worldheart Levacor PediMag (Thoratec/Levitronix) Cardiac Assist Protek Duo HeartMate III Impella CP Impella RP ReliantHeartAssist 5 ReliantHeart aVAD AbioCor SynCardia CardioWest Other, Specify"
UNOS_THRR_DYSFUNCTION,TXP24_VAD_BRND1_OTH,N,23,VARCHAR,No,"Brand of the first ventricular assist device (VAD) used by the patient 24 hours after transplant, if it is not one of the available options. Brand of the first ventricular assist device (VAD) used by the patient 24 hours after transplant, if it is not one of the available options."
UNOS_THRR_DYSFUNCTION,TXP24_VAD_BRAND2_C_NAME,N,24,VARCHAR,No,"Brand of the second ventricular assist device (VAD) used by the patient 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
Abiomed BVS 5000
Berlin Heart
Biomedicus
Medos
Thoratec
Thoratec IVAD
Toyobo
Abiomed AB5000
Berlin Heart EXCOR
Cardiac Assist Tandem Heart
Evaheart
HeartMate II
HeartMate XVE
Heartsaver VAD
Heartware HVAD
Impella Recover 2.5
Impella Recover 5.0
Jarvik 2000
CentriMag (Thoratec/Levitronix)
Maquet Josta Rotaflow
MicroMed DeBakey
MicroMed DeBakey - Child
Terumo DuraHeart
Thoratec PVAD
Ventracor VentrAssist
Worldheart Levacor
PediMag (Thoratec/Levitronix)
Cardiac Assist Protek Duo
HeartMate III
Impella CP
Impella RP
ReliantHeartAssist 5
ReliantHeart aVAD
Other, Specify Brand of the second ventricular assist device (VAD) used by the patient 24 hours after transplant. May contain organization-specific values: No Category Entries: Abiomed BVS 5000 Berlin Heart Biomedicus Medos Thoratec Thoratec IVAD Toyobo Abiomed AB5000 Berlin Heart EXCOR Cardiac Assist Tandem Heart Evaheart HeartMate II HeartMate XVE Heartsaver VAD Heartware HVAD Impella Recover 2.5 Impella Recover 5.0 Jarvik 2000 CentriMag (Thoratec/Levitronix) Maquet Josta Rotaflow MicroMed DeBakey MicroMed DeBakey - Child Terumo DuraHeart Thoratec PVAD Ventracor VentrAssist Worldheart Levacor PediMag (Thoratec/Levitronix) Cardiac Assist Protek Duo HeartMate III Impella CP Impella RP ReliantHeartAssist 5 ReliantHeart aVAD Other, Specify"
UNOS_THRR_DYSFUNCTION,TXP24_VAD_BRND2_OTH,N,25,VARCHAR,No,"Stores the brand of the second ventricular assist device (VAD) used by the patient 24 hours after transplant, if it is not one of the available options. Stores the brand of the second ventricular assist device (VAD) used by the patient 24 hours after transplant, if it is not one of the available options."
UNOS_THRR_DYSFUNCTION,TXP24_EPOPROSTENL_C_NAME,N,26,VARCHAR,No,"Stores whether the patient received epoprostenol 24 hours after transplant.
The category values for this column were already listed for column: TXP24_PGD_C_NAME Stores whether the patient received epoprostenol 24 hours after transplant. The category values for this column were already listed for column: TXP24_PGD_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_INOSP_EPNPH_C_NAME,N,27,VARCHAR,No,"Stores the amount of epinephrine the patient received 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
None
Low (<=0.05)
Moderate (>0.05 - <=0.10)
High (>0.10)
Unknown Stores the amount of epinephrine the patient received 24 hours after transplant. May contain organization-specific values: No Category Entries: None Low (<=0.05) Moderate (>0.05 - <=0.10) High (>0.10) Unknown"
UNOS_THRR_DYSFUNCTION,TXP24_INOSP_MLRNO_C_NAME,N,28,VARCHAR,No,"Stores the amount of milrinone the patient received 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
None
Low (<=0.30)
Moderate (>0.30 - <=0.50)
High (>0.50)
Unknown Stores the amount of milrinone the patient received 24 hours after transplant. May contain organization-specific values: No Category Entries: None Low (<=0.30) Moderate (>0.30 - <=0.50) High (>0.50) Unknown"
UNOS_THRR_DYSFUNCTION,TXP24_INOSP_DOBTM_C_NAME,N,29,VARCHAR,No,"Stores the amount of dobutamine the patient received 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
None
Low (<=3.00)
Moderate (>3.00 - <=7.50)
High (>7.50)
Unknown Stores the amount of dobutamine the patient received 24 hours after transplant. May contain organization-specific values: No Category Entries: None Low (<=3.00) Moderate (>3.00 - <=7.50) High (>7.50) Unknown"
UNOS_THRR_DYSFUNCTION,TXP24_INOSP_DOPMN_C_NAME,N,30,VARCHAR,No,"Stores the amount of dopamine the patient received 24 hours after transplant.
The category values for this column were already listed for column: TXP24_INOSP_DOBTM_C_NAME Stores the amount of dopamine the patient received 24 hours after transplant. The category values for this column were already listed for column: TXP24_INOSP_DOBTM_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_LEVO_NL_C_NAME,N,31,VARCHAR,No,"Stores whether the patient received norepinephrine (levophed) 24 hours after transplant.
The category values for this column were already listed for column: TXP24_PGD_C_NAME Stores whether the patient received norepinephrine (levophed) 24 hours after transplant. The category values for this column were already listed for column: TXP24_PGD_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_LVNLV_UNIT_C_NAME,N,32,VARCHAR,No,"Stores the unit of norepinephrine (levophed) the patient received 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
mcg/min
mcg/kg/min Stores the unit of norepinephrine (levophed) the patient received 24 hours after transplant. May contain organization-specific values: No Category Entries: mcg/min mcg/kg/min"
UNOS_THRR_DYSFUNCTION,TXP24_LVNLV_MCGMN_C_NAME,N,33,VARCHAR,No,"Stores the amount of norepinephrine (levophed) the patient received in mcg/min, 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
Low (<=5.00)
Moderate (>5.00 - <=12.00)
High (>12.00) Stores the amount of norepinephrine (levophed) the patient received in mcg/min, 24 hours after transplant. May contain organization-specific values: No Category Entries: Low (<=5.00) Moderate (>5.00 - <=12.00) High (>12.00)"
UNOS_THRR_DYSFUNCTION,TXP24_LVNLV_MCKMN_C_NAME,N,34,VARCHAR,No,"Stores the amount of norepinephrine (levophed) the patient received in mcg/kg/min, 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
Low (<=0.05)
Moderate (>0.05 - <=0.10)
High (>0.10) Stores the amount of norepinephrine (levophed) the patient received in mcg/kg/min, 24 hours after transplant. May contain organization-specific values: No Category Entries: Low (<=0.05) Moderate (>0.05 - <=0.10) High (>0.10)"
UNOS_THRR_DYSFUNCTION,TXP24_NEO_P_N_C_NAME,N,35,VARCHAR,No,"Stores whether the patient received phenylephrine (neosynephrine) 24 hours after transplant.
The category values for this column were already listed for column: TXP24_PGD_C_NAME Stores whether the patient received phenylephrine (neosynephrine) 24 hours after transplant. The category values for this column were already listed for column: TXP24_PGD_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_N_PN_UNIT_C_NAME,N,36,VARCHAR,No,"Stores the unit of phenylephrine (neosynephrine) the patient received 24 hours after transplant.
The category values for this column were already listed for column: TXP24_LVNLV_UNIT_C_NAME Stores the unit of phenylephrine (neosynephrine) the patient received 24 hours after transplant. The category values for this column were already listed for column: TXP24_LVNLV_UNIT_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_N_PN_MCGMIN_C_NAME,N,37,VARCHAR,No,"Stores the amount of phenylephrine (neosynephrine) the patient received in mcg/min, 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
Low (<=100.00)
Moderate (>100.00 - <=200.00)
High (>200.00) Stores the amount of phenylephrine (neosynephrine) the patient received in mcg/min, 24 hours after transplant. May contain organization-specific values: No Category Entries: Low (<=100.00) Moderate (>100.00 - <=200.00) High (>200.00)"
UNOS_THRR_DYSFUNCTION,TXP24_N_PHN_MCKMN_C_NAME,N,38,VARCHAR,No,"Stores the amount of phenylephrine (neosynephrine) the patient received in mcg/kg/min, 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
Low (<=1.50)
Moderate (>1.50 - <=4.00)
High (>4.00) Stores the amount of phenylephrine (neosynephrine) the patient received in mcg/kg/min, 24 hours after transplant. May contain organization-specific values: No Category Entries: Low (<=1.50) Moderate (>1.50 - <=4.00) High (>4.00)"
UNOS_THRR_DYSFUNCTION,TXP24_VASOPRESSRS_C_NAME,N,39,VARCHAR,No,"Stores whether the patient received vasopressin (pitressin) 24 hours after transplant.
May contain organization-specific values: No
Category Entries:
None
Low (<=0.05)
Moderate (>0.05 - <=0.08)
High (>0.08)
Unknown Stores whether the patient received vasopressin (pitressin) 24 hours after transplant. May contain organization-specific values: No Category Entries: None Low (<=0.05) Moderate (>0.05 - <=0.08) High (>0.08) Unknown"
UNOS_THRR_DYSFUNCTION,TXP72_PGD_C_NAME,N,40,VARCHAR,No,"Stores whether primary graft dysfunction (PGD) is present for the patient 72 hours after transplant.
The category values for this column were already listed for column: TXP24_PGD_C_NAME Stores whether primary graft dysfunction (PGD) is present for the patient 72 hours after transplant. The category values for this column were already listed for column: TXP24_PGD_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_PGD_LV_C_NAME,N,41,VARCHAR,No,"Stores whether primary graft dysfunction - left ventricular (PGD-LV) was present 72 hours after transplant.
The category values for this column were already listed for column: TXP24_PGD_C_NAME Stores whether primary graft dysfunction - left ventricular (PGD-LV) was present 72 hours after transplant. The category values for this column were already listed for column: TXP24_PGD_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_PGD_RV_C_NAME,N,42,VARCHAR,No,"Stores whether primary graft dysfunction - right ventricular (PGD-RV) was present 72 hours after transplant.
The category values for this column were already listed for column: TXP24_PGD_C_NAME Stores whether primary graft dysfunction - right ventricular (PGD-RV) was present 72 hours after transplant. The category values for this column were already listed for column: TXP24_PGD_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_LVEF_C_NAME,N,43,VARCHAR,No,"Stores the left ventricular ejection fraction (LVEF) for the patient 72 hours after transplant.
May contain organization-specific values: No
Category Entries:
Severely Depressed LV Function (EF <30%)
Moderately Depressed LV Function (EF >=30% - <40%)
Mildly Depressed LV Function (EF >=40% - <50%)
Normal LV Function (EF >=50%)
Unknown Stores the left ventricular ejection fraction (LVEF) for the patient 72 hours after transplant. May contain organization-specific values: No Category Entries: Severely Depressed LV Function (EF <30%) Moderately Depressed LV Function (EF >=30% - <40%) Mildly Depressed LV Function (EF >=40% - <50%) Normal LV Function (EF >=50%) Unknown"
UNOS_THRR_DYSFUNCTION,TXP72_LA_PRES,N,44,NUMERIC,No,Stores the left atrial (LA) pressure for the patient 72 hours after transplant. Stores the left atrial (LA) pressure for the patient 72 hours after transplant.
UNOS_THRR_DYSFUNCTION,TXP72_LA_PRES_ST_C_NAME,N,45,VARCHAR,No,"Stores the left atrial (LA) pressure status for the patient 72 hours after transplant.
The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME Stores the left atrial (LA) pressure status for the patient 72 hours after transplant. The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_PCWP,N,46,NUMERIC,No,Stores the Pulmonary Capillary Wedge Pressure (PCWP) for the patient 72 hours after transplant. Stores the Pulmonary Capillary Wedge Pressure (PCWP) for the patient 72 hours after transplant.
UNOS_THRR_DYSFUNCTION,TXP72_PCWP_ST_C_NAME,N,47,VARCHAR,No,"Stores the Pulmonary Capillary Wedge Pressure (PCWP) status for the patient 72 hours after transplant.
The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME Stores the Pulmonary Capillary Wedge Pressure (PCWP) status for the patient 72 hours after transplant. The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_RA_PRES,N,48,NUMERIC,No,Stores the right atrial (RA) pressure for the patient 72 hours after transplant. Stores the right atrial (RA) pressure for the patient 72 hours after transplant.
UNOS_THRR_DYSFUNCTION,TXP72_RA_PRES_ST_C_NAME,N,49,VARCHAR,No,"Stores the right atrial (RA) pressure status for the patient 72 hours after transplant.
The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME Stores the right atrial (RA) pressure status for the patient 72 hours after transplant. The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_PA_SYS_PRES,N,50,NUMERIC,No,Stores the Pulmonary Artery (PA) Systolic Pressure for the patient 72 hours after transplant. Stores the Pulmonary Artery (PA) Systolic Pressure for the patient 72 hours after transplant.
UNOS_THRR_DYSFUNCTION,TXP72_PASYSPRS_ST_C_NAME,N,51,VARCHAR,No,"Stores the Pulmonary Artery (PA) Systolic Pressure status for the patient 72 hours after transplant.
The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME Stores the Pulmonary Artery (PA) Systolic Pressure status for the patient 72 hours after transplant. The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_DIA_PRES,N,52,NUMERIC,No,Stores the Pulmonary Artery (PA) Diastolic Pressure for the patient 72 hours after transplant. Stores the Pulmonary Artery (PA) Diastolic Pressure for the patient 72 hours after transplant.
UNOS_THRR_DYSFUNCTION,TXP72_DIA_PRES_ST_C_NAME,N,53,VARCHAR,No,"Stores the Pulmonary Artery (PA) Diastolic Pressure status for the patient 72 hours after transplant.
The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME Stores the Pulmonary Artery (PA) Diastolic Pressure status for the patient 72 hours after transplant. The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_CO,N,54,NUMERIC,No,Stores the Cardiac Output (CO) for the patient 72 hours after transplant. Stores the Cardiac Output (CO) for the patient 72 hours after transplant.
UNOS_THRR_DYSFUNCTION,TXP72_CO_ST_C_NAME,N,55,VARCHAR,No,"Stores the Cardiac Output (CO) status for the patient 72 hours after transplant.
The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME Stores the Cardiac Output (CO) status for the patient 72 hours after transplant. The category values for this column were already listed for column: TXP24_LA_PRES_ST_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_PAT_LIFESUP_YN,N,56,VARCHAR,No,"Stores whether the patient was on life support 72 hours after transplant.
The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN Stores whether the patient was on life support 72 hours after transplant. The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN"
UNOS_THRR_DYSFUNCTION,TXP72_ECMO_YN,N,57,VARCHAR,No,"Stores whether the patient was on an extracorporeal membrane oxygenation machine (ECMO) for life support 72 hours after transplant.
The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN Stores whether the patient was on an extracorporeal membrane oxygenation machine (ECMO) for life support 72 hours after transplant. The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN"
UNOS_THRR_DYSFUNCTION,TXP72_IA_BLON_PMP_YN,N,58,VARCHAR,No,"Stores whether the patient was on an intra-aortic balloon pump for life support 72 hours after transplant.
The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN Stores whether the patient was on an intra-aortic balloon pump for life support 72 hours after transplant. The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN"
UNOS_THRR_DYSFUNCTION,TXP72_INH_NO_YN,N,59,VARCHAR,No,"Stores whether the patient was receiving inhaled nitric oxide for life support 72 hours after transplant.
The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN Stores whether the patient was receiving inhaled nitric oxide for life support 72 hours after transplant. The category values for this column were already listed for column: TXP24_PAT_LIFESUP_YN"
UNOS_THRR_DYSFUNCTION,TXP72_PAT_ON_VAD_C_NAME,N,60,VARCHAR,No,"Stores whether the transplant recipient was on a ventricular assist device (VAD) 72 hours after transplant.
The category values for this column were already listed for column: TXP24_PAT_ON_VAD_C_NAME Stores whether the transplant recipient was on a ventricular assist device (VAD) 72 hours after transplant. The category values for this column were already listed for column: TXP24_PAT_ON_VAD_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_VAD_BRAND1_C_NAME,N,61,VARCHAR,No,"Stores the brand of the first ventricular assist device (VAD) used by the patient 72 hours after transplant.
The category values for this column were already listed for column: TXP24_VAD_BRAND1_C_NAME Stores the brand of the first ventricular assist device (VAD) used by the patient 72 hours after transplant. The category values for this column were already listed for column: TXP24_VAD_BRAND1_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_VAD_BRND1_OTH,N,62,VARCHAR,No,"Stores the brand of the first ventricular assist device (VAD) used by the patient 72 hours after transplant, if it is not one of the available options. Stores the brand of the first ventricular assist device (VAD) used by the patient 72 hours after transplant, if it is not one of the available options."
UNOS_THRR_DYSFUNCTION,TXP72_VAD_BRAND2_C_NAME,N,63,VARCHAR,No,"Stores the brand of the second ventricular (VAD) assist device used by the patient 72 hours after transplant.
The category values for this column were already listed for column: TXP24_VAD_BRAND2_C_NAME Stores the brand of the second ventricular (VAD) assist device used by the patient 72 hours after transplant. The category values for this column were already listed for column: TXP24_VAD_BRAND2_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_VAD_BRND2_OTH,N,64,VARCHAR,No,"Stores the brand of the second ventricular assist device (VAD) used by the patient 72 hours after transplant, if it is not one of the available options. Stores the brand of the second ventricular assist device (VAD) used by the patient 72 hours after transplant, if it is not one of the available options."
UNOS_THRR_DYSFUNCTION,TXP72_EPOPROSTENL_C_NAME,N,65,VARCHAR,No,"Stores whether the patient received epoprostenol 72 hours after transplant.
The category values for this column were already listed for column: TXP24_PGD_C_NAME Stores whether the patient received epoprostenol 72 hours after transplant. The category values for this column were already listed for column: TXP24_PGD_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_INOSP_EPNPH_C_NAME,N,66,VARCHAR,No,"Stores the amount of epinephrine the patient received 72 hours after transplant.
The category values for this column were already listed for column: TXP24_INOSP_EPNPH_C_NAME Stores the amount of epinephrine the patient received 72 hours after transplant. The category values for this column were already listed for column: TXP24_INOSP_EPNPH_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_INOSP_MLRNO_C_NAME,N,67,VARCHAR,No,"Stores the amount of milrinone the patient received 72 hours after transplant.
The category values for this column were already listed for column: TXP24_INOSP_MLRNO_C_NAME Stores the amount of milrinone the patient received 72 hours after transplant. The category values for this column were already listed for column: TXP24_INOSP_MLRNO_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_INOSP_DOBTM_C_NAME,N,68,VARCHAR,No,"Stores the amount of dobutamine the patient received 72 hours after transplant.
The category values for this column were already listed for column: TXP24_INOSP_DOBTM_C_NAME Stores the amount of dobutamine the patient received 72 hours after transplant. The category values for this column were already listed for column: TXP24_INOSP_DOBTM_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_INOSP_DOPMN_C_NAME,N,69,VARCHAR,No,"Stores the amount of dopamine the patient received 72 hours after transplant.
The category values for this column were already listed for column: TXP24_INOSP_DOBTM_C_NAME Stores the amount of dopamine the patient received 72 hours after transplant. The category values for this column were already listed for column: TXP24_INOSP_DOBTM_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_LEVO_NL_C_NAME,N,70,VARCHAR,No,"Stores whether the patient received norepinephrine (levophed) 72 hours after transplant.
The category values for this column were already listed for column: TXP24_PGD_C_NAME Stores whether the patient received norepinephrine (levophed) 72 hours after transplant. The category values for this column were already listed for column: TXP24_PGD_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_LVNLV_UNIT_C_NAME,N,71,VARCHAR,No,"Stores the unit of norepinephrine (levophed) the patient received 72 hours after transplant.
The category values for this column were already listed for column: TXP24_LVNLV_UNIT_C_NAME Stores the unit of norepinephrine (levophed) the patient received 72 hours after transplant. The category values for this column were already listed for column: TXP24_LVNLV_UNIT_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_LVNLV_MCGMN_C_NAME,N,72,VARCHAR,No,"Stores the amount of norepinephrine (levophed) the patient received in mcg/min, 72 hours after transplant.
The category values for this column were already listed for column: TXP24_LVNLV_MCGMN_C_NAME Stores the amount of norepinephrine (levophed) the patient received in mcg/min, 72 hours after transplant. The category values for this column were already listed for column: TXP24_LVNLV_MCGMN_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_LVNLV_MCKMN_C_NAME,N,73,VARCHAR,No,"Stores the amount of norepinephrine (levophed) the patient received in mcg/kg/min, 72 hours after transplant.
The category values for this column were already listed for column: TXP24_LVNLV_MCKMN_C_NAME Stores the amount of norepinephrine (levophed) the patient received in mcg/kg/min, 72 hours after transplant. The category values for this column were already listed for column: TXP24_LVNLV_MCKMN_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_NEO_P_N_C_NAME,N,74,VARCHAR,No,"Stores whether the patient received phenylephrine (neosynephrine) 72 hours after transplant.
The category values for this column were already listed for column: TXP24_PGD_C_NAME Stores whether the patient received phenylephrine (neosynephrine) 72 hours after transplant. The category values for this column were already listed for column: TXP24_PGD_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_N_PN_UNIT_C_NAME,N,75,VARCHAR,No,"Stores the unit of phenylephrine (neosynephrine) the patient received 72 hours after transplant.
The category values for this column were already listed for column: TXP24_LVNLV_UNIT_C_NAME Stores the unit of phenylephrine (neosynephrine) the patient received 72 hours after transplant. The category values for this column were already listed for column: TXP24_LVNLV_UNIT_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_N_PN_MCGMIN_C_NAME,N,76,VARCHAR,No,"Stores the amount of phenylephrine (neosynephrine) the patient received in mcg/min, 72 hours after transplant.
The category values for this column were already listed for column: TXP24_N_PN_MCGMIN_C_NAME Stores the amount of phenylephrine (neosynephrine) the patient received in mcg/min, 72 hours after transplant. The category values for this column were already listed for column: TXP24_N_PN_MCGMIN_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_N_PHN_MCKMN_C_NAME,N,77,VARCHAR,No,"Stores the amount of phenylephrine (neosynephrine) the patient received in mcg/kg/min, 72 hours after transplant.
The category values for this column were already listed for column: TXP24_N_PHN_MCKMN_C_NAME Stores the amount of phenylephrine (neosynephrine) the patient received in mcg/kg/min, 72 hours after transplant. The category values for this column were already listed for column: TXP24_N_PHN_MCKMN_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP72_VASOPRESSRS_C_NAME,N,78,VARCHAR,No,"Stores whether the patient received vasopressin (pitressin) 72 hours after transplant.
The category values for this column were already listed for column: TXP24_VASOPRESSRS_C_NAME Stores whether the patient received vasopressin (pitressin) 72 hours after transplant. The category values for this column were already listed for column: TXP24_VASOPRESSRS_C_NAME"
UNOS_THRR_DYSFUNCTION,TXP24_LVEF_C_NAME,N,79,VARCHAR,No,"Left ventricular ejection fraction (LVEF) 24 hours after transplant.
The category values for this column were already listed for column: TXP72_LVEF_C_NAME Left ventricular ejection fraction (LVEF) 24 hours after transplant. The category values for this column were already listed for column: TXP72_LVEF_C_NAME"
URETER_BIOPSY,RESULT_ID,N,1,VARCHAR,No,The unique identifier for the result record. The unique identifier for the result record.
URETER_BIOPSY,CAP_COMMENTS,N,2,VARCHAR,No,CAP synoptic form item: General comments. CAP synoptic form item: General comments.
URETER_BIOPSY,HISTO_TYPE_SPECIFY,N,3,VARCHAR,No,CAP synoptic form item: Specify histologic type. CAP synoptic form item: Specify histologic type.
URETER_BIOPSY,SPECIMEN_OTHER_SPFY,N,4,VARCHAR,No,CAP synoptic form item: Specify other specimen. CAP synoptic form item: Specify other specimen.
URETER_BIOPSY,PRIMARY_TUMOR_C_NAME,N,5,VARCHAR,No,"CAP synoptic form item: Primary Tumor (pT).
May contain organization-specific values: Yes
Category Entries:
pTX: Cannot be determined
pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or
pTX: Cannot be assessed
pT0: No evidence of primary tumor
pTis: Carcinoma in situ
pTis (DCIS): Ductal carcinoma in situ
pTis (LCIS): Lobular carcinoma in situ
pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and
pTis: Carcinoma in situ, intraepithelial (no invasion)
pTis: Carcinoma in situ, invasion of lamina propria
pTis: High-grade dysplasia / carcinoma in situ
pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa)
pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I)
Encapsulated
Extracapsular extension without adjacent organ involvement
Extension into adjacent organs
Extension into spinal canal
pTa: Papillary noninvasive carcinoma
pTa: Noninvasive papillary carcinoma
pTis: Intratubular germ cell neoplasia only (carcinoma in situ)
pTis: Flat carcinoma in situ
pTis: Carcinoma in situ: flat tumor
Iris
Ciliary Body and Choroid
pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion
pT1: Tumor limited to ampulla of Vater or sphincter of Oddi
pT1: Tumor 2 cm or less in greatest dimension
pT1: Tumor invades submucosa
pT1: Tumor confined to the bile duct histologically
pT1: Solitary tumor without vascular invasion
pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue
pT1: Tumor 8 cm or less in greatest dimension
pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion)
pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension
pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension
pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension
pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium
pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium
pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa
pT1a: Tumor invades lamina propria or muscularis mucosae
pT1a: Tumor invades lamina propria
pT1 (I): Tumor limited to fallopian tube(s)
pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites
pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites
pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa
pT1b: Tumor invades submucosa
pT1b: Tumor invades muscle layer
pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney
pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney
pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to  kidney
pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura
pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by 
pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I)
pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or
pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or
pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm
pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm
pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N
pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface
pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule 
pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension
pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen
pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal
pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen
pT1: Tumor invades subepithelial connective tissue (lamina propria)
pT1: Tumor confined to the eye with no optic nerve or choroidal invasion
pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor
pT1b: Tumor 5 cm or less in greatest dimension, deep tumor
pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features
pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion
pT1: Tumor size 2 cm or less, limited to thyroid
pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid
pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid
pT1 (I): Tumor confined to uterus
pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically
pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less
pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth
pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2
pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension
pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension
pT1 (I): Tumor confined to vaginal wall
pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum
pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more
pT2: Tumor greater than 5 cm, no extra-adrenal invasion
pT2: Tumor invades duodenal wall
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension
pT2: Tumor invades muscularis propria
pT2: Tumor invades beyond the wall of the bile duct
pT2a: Solitary tumor with vascular invasion
pT2b: Multiple tumors, with or without vascular invasion
pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue
pT2b: Tumor invades adjacent hepatic parenchyma
pT2: Tumor more than 8 cm in greatest dimension
pT2: Tumor > 20 mm but <= 50 mm in greatest dimension
pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend 
pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension
pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries
pT2b (IIB): Extension to other pelvic structures
pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites
pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney
pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney
pT2b: Tumor more than 10 cm, limited to the kidney
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension
pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l
pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension
pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension)
pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, 
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration
pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell
pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or
pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 
pT2: Tumor with parapharyngeal extension
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or
pT2: Organ confined
pT2a: Unilateral, involving one-half of 1 side or less
pT2b: Unilateral, involving more than one-half of 1 side but not both sides
pT2c: Bilateral disease
pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion
pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor
pT2: Tumor greater than 2 cm in greatest dimension with or without one additional
pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion
pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid 
pT2 (II): Tumor extends outside of the uterus but is limited to genital structures
pT2a: Tumor invades superficial muscularis propria (inner half)
pT2b: Tumor invades deep muscularis propria (outer half)
pT2a (IIA): Tumor without parametrial invasion
pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen
pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension
pT2b (IIB): Tumor with parametrial invasion
pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall
pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures 
pT3: Tumor of any size with local invasion, but not invading adjacent organs
pT3: Tumor invades pancreas
pT3: Tumor more than 5 cm in greatest dimension
pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix
pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of
pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas
pT3: Tumor invades unilateral branches of the portal vein or hepatic artery
pT3: Discontinuous tumors in primary bone site (not including skip metastases)
pT3: Tumor > 50 mm in greatest dimension
pT3: Tumor invades through the muscularis propria into pericolorectal tissues
pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis)
pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve
pT3: Tumor invades adventitia
pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis
pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis
pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen
pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen
pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver
pT3a: Multiple tumors more than 5 cm
pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins
pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal
pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) 
pT3b: Tumor grossly extends into the vena cava below the diaphragm
pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava
pT3: Mucosal disease
pT3: Tumor more than 4 cm in greatest dimension
pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that
pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I)
pT3: Locally advanced but potentially resectable tumor that involves all of the
pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration
pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration
pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor)
pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen
pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or 
pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis
pT3: Tumor invades bony structures of skull base and / or paranasal sinuses
pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary
pT3a: Extraprostatic extension or microscopic invasion of bladder neck
pT3b: Seminal vesicle invasion
pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma
pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion
pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion
pT3: Tumor invades through the muscularis propria into the subserosa or into the
pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone
pT3: Tumor invades subserosal connective tissue, without involvement of
pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion
pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension
pT3: Tumor invades beyond muscularis propria into periureteric fat
pT3a: Microscopically
pT3b: Macroscopically (extravesicular mass)
pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall
pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney
pT3 (III): Tumor extends to pelvic wall
pT3 (FIGO IVA): Tumor of any size with extension to any of the following
pT4: Tumor of any size with invasion of adjacent organs
pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures
pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder
pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within
pT4: Tumor involves the celiac axis or the superior mesenteric artery
pT4: Tumor with periductal invasion
pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati
pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa 
pT4: Tumor invades adjacent structures 
pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic
pT4: Tmr w/ direct invasion of adj. organs other than gallbladder 
pT4: Tmr invades beyond Gerota’s fascia
pT4: Tumor of any size that invades any of the following: mediastinum, heart, great
pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral
pT4: Tumor with intracranial extension and / or involvement of cranial nerves,
pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J)
pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat
pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified
pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified
pT4: Tumor with direct or perineural invasion of skull base or axial skeleton
pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure
pT4: Tumor invades scrotum with or without vascular / lymphatic invasion
pT4: Tumor invades adjacent organs
pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis
pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis
pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi
pT4a: Tumor penetrates the visceral peritoneum
pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas
pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria
pT4c: Both T4a and T4b
pT4d: Inflammatory carcinoma
pT4b: Tumor directly invades other organs or structures
pT4b: Tumor directly invades or is adherent to other organs or structures
pT4a: Resectable tumor invading pleura, pericardium, or diaphragm
pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body
Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells
Primary Tumor (pT): Supraglottis
Primary Tumor (pT): Glottis
Primary Tumor (pT): Subglottis
pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone,
pT4b: Very advanced disease. Tumor involving brain, dura, skull base,
pT4a: Moderately advanced local disease.
pT4b: Very advanced local disease. 
pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal,
pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates
pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration
pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration
Primary Tumor (pT): Maxillary Sinus
Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus
pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic
pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid 
pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage,
pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases
pT4a: Tumor involves visceral peritoneum (serosal surface)
pT4b: Tumor directly invades adjacent structures
pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid
pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid
pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable
pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable
pT4a: Tumor invades prostatic stroma or uterus or vagina
pT4b: Tumor invades pelvic wall or abdominal wall
Not identified CAP synoptic form item: Primary Tumor (pT). May contain organization-specific values: Yes Category Entries: pTX: Cannot be determined pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or pTX: Cannot be assessed pT0: No evidence of primary tumor pTis: Carcinoma in situ pTis (DCIS): Ductal carcinoma in situ pTis (LCIS): Lobular carcinoma in situ pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and pTis: Carcinoma in situ, intraepithelial (no invasion) pTis: Carcinoma in situ, invasion of lamina propria pTis: High-grade dysplasia / carcinoma in situ pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa) pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I) Encapsulated Extracapsular extension without adjacent organ involvement Extension into adjacent organs Extension into spinal canal pTa: Papillary noninvasive carcinoma pTa: Noninvasive papillary carcinoma pTis: Intratubular germ cell neoplasia only (carcinoma in situ) pTis: Flat carcinoma in situ pTis: Carcinoma in situ: flat tumor Iris Ciliary Body and Choroid pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion pT1: Tumor limited to ampulla of Vater or sphincter of Oddi pT1: Tumor 2 cm or less in greatest dimension pT1: Tumor invades submucosa pT1: Tumor confined to the bile duct histologically pT1: Solitary tumor without vascular invasion pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue pT1: Tumor 8 cm or less in greatest dimension pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion) pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa pT1a: Tumor invades lamina propria or muscularis mucosae pT1a: Tumor invades lamina propria pT1 (I): Tumor limited to fallopian tube(s) pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa pT1b: Tumor invades submucosa pT1b: Tumor invades muscle layer pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to  kidney pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I) pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen pT1: Tumor invades subepithelial connective tissue (lamina propria) pT1: Tumor confined to the eye with no optic nerve or choroidal invasion pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor pT1b: Tumor 5 cm or less in greatest dimension, deep tumor pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion pT1: Tumor size 2 cm or less, limited to thyroid pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid pT1 (I): Tumor confined to uterus pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2 pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension pT1 (I): Tumor confined to vaginal wall pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more pT2: Tumor greater than 5 cm, no extra-adrenal invasion pT2: Tumor invades duodenal wall pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension pT2: Tumor invades muscularis propria pT2: Tumor invades beyond the wall of the bile duct pT2a: Solitary tumor with vascular invasion pT2b: Multiple tumors, with or without vascular invasion pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue pT2b: Tumor invades adjacent hepatic parenchyma pT2: Tumor more than 8 cm in greatest dimension pT2: Tumor > 20 mm but <= 50 mm in greatest dimension pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries pT2b (IIB): Extension to other pelvic structures pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney pT2b: Tumor more than 10 cm, limited to the kidney pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension) pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than pT2: Tumor with parapharyngeal extension pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or pT2: Organ confined pT2a: Unilateral, involving one-half of 1 side or less pT2b: Unilateral, involving more than one-half of 1 side but not both sides pT2c: Bilateral disease pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor pT2b: Tumor more than 5 cm in greatest dimension, deep tumor pT2: Tumor greater than 2 cm in greatest dimension with or without one additional pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid pT2 (II): Tumor extends outside of the uterus but is limited to genital structures pT2a: Tumor invades superficial muscularis propria (inner half) pT2b: Tumor invades deep muscularis propria (outer half) pT2a (IIA): Tumor without parametrial invasion pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension pT2b (IIB): Tumor with parametrial invasion pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures pT3: Tumor of any size with local invasion, but not invading adjacent organs pT3: Tumor invades pancreas pT3: Tumor more than 5 cm in greatest dimension pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas pT3: Tumor invades unilateral branches of the portal vein or hepatic artery pT3: Discontinuous tumors in primary bone site (not including skip metastases) pT3: Tumor > 50 mm in greatest dimension pT3: Tumor invades through the muscularis propria into pericolorectal tissues pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis) pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve pT3: Tumor invades adventitia pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver pT3a: Multiple tumors more than 5 cm pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) pT3b: Tumor grossly extends into the vena cava below the diaphragm pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava pT3: Mucosal disease pT3: Tumor more than 4 cm in greatest dimension pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I) pT3: Locally advanced but potentially resectable tumor that involves all of the pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis pT3: Tumor invades bony structures of skull base and / or paranasal sinuses pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary pT3a: Extraprostatic extension or microscopic invasion of bladder neck pT3b: Seminal vesicle invasion pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion pT3: Tumor invades through the muscularis propria into the subserosa or into the pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone pT3: Tumor invades subserosal connective tissue, without involvement of pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension pT3: Tumor invades beyond muscularis propria into periureteric fat pT3a: Microscopically pT3b: Macroscopically (extravesicular mass) pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney pT3 (III): Tumor extends to pelvic wall pT3 (FIGO IVA): Tumor of any size with extension to any of the following pT4: Tumor of any size with invasion of adjacent organs pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within pT4: Tumor involves the celiac axis or the superior mesenteric artery pT4: Tumor with periductal invasion pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa pT4: Tumor invades adjacent structures pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic pT4: Tmr w/ direct invasion of adj. organs other than gallbladder pT4: Tmr invades beyond Gerota’s fascia pT4: Tumor of any size that invades any of the following: mediastinum, heart, great pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral pT4: Tumor with intracranial extension and / or involvement of cranial nerves, pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J) pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified pT4: Tumor with direct or perineural invasion of skull base or axial skeleton pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure pT4: Tumor invades scrotum with or without vascular / lymphatic invasion pT4: Tumor invades adjacent organs pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi pT4a: Tumor penetrates the visceral peritoneum pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria pT4c: Both T4a and T4b pT4d: Inflammatory carcinoma pT4b: Tumor directly invades other organs or structures pT4b: Tumor directly invades or is adherent to other organs or structures pT4a: Resectable tumor invading pleura, pericardium, or diaphragm pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells Primary Tumor (pT): Supraglottis Primary Tumor (pT): Glottis Primary Tumor (pT): Subglottis pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, pT4b: Very advanced disease. Tumor involving brain, dura, skull base, pT4a: Moderately advanced local disease. pT4b: Very advanced local disease. pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal, pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration Primary Tumor (pT): Maxillary Sinus Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage, pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases pT4a: Tumor involves visceral peritoneum (serosal surface) pT4b: Tumor directly invades adjacent structures pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable pT4a: Tumor invades prostatic stroma or uterus or vagina pT4b: Tumor invades pelvic wall or abdominal wall Not identified"
URETER_BIOPSY,ADDL_PATH_FIND_SPFY,N,6,VARCHAR,No,CAP synoptic form item: Specify additional pathologic findings. CAP synoptic form item: Specify additional pathologic findings.
URETER_BIOPSY,OTHER_TM_CONFIG_S,N,7,VARCHAR,No,CAP synoptic form item: Specify other tumor configuration. CAP synoptic form item: Specify other tumor configuration.
URETER_BIOPSY,ADQCY_DETER_T_CAT_C_NAME,N,8,VARCHAR,No,"CAP synoptic form item: Adequacy of Material for Determining T Category.
May contain organization-specific values: Yes
Category Entries:
Muscularis propria not identified
Muscularis propria present
Indeterminate CAP synoptic form item: Adequacy of Material for Determining T Category. May contain organization-specific values: Yes Category Entries: Muscularis propria not identified Muscularis propria present Indeterminate"
URETER_BIOPSY,HG_URTL_CCNM_C_NAME,N,9,VARCHAR,No,"CAP synoptic form item: Histologic Grade Urothelial Carcinoma.
May contain organization-specific values: Yes
Category Entries:
Low-grade
High-grade
Not applicable
Cannot be determined
Other CAP synoptic form item: Histologic Grade Urothelial Carcinoma. May contain organization-specific values: Yes Category Entries: Low-grade High-grade Not applicable Cannot be determined Other"
URETER_BIOPSY,HG_URTL_CCNM_S,N,10,VARCHAR,No,CAP synoptic form item: Specify the details of Histologic Grade Urothelial carcinoma. CAP synoptic form item: Specify the details of Histologic Grade Urothelial carcinoma.
URETER_BIOPSY,HG_ADEN_SQUA_CC_C_NAME,N,11,VARCHAR,No,"CAP synoptic form item: Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma.
May contain organization-specific values: Yes
Category Entries:
Not applicable
Cannot be determined
GX: Cannot be assessed
G1: Well differentiated
G2: Moderately differentiated
G3: Poorly differentiated
Other CAP synoptic form item: Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma. May contain organization-specific values: Yes Category Entries: Not applicable Cannot be determined GX: Cannot be assessed G1: Well differentiated G2: Moderately differentiated G3: Poorly differentiated Other"
URETER_BIOPSY,ADEN_SQUA_CCS,N,12,VARCHAR,No,CAP synoptic form item: Specify Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma. CAP synoptic form item: Specify Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma.
URETER_BIOPSY,UROT_CCM_W_VAR_HIST,N,13,VARCHAR,No,CAP synoptic form item: Specify the details of Urothelial carcinoma with variant histology. CAP synoptic form item: Specify the details of Urothelial carcinoma with variant histology.
URETER_BIOPSY,SQM_C_CCNM_VAR_HIST,N,14,VARCHAR,No,"CAP synoptic form item: Specify the details of Squamous cell carcinoma, variant histology. CAP synoptic form item: Specify the details of Squamous cell carcinoma, variant histology."
URETER_BIOPSY,ADNCCNM_VAR_HIST,N,15,VARCHAR,No,"CAP synoptic form item: Specify the details of Adenocarcinoma, variant histology. CAP synoptic form item: Specify the details of Adenocarcinoma, variant histology."
URETER_BIOPSY,UNDIFF_CCNM,N,16,VARCHAR,No,CAP synoptic form item: Specify the details of undifferentiated carcinoma. CAP synoptic form item: Specify the details of undifferentiated carcinoma.
URETER_BIOPSY,HIST_TP_MIX_CT,N,17,VARCHAR,No,CAP synoptic form item: Specify the details of mixed cell type. CAP synoptic form item: Specify the details of mixed cell type.
URETER_BIOPSY,HIST_GRADE_CBD_YN,N,18,VARCHAR,No,"CAP synoptic form item: Histologic Grade Cannot Be Determined.
May contain organization-specific values: No
Category Entries:
No
Yes CAP synoptic form item: Histologic Grade Cannot Be Determined. May contain organization-specific values: No Category Entries: No Yes"
URETER_RESECTION,RESULT_ID,N,1,VARCHAR,No,The unique identifier for the result record. The unique identifier for the result record.
URETER_RESECTION,CAP_COMMENTS,N,2,VARCHAR,No,CAP synoptic form item: General comments. CAP synoptic form item: General comments.
URETER_RESECTION,SPEC_PROC_SPECIFY,N,3,VARCHAR,No,CAP synoptic form item: Specify the Specimen Procedure. CAP synoptic form item: Specify the Specimen Procedure.
URETER_RESECTION,TUMOR_SIZE_GREAT,N,4,NUMERIC,No,CAP synoptic form item: Tumor Greatest Size. CAP synoptic form item: Tumor Greatest Size.
URETER_RESECTION,TUMOR_SIZE_ADDL,N,5,NUMERIC,No,CAP synoptic form item: Tumor Size (length). CAP synoptic form item: Tumor Size (length).
URETER_RESECTION,TUMOR_SIZE_ADDL2,N,6,NUMERIC,No,CAP synoptic form item: Tumor Size (width). CAP synoptic form item: Tumor Size (width).
URETER_RESECTION,TUMOR_SIZE_SPECIFY,N,7,VARCHAR,No,CAP synoptic form item: Specify Tumor Size. CAP synoptic form item: Specify Tumor Size.
URETER_RESECTION,HISTO_TYPE_SPECIFY,N,8,VARCHAR,No,CAP synoptic form item: Specify histologic type. CAP synoptic form item: Specify histologic type.
URETER_RESECTION,REGIONL_LYMPH_ND_C_NAME,N,9,VARCHAR,No,"CAP synoptic form item: Regional Lymph Nodes (pN).
May contain organization-specific values: Yes
Category Entries:
pNX: Cannot be assessed
pN0: No regional lymph node metastasis
pN1: Regional lymph node metastasis
pN1: Metastasis in perirectal lymph nodes
pN1: Metastasis in 1 to 3 regional lymph nodes
pN1a: Metastasis in 1 regional lymph node
pN1b: Metastasis in 2 to 3 regional lymph nodes
pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta
pN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes
pN1: Regional lymph node metastasis involving 1 to 2 nodes
pN1 (IIIC): Regional lymph node metastasis
pN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery
pN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension
pN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes, 
pN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes
pN1a: Clinically occult (microscopic) metastasis
pN1b: Clinically apparent (macroscopic) metastasis
pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension
pN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension
pN1: Metastasis in 1 to 2 perigastric lymph nodes
pN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension,
pN1a: Nodal metastases to Level VI lymph nodes
pN1b: Metastases to unilateral, bilateral or contralateral cervical 
pN1: Single regional lymph node metastasis in the true pelvis 
pN1 (IVB): Pelvic or inguinal lymph node metastasis
pN1: Metastasis in regional lymph node or nodes
pN1: Regional lymph node involvement (preauricular, cervical, submandibular)
pN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s)
pN2: Metastasis in 4 or more regional lymph nodes
pN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd
pN2a: Metastasis in 4 to 6 regional lymph nodes
pN2b: Metastasis in 7 or more regional lymph nodes
pN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho
pN2: 3 to 6 nodes involved
pN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than
pN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension
pN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension
pN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen.
pN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s)
pN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes 
pN2a: Clinically occult (microscopic) metastasis
pN2b: Clinically apparent (macroscopic) metastasis
pN2c: Satellite or in-transit metastasis without nodal metastasis
pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension
pN2: Metastasis in a single regional lymph node, more than 2 cm but not more than
pN2: Metastasis in 3 to 6 perigastric lymph nodes
pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm 
pN2: Multiple regional lymph node metastasis in the true pelvis 
pN2: Distant lymph node involvement
pN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il
pN3: 7 or more nodes involved
pN3: Metastasis in a lymph node more than 6 cm in greatest dimension
pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or
pN3: Metastases in the contralateral mediastinal, contralateral internal mammary,
pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or
pN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa
pN3a: Greater than 6 cm in dimension
pN3b: Extension to the supraclavicular fossa
pN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension
pN3: Metastasis in 7 or more perigastric lymph nodes
pN3a: Metastasis in 7 to 15 perigastric lymph nodes
pN3b: Metastasis in 16 or more perigastric lymph nodes
pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension
pN3: Lymph node metastasis to the common iliac lymph nodes
pN1: One or two regional lymph nodes with the following features
pN2 (FIGO IIIB): Regional lymph node metastasis with the following features
pN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis CAP synoptic form item: Regional Lymph Nodes (pN). May contain organization-specific values: Yes Category Entries: pNX: Cannot be assessed pN0: No regional lymph node metastasis pN1: Regional lymph node metastasis pN1: Metastasis in perirectal lymph nodes pN1: Metastasis in 1 to 3 regional lymph nodes pN1a: Metastasis in 1 regional lymph node pN1b: Metastasis in 2 to 3 regional lymph nodes pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta pN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes pN1: Regional lymph node metastasis involving 1 to 2 nodes pN1 (IIIC): Regional lymph node metastasis pN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery pN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension pN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes, pN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes pN1a: Clinically occult (microscopic) metastasis pN1b: Clinically apparent (macroscopic) metastasis pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension pN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension pN1: Metastasis in 1 to 2 perigastric lymph nodes pN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension, pN1a: Nodal metastases to Level VI lymph nodes pN1b: Metastases to unilateral, bilateral or contralateral cervical pN1: Single regional lymph node metastasis in the true pelvis pN1 (IVB): Pelvic or inguinal lymph node metastasis pN1: Metastasis in regional lymph node or nodes pN1: Regional lymph node involvement (preauricular, cervical, submandibular) pN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s) pN2: Metastasis in 4 or more regional lymph nodes pN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd pN2a: Metastasis in 4 to 6 regional lymph nodes pN2b: Metastasis in 7 or more regional lymph nodes pN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho pN2: 3 to 6 nodes involved pN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than pN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension pN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension pN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen. pN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s) pN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes pN2a: Clinically occult (microscopic) metastasis pN2b: Clinically apparent (macroscopic) metastasis pN2c: Satellite or in-transit metastasis without nodal metastasis pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension pN2: Metastasis in a single regional lymph node, more than 2 cm but not more than pN2: Metastasis in 3 to 6 perigastric lymph nodes pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm pN2: Multiple regional lymph node metastasis in the true pelvis pN2: Distant lymph node involvement pN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il pN3: 7 or more nodes involved pN3: Metastasis in a lymph node more than 6 cm in greatest dimension pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or pN3: Metastases in the contralateral mediastinal, contralateral internal mammary, pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or pN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa pN3a: Greater than 6 cm in dimension pN3b: Extension to the supraclavicular fossa pN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension pN3: Metastasis in 7 or more perigastric lymph nodes pN3a: Metastasis in 7 to 15 perigastric lymph nodes pN3b: Metastasis in 16 or more perigastric lymph nodes pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension pN3: Lymph node metastasis to the common iliac lymph nodes pN1: One or two regional lymph nodes with the following features pN2 (FIGO IIIB): Regional lymph node metastasis with the following features pN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis"
URETER_RESECTION,REG_LN_NUM_EXM,N,10,NUMERIC,No,CAP synoptic form item: Regional Lymph Nodes Number Examined. CAP synoptic form item: Regional Lymph Nodes Number Examined.
URETER_RESECTION,REG_LN_NUM_INV,N,11,NUMERIC,No,CAP synoptic form item: Regional Lymph Nodes Number Involved. CAP synoptic form item: Regional Lymph Nodes Number Involved.
URETER_RESECTION,PRIMARY_TUMOR_C_NAME,N,12,VARCHAR,No,"CAP synoptic form item: Primary Tumor (pT).
May contain organization-specific values: Yes
Category Entries:
pTX: Cannot be determined
pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or
pTX: Cannot be assessed
pT0: No evidence of primary tumor
pTis: Carcinoma in situ
pTis (DCIS): Ductal carcinoma in situ
pTis (LCIS): Lobular carcinoma in situ
pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and
pTis: Carcinoma in situ, intraepithelial (no invasion)
pTis: Carcinoma in situ, invasion of lamina propria
pTis: High-grade dysplasia / carcinoma in situ
pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa)
pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I)
Encapsulated
Extracapsular extension without adjacent organ involvement
Extension into adjacent organs
Extension into spinal canal
pTa: Papillary noninvasive carcinoma
pTa: Noninvasive papillary carcinoma
pTis: Intratubular germ cell neoplasia only (carcinoma in situ)
pTis: Flat carcinoma in situ
pTis: Carcinoma in situ: flat tumor
Iris
Ciliary Body and Choroid
pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion
pT1: Tumor limited to ampulla of Vater or sphincter of Oddi
pT1: Tumor 2 cm or less in greatest dimension
pT1: Tumor invades submucosa
pT1: Tumor confined to the bile duct histologically
pT1: Solitary tumor without vascular invasion
pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue
pT1: Tumor 8 cm or less in greatest dimension
pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion)
pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension
pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension
pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension
pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium
pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium
pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa
pT1a: Tumor invades lamina propria or muscularis mucosae
pT1a: Tumor invades lamina propria
pT1 (I): Tumor limited to fallopian tube(s)
pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites
pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites
pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa
pT1b: Tumor invades submucosa
pT1b: Tumor invades muscle layer
pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney
pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney
pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to  kidney
pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura
pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by 
pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I)
pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or
pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or
pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm
pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm
pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N
pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface
pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule 
pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension
pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen
pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal
pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen
pT1: Tumor invades subepithelial connective tissue (lamina propria)
pT1: Tumor confined to the eye with no optic nerve or choroidal invasion
pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor
pT1b: Tumor 5 cm or less in greatest dimension, deep tumor
pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features
pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion
pT1: Tumor size 2 cm or less, limited to thyroid
pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid
pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid
pT1 (I): Tumor confined to uterus
pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically
pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less
pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth
pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2
pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension
pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension
pT1 (I): Tumor confined to vaginal wall
pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum
pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more
pT2: Tumor greater than 5 cm, no extra-adrenal invasion
pT2: Tumor invades duodenal wall
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension
pT2: Tumor invades muscularis propria
pT2: Tumor invades beyond the wall of the bile duct
pT2a: Solitary tumor with vascular invasion
pT2b: Multiple tumors, with or without vascular invasion
pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue
pT2b: Tumor invades adjacent hepatic parenchyma
pT2: Tumor more than 8 cm in greatest dimension
pT2: Tumor > 20 mm but <= 50 mm in greatest dimension
pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend 
pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension
pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries
pT2b (IIB): Extension to other pelvic structures
pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites
pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney
pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney
pT2b: Tumor more than 10 cm, limited to the kidney
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension
pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l
pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension
pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension)
pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, 
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration
pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell
pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or
pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 
pT2: Tumor with parapharyngeal extension
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or
pT2: Organ confined
pT2a: Unilateral, involving one-half of 1 side or less
pT2b: Unilateral, involving more than one-half of 1 side but not both sides
pT2c: Bilateral disease
pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion
pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor
pT2: Tumor greater than 2 cm in greatest dimension with or without one additional
pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion
pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid 
pT2 (II): Tumor extends outside of the uterus but is limited to genital structures
pT2a: Tumor invades superficial muscularis propria (inner half)
pT2b: Tumor invades deep muscularis propria (outer half)
pT2a (IIA): Tumor without parametrial invasion
pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen
pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension
pT2b (IIB): Tumor with parametrial invasion
pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall
pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures 
pT3: Tumor of any size with local invasion, but not invading adjacent organs
pT3: Tumor invades pancreas
pT3: Tumor more than 5 cm in greatest dimension
pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix
pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of
pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas
pT3: Tumor invades unilateral branches of the portal vein or hepatic artery
pT3: Discontinuous tumors in primary bone site (not including skip metastases)
pT3: Tumor > 50 mm in greatest dimension
pT3: Tumor invades through the muscularis propria into pericolorectal tissues
pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis)
pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve
pT3: Tumor invades adventitia
pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis
pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis
pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen
pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen
pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver
pT3a: Multiple tumors more than 5 cm
pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins
pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal
pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) 
pT3b: Tumor grossly extends into the vena cava below the diaphragm
pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava
pT3: Mucosal disease
pT3: Tumor more than 4 cm in greatest dimension
pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that
pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I)
pT3: Locally advanced but potentially resectable tumor that involves all of the
pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration
pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration
pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor)
pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen
pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or 
pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis
pT3: Tumor invades bony structures of skull base and / or paranasal sinuses
pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary
pT3a: Extraprostatic extension or microscopic invasion of bladder neck
pT3b: Seminal vesicle invasion
pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma
pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion
pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion
pT3: Tumor invades through the muscularis propria into the subserosa or into the
pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone
pT3: Tumor invades subserosal connective tissue, without involvement of
pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion
pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension
pT3: Tumor invades beyond muscularis propria into periureteric fat
pT3a: Microscopically
pT3b: Macroscopically (extravesicular mass)
pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall
pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney
pT3 (III): Tumor extends to pelvic wall
pT3 (FIGO IVA): Tumor of any size with extension to any of the following
pT4: Tumor of any size with invasion of adjacent organs
pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures
pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder
pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within
pT4: Tumor involves the celiac axis or the superior mesenteric artery
pT4: Tumor with periductal invasion
pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati
pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa 
pT4: Tumor invades adjacent structures 
pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic
pT4: Tmr w/ direct invasion of adj. organs other than gallbladder 
pT4: Tmr invades beyond Gerota’s fascia
pT4: Tumor of any size that invades any of the following: mediastinum, heart, great
pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral
pT4: Tumor with intracranial extension and / or involvement of cranial nerves,
pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J)
pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat
pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified
pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified
pT4: Tumor with direct or perineural invasion of skull base or axial skeleton
pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure
pT4: Tumor invades scrotum with or without vascular / lymphatic invasion
pT4: Tumor invades adjacent organs
pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis
pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis
pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi
pT4a: Tumor penetrates the visceral peritoneum
pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas
pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria
pT4c: Both T4a and T4b
pT4d: Inflammatory carcinoma
pT4b: Tumor directly invades other organs or structures
pT4b: Tumor directly invades or is adherent to other organs or structures
pT4a: Resectable tumor invading pleura, pericardium, or diaphragm
pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body
Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells
Primary Tumor (pT): Supraglottis
Primary Tumor (pT): Glottis
Primary Tumor (pT): Subglottis
pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone,
pT4b: Very advanced disease. Tumor involving brain, dura, skull base,
pT4a: Moderately advanced local disease.
pT4b: Very advanced local disease. 
pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal,
pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates
pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration
pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration
Primary Tumor (pT): Maxillary Sinus
Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus
pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic
pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid 
pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage,
pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases
pT4a: Tumor involves visceral peritoneum (serosal surface)
pT4b: Tumor directly invades adjacent structures
pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid
pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid
pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable
pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable
pT4a: Tumor invades prostatic stroma or uterus or vagina
pT4b: Tumor invades pelvic wall or abdominal wall
Not identified CAP synoptic form item: Primary Tumor (pT). May contain organization-specific values: Yes Category Entries: pTX: Cannot be determined pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or pTX: Cannot be assessed pT0: No evidence of primary tumor pTis: Carcinoma in situ pTis (DCIS): Ductal carcinoma in situ pTis (LCIS): Lobular carcinoma in situ pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and pTis: Carcinoma in situ, intraepithelial (no invasion) pTis: Carcinoma in situ, invasion of lamina propria pTis: High-grade dysplasia / carcinoma in situ pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa) pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I) Encapsulated Extracapsular extension without adjacent organ involvement Extension into adjacent organs Extension into spinal canal pTa: Papillary noninvasive carcinoma pTa: Noninvasive papillary carcinoma pTis: Intratubular germ cell neoplasia only (carcinoma in situ) pTis: Flat carcinoma in situ pTis: Carcinoma in situ: flat tumor Iris Ciliary Body and Choroid pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion pT1: Tumor limited to ampulla of Vater or sphincter of Oddi pT1: Tumor 2 cm or less in greatest dimension pT1: Tumor invades submucosa pT1: Tumor confined to the bile duct histologically pT1: Solitary tumor without vascular invasion pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue pT1: Tumor 8 cm or less in greatest dimension pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion) pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa pT1a: Tumor invades lamina propria or muscularis mucosae pT1a: Tumor invades lamina propria pT1 (I): Tumor limited to fallopian tube(s) pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa pT1b: Tumor invades submucosa pT1b: Tumor invades muscle layer pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to  kidney pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I) pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen pT1: Tumor invades subepithelial connective tissue (lamina propria) pT1: Tumor confined to the eye with no optic nerve or choroidal invasion pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor pT1b: Tumor 5 cm or less in greatest dimension, deep tumor pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion pT1: Tumor size 2 cm or less, limited to thyroid pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid pT1 (I): Tumor confined to uterus pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2 pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension pT1 (I): Tumor confined to vaginal wall pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more pT2: Tumor greater than 5 cm, no extra-adrenal invasion pT2: Tumor invades duodenal wall pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension pT2: Tumor invades muscularis propria pT2: Tumor invades beyond the wall of the bile duct pT2a: Solitary tumor with vascular invasion pT2b: Multiple tumors, with or without vascular invasion pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue pT2b: Tumor invades adjacent hepatic parenchyma pT2: Tumor more than 8 cm in greatest dimension pT2: Tumor > 20 mm but <= 50 mm in greatest dimension pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries pT2b (IIB): Extension to other pelvic structures pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney pT2b: Tumor more than 10 cm, limited to the kidney pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension) pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than pT2: Tumor with parapharyngeal extension pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or pT2: Organ confined pT2a: Unilateral, involving one-half of 1 side or less pT2b: Unilateral, involving more than one-half of 1 side but not both sides pT2c: Bilateral disease pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor pT2b: Tumor more than 5 cm in greatest dimension, deep tumor pT2: Tumor greater than 2 cm in greatest dimension with or without one additional pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid pT2 (II): Tumor extends outside of the uterus but is limited to genital structures pT2a: Tumor invades superficial muscularis propria (inner half) pT2b: Tumor invades deep muscularis propria (outer half) pT2a (IIA): Tumor without parametrial invasion pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension pT2b (IIB): Tumor with parametrial invasion pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures pT3: Tumor of any size with local invasion, but not invading adjacent organs pT3: Tumor invades pancreas pT3: Tumor more than 5 cm in greatest dimension pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas pT3: Tumor invades unilateral branches of the portal vein or hepatic artery pT3: Discontinuous tumors in primary bone site (not including skip metastases) pT3: Tumor > 50 mm in greatest dimension pT3: Tumor invades through the muscularis propria into pericolorectal tissues pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis) pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve pT3: Tumor invades adventitia pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver pT3a: Multiple tumors more than 5 cm pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) pT3b: Tumor grossly extends into the vena cava below the diaphragm pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava pT3: Mucosal disease pT3: Tumor more than 4 cm in greatest dimension pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I) pT3: Locally advanced but potentially resectable tumor that involves all of the pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis pT3: Tumor invades bony structures of skull base and / or paranasal sinuses pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary pT3a: Extraprostatic extension or microscopic invasion of bladder neck pT3b: Seminal vesicle invasion pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion pT3: Tumor invades through the muscularis propria into the subserosa or into the pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone pT3: Tumor invades subserosal connective tissue, without involvement of pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension pT3: Tumor invades beyond muscularis propria into periureteric fat pT3a: Microscopically pT3b: Macroscopically (extravesicular mass) pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney pT3 (III): Tumor extends to pelvic wall pT3 (FIGO IVA): Tumor of any size with extension to any of the following pT4: Tumor of any size with invasion of adjacent organs pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within pT4: Tumor involves the celiac axis or the superior mesenteric artery pT4: Tumor with periductal invasion pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa pT4: Tumor invades adjacent structures pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic pT4: Tmr w/ direct invasion of adj. organs other than gallbladder pT4: Tmr invades beyond Gerota’s fascia pT4: Tumor of any size that invades any of the following: mediastinum, heart, great pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral pT4: Tumor with intracranial extension and / or involvement of cranial nerves, pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J) pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified pT4: Tumor with direct or perineural invasion of skull base or axial skeleton pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure pT4: Tumor invades scrotum with or without vascular / lymphatic invasion pT4: Tumor invades adjacent organs pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi pT4a: Tumor penetrates the visceral peritoneum pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria pT4c: Both T4a and T4b pT4d: Inflammatory carcinoma pT4b: Tumor directly invades other organs or structures pT4b: Tumor directly invades or is adherent to other organs or structures pT4a: Resectable tumor invading pleura, pericardium, or diaphragm pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells Primary Tumor (pT): Supraglottis Primary Tumor (pT): Glottis Primary Tumor (pT): Subglottis pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, pT4b: Very advanced disease. Tumor involving brain, dura, skull base, pT4a: Moderately advanced local disease. pT4b: Very advanced local disease. pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal, pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration Primary Tumor (pT): Maxillary Sinus Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage, pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases pT4a: Tumor involves visceral peritoneum (serosal surface) pT4b: Tumor directly invades adjacent structures pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable pT4a: Tumor invades prostatic stroma or uterus or vagina pT4b: Tumor invades pelvic wall or abdominal wall Not identified"
URETER_RESECTION,DISTNT_METASTASIS_C_NAME,N,13,VARCHAR,No,"CAP synoptic form item: Distant Metastasis.
May contain organization-specific values: Yes
Category Entries:
Not applicable
cM0 (i+): No clinical or radiographic evidence of distant metastasis
pM0: No distant metastasis
pM1: Distant metastasis
pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx
pM1b: Nonperitoneal metastasis
pM1: Distant detectable metastasis as determined by classic clinical
pM1 (IVB): Distant metastasis
pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or
pM1b: Distant metastases outside the lung / pleura
pM1: Distant metastasis (documented in this specimen)
pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes
pM1b: Metastasis to lung
pM1c: Metastasis to all other visceral sites or distant metastasis at any site
pM1a: Nonregional lymph node(s)
pM1b: Bone(s)
pM1c: Other site(s) with or without bone disease
pM1: Metastasis to sites other than CNS
pM1a: Single lesion
pM1b: Multiple lesions
pM1c: CNS metastasis
pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement
pM1e: Leptomeningeal and / or CSF involvement
pM1a: Non-regional lymph nodes or pulmonary metastasis
pM1b: Distant metastasis other than to nonregional lymph nodes and lungs
pM1a (III): Tumor extends to the lungs with or without genital tract involvement
pM1b (IV): Tumor involves other metastatic sites
pM1a: Largest diameter of the largest metastasis 3 cm or less
pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm
pM1c: Largest diameter of the largest metastasis 8 cm or more
pM1a: Lung
pM1b: Metastasis involving distant sites other than lung (including skip metastases)
Distant Metastasis present (includes metastasis to lymph nodes) CAP synoptic form item: Distant Metastasis. May contain organization-specific values: Yes Category Entries: Not applicable cM0 (i+): No clinical or radiographic evidence of distant metastasis pM0: No distant metastasis pM1: Distant metastasis pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx pM1b: Nonperitoneal metastasis pM1: Distant detectable metastasis as determined by classic clinical pM1 (IVB): Distant metastasis pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or pM1b: Distant metastases outside the lung / pleura pM1: Distant metastasis (documented in this specimen) pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes pM1b: Metastasis to lung pM1c: Metastasis to all other visceral sites or distant metastasis at any site pM1a: Nonregional lymph node(s) pM1b: Bone(s) pM1c: Other site(s) with or without bone disease pM1: Metastasis to sites other than CNS pM1a: Single lesion pM1b: Multiple lesions pM1c: CNS metastasis pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement pM1e: Leptomeningeal and / or CSF involvement pM1a: Non-regional lymph nodes or pulmonary metastasis pM1b: Distant metastasis other than to nonregional lymph nodes and lungs pM1a (III): Tumor extends to the lungs with or without genital tract involvement pM1b (IV): Tumor involves other metastatic sites pM1a: Largest diameter of the largest metastasis 3 cm or less pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm pM1c: Largest diameter of the largest metastasis 8 cm or more pM1a: Lung pM1b: Metastasis involving distant sites other than lung (including skip metastases) Distant Metastasis present (includes metastasis to lymph nodes)"
URETER_RESECTION,DSTNT_METASTATIS_ST,N,14,VARCHAR,No,CAP synoptic form item: Distant Metastatis Sites. CAP synoptic form item: Distant Metastatis Sites.
URETER_RESECTION,ADDL_PATH_FIND_SPFY,N,15,VARCHAR,No,CAP synoptic form item: Specify additional pathologic findings. CAP synoptic form item: Specify additional pathologic findings.
URETER_RESECTION,OTHER_MARGIN_SPFY,N,16,VARCHAR,No,CAP synoptic form item: Specify other margin. CAP synoptic form item: Specify other margin.
URETER_RESECTION,OTHER_TM_CONFIG_S,N,17,VARCHAR,No,CAP synoptic form item: Specify other tumor configuration. CAP synoptic form item: Specify other tumor configuration.
URETER_RESECTION,HG_URTL_CCNM_C_NAME,N,18,VARCHAR,No,"CAP synoptic form item: Histologic Grade Urothelial Carcinoma.
May contain organization-specific values: Yes
Category Entries:
Low-grade
High-grade
Not applicable
Cannot be determined
Other CAP synoptic form item: Histologic Grade Urothelial Carcinoma. May contain organization-specific values: Yes Category Entries: Low-grade High-grade Not applicable Cannot be determined Other"
URETER_RESECTION,HG_URTL_CCNM_S,N,19,VARCHAR,No,CAP synoptic form item: Specify the details of Histologic Grade Urothelial carcinoma. CAP synoptic form item: Specify the details of Histologic Grade Urothelial carcinoma.
URETER_RESECTION,HG_ADEN_SQUA_CC_C_NAME,N,20,VARCHAR,No,"CAP synoptic form item: Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma.
May contain organization-specific values: Yes
Category Entries:
Not applicable
Cannot be determined
GX: Cannot be assessed
G1: Well differentiated
G2: Moderately differentiated
G3: Poorly differentiated
Other CAP synoptic form item: Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma. May contain organization-specific values: Yes Category Entries: Not applicable Cannot be determined GX: Cannot be assessed G1: Well differentiated G2: Moderately differentiated G3: Poorly differentiated Other"
URETER_RESECTION,ADEN_SQUA_CCS,N,21,VARCHAR,No,CAP synoptic form item: Specify Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma. CAP synoptic form item: Specify Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma.
URETER_RESECTION,UROT_CCM_W_VAR_HIST,N,22,VARCHAR,No,CAP synoptic form item: Specify the details of Urothelial carcinoma with variant histology. CAP synoptic form item: Specify the details of Urothelial carcinoma with variant histology.
URETER_RESECTION,SQM_C_CCNM_VAR_HIST,N,23,VARCHAR,No,"CAP synoptic form item: Specify the details of Squamous cell carcinoma, variant histology. CAP synoptic form item: Specify the details of Squamous cell carcinoma, variant histology."
URETER_RESECTION,ADNCCNM_VAR_HIST,N,24,VARCHAR,No,"CAP synoptic form item: Specify the details of Adenocarcinoma, variant histology. CAP synoptic form item: Specify the details of Adenocarcinoma, variant histology."
URETER_RESECTION,UNDIFF_CCNM,N,25,VARCHAR,No,CAP synoptic form item: Specify the details of undifferentiated carcinoma. CAP synoptic form item: Specify the details of undifferentiated carcinoma.
URETER_RESECTION,HIST_TP_MIX_CT,N,26,VARCHAR,No,CAP synoptic form item: Specify the details of mixed cell type. CAP synoptic form item: Specify the details of mixed cell type.
URETER_RESECTION,GLOMERULAR_DIS_SPFY,N,27,VARCHAR,No,CAP synoptic form item: Specify Glomerular disease. CAP synoptic form item: Specify Glomerular disease.
URETER_RESECTION,TUBULNTST_DIS_SPFY,N,28,VARCHAR,No,CAP synoptic form item: Specify Tubulointerstitial disease. CAP synoptic form item: Specify Tubulointerstitial disease.
URETER_RESECTION,VASCULAR_DIS_SPFY,N,29,VARCHAR,No,CAP synoptic form item: Specify Vascular disease. CAP synoptic form item: Specify Vascular disease.
URETER_RESECTION,PATH_NON_KIDNY_SPFY,N,30,VARCHAR,No,CAP synoptic form item: Specify Pathologic Findings in Nonneoplastic Kidney. CAP synoptic form item: Specify Pathologic Findings in Nonneoplastic Kidney.
URETER_RESECTION,INFLAMMATION_SPFY,N,31,VARCHAR,No,CAP synoptic form item: Specify Inflammation. CAP synoptic form item: Specify Inflammation.
URETER_RESECTION,MARGIN_INV_SPECIFY,N,32,VARCHAR,No,CAP synoptic form item: Margins Invasive Specify Margins Per Orientation. CAP synoptic form item: Margins Invasive Specify Margins Per Orientation.
URETER_RESECTION,MARG_INV_DIST_CLOSE,N,33,NUMERIC,No,CAP synoptic form item: Margins Invasive Distance of Invasive Carcinoma from Closest Margin. CAP synoptic form item: Margins Invasive Distance of Invasive Carcinoma from Closest Margin.
URETER_RESECTION,MG_IVLV_INV_CCNM_C_NAME,N,34,VARCHAR,No,"CAP synoptic form item: Margin Involvement by Invasive Carcinoma.
May contain organization-specific values: Yes
Category Entries:
Cannot be assessed
Margins uninvolved by invasive carcinoma
Margin(s) involved by invasive carcinoma CAP synoptic form item: Margin Involvement by Invasive Carcinoma. May contain organization-specific values: Yes Category Entries: Cannot be assessed Margins uninvolved by invasive carcinoma Margin(s) involved by invasive carcinoma"
URETER_RESECTION,MG_IVLV_CCNM_ST_C_NAME,N,35,VARCHAR,No,"CAP synoptic form item: Margin Involvement by Carcinoma in situ.
May contain organization-specific values: Yes
Category Entries:
Cannot be assessed
Margin(s) uninvolved by carcinoma in situ
Margin(s) involved by carcinoma in situ CAP synoptic form item: Margin Involvement by Carcinoma in situ. May contain organization-specific values: Yes Category Entries: Cannot be assessed Margin(s) uninvolved by carcinoma in situ Margin(s) involved by carcinoma in situ"
URIN_BLADDER_BIOPS,RESULT_ID,N,1,VARCHAR,No,The unique identifier for the result record. The unique identifier for the result record.
URIN_BLADDER_BIOPS,CAP_COMMENTS,N,2,VARCHAR,No,CAP synoptic form item: General comments. CAP synoptic form item: General comments.
URIN_BLADDER_BIOPS,SPEC_PROC_SPECIFY,N,3,VARCHAR,No,CAP synoptic form item: Specify the Specimen Procedure. CAP synoptic form item: Specify the Specimen Procedure.
URIN_BLADDER_BIOPS,UROT_CCM_W_VAR_HIST,N,4,VARCHAR,No,CAP synoptic form item: Specify the details of Urothelial carcinoma with variant histology. CAP synoptic form item: Specify the details of Urothelial carcinoma with variant histology.
URIN_BLADDER_BIOPS,SQM_C_CCNM_VAR_HIST,N,5,VARCHAR,No,"CAP synoptic form item: Specify the details of Squamous cell carcinoma, variant histology. CAP synoptic form item: Specify the details of Squamous cell carcinoma, variant histology."
URIN_BLADDER_BIOPS,ADNCCNM_VAR_HIST,N,6,VARCHAR,No,"CAP synoptic form item: Specify the details of Adenocarcinoma, variant histology. CAP synoptic form item: Specify the details of Adenocarcinoma, variant histology."
URIN_BLADDER_BIOPS,UNDIFF_CCNM,N,7,VARCHAR,No,CAP synoptic form item: Specify the details of undifferentiated carcinoma. CAP synoptic form item: Specify the details of undifferentiated carcinoma.
URIN_BLADDER_BIOPS,HIST_TP_MIX_CT,N,8,VARCHAR,No,CAP synoptic form item: Specify the details of mixed cell type. CAP synoptic form item: Specify the details of mixed cell type.
URIN_BLADDER_BIOPS,HISTO_TYPE_SPECIFY,N,9,VARCHAR,No,CAP synoptic form item: Specify histologic type. CAP synoptic form item: Specify histologic type.
URIN_BLADDER_BIOPS,HG_URTL_CCNM_C_NAME,N,10,VARCHAR,No,"CAP synoptic form item: Histologic Grade Urothelial Carcinoma.
May contain organization-specific values: Yes
Category Entries:
Low-grade
High-grade
Not applicable
Cannot be determined
Other CAP synoptic form item: Histologic Grade Urothelial Carcinoma. May contain organization-specific values: Yes Category Entries: Low-grade High-grade Not applicable Cannot be determined Other"
URIN_BLADDER_BIOPS,HG_URTL_CCNM_S,N,11,VARCHAR,No,CAP synoptic form item: Specify the details of Histologic Grade Urothelial carcinoma. CAP synoptic form item: Specify the details of Histologic Grade Urothelial carcinoma.
URIN_BLADDER_BIOPS,HG_ADEN_SQUA_CC_C_NAME,N,12,VARCHAR,No,"CAP synoptic form item: Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma.
May contain organization-specific values: Yes
Category Entries:
Not applicable
Cannot be determined
GX: Cannot be assessed
G1: Well differentiated
G2: Moderately differentiated
G3: Poorly differentiated
Other CAP synoptic form item: Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma. May contain organization-specific values: Yes Category Entries: Not applicable Cannot be determined GX: Cannot be assessed G1: Well differentiated G2: Moderately differentiated G3: Poorly differentiated Other"
URIN_BLADDER_BIOPS,ADEN_SQUA_CCS,N,13,VARCHAR,No,CAP synoptic form item: Specify Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma. CAP synoptic form item: Specify Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma.
URIN_BLADDER_BIOPS,OTHER_TM_CONFIG_S,N,14,VARCHAR,No,CAP synoptic form item: Specify other tumor configuration. CAP synoptic form item: Specify other tumor configuration.
URIN_BLADDER_BIOPS,AM_MUS_PROP_INV_C_NAME,N,15,VARCHAR,No,"CAP synoptic form item: Determine Adequacy of Material for Muscularis Propria Invasion.
May contain organization-specific values: Yes
Category Entries:
Muscularis propria (detrusor muscle) not identified
Muscularis propria (detrusor muscle) present
Presence of muscularis propria indeterminate CAP synoptic form item: Determine Adequacy of Material for Muscularis Propria Invasion. May contain organization-specific values: Yes Category Entries: Muscularis propria (detrusor muscle) not identified Muscularis propria (detrusor muscle) present Presence of muscularis propria indeterminate"
URIN_BLADDER_BIOPS,ADDL_PATH_FIND_SPFY,N,16,VARCHAR,No,CAP synoptic form item: Specify additional pathologic findings. CAP synoptic form item: Specify additional pathologic findings.
URIN_BLADDER_CPTR,RESULT_ID,N,1,VARCHAR,No,The unique identifier for the result record. The unique identifier for the result record.
URIN_BLADDER_CPTR,TUMOR_SITE_SPECIFY,N,2,VARCHAR,No,CAP synoptic form item: Specify tumor site. CAP synoptic form item: Specify tumor site.
URIN_BLADDER_CPTR,CAP_COMMENTS,N,3,VARCHAR,No,CAP synoptic form item: General comments. CAP synoptic form item: General comments.
URIN_BLADDER_CPTR,SPEC_PROC_SPECIFY,N,4,VARCHAR,No,CAP synoptic form item: Specify the Specimen Procedure. CAP synoptic form item: Specify the Specimen Procedure.
URIN_BLADDER_CPTR,TUMOR_SIZE_GREAT,N,5,NUMERIC,No,CAP synoptic form item: Tumor Greatest Size. CAP synoptic form item: Tumor Greatest Size.
URIN_BLADDER_CPTR,TUMOR_SIZE_ADDL,N,6,NUMERIC,No,CAP synoptic form item: Tumor Size (length). CAP synoptic form item: Tumor Size (length).
URIN_BLADDER_CPTR,TUMOR_SIZE_ADDL2,N,7,NUMERIC,No,CAP synoptic form item: Tumor Size (width). CAP synoptic form item: Tumor Size (width).
URIN_BLADDER_CPTR,TUMOR_SIZE_SPECIFY,N,8,VARCHAR,No,CAP synoptic form item: Specify Tumor Size. CAP synoptic form item: Specify Tumor Size.
URIN_BLADDER_CPTR,MICRO_TMR_EXT_SPFY,N,9,VARCHAR,No,CAP synoptic form item: Specify Microscopic Tumor Extension. CAP synoptic form item: Specify Microscopic Tumor Extension.
URIN_BLADDER_CPTR,SPECIMEN_OTHER_SPFY,N,10,VARCHAR,No,CAP synoptic form item: Specify other specimen. CAP synoptic form item: Specify other specimen.
URIN_BLADDER_CPTR,REGIONL_LYMPH_ND_C_NAME,N,11,VARCHAR,No,"CAP synoptic form item: Regional Lymph Nodes (pN).
May contain organization-specific values: Yes
Category Entries:
pNX: Cannot be assessed
pN0: No regional lymph node metastasis
pN1: Regional lymph node metastasis
pN1: Metastasis in perirectal lymph nodes
pN1: Metastasis in 1 to 3 regional lymph nodes
pN1a: Metastasis in 1 regional lymph node
pN1b: Metastasis in 2 to 3 regional lymph nodes
pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta
pN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes
pN1: Regional lymph node metastasis involving 1 to 2 nodes
pN1 (IIIC): Regional lymph node metastasis
pN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery
pN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension
pN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes, 
pN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes
pN1a: Clinically occult (microscopic) metastasis
pN1b: Clinically apparent (macroscopic) metastasis
pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension
pN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension
pN1: Metastasis in 1 to 2 perigastric lymph nodes
pN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension,
pN1a: Nodal metastases to Level VI lymph nodes
pN1b: Metastases to unilateral, bilateral or contralateral cervical 
pN1: Single regional lymph node metastasis in the true pelvis 
pN1 (IVB): Pelvic or inguinal lymph node metastasis
pN1: Metastasis in regional lymph node or nodes
pN1: Regional lymph node involvement (preauricular, cervical, submandibular)
pN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s)
pN2: Metastasis in 4 or more regional lymph nodes
pN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd
pN2a: Metastasis in 4 to 6 regional lymph nodes
pN2b: Metastasis in 7 or more regional lymph nodes
pN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho
pN2: 3 to 6 nodes involved
pN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than
pN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension
pN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension
pN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen.
pN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s)
pN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes 
pN2a: Clinically occult (microscopic) metastasis
pN2b: Clinically apparent (macroscopic) metastasis
pN2c: Satellite or in-transit metastasis without nodal metastasis
pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension
pN2: Metastasis in a single regional lymph node, more than 2 cm but not more than
pN2: Metastasis in 3 to 6 perigastric lymph nodes
pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm 
pN2: Multiple regional lymph node metastasis in the true pelvis 
pN2: Distant lymph node involvement
pN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il
pN3: 7 or more nodes involved
pN3: Metastasis in a lymph node more than 6 cm in greatest dimension
pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or
pN3: Metastases in the contralateral mediastinal, contralateral internal mammary,
pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or
pN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa
pN3a: Greater than 6 cm in dimension
pN3b: Extension to the supraclavicular fossa
pN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension
pN3: Metastasis in 7 or more perigastric lymph nodes
pN3a: Metastasis in 7 to 15 perigastric lymph nodes
pN3b: Metastasis in 16 or more perigastric lymph nodes
pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension
pN3: Lymph node metastasis to the common iliac lymph nodes
pN1: One or two regional lymph nodes with the following features
pN2 (FIGO IIIB): Regional lymph node metastasis with the following features
pN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis CAP synoptic form item: Regional Lymph Nodes (pN). May contain organization-specific values: Yes Category Entries: pNX: Cannot be assessed pN0: No regional lymph node metastasis pN1: Regional lymph node metastasis pN1: Metastasis in perirectal lymph nodes pN1: Metastasis in 1 to 3 regional lymph nodes pN1a: Metastasis in 1 regional lymph node pN1b: Metastasis in 2 to 3 regional lymph nodes pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta pN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes pN1: Regional lymph node metastasis involving 1 to 2 nodes pN1 (IIIC): Regional lymph node metastasis pN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery pN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension pN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes, pN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes pN1a: Clinically occult (microscopic) metastasis pN1b: Clinically apparent (macroscopic) metastasis pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension pN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension pN1: Metastasis in 1 to 2 perigastric lymph nodes pN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension, pN1a: Nodal metastases to Level VI lymph nodes pN1b: Metastases to unilateral, bilateral or contralateral cervical pN1: Single regional lymph node metastasis in the true pelvis pN1 (IVB): Pelvic or inguinal lymph node metastasis pN1: Metastasis in regional lymph node or nodes pN1: Regional lymph node involvement (preauricular, cervical, submandibular) pN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s) pN2: Metastasis in 4 or more regional lymph nodes pN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd pN2a: Metastasis in 4 to 6 regional lymph nodes pN2b: Metastasis in 7 or more regional lymph nodes pN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho pN2: 3 to 6 nodes involved pN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than pN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension pN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension pN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen. pN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s) pN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes pN2a: Clinically occult (microscopic) metastasis pN2b: Clinically apparent (macroscopic) metastasis pN2c: Satellite or in-transit metastasis without nodal metastasis pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension pN2: Metastasis in a single regional lymph node, more than 2 cm but not more than pN2: Metastasis in 3 to 6 perigastric lymph nodes pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm pN2: Multiple regional lymph node metastasis in the true pelvis pN2: Distant lymph node involvement pN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il pN3: 7 or more nodes involved pN3: Metastasis in a lymph node more than 6 cm in greatest dimension pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or pN3: Metastases in the contralateral mediastinal, contralateral internal mammary, pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or pN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa pN3a: Greater than 6 cm in dimension pN3b: Extension to the supraclavicular fossa pN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension pN3: Metastasis in 7 or more perigastric lymph nodes pN3a: Metastasis in 7 to 15 perigastric lymph nodes pN3b: Metastasis in 16 or more perigastric lymph nodes pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension pN3: Lymph node metastasis to the common iliac lymph nodes pN1: One or two regional lymph nodes with the following features pN2 (FIGO IIIB): Regional lymph node metastasis with the following features pN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis"
URIN_BLADDER_CPTR,REG_LN_NUM_EXM,N,12,NUMERIC,No,CAP synoptic form item: Regional Lymph Nodes Number Examined. CAP synoptic form item: Regional Lymph Nodes Number Examined.
URIN_BLADDER_CPTR,REG_LN_NUM_INV,N,13,NUMERIC,No,CAP synoptic form item: Regional Lymph Nodes Number Involved. CAP synoptic form item: Regional Lymph Nodes Number Involved.
URIN_BLADDER_CPTR,PRIMARY_TUMOR_C_NAME,N,14,VARCHAR,No,"CAP synoptic form item: Primary Tumor (pT).
May contain organization-specific values: Yes
Category Entries:
pTX: Cannot be determined
pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or
pTX: Cannot be assessed
pT0: No evidence of primary tumor
pTis: Carcinoma in situ
pTis (DCIS): Ductal carcinoma in situ
pTis (LCIS): Lobular carcinoma in situ
pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and
pTis: Carcinoma in situ, intraepithelial (no invasion)
pTis: Carcinoma in situ, invasion of lamina propria
pTis: High-grade dysplasia / carcinoma in situ
pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa)
pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I)
Encapsulated
Extracapsular extension without adjacent organ involvement
Extension into adjacent organs
Extension into spinal canal
pTa: Papillary noninvasive carcinoma
pTa: Noninvasive papillary carcinoma
pTis: Intratubular germ cell neoplasia only (carcinoma in situ)
pTis: Flat carcinoma in situ
pTis: Carcinoma in situ: flat tumor
Iris
Ciliary Body and Choroid
pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion
pT1: Tumor limited to ampulla of Vater or sphincter of Oddi
pT1: Tumor 2 cm or less in greatest dimension
pT1: Tumor invades submucosa
pT1: Tumor confined to the bile duct histologically
pT1: Solitary tumor without vascular invasion
pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue
pT1: Tumor 8 cm or less in greatest dimension
pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion)
pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension
pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension
pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension
pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium
pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium
pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa
pT1a: Tumor invades lamina propria or muscularis mucosae
pT1a: Tumor invades lamina propria
pT1 (I): Tumor limited to fallopian tube(s)
pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites
pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites
pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa
pT1b: Tumor invades submucosa
pT1b: Tumor invades muscle layer
pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney
pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney
pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to  kidney
pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura
pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by 
pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I)
pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or
pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or
pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm
pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm
pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N
pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface
pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule 
pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension
pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen
pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal
pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen
pT1: Tumor invades subepithelial connective tissue (lamina propria)
pT1: Tumor confined to the eye with no optic nerve or choroidal invasion
pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor
pT1b: Tumor 5 cm or less in greatest dimension, deep tumor
pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features
pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion
pT1: Tumor size 2 cm or less, limited to thyroid
pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid
pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid
pT1 (I): Tumor confined to uterus
pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically
pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less
pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth
pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2
pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension
pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension
pT1 (I): Tumor confined to vaginal wall
pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum
pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more
pT2: Tumor greater than 5 cm, no extra-adrenal invasion
pT2: Tumor invades duodenal wall
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension
pT2: Tumor invades muscularis propria
pT2: Tumor invades beyond the wall of the bile duct
pT2a: Solitary tumor with vascular invasion
pT2b: Multiple tumors, with or without vascular invasion
pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue
pT2b: Tumor invades adjacent hepatic parenchyma
pT2: Tumor more than 8 cm in greatest dimension
pT2: Tumor > 20 mm but <= 50 mm in greatest dimension
pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend 
pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension
pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries
pT2b (IIB): Extension to other pelvic structures
pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites
pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney
pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney
pT2b: Tumor more than 10 cm, limited to the kidney
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension
pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l
pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension
pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension)
pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, 
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration
pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell
pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or
pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 
pT2: Tumor with parapharyngeal extension
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or
pT2: Organ confined
pT2a: Unilateral, involving one-half of 1 side or less
pT2b: Unilateral, involving more than one-half of 1 side but not both sides
pT2c: Bilateral disease
pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion
pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor
pT2: Tumor greater than 2 cm in greatest dimension with or without one additional
pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion
pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid 
pT2 (II): Tumor extends outside of the uterus but is limited to genital structures
pT2a: Tumor invades superficial muscularis propria (inner half)
pT2b: Tumor invades deep muscularis propria (outer half)
pT2a (IIA): Tumor without parametrial invasion
pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen
pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension
pT2b (IIB): Tumor with parametrial invasion
pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall
pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures 
pT3: Tumor of any size with local invasion, but not invading adjacent organs
pT3: Tumor invades pancreas
pT3: Tumor more than 5 cm in greatest dimension
pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix
pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of
pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas
pT3: Tumor invades unilateral branches of the portal vein or hepatic artery
pT3: Discontinuous tumors in primary bone site (not including skip metastases)
pT3: Tumor > 50 mm in greatest dimension
pT3: Tumor invades through the muscularis propria into pericolorectal tissues
pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis)
pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve
pT3: Tumor invades adventitia
pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis
pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis
pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen
pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen
pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver
pT3a: Multiple tumors more than 5 cm
pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins
pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal
pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) 
pT3b: Tumor grossly extends into the vena cava below the diaphragm
pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava
pT3: Mucosal disease
pT3: Tumor more than 4 cm in greatest dimension
pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that
pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I)
pT3: Locally advanced but potentially resectable tumor that involves all of the
pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration
pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration
pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor)
pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen
pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or 
pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis
pT3: Tumor invades bony structures of skull base and / or paranasal sinuses
pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary
pT3a: Extraprostatic extension or microscopic invasion of bladder neck
pT3b: Seminal vesicle invasion
pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma
pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion
pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion
pT3: Tumor invades through the muscularis propria into the subserosa or into the
pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone
pT3: Tumor invades subserosal connective tissue, without involvement of
pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion
pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension
pT3: Tumor invades beyond muscularis propria into periureteric fat
pT3a: Microscopically
pT3b: Macroscopically (extravesicular mass)
pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall
pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney
pT3 (III): Tumor extends to pelvic wall
pT3 (FIGO IVA): Tumor of any size with extension to any of the following
pT4: Tumor of any size with invasion of adjacent organs
pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures
pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder
pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within
pT4: Tumor involves the celiac axis or the superior mesenteric artery
pT4: Tumor with periductal invasion
pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati
pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa 
pT4: Tumor invades adjacent structures 
pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic
pT4: Tmr w/ direct invasion of adj. organs other than gallbladder 
pT4: Tmr invades beyond Gerota’s fascia
pT4: Tumor of any size that invades any of the following: mediastinum, heart, great
pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral
pT4: Tumor with intracranial extension and / or involvement of cranial nerves,
pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J)
pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat
pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified
pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified
pT4: Tumor with direct or perineural invasion of skull base or axial skeleton
pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure
pT4: Tumor invades scrotum with or without vascular / lymphatic invasion
pT4: Tumor invades adjacent organs
pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis
pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis
pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi
pT4a: Tumor penetrates the visceral peritoneum
pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas
pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria
pT4c: Both T4a and T4b
pT4d: Inflammatory carcinoma
pT4b: Tumor directly invades other organs or structures
pT4b: Tumor directly invades or is adherent to other organs or structures
pT4a: Resectable tumor invading pleura, pericardium, or diaphragm
pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body
Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells
Primary Tumor (pT): Supraglottis
Primary Tumor (pT): Glottis
Primary Tumor (pT): Subglottis
pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone,
pT4b: Very advanced disease. Tumor involving brain, dura, skull base,
pT4a: Moderately advanced local disease.
pT4b: Very advanced local disease. 
pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal,
pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates
pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration
pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration
Primary Tumor (pT): Maxillary Sinus
Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus
pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic
pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid 
pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage,
pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases
pT4a: Tumor involves visceral peritoneum (serosal surface)
pT4b: Tumor directly invades adjacent structures
pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid
pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid
pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable
pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable
pT4a: Tumor invades prostatic stroma or uterus or vagina
pT4b: Tumor invades pelvic wall or abdominal wall
Not identified CAP synoptic form item: Primary Tumor (pT). May contain organization-specific values: Yes Category Entries: pTX: Cannot be determined pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or pTX: Cannot be assessed pT0: No evidence of primary tumor pTis: Carcinoma in situ pTis (DCIS): Ductal carcinoma in situ pTis (LCIS): Lobular carcinoma in situ pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and pTis: Carcinoma in situ, intraepithelial (no invasion) pTis: Carcinoma in situ, invasion of lamina propria pTis: High-grade dysplasia / carcinoma in situ pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa) pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I) Encapsulated Extracapsular extension without adjacent organ involvement Extension into adjacent organs Extension into spinal canal pTa: Papillary noninvasive carcinoma pTa: Noninvasive papillary carcinoma pTis: Intratubular germ cell neoplasia only (carcinoma in situ) pTis: Flat carcinoma in situ pTis: Carcinoma in situ: flat tumor Iris Ciliary Body and Choroid pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion pT1: Tumor limited to ampulla of Vater or sphincter of Oddi pT1: Tumor 2 cm or less in greatest dimension pT1: Tumor invades submucosa pT1: Tumor confined to the bile duct histologically pT1: Solitary tumor without vascular invasion pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue pT1: Tumor 8 cm or less in greatest dimension pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion) pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa pT1a: Tumor invades lamina propria or muscularis mucosae pT1a: Tumor invades lamina propria pT1 (I): Tumor limited to fallopian tube(s) pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa pT1b: Tumor invades submucosa pT1b: Tumor invades muscle layer pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to  kidney pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I) pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen pT1: Tumor invades subepithelial connective tissue (lamina propria) pT1: Tumor confined to the eye with no optic nerve or choroidal invasion pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor pT1b: Tumor 5 cm or less in greatest dimension, deep tumor pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion pT1: Tumor size 2 cm or less, limited to thyroid pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid pT1 (I): Tumor confined to uterus pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2 pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension pT1 (I): Tumor confined to vaginal wall pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more pT2: Tumor greater than 5 cm, no extra-adrenal invasion pT2: Tumor invades duodenal wall pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension pT2: Tumor invades muscularis propria pT2: Tumor invades beyond the wall of the bile duct pT2a: Solitary tumor with vascular invasion pT2b: Multiple tumors, with or without vascular invasion pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue pT2b: Tumor invades adjacent hepatic parenchyma pT2: Tumor more than 8 cm in greatest dimension pT2: Tumor > 20 mm but <= 50 mm in greatest dimension pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries pT2b (IIB): Extension to other pelvic structures pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney pT2b: Tumor more than 10 cm, limited to the kidney pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension) pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than pT2: Tumor with parapharyngeal extension pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or pT2: Organ confined pT2a: Unilateral, involving one-half of 1 side or less pT2b: Unilateral, involving more than one-half of 1 side but not both sides pT2c: Bilateral disease pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor pT2b: Tumor more than 5 cm in greatest dimension, deep tumor pT2: Tumor greater than 2 cm in greatest dimension with or without one additional pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid pT2 (II): Tumor extends outside of the uterus but is limited to genital structures pT2a: Tumor invades superficial muscularis propria (inner half) pT2b: Tumor invades deep muscularis propria (outer half) pT2a (IIA): Tumor without parametrial invasion pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension pT2b (IIB): Tumor with parametrial invasion pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures pT3: Tumor of any size with local invasion, but not invading adjacent organs pT3: Tumor invades pancreas pT3: Tumor more than 5 cm in greatest dimension pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas pT3: Tumor invades unilateral branches of the portal vein or hepatic artery pT3: Discontinuous tumors in primary bone site (not including skip metastases) pT3: Tumor > 50 mm in greatest dimension pT3: Tumor invades through the muscularis propria into pericolorectal tissues pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis) pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve pT3: Tumor invades adventitia pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver pT3a: Multiple tumors more than 5 cm pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) pT3b: Tumor grossly extends into the vena cava below the diaphragm pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava pT3: Mucosal disease pT3: Tumor more than 4 cm in greatest dimension pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I) pT3: Locally advanced but potentially resectable tumor that involves all of the pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis pT3: Tumor invades bony structures of skull base and / or paranasal sinuses pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary pT3a: Extraprostatic extension or microscopic invasion of bladder neck pT3b: Seminal vesicle invasion pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion pT3: Tumor invades through the muscularis propria into the subserosa or into the pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone pT3: Tumor invades subserosal connective tissue, without involvement of pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension pT3: Tumor invades beyond muscularis propria into periureteric fat pT3a: Microscopically pT3b: Macroscopically (extravesicular mass) pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney pT3 (III): Tumor extends to pelvic wall pT3 (FIGO IVA): Tumor of any size with extension to any of the following pT4: Tumor of any size with invasion of adjacent organs pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within pT4: Tumor involves the celiac axis or the superior mesenteric artery pT4: Tumor with periductal invasion pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa pT4: Tumor invades adjacent structures pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic pT4: Tmr w/ direct invasion of adj. organs other than gallbladder pT4: Tmr invades beyond Gerota’s fascia pT4: Tumor of any size that invades any of the following: mediastinum, heart, great pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral pT4: Tumor with intracranial extension and / or involvement of cranial nerves, pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J) pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified pT4: Tumor with direct or perineural invasion of skull base or axial skeleton pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure pT4: Tumor invades scrotum with or without vascular / lymphatic invasion pT4: Tumor invades adjacent organs pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi pT4a: Tumor penetrates the visceral peritoneum pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria pT4c: Both T4a and T4b pT4d: Inflammatory carcinoma pT4b: Tumor directly invades other organs or structures pT4b: Tumor directly invades or is adherent to other organs or structures pT4a: Resectable tumor invading pleura, pericardium, or diaphragm pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells Primary Tumor (pT): Supraglottis Primary Tumor (pT): Glottis Primary Tumor (pT): Subglottis pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, pT4b: Very advanced disease. Tumor involving brain, dura, skull base, pT4a: Moderately advanced local disease. pT4b: Very advanced local disease. pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal, pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration Primary Tumor (pT): Maxillary Sinus Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage, pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases pT4a: Tumor involves visceral peritoneum (serosal surface) pT4b: Tumor directly invades adjacent structures pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable pT4a: Tumor invades prostatic stroma or uterus or vagina pT4b: Tumor invades pelvic wall or abdominal wall Not identified"
URIN_BLADDER_CPTR,DISTNT_METASTASIS_C_NAME,N,15,VARCHAR,No,"CAP synoptic form item: Distant Metastasis.
May contain organization-specific values: Yes
Category Entries:
Not applicable
cM0 (i+): No clinical or radiographic evidence of distant metastasis
pM0: No distant metastasis
pM1: Distant metastasis
pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx
pM1b: Nonperitoneal metastasis
pM1: Distant detectable metastasis as determined by classic clinical
pM1 (IVB): Distant metastasis
pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or
pM1b: Distant metastases outside the lung / pleura
pM1: Distant metastasis (documented in this specimen)
pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes
pM1b: Metastasis to lung
pM1c: Metastasis to all other visceral sites or distant metastasis at any site
pM1a: Nonregional lymph node(s)
pM1b: Bone(s)
pM1c: Other site(s) with or without bone disease
pM1: Metastasis to sites other than CNS
pM1a: Single lesion
pM1b: Multiple lesions
pM1c: CNS metastasis
pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement
pM1e: Leptomeningeal and / or CSF involvement
pM1a: Non-regional lymph nodes or pulmonary metastasis
pM1b: Distant metastasis other than to nonregional lymph nodes and lungs
pM1a (III): Tumor extends to the lungs with or without genital tract involvement
pM1b (IV): Tumor involves other metastatic sites
pM1a: Largest diameter of the largest metastasis 3 cm or less
pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm
pM1c: Largest diameter of the largest metastasis 8 cm or more
pM1a: Lung
pM1b: Metastasis involving distant sites other than lung (including skip metastases)
Distant Metastasis present (includes metastasis to lymph nodes) CAP synoptic form item: Distant Metastasis. May contain organization-specific values: Yes Category Entries: Not applicable cM0 (i+): No clinical or radiographic evidence of distant metastasis pM0: No distant metastasis pM1: Distant metastasis pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx pM1b: Nonperitoneal metastasis pM1: Distant detectable metastasis as determined by classic clinical pM1 (IVB): Distant metastasis pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or pM1b: Distant metastases outside the lung / pleura pM1: Distant metastasis (documented in this specimen) pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes pM1b: Metastasis to lung pM1c: Metastasis to all other visceral sites or distant metastasis at any site pM1a: Nonregional lymph node(s) pM1b: Bone(s) pM1c: Other site(s) with or without bone disease pM1: Metastasis to sites other than CNS pM1a: Single lesion pM1b: Multiple lesions pM1c: CNS metastasis pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement pM1e: Leptomeningeal and / or CSF involvement pM1a: Non-regional lymph nodes or pulmonary metastasis pM1b: Distant metastasis other than to nonregional lymph nodes and lungs pM1a (III): Tumor extends to the lungs with or without genital tract involvement pM1b (IV): Tumor involves other metastatic sites pM1a: Largest diameter of the largest metastasis 3 cm or less pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm pM1c: Largest diameter of the largest metastasis 8 cm or more pM1a: Lung pM1b: Metastasis involving distant sites other than lung (including skip metastases) Distant Metastasis present (includes metastasis to lymph nodes)"
URIN_BLADDER_CPTR,DSTNT_METASTATIS_ST,N,16,VARCHAR,No,CAP synoptic form item: Distant Metastatis Sites. CAP synoptic form item: Distant Metastatis Sites.
URIN_BLADDER_CPTR,ADDL_PATH_FIND_SPFY,N,17,VARCHAR,No,CAP synoptic form item: Specify additional pathologic findings. CAP synoptic form item: Specify additional pathologic findings.
URIN_BLADDER_CPTR,SPEC_MG_IVLV_INV_CC,N,18,VARCHAR,No,CAP synoptic form item: Specify Margin Involved by Invasive Carcinoma. CAP synoptic form item: Specify Margin Involved by Invasive Carcinoma.
URIN_BLADDER_CPTR,OTHER_TM_CONFIG_S,N,19,VARCHAR,No,CAP synoptic form item: Specify other tumor configuration. CAP synoptic form item: Specify other tumor configuration.
URIN_BLADDER_CPTR,HIST_TYP_NONCL_SPFY,N,20,VARCHAR,No,CAP synoptic form item: Specify other or nonclassifiable histologic type. CAP synoptic form item: Specify other or nonclassifiable histologic type.
URIN_BLADDER_CPTR,HG_URTL_CCNM_C_NAME,N,21,VARCHAR,No,"CAP synoptic form item: Histologic Grade Urothelial Carcinoma.
May contain organization-specific values: Yes
Category Entries:
Low-grade
High-grade
Not applicable
Cannot be determined
Other CAP synoptic form item: Histologic Grade Urothelial Carcinoma. May contain organization-specific values: Yes Category Entries: Low-grade High-grade Not applicable Cannot be determined Other"
URIN_BLADDER_CPTR,HG_URTL_CCNM_S,N,22,VARCHAR,No,CAP synoptic form item: Specify the details of Histologic Grade Urothelial carcinoma. CAP synoptic form item: Specify the details of Histologic Grade Urothelial carcinoma.
URIN_BLADDER_CPTR,HG_ADEN_SQUA_CC_C_NAME,N,23,VARCHAR,No,"CAP synoptic form item: Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma.
May contain organization-specific values: Yes
Category Entries:
Not applicable
Cannot be determined
GX: Cannot be assessed
G1: Well differentiated
G2: Moderately differentiated
G3: Poorly differentiated
Other CAP synoptic form item: Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma. May contain organization-specific values: Yes Category Entries: Not applicable Cannot be determined GX: Cannot be assessed G1: Well differentiated G2: Moderately differentiated G3: Poorly differentiated Other"
URIN_BLADDER_CPTR,ADEN_SQUA_CCS,N,24,VARCHAR,No,CAP synoptic form item: Specify Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma. CAP synoptic form item: Specify Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma.
URIN_BLADDER_CPTR,UROT_CCM_W_VAR_HIST,N,25,VARCHAR,No,CAP synoptic form item: Specify the details of Urothelial carcinoma with variant histology. CAP synoptic form item: Specify the details of Urothelial carcinoma with variant histology.
URIN_BLADDER_CPTR,SQM_C_CCNM_VAR_HIST,N,26,VARCHAR,No,"CAP synoptic form item: Specify the details of Squamous cell carcinoma, variant histology. CAP synoptic form item: Specify the details of Squamous cell carcinoma, variant histology."
URIN_BLADDER_CPTR,ADNCCNM_VAR_HIST,N,27,VARCHAR,No,"CAP synoptic form item: Specify the details of Adenocarcinoma, variant histology. CAP synoptic form item: Specify the details of Adenocarcinoma, variant histology."
URIN_BLADDER_CPTR,UNDIFF_CCNM,N,28,VARCHAR,No,CAP synoptic form item: Specify the details of undifferentiated carcinoma. CAP synoptic form item: Specify the details of undifferentiated carcinoma.
URIN_BLADDER_CPTR,HIST_TP_MIX_CT,N,29,VARCHAR,No,CAP synoptic form item: Specify the details of mixed cell type. CAP synoptic form item: Specify the details of mixed cell type.
URIN_BLADDER_CPTR,MG_IVLV_INV_CCNM_C_NAME,N,30,VARCHAR,No,"CAP synoptic form item: Margin Involvement by Invasive Carcinoma.
May contain organization-specific values: Yes
Category Entries:
Cannot be assessed
Margins uninvolved by invasive carcinoma
Margin(s) involved by invasive carcinoma CAP synoptic form item: Margin Involvement by Invasive Carcinoma. May contain organization-specific values: Yes Category Entries: Cannot be assessed Margins uninvolved by invasive carcinoma Margin(s) involved by invasive carcinoma"
URIN_BLADDER_CPTR,MG_UVLV_IC_DSTNC_IC,N,31,NUMERIC,No,CAP synoptic form item: Margins uninvolved by invasive carcinoma - Distance of Invasive Carcinoma from Closest Margin. CAP synoptic form item: Margins uninvolved by invasive carcinoma - Distance of Invasive Carcinoma from Closest Margin.
URIN_BLADDER_CPTR,MG_UVLV_IC_SM,N,32,VARCHAR,No,CAP synoptic form item: Specify Margin for Margins uninvolved by invasive carcinoma. CAP synoptic form item: Specify Margin for Margins uninvolved by invasive carcinoma.
URIN_BLADDER_CPTR,MG_IVLV_CCNM_SS,N,33,VARCHAR,No,CAP synoptic form item: Specify Margins involved by carcinoma in situ. CAP synoptic form item: Specify Margins involved by carcinoma in situ.
URIN_BLADDER_CPTR,MG_IVLV_CCNM_ST_C_NAME,N,34,VARCHAR,No,"CAP synoptic form item: Margin Involvement by Carcinoma in situ.
May contain organization-specific values: Yes
Category Entries:
Cannot be assessed
Margin(s) uninvolved by carcinoma in situ
Margin(s) involved by carcinoma in situ CAP synoptic form item: Margin Involvement by Carcinoma in situ. May contain organization-specific values: Yes Category Entries: Cannot be assessed Margin(s) uninvolved by carcinoma in situ Margin(s) involved by carcinoma in situ"
USED_FORMS_LIST_FINDING,FINDING_ID,N,1,NUMERIC,No,The unique identifier (.1 item) for the finding record. The unique identifier (.1 item) for the finding record.
USED_FORMS_LIST_FINDING,LINE,N,2,INTEGER,No,The line number for the information associated with this record. Multiple pieces of information can be associated with this record. The line number for the information associated with this record. Multiple pieces of information can be associated with this record.
USED_FORMS_LIST_FINDING,USED_FORMS_LIST,N,3,VARCHAR,No,This item stores the used forms list in Echo/Cath/Registry/Procedure log module. This item stores the used forms list in Echo/Cath/Registry/Procedure log module.
USER_AUTHORITY,ALERT_ID,N,1,NUMERIC,No,The unique identifier for the med alert record. The unique identifier for the med alert record.
USER_AUTHORITY,CONTACT_DATE_REAL,N,2,FLOAT,No,"A unique contact date in decimal format. The integer portion of the number indicates the date of contact. The digits after the decimal distinguish different contacts on the same date and are unique for each contact on that date. For example, .00 is the first/only contact, .01 is the second contact, etc. A unique contact date in decimal format. The integer portion of the number indicates the date of contact. The digits after the decimal distinguish different contacts on the same date and are unique for each contact on that date. For example, .00 is the first/only contact, .01 is the second contact, etc."
USER_AUTHORITY,LINE,N,3,INTEGER,No,The line number for the information associated with this contact. Multiple pieces of information can be associated with this contact. The line number for the information associated with this contact. Multiple pieces of information can be associated with this contact.
USER_AUTHORITY,USER_AUTHORITY_C_NAME,N,4,VARCHAR,No,"The discrete authorities that were being tracked at the time the user interacted with the warning.
May contain organization-specific values: No
Category Entries:
Prescription Clinical Review The discrete authorities that were being tracked at the time the user interacted with the warning. May contain organization-specific values: No Category Entries: Prescription Clinical Review"
USER_AUTHORITY,AUTHORITY_STATE_C_NAME,N,5,VARCHAR,No,"The state of the discrete authorities that were being tracked at the time the user interacted with the warning.
May contain organization-specific values: No
Category Entries:
Unknown Authority
Has Authority
Does Not Have Authority The state of the discrete authorities that were being tracked at the time the user interacted with the warning. May contain organization-specific values: No Category Entries: Unknown Authority Has Authority Does Not Have Authority"
USES_SAFE_SEX,PAT_ENC_CSN_ID,N,1,NUMERIC,No,"The unique contact serial number for this contact. This number is unique across all patient encounters in your system. If you use IntraConnect, this is the Unique Contact Identifier (UCI). The unique contact serial number for this contact. This number is unique across all patient encounters in your system. If you use IntraConnect, this is the Unique Contact Identifier (UCI)."
USES_SAFE_SEX,LINE,N,2,INTEGER,No,The line number for the information associated with this contact. Multiple pieces of information can be associated with this contact. The line number for the information associated with this contact. Multiple pieces of information can be associated with this contact.
USES_SAFE_SEX,USES_SAFE_SEX_C_NAME,N,3,VARCHAR,No,"The birth control / protection category ID for the patient's current encounter representing what a patient uses for safe sex. There can be multiple IDs associated with one encounter.
May contain organization-specific values: Yes
Category Entries:
Condom
Pill
Diaphragm
I.U.D.
Surgical
Spermicide
Implant
Rhythm
Injection
Sponge
Inserts
Abstinence The birth control / protection category ID for the patient's current encounter representing what a patient uses for safe sex. There can be multiple IDs associated with one encounter. May contain organization-specific values: Yes Category Entries: Condom Pill Diaphragm I.U.D. Surgical Spermicide Implant Rhythm Injection Sponge Inserts Abstinence"
UTERINE_CERVIX_EXC,RESULT_ID,N,1,VARCHAR,No,The unique identifier for the result record. The unique identifier for the result record.
UTERINE_CERVIX_EXC,TUMOR_SITE_SPECIFY,N,2,VARCHAR,No,CAP synoptic form item: Specify tumor site. CAP synoptic form item: Specify tumor site.
UTERINE_CERVIX_EXC,CAP_COMMENTS,N,3,VARCHAR,No,CAP synoptic form item: General comments. CAP synoptic form item: General comments.
UTERINE_CERVIX_EXC,SPEC_PROC_SPECIFY,N,4,VARCHAR,No,CAP synoptic form item: Specify the Specimen Procedure. CAP synoptic form item: Specify the Specimen Procedure.
UTERINE_CERVIX_EXC,TUMOR_SIZE_GREAT,N,5,NUMERIC,No,CAP synoptic form item: Tumor Greatest Size. CAP synoptic form item: Tumor Greatest Size.
UTERINE_CERVIX_EXC,TUMOR_SIZE_ADDL,N,6,NUMERIC,No,CAP synoptic form item: Tumor Size (length). CAP synoptic form item: Tumor Size (length).
UTERINE_CERVIX_EXC,TUMOR_SIZE_ADDL2,N,7,NUMERIC,No,CAP synoptic form item: Tumor Size (width). CAP synoptic form item: Tumor Size (width).
UTERINE_CERVIX_EXC,TUMOR_SIZE_SPECIFY,N,8,VARCHAR,No,CAP synoptic form item: Specify Tumor Size. CAP synoptic form item: Specify Tumor Size.
UTERINE_CERVIX_EXC,SPECIMEN_OTHER_SPFY,N,9,VARCHAR,No,CAP synoptic form item: Specify other specimen. CAP synoptic form item: Specify other specimen.
UTERINE_CERVIX_EXC,ADDL_PATH_FIND_SPFY,N,10,VARCHAR,No,CAP synoptic form item: Specify additional pathologic findings. CAP synoptic form item: Specify additional pathologic findings.
UTERINE_CERVIX_EXC,HISTOLOGIC_GRADE_C_NAME,N,11,VARCHAR,No,"CAP synoptic form item: Histologic Grade.
May contain organization-specific values: Yes
Category Entries:
Not applicable
GX: Cannot be assessed
G1: Well differentiated
G2: Moderately differentiated
G3: Poorly differentiated
G4: Undifferentiated
G4: Undifferentiated / anaplastic
WHO grade not assigned
Low-grade (well-differentiated to moderately differentiated)
High-grade (poorly differentiated to undifferentiated)
FIGO Grade 1
FIGO Grade 2
FIGO Grade 3
Favorable (purely epithelial, fetal subtype, mitotically inactive with <=2 mitoses in
Less favorable (all subtypes other than those designated ""Favorable"" or ""Unfavorable""
Unfavorable (small cell undifferentiated or rhabdoid as the predominant or sole histo
Gleason Pattern
Ungraded sarcoma
pGX: Grade cannot be assessed
pG1: Spindle cell melanoma
pG2: Mixed cell melanoma
pG3: Epithelioid cell melanoma
WHO Grade I
WHO Grade II
WHO Grade III
WHO Grade IV
pG1: Well differentiated
pG2: Moderately differentiated
pG3: Poorly differentiated
pG4: Undifferentiated
FNCLCC Grade 1
FNCLCC Grade 2
FNCLCC Grade 3
Grade 1
Grade 2
Grade 3
Cannot be determined
Other CAP synoptic form item: Histologic Grade. May contain organization-specific values: Yes Category Entries: Not applicable GX: Cannot be assessed G1: Well differentiated G2: Moderately differentiated G3: Poorly differentiated G4: Undifferentiated G4: Undifferentiated / anaplastic WHO grade not assigned Low-grade (well-differentiated to moderately differentiated) High-grade (poorly differentiated to undifferentiated) FIGO Grade 1 FIGO Grade 2 FIGO Grade 3 Favorable (purely epithelial, fetal subtype, mitotically inactive with <=2 mitoses in Less favorable (all subtypes other than those designated ""Favorable"" or ""Unfavorable"" Unfavorable (small cell undifferentiated or rhabdoid as the predominant or sole histo Gleason Pattern Ungraded sarcoma pGX: Grade cannot be assessed pG1: Spindle cell melanoma pG2: Mixed cell melanoma pG3: Epithelioid cell melanoma WHO Grade I WHO Grade II WHO Grade III WHO Grade IV pG1: Well differentiated pG2: Moderately differentiated pG3: Poorly differentiated pG4: Undifferentiated FNCLCC Grade 1 FNCLCC Grade 2 FNCLCC Grade 3 Grade 1 Grade 2 Grade 3 Cannot be determined Other"
UTERINE_CERVIX_EXC,HIST_TYP_NONCL_SPFY,N,12,VARCHAR,No,CAP synoptic form item: Specify other or nonclassifiable histologic type. CAP synoptic form item: Specify other or nonclassifiable histologic type.
UTERINE_CERVIX_EXC,HIST_TP_SQUA_CCNM_S,N,13,VARCHAR,No,CAP synoptic form item: Specify details for Histologic Type Squamous cell carcinoma. CAP synoptic form item: Specify details for Histologic Type Squamous cell carcinoma.
UTERINE_CERVIX_EXC,HIST_TP_ADCCNM_OS,N,14,VARCHAR,No,CAP synoptic form item: Specify other details for Histologic Type Adenocarcinoma. CAP synoptic form item: Specify other details for Histologic Type Adenocarcinoma.
UTERINE_CERVIX_EXC,STRML_INVSN_DEPTH,N,15,NUMERIC,No,CAP synoptic form item: Specify Stromal Invasion Depth. CAP synoptic form item: Specify Stromal Invasion Depth.
UTERINE_CERVIX_EXC,STRML_INVSN_HRZL_XT,N,16,NUMERIC,No,CAP synoptic form item: Specify Stromal Invasion Horizontal Extent. CAP synoptic form item: Specify Stromal Invasion Horizontal Extent.
UTERINE_CERVIX_EXC,ENDC_MG_CNNT_ASSD_C_NAME,N,17,VARCHAR,No,"CAP synoptic form item: Endocervical Margin invasive carcinoma.
May contain organization-specific values: Yes
Category Entries:
Not involved by invasive carcinoma
Involved by invasive carcinoma
Not involved by intraepithelial squamous neoplasia
Involved by intraepithelial squamous neoplasia
Not involved by adenocarcinoma in situ
Involved by adenocarcinoma in situ CAP synoptic form item: Endocervical Margin invasive carcinoma. May contain organization-specific values: Yes Category Entries: Not involved by invasive carcinoma Involved by invasive carcinoma Not involved by intraepithelial squamous neoplasia Involved by intraepithelial squamous neoplasia Not involved by adenocarcinoma in situ Involved by adenocarcinoma in situ"
UTERINE_CERVIX_EXC,ENDC_MG_IVLV_IC_C_NAME,N,18,VARCHAR,No,"CAP synoptic form item: Endocervical Margin Involved by Invasive Carcinoma.
May contain organization-specific values: Yes
Category Entries:
Focal
Diffuse CAP synoptic form item: Endocervical Margin Involved by Invasive Carcinoma. May contain organization-specific values: Yes Category Entries: Focal Diffuse"
UTERINE_CERVIX_EXC,DSTC_INVS_CCNM_XM,N,19,NUMERIC,No,CAP synoptic form item: Specify Distance of Invasive Carcinoma from Margin for Not involved by invasive carcinoma when Exocervical Margin cannot be assessed. CAP synoptic form item: Specify Distance of Invasive Carcinoma from Margin for Not involved by invasive carcinoma when Exocervical Margin cannot be assessed.
UTERINE_CERVIX_EXC,XCVL_MG_INV_CCNM_LC,N,20,VARCHAR,No,CAP synoptic form item: Specify location for Exocervical Margin Involved by invasive carcinoma. CAP synoptic form item: Specify location for Exocervical Margin Involved by invasive carcinoma.
UTERINE_CERVIX_EXC,XCVC_MG_IVLV_IC_C_NAME,N,21,VARCHAR,No,"CAP synoptic form item: Exocervical Margin Involved by Invasive Carcinoma.
May contain organization-specific values: Yes
Category Entries:
Focal
Diffuse CAP synoptic form item: Exocervical Margin Involved by Invasive Carcinoma. May contain organization-specific values: Yes Category Entries: Focal Diffuse"
UTERINE_CERVIX_EXC,ITAEP_SQM_NPS_GRD,N,22,VARCHAR,No,CAP synoptic form item: Specify grade for Exocervical Margin Involved by intraepithelial squamous neoplasia. CAP synoptic form item: Specify grade for Exocervical Margin Involved by intraepithelial squamous neoplasia.
UTERINE_CERVIX_EXC,DSTNC_INV_CCNM_EM,N,23,NUMERIC,No,CAP synoptic form item: Specify distance of invasive carcinoma from Endocervical Margin when invasive carcinoma not involved. CAP synoptic form item: Specify distance of invasive carcinoma from Endocervical Margin when invasive carcinoma not involved.
UTERINE_CERVIX_EXC,EM_NINVSV_CCNM_LOC,N,24,VARCHAR,No,CAP synoptic form item: Specify location for Endocervical Margin not Involved by invasive carcinoma. CAP synoptic form item: Specify location for Endocervical Margin not Involved by invasive carcinoma.
UTERINE_CERVIX_EXC,EM_INVSV_CCNM_LOC,N,25,VARCHAR,No,CAP synoptic form item: Specify location for Endocervical Margin Involved by invasive carcinoma. CAP synoptic form item: Specify location for Endocervical Margin Involved by invasive carcinoma.
UTERINE_CERVIX_EXC,EM_IVLV_ISN_GRD,N,26,VARCHAR,No,CAP synoptic form item: Specify grade for Endocervical Margin Involved by intraepithelial squamous neoplasia. CAP synoptic form item: Specify grade for Endocervical Margin Involved by intraepithelial squamous neoplasia.
UTERINE_CERVIX_EXC,DSTNC_INV_CCNM_DMNA,N,27,NUMERIC,No,CAP synoptic form item: Specify Distance of Invasive Carcinoma from Margin for Deep Margin when Margins cannot be assessed and Not involved by invasive carcinoma. CAP synoptic form item: Specify Distance of Invasive Carcinoma from Margin for Deep Margin when Margins cannot be assessed and Not involved by invasive carcinoma.
UTERINE_CERVIX_EXC,DM_NA_UIC_LOC,N,28,VARCHAR,No,CAP synoptic form item: Specify location for Deep Margin when Uninvolved. CAP synoptic form item: Specify location for Deep Margin when Uninvolved.
UTERINE_CERVIX_EXC,DM_NA_IIC_LOC,N,29,VARCHAR,No,CAP synoptic form item: Specify location for Deep Margin when Involved. CAP synoptic form item: Specify location for Deep Margin when Involved.
UTERINE_CERVIX_EXC,DM_NA_IISN_GRD,N,30,VARCHAR,No,CAP synoptic form item: Specify grade for Deep Margin when Margins cannot be assessed and involved by intraepithelial squamous neoplasia. CAP synoptic form item: Specify grade for Deep Margin when Margins cannot be assessed and involved by intraepithelial squamous neoplasia.
UTERINE_CERVIX_EXC,XCRVCL_MG_IIC_LOC,N,31,VARCHAR,No,CAP synoptic form item: Specify location for Exocervical Margin Not involved by invasive carcinoma. CAP synoptic form item: Specify location for Exocervical Margin Not involved by invasive carcinoma.
UTERINE_CERVIX_EXC,END_MG_INT_SQM_NP_C_NAME,N,32,VARCHAR,No,"CAP synoptic form item: Endocervical Margin intraepithelial squamous neoplasia.
May contain organization-specific values: Yes
Category Entries:
Not involved by intraepithelial squamous neoplasia
Involved by intraepithelial squamous neoplasia CAP synoptic form item: Endocervical Margin intraepithelial squamous neoplasia. May contain organization-specific values: Yes Category Entries: Not involved by intraepithelial squamous neoplasia Involved by intraepithelial squamous neoplasia"
UTERINE_CERVIX_EXC,END_MG_ADC_ST_C_NAME,N,33,VARCHAR,No,"CAP synoptic form item: Endocervical Margin adenocarcinoma in situ.
May contain organization-specific values: Yes
Category Entries:
Not involved by adenocarcinoma in situ
Involved by adenocarcinoma in situ CAP synoptic form item: Endocervical Margin adenocarcinoma in situ. May contain organization-specific values: Yes Category Entries: Not involved by adenocarcinoma in situ Involved by adenocarcinoma in situ"
UTERINE_CERVIX_EXC,DM_INV_CCNM_C_NAME,N,34,VARCHAR,No,"CAP synoptic form item: Deep Margin invasive carcinoma.
The category values for this column were already listed for column: ENDC_MG_CNNT_ASSD_C_NAME CAP synoptic form item: Deep Margin invasive carcinoma. The category values for this column were already listed for column: ENDC_MG_CNNT_ASSD_C_NAME"
UTERINE_CERVIX_EXC,DM_INT_SQM_NPS_C_NAME,N,35,VARCHAR,No,"CAP synoptic form item: Deep Margin intraepithelial squamous neoplasia.
The category values for this column were already listed for column: END_MG_INT_SQM_NP_C_NAME CAP synoptic form item: Deep Margin intraepithelial squamous neoplasia. The category values for this column were already listed for column: END_MG_INT_SQM_NP_C_NAME"
UTERINE_CERVIX_EXC,DM_ADCNM_ST_C_NAME,N,36,VARCHAR,No,"CAP synoptic form item: Deep Margin adenocarcinoma in situ.
The category values for this column were already listed for column: END_MG_ADC_ST_C_NAME CAP synoptic form item: Deep Margin adenocarcinoma in situ. The category values for this column were already listed for column: END_MG_ADC_ST_C_NAME"
UTERINE_CERVIX_EXC,XM_INT_SQM_NPS_C_NAME,N,37,VARCHAR,No,"CAP synoptic form item: Exocervical Margin intraepithelial squamous neoplasia.
The category values for this column were already listed for column: END_MG_INT_SQM_NP_C_NAME CAP synoptic form item: Exocervical Margin intraepithelial squamous neoplasia. The category values for this column were already listed for column: END_MG_INT_SQM_NP_C_NAME"
UTERINE_CERVIX_EXC,XM_ADNCNM_ST_C_NAME,N,38,VARCHAR,No,"CAP synoptic form item: Exocervical Margin adenocarcinoma in situ.
The category values for this column were already listed for column: END_MG_ADC_ST_C_NAME CAP synoptic form item: Exocervical Margin adenocarcinoma in situ. The category values for this column were already listed for column: END_MG_ADC_ST_C_NAME"
UTERINE_CERVIX_EXC,XCVCL_MG_CNNT_ASD_C_NAME,N,39,VARCHAR,No,"CAP synoptic form item: Exocervical Margin invasive carcinoma.
The category values for this column were already listed for column: ENDC_MG_CNNT_ASSD_C_NAME CAP synoptic form item: Exocervical Margin invasive carcinoma. The category values for this column were already listed for column: ENDC_MG_CNNT_ASSD_C_NAME"
UTERINE_CERVIX_THP,RESULT_ID,N,1,VARCHAR,No,The unique identifier for the result record. The unique identifier for the result record.
UTERINE_CERVIX_THP,TUMOR_SITE_SPECIFY,N,2,VARCHAR,No,CAP synoptic form item: Specify tumor site. CAP synoptic form item: Specify tumor site.
UTERINE_CERVIX_THP,CAP_COMMENTS,N,3,VARCHAR,No,CAP synoptic form item: General comments. CAP synoptic form item: General comments.
UTERINE_CERVIX_THP,TUMOR_SIZE_GREAT,N,4,NUMERIC,No,CAP synoptic form item: Tumor Greatest Size. CAP synoptic form item: Tumor Greatest Size.
UTERINE_CERVIX_THP,TUMOR_SIZE_ADDL,N,5,NUMERIC,No,CAP synoptic form item: Tumor Size (length). CAP synoptic form item: Tumor Size (length).
UTERINE_CERVIX_THP,TUMOR_SIZE_ADDL2,N,6,NUMERIC,No,CAP synoptic form item: Tumor Size (width). CAP synoptic form item: Tumor Size (width).
UTERINE_CERVIX_THP,TUMOR_SIZE_SPECIFY,N,7,VARCHAR,No,CAP synoptic form item: Specify Tumor Size. CAP synoptic form item: Specify Tumor Size.
UTERINE_CERVIX_THP,SPECIMEN_OTHER_SPFY,N,8,VARCHAR,No,CAP synoptic form item: Specify other specimen. CAP synoptic form item: Specify other specimen.
UTERINE_CERVIX_THP,REGIONL_LYMPH_ND_C_NAME,N,9,VARCHAR,No,"CAP synoptic form item: Regional Lymph Nodes (pN).
May contain organization-specific values: Yes
Category Entries:
pNX: Cannot be assessed
pN0: No regional lymph node metastasis
pN1: Regional lymph node metastasis
pN1: Metastasis in perirectal lymph nodes
pN1: Metastasis in 1 to 3 regional lymph nodes
pN1a: Metastasis in 1 regional lymph node
pN1b: Metastasis in 2 to 3 regional lymph nodes
pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta
pN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes
pN1: Regional lymph node metastasis involving 1 to 2 nodes
pN1 (IIIC): Regional lymph node metastasis
pN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery
pN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension
pN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes, 
pN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes
pN1a: Clinically occult (microscopic) metastasis
pN1b: Clinically apparent (macroscopic) metastasis
pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension
pN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension
pN1: Metastasis in 1 to 2 perigastric lymph nodes
pN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension,
pN1a: Nodal metastases to Level VI lymph nodes
pN1b: Metastases to unilateral, bilateral or contralateral cervical 
pN1: Single regional lymph node metastasis in the true pelvis 
pN1 (IVB): Pelvic or inguinal lymph node metastasis
pN1: Metastasis in regional lymph node or nodes
pN1: Regional lymph node involvement (preauricular, cervical, submandibular)
pN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s)
pN2: Metastasis in 4 or more regional lymph nodes
pN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd
pN2a: Metastasis in 4 to 6 regional lymph nodes
pN2b: Metastasis in 7 or more regional lymph nodes
pN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho
pN2: 3 to 6 nodes involved
pN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than
pN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension
pN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension
pN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen.
pN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s)
pN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes 
pN2a: Clinically occult (microscopic) metastasis
pN2b: Clinically apparent (macroscopic) metastasis
pN2c: Satellite or in-transit metastasis without nodal metastasis
pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension
pN2: Metastasis in a single regional lymph node, more than 2 cm but not more than
pN2: Metastasis in 3 to 6 perigastric lymph nodes
pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm 
pN2: Multiple regional lymph node metastasis in the true pelvis 
pN2: Distant lymph node involvement
pN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il
pN3: 7 or more nodes involved
pN3: Metastasis in a lymph node more than 6 cm in greatest dimension
pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or
pN3: Metastases in the contralateral mediastinal, contralateral internal mammary,
pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or
pN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa
pN3a: Greater than 6 cm in dimension
pN3b: Extension to the supraclavicular fossa
pN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension
pN3: Metastasis in 7 or more perigastric lymph nodes
pN3a: Metastasis in 7 to 15 perigastric lymph nodes
pN3b: Metastasis in 16 or more perigastric lymph nodes
pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension
pN3: Lymph node metastasis to the common iliac lymph nodes
pN1: One or two regional lymph nodes with the following features
pN2 (FIGO IIIB): Regional lymph node metastasis with the following features
pN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis CAP synoptic form item: Regional Lymph Nodes (pN). May contain organization-specific values: Yes Category Entries: pNX: Cannot be assessed pN0: No regional lymph node metastasis pN1: Regional lymph node metastasis pN1: Metastasis in perirectal lymph nodes pN1: Metastasis in 1 to 3 regional lymph nodes pN1a: Metastasis in 1 regional lymph node pN1b: Metastasis in 2 to 3 regional lymph nodes pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta pN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes pN1: Regional lymph node metastasis involving 1 to 2 nodes pN1 (IIIC): Regional lymph node metastasis pN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery pN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension pN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes, pN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes pN1a: Clinically occult (microscopic) metastasis pN1b: Clinically apparent (macroscopic) metastasis pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension pN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension pN1: Metastasis in 1 to 2 perigastric lymph nodes pN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension, pN1a: Nodal metastases to Level VI lymph nodes pN1b: Metastases to unilateral, bilateral or contralateral cervical pN1: Single regional lymph node metastasis in the true pelvis pN1 (IVB): Pelvic or inguinal lymph node metastasis pN1: Metastasis in regional lymph node or nodes pN1: Regional lymph node involvement (preauricular, cervical, submandibular) pN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s) pN2: Metastasis in 4 or more regional lymph nodes pN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd pN2a: Metastasis in 4 to 6 regional lymph nodes pN2b: Metastasis in 7 or more regional lymph nodes pN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho pN2: 3 to 6 nodes involved pN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than pN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension pN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension pN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen. pN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s) pN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes pN2a: Clinically occult (microscopic) metastasis pN2b: Clinically apparent (macroscopic) metastasis pN2c: Satellite or in-transit metastasis without nodal metastasis pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension pN2: Metastasis in a single regional lymph node, more than 2 cm but not more than pN2: Metastasis in 3 to 6 perigastric lymph nodes pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm pN2: Multiple regional lymph node metastasis in the true pelvis pN2: Distant lymph node involvement pN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il pN3: 7 or more nodes involved pN3: Metastasis in a lymph node more than 6 cm in greatest dimension pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or pN3: Metastases in the contralateral mediastinal, contralateral internal mammary, pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or pN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa pN3a: Greater than 6 cm in dimension pN3b: Extension to the supraclavicular fossa pN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension pN3: Metastasis in 7 or more perigastric lymph nodes pN3a: Metastasis in 7 to 15 perigastric lymph nodes pN3b: Metastasis in 16 or more perigastric lymph nodes pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension pN3: Lymph node metastasis to the common iliac lymph nodes pN1: One or two regional lymph nodes with the following features pN2 (FIGO IIIB): Regional lymph node metastasis with the following features pN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis"
UTERINE_CERVIX_THP,PRIMARY_TUMOR_C_NAME,N,10,VARCHAR,No,"CAP synoptic form item: Primary Tumor (pT).
May contain organization-specific values: Yes
Category Entries:
pTX: Cannot be determined
pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or
pTX: Cannot be assessed
pT0: No evidence of primary tumor
pTis: Carcinoma in situ
pTis (DCIS): Ductal carcinoma in situ
pTis (LCIS): Lobular carcinoma in situ
pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and
pTis: Carcinoma in situ, intraepithelial (no invasion)
pTis: Carcinoma in situ, invasion of lamina propria
pTis: High-grade dysplasia / carcinoma in situ
pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa)
pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I)
Encapsulated
Extracapsular extension without adjacent organ involvement
Extension into adjacent organs
Extension into spinal canal
pTa: Papillary noninvasive carcinoma
pTa: Noninvasive papillary carcinoma
pTis: Intratubular germ cell neoplasia only (carcinoma in situ)
pTis: Flat carcinoma in situ
pTis: Carcinoma in situ: flat tumor
Iris
Ciliary Body and Choroid
pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion
pT1: Tumor limited to ampulla of Vater or sphincter of Oddi
pT1: Tumor 2 cm or less in greatest dimension
pT1: Tumor invades submucosa
pT1: Tumor confined to the bile duct histologically
pT1: Solitary tumor without vascular invasion
pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue
pT1: Tumor 8 cm or less in greatest dimension
pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion)
pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension
pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension
pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension
pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium
pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium
pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa
pT1a: Tumor invades lamina propria or muscularis mucosae
pT1a: Tumor invades lamina propria
pT1 (I): Tumor limited to fallopian tube(s)
pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites
pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites
pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa
pT1b: Tumor invades submucosa
pT1b: Tumor invades muscle layer
pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney
pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney
pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to  kidney
pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura
pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by 
pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I)
pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or
pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or
pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm
pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm
pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N
pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface
pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule 
pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension
pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen
pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal
pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen
pT1: Tumor invades subepithelial connective tissue (lamina propria)
pT1: Tumor confined to the eye with no optic nerve or choroidal invasion
pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor
pT1b: Tumor 5 cm or less in greatest dimension, deep tumor
pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features
pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion
pT1: Tumor size 2 cm or less, limited to thyroid
pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid
pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid
pT1 (I): Tumor confined to uterus
pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically
pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less
pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth
pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2
pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension
pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension
pT1 (I): Tumor confined to vaginal wall
pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum
pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more
pT2: Tumor greater than 5 cm, no extra-adrenal invasion
pT2: Tumor invades duodenal wall
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension
pT2: Tumor invades muscularis propria
pT2: Tumor invades beyond the wall of the bile duct
pT2a: Solitary tumor with vascular invasion
pT2b: Multiple tumors, with or without vascular invasion
pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue
pT2b: Tumor invades adjacent hepatic parenchyma
pT2: Tumor more than 8 cm in greatest dimension
pT2: Tumor > 20 mm but <= 50 mm in greatest dimension
pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend 
pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension
pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries
pT2b (IIB): Extension to other pelvic structures
pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites
pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney
pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney
pT2b: Tumor more than 10 cm, limited to the kidney
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension
pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l
pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension
pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension)
pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, 
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration
pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell
pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or
pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 
pT2: Tumor with parapharyngeal extension
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or
pT2: Organ confined
pT2a: Unilateral, involving one-half of 1 side or less
pT2b: Unilateral, involving more than one-half of 1 side but not both sides
pT2c: Bilateral disease
pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion
pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor
pT2: Tumor greater than 2 cm in greatest dimension with or without one additional
pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion
pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid 
pT2 (II): Tumor extends outside of the uterus but is limited to genital structures
pT2a: Tumor invades superficial muscularis propria (inner half)
pT2b: Tumor invades deep muscularis propria (outer half)
pT2a (IIA): Tumor without parametrial invasion
pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen
pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension
pT2b (IIB): Tumor with parametrial invasion
pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall
pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures 
pT3: Tumor of any size with local invasion, but not invading adjacent organs
pT3: Tumor invades pancreas
pT3: Tumor more than 5 cm in greatest dimension
pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix
pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of
pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas
pT3: Tumor invades unilateral branches of the portal vein or hepatic artery
pT3: Discontinuous tumors in primary bone site (not including skip metastases)
pT3: Tumor > 50 mm in greatest dimension
pT3: Tumor invades through the muscularis propria into pericolorectal tissues
pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis)
pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve
pT3: Tumor invades adventitia
pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis
pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis
pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen
pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen
pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver
pT3a: Multiple tumors more than 5 cm
pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins
pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal
pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) 
pT3b: Tumor grossly extends into the vena cava below the diaphragm
pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava
pT3: Mucosal disease
pT3: Tumor more than 4 cm in greatest dimension
pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that
pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I)
pT3: Locally advanced but potentially resectable tumor that involves all of the
pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration
pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration
pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor)
pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen
pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or 
pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis
pT3: Tumor invades bony structures of skull base and / or paranasal sinuses
pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary
pT3a: Extraprostatic extension or microscopic invasion of bladder neck
pT3b: Seminal vesicle invasion
pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma
pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion
pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion
pT3: Tumor invades through the muscularis propria into the subserosa or into the
pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone
pT3: Tumor invades subserosal connective tissue, without involvement of
pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion
pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension
pT3: Tumor invades beyond muscularis propria into periureteric fat
pT3a: Microscopically
pT3b: Macroscopically (extravesicular mass)
pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall
pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney
pT3 (III): Tumor extends to pelvic wall
pT3 (FIGO IVA): Tumor of any size with extension to any of the following
pT4: Tumor of any size with invasion of adjacent organs
pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures
pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder
pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within
pT4: Tumor involves the celiac axis or the superior mesenteric artery
pT4: Tumor with periductal invasion
pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati
pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa 
pT4: Tumor invades adjacent structures 
pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic
pT4: Tmr w/ direct invasion of adj. organs other than gallbladder 
pT4: Tmr invades beyond Gerota’s fascia
pT4: Tumor of any size that invades any of the following: mediastinum, heart, great
pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral
pT4: Tumor with intracranial extension and / or involvement of cranial nerves,
pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J)
pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat
pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified
pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified
pT4: Tumor with direct or perineural invasion of skull base or axial skeleton
pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure
pT4: Tumor invades scrotum with or without vascular / lymphatic invasion
pT4: Tumor invades adjacent organs
pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis
pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis
pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi
pT4a: Tumor penetrates the visceral peritoneum
pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas
pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria
pT4c: Both T4a and T4b
pT4d: Inflammatory carcinoma
pT4b: Tumor directly invades other organs or structures
pT4b: Tumor directly invades or is adherent to other organs or structures
pT4a: Resectable tumor invading pleura, pericardium, or diaphragm
pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body
Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells
Primary Tumor (pT): Supraglottis
Primary Tumor (pT): Glottis
Primary Tumor (pT): Subglottis
pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone,
pT4b: Very advanced disease. Tumor involving brain, dura, skull base,
pT4a: Moderately advanced local disease.
pT4b: Very advanced local disease. 
pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal,
pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates
pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration
pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration
Primary Tumor (pT): Maxillary Sinus
Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus
pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic
pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid 
pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage,
pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases
pT4a: Tumor involves visceral peritoneum (serosal surface)
pT4b: Tumor directly invades adjacent structures
pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid
pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid
pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable
pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable
pT4a: Tumor invades prostatic stroma or uterus or vagina
pT4b: Tumor invades pelvic wall or abdominal wall
Not identified CAP synoptic form item: Primary Tumor (pT). May contain organization-specific values: Yes Category Entries: pTX: Cannot be determined pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or pTX: Cannot be assessed pT0: No evidence of primary tumor pTis: Carcinoma in situ pTis (DCIS): Ductal carcinoma in situ pTis (LCIS): Lobular carcinoma in situ pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and pTis: Carcinoma in situ, intraepithelial (no invasion) pTis: Carcinoma in situ, invasion of lamina propria pTis: High-grade dysplasia / carcinoma in situ pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa) pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I) Encapsulated Extracapsular extension without adjacent organ involvement Extension into adjacent organs Extension into spinal canal pTa: Papillary noninvasive carcinoma pTa: Noninvasive papillary carcinoma pTis: Intratubular germ cell neoplasia only (carcinoma in situ) pTis: Flat carcinoma in situ pTis: Carcinoma in situ: flat tumor Iris Ciliary Body and Choroid pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion pT1: Tumor limited to ampulla of Vater or sphincter of Oddi pT1: Tumor 2 cm or less in greatest dimension pT1: Tumor invades submucosa pT1: Tumor confined to the bile duct histologically pT1: Solitary tumor without vascular invasion pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue pT1: Tumor 8 cm or less in greatest dimension pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion) pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa pT1a: Tumor invades lamina propria or muscularis mucosae pT1a: Tumor invades lamina propria pT1 (I): Tumor limited to fallopian tube(s) pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa pT1b: Tumor invades submucosa pT1b: Tumor invades muscle layer pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to  kidney pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I) pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen pT1: Tumor invades subepithelial connective tissue (lamina propria) pT1: Tumor confined to the eye with no optic nerve or choroidal invasion pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor pT1b: Tumor 5 cm or less in greatest dimension, deep tumor pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion pT1: Tumor size 2 cm or less, limited to thyroid pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid pT1 (I): Tumor confined to uterus pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2 pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension pT1 (I): Tumor confined to vaginal wall pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more pT2: Tumor greater than 5 cm, no extra-adrenal invasion pT2: Tumor invades duodenal wall pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension pT2: Tumor invades muscularis propria pT2: Tumor invades beyond the wall of the bile duct pT2a: Solitary tumor with vascular invasion pT2b: Multiple tumors, with or without vascular invasion pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue pT2b: Tumor invades adjacent hepatic parenchyma pT2: Tumor more than 8 cm in greatest dimension pT2: Tumor > 20 mm but <= 50 mm in greatest dimension pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries pT2b (IIB): Extension to other pelvic structures pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney pT2b: Tumor more than 10 cm, limited to the kidney pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension) pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than pT2: Tumor with parapharyngeal extension pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or pT2: Organ confined pT2a: Unilateral, involving one-half of 1 side or less pT2b: Unilateral, involving more than one-half of 1 side but not both sides pT2c: Bilateral disease pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor pT2b: Tumor more than 5 cm in greatest dimension, deep tumor pT2: Tumor greater than 2 cm in greatest dimension with or without one additional pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid pT2 (II): Tumor extends outside of the uterus but is limited to genital structures pT2a: Tumor invades superficial muscularis propria (inner half) pT2b: Tumor invades deep muscularis propria (outer half) pT2a (IIA): Tumor without parametrial invasion pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension pT2b (IIB): Tumor with parametrial invasion pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures pT3: Tumor of any size with local invasion, but not invading adjacent organs pT3: Tumor invades pancreas pT3: Tumor more than 5 cm in greatest dimension pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas pT3: Tumor invades unilateral branches of the portal vein or hepatic artery pT3: Discontinuous tumors in primary bone site (not including skip metastases) pT3: Tumor > 50 mm in greatest dimension pT3: Tumor invades through the muscularis propria into pericolorectal tissues pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis) pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve pT3: Tumor invades adventitia pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver pT3a: Multiple tumors more than 5 cm pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) pT3b: Tumor grossly extends into the vena cava below the diaphragm pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava pT3: Mucosal disease pT3: Tumor more than 4 cm in greatest dimension pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I) pT3: Locally advanced but potentially resectable tumor that involves all of the pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis pT3: Tumor invades bony structures of skull base and / or paranasal sinuses pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary pT3a: Extraprostatic extension or microscopic invasion of bladder neck pT3b: Seminal vesicle invasion pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion pT3: Tumor invades through the muscularis propria into the subserosa or into the pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone pT3: Tumor invades subserosal connective tissue, without involvement of pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension pT3: Tumor invades beyond muscularis propria into periureteric fat pT3a: Microscopically pT3b: Macroscopically (extravesicular mass) pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney pT3 (III): Tumor extends to pelvic wall pT3 (FIGO IVA): Tumor of any size with extension to any of the following pT4: Tumor of any size with invasion of adjacent organs pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within pT4: Tumor involves the celiac axis or the superior mesenteric artery pT4: Tumor with periductal invasion pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa pT4: Tumor invades adjacent structures pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic pT4: Tmr w/ direct invasion of adj. organs other than gallbladder pT4: Tmr invades beyond Gerota’s fascia pT4: Tumor of any size that invades any of the following: mediastinum, heart, great pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral pT4: Tumor with intracranial extension and / or involvement of cranial nerves, pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J) pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified pT4: Tumor with direct or perineural invasion of skull base or axial skeleton pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure pT4: Tumor invades scrotum with or without vascular / lymphatic invasion pT4: Tumor invades adjacent organs pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi pT4a: Tumor penetrates the visceral peritoneum pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria pT4c: Both T4a and T4b pT4d: Inflammatory carcinoma pT4b: Tumor directly invades other organs or structures pT4b: Tumor directly invades or is adherent to other organs or structures pT4a: Resectable tumor invading pleura, pericardium, or diaphragm pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells Primary Tumor (pT): Supraglottis Primary Tumor (pT): Glottis Primary Tumor (pT): Subglottis pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, pT4b: Very advanced disease. Tumor involving brain, dura, skull base, pT4a: Moderately advanced local disease. pT4b: Very advanced local disease. pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal, pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration Primary Tumor (pT): Maxillary Sinus Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage, pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases pT4a: Tumor involves visceral peritoneum (serosal surface) pT4b: Tumor directly invades adjacent structures pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable pT4a: Tumor invades prostatic stroma or uterus or vagina pT4b: Tumor invades pelvic wall or abdominal wall Not identified"
UTERINE_CERVIX_THP,DISTNT_METASTASIS_C_NAME,N,11,VARCHAR,No,"CAP synoptic form item: Distant Metastasis.
May contain organization-specific values: Yes
Category Entries:
Not applicable
cM0 (i+): No clinical or radiographic evidence of distant metastasis
pM0: No distant metastasis
pM1: Distant metastasis
pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx
pM1b: Nonperitoneal metastasis
pM1: Distant detectable metastasis as determined by classic clinical
pM1 (IVB): Distant metastasis
pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or
pM1b: Distant metastases outside the lung / pleura
pM1: Distant metastasis (documented in this specimen)
pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes
pM1b: Metastasis to lung
pM1c: Metastasis to all other visceral sites or distant metastasis at any site
pM1a: Nonregional lymph node(s)
pM1b: Bone(s)
pM1c: Other site(s) with or without bone disease
pM1: Metastasis to sites other than CNS
pM1a: Single lesion
pM1b: Multiple lesions
pM1c: CNS metastasis
pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement
pM1e: Leptomeningeal and / or CSF involvement
pM1a: Non-regional lymph nodes or pulmonary metastasis
pM1b: Distant metastasis other than to nonregional lymph nodes and lungs
pM1a (III): Tumor extends to the lungs with or without genital tract involvement
pM1b (IV): Tumor involves other metastatic sites
pM1a: Largest diameter of the largest metastasis 3 cm or less
pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm
pM1c: Largest diameter of the largest metastasis 8 cm or more
pM1a: Lung
pM1b: Metastasis involving distant sites other than lung (including skip metastases)
Distant Metastasis present (includes metastasis to lymph nodes) CAP synoptic form item: Distant Metastasis. May contain organization-specific values: Yes Category Entries: Not applicable cM0 (i+): No clinical or radiographic evidence of distant metastasis pM0: No distant metastasis pM1: Distant metastasis pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx pM1b: Nonperitoneal metastasis pM1: Distant detectable metastasis as determined by classic clinical pM1 (IVB): Distant metastasis pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or pM1b: Distant metastases outside the lung / pleura pM1: Distant metastasis (documented in this specimen) pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes pM1b: Metastasis to lung pM1c: Metastasis to all other visceral sites or distant metastasis at any site pM1a: Nonregional lymph node(s) pM1b: Bone(s) pM1c: Other site(s) with or without bone disease pM1: Metastasis to sites other than CNS pM1a: Single lesion pM1b: Multiple lesions pM1c: CNS metastasis pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement pM1e: Leptomeningeal and / or CSF involvement pM1a: Non-regional lymph nodes or pulmonary metastasis pM1b: Distant metastasis other than to nonregional lymph nodes and lungs pM1a (III): Tumor extends to the lungs with or without genital tract involvement pM1b (IV): Tumor involves other metastatic sites pM1a: Largest diameter of the largest metastasis 3 cm or less pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm pM1c: Largest diameter of the largest metastasis 8 cm or more pM1a: Lung pM1b: Metastasis involving distant sites other than lung (including skip metastases) Distant Metastasis present (includes metastasis to lymph nodes)"
UTERINE_CERVIX_THP,ADDL_PATH_FIND_SPFY,N,12,VARCHAR,No,CAP synoptic form item: Specify additional pathologic findings. CAP synoptic form item: Specify additional pathologic findings.
UTERINE_CERVIX_THP,HISTOLOGIC_GRADE_C_NAME,N,13,VARCHAR,No,"CAP synoptic form item: Histologic Grade.
May contain organization-specific values: Yes
Category Entries:
Not applicable
GX: Cannot be assessed
G1: Well differentiated
G2: Moderately differentiated
G3: Poorly differentiated
G4: Undifferentiated
G4: Undifferentiated / anaplastic
WHO grade not assigned
Low-grade (well-differentiated to moderately differentiated)
High-grade (poorly differentiated to undifferentiated)
FIGO Grade 1
FIGO Grade 2
FIGO Grade 3
Favorable (purely epithelial, fetal subtype, mitotically inactive with <=2 mitoses in
Less favorable (all subtypes other than those designated ""Favorable"" or ""Unfavorable""
Unfavorable (small cell undifferentiated or rhabdoid as the predominant or sole histo
Gleason Pattern
Ungraded sarcoma
pGX: Grade cannot be assessed
pG1: Spindle cell melanoma
pG2: Mixed cell melanoma
pG3: Epithelioid cell melanoma
WHO Grade I
WHO Grade II
WHO Grade III
WHO Grade IV
pG1: Well differentiated
pG2: Moderately differentiated
pG3: Poorly differentiated
pG4: Undifferentiated
FNCLCC Grade 1
FNCLCC Grade 2
FNCLCC Grade 3
Grade 1
Grade 2
Grade 3
Cannot be determined
Other CAP synoptic form item: Histologic Grade. May contain organization-specific values: Yes Category Entries: Not applicable GX: Cannot be assessed G1: Well differentiated G2: Moderately differentiated G3: Poorly differentiated G4: Undifferentiated G4: Undifferentiated / anaplastic WHO grade not assigned Low-grade (well-differentiated to moderately differentiated) High-grade (poorly differentiated to undifferentiated) FIGO Grade 1 FIGO Grade 2 FIGO Grade 3 Favorable (purely epithelial, fetal subtype, mitotically inactive with <=2 mitoses in Less favorable (all subtypes other than those designated ""Favorable"" or ""Unfavorable"" Unfavorable (small cell undifferentiated or rhabdoid as the predominant or sole histo Gleason Pattern Ungraded sarcoma pGX: Grade cannot be assessed pG1: Spindle cell melanoma pG2: Mixed cell melanoma pG3: Epithelioid cell melanoma WHO Grade I WHO Grade II WHO Grade III WHO Grade IV pG1: Well differentiated pG2: Moderately differentiated pG3: Poorly differentiated pG4: Undifferentiated FNCLCC Grade 1 FNCLCC Grade 2 FNCLCC Grade 3 Grade 1 Grade 2 Grade 3 Cannot be determined Other"
UTERINE_CERVIX_THP,HIST_TYP_NONCL_SPFY,N,14,VARCHAR,No,CAP synoptic form item: Specify other or nonclassifiable histologic type. CAP synoptic form item: Specify other or nonclassifiable histologic type.
UTERINE_CERVIX_THP,HIST_TP_SQUA_CCNM_S,N,15,VARCHAR,No,CAP synoptic form item: Specify details for Histologic Type Squamous cell carcinoma. CAP synoptic form item: Specify details for Histologic Type Squamous cell carcinoma.
UTERINE_CERVIX_THP,HIST_TP_ADCCNM_OS,N,16,VARCHAR,No,CAP synoptic form item: Specify other details for Histologic Type Adenocarcinoma. CAP synoptic form item: Specify other details for Histologic Type Adenocarcinoma.
UTERINE_CERVIX_THP,ADF_ITAPTLL_NPLS_S,N,17,VARCHAR,No,CAP synoptic form item: Specify type and grade for Intraepithelial neoplasia in Additional Pathologic Findings section. CAP synoptic form item: Specify type and grade for Intraepithelial neoplasia in Additional Pathologic Findings section.
UTERINE_CERVIX_THP,MG_UVLV_IC_DSTNC_IC,N,18,NUMERIC,No,CAP synoptic form item: Margins uninvolved by invasive carcinoma - Distance of Invasive Carcinoma from Closest Margin. CAP synoptic form item: Margins uninvolved by invasive carcinoma - Distance of Invasive Carcinoma from Closest Margin.
UTERINE_CERVIX_THP,MG_UVLV_IC_SM,N,19,VARCHAR,No,CAP synoptic form item: Specify Margin for Margins uninvolved by invasive carcinoma. CAP synoptic form item: Specify Margin for Margins uninvolved by invasive carcinoma.
UTERINE_CERVIX_THP,MGN_UVLV_IVS_CCNM_C_NAME,N,20,VARCHAR,No,"CAP synoptic form item: Margins uninvolved by invasive carcinoma.
May contain organization-specific values: Yes
Category Entries:
Carcinoma in situ not identified at distal margin
Carcinoma in situ present at distal margin
Dysplasia / carcinoma in situ not identified at margin
Dysplasia / carcinoma in situ present at margin CAP synoptic form item: Margins uninvolved by invasive carcinoma. May contain organization-specific values: Yes Category Entries: Carcinoma in situ not identified at distal margin Carcinoma in situ present at distal margin Dysplasia / carcinoma in situ not identified at margin Dysplasia / carcinoma in situ present at margin"
UTERINE_CERVIX_THP,MGN_IVLV_IVS_CCNM_S,N,21,VARCHAR,No,CAP synoptic form item: Specify details for Margin Involvement by Invasive Carcinoma. CAP synoptic form item: Specify details for Margin Involvement by Invasive Carcinoma.
UTERINE_CERVIX_THP,ANCLR_STD_SPEC,N,22,VARCHAR,No,CAP synoptic form item: Specify details for ancillary studies. CAP synoptic form item: Specify details for ancillary studies.
UTERINE_CERVIX_THP,PN1_RGNL_LNM_NUM_XM,N,23,VARCHAR,No,CAP synoptic form item: Specify number examined for Regional Lymph Nodes (pN) pN1 Regional lymph node metastasis. CAP synoptic form item: Specify number examined for Regional Lymph Nodes (pN) pN1 Regional lymph node metastasis.
UTERINE_CERVIX_THP,PN1_RGNL_LNM_NUM_IV,N,24,VARCHAR,No,CAP synoptic form item: Specify number involved for Regional Lymph Nodes (pN) pN1 Regional lymph node metastasis. CAP synoptic form item: Specify number involved for Regional Lymph Nodes (pN) pN1 Regional lymph node metastasis.
UTERINE_CERVIX_THP,DSTNT_MTSTS_PM1_ST,N,25,VARCHAR,No,CAP synoptic form item: Specify Site for Distant Metastases pM pM1 IVB Distant metastasis. CAP synoptic form item: Specify Site for Distant Metastases pM pM1 IVB Distant metastasis.
UTERINE_CERVIX_THP,SPEC_PROC_SPECIFY,N,26,VARCHAR,No,CAP synoptic form item: Specify the Specimen Procedure. CAP synoptic form item: Specify the Specimen Procedure.
UVEAL_MELANOMA,RESULT_ID,N,1,VARCHAR,No,The unique identifier for the result record. The unique identifier for the result record.
UVEAL_MELANOMA,SPEC_SITE_C_NAME,N,2,VARCHAR,No,"CAP synoptic form item: Specimen Site.
May contain organization-specific values: Yes
Category Entries:
Ocular structure CAP synoptic form item: Specimen Site. May contain organization-specific values: Yes Category Entries: Ocular structure"
UVEAL_MELANOMA,TM_BS_SZ_SPC,N,3,NUMERIC,No,CAP synoptic form item: Specify Tumor Basal Size on Transillumination. CAP synoptic form item: Specify Tumor Basal Size on Transillumination.
UVEAL_MELANOMA,TM_BS_SZ_TSLM2,N,4,NUMERIC,No,CAP synoptic form item: Specify another Tumor Basal Size on Transillumination. CAP synoptic form item: Specify another Tumor Basal Size on Transillumination.
UVEAL_MELANOMA,TLS_DSTN_AET_LCE,N,5,NUMERIC,No,CAP synoptic form item: Specify Distance from Anterior Edge of Tumor to Limbus at Cut Edge for Tumor Location After Sectioning. CAP synoptic form item: Specify Distance from Anterior Edge of Tumor to Limbus at Cut Edge for Tumor Location After Sectioning.
UVEAL_MELANOMA,TLS_DSTN_OD_MTB,N,6,NUMERIC,No,CAP synoptic form item: Specify Distance of Posterior Margin of Tumor Base from Edge of Optic Disc for Tumor Location After Sectioning. CAP synoptic form item: Specify Distance of Posterior Margin of Tumor Base from Edge of Optic Disc for Tumor Location After Sectioning.
UVEAL_MELANOMA,SPEC_SZ_XNTRTN_C_NAME,N,7,VARCHAR,No,"CAP synoptic form item: Specimen Size For Exenteration.
May contain organization-specific values: Yes
Category Entries:
Greatest dimension
Cannot be determined CAP synoptic form item: Specimen Size For Exenteration. May contain organization-specific values: Yes Category Entries: Greatest dimension Cannot be determined"
UVEAL_MELANOMA,SPEC_SZ_NCLTN_NDS,N,8,VARCHAR,No,CAP synoptic form item: Specify Specimen Size For Enucleation Cannot be determined. CAP synoptic form item: Specify Specimen Size For Enucleation Cannot be determined.
UVEAL_MELANOMA,SP_SZ_NCT_ND_AD,N,9,NUMERIC,No,CAP synoptic form item: Specify Anteroposterior Diameter of specimen size For Enucleation when Cannot be determined. CAP synoptic form item: Specify Anteroposterior Diameter of specimen size For Enucleation when Cannot be determined.
UVEAL_MELANOMA,SP_SZ_NCLT_ND_HD,N,10,NUMERIC,No,CAP synoptic form item: Specify Horizontal Diameter of specimen size For Enucleation when Cannot be determined. CAP synoptic form item: Specify Horizontal Diameter of specimen size For Enucleation when Cannot be determined.
UVEAL_MELANOMA,SP_SZ_NCLT_ND_VD,N,11,NUMERIC,No,CAP synoptic form item: Specify Vertical Diameter of specimen size For Enucleation when Cannot be determined. CAP synoptic form item: Specify Vertical Diameter of specimen size For Enucleation when Cannot be determined.
UVEAL_MELANOMA,SP_SZ_NCLT_ND_ONL,N,12,NUMERIC,No,CAP synoptic form item: Specify Length of optic nerve of specimen size For Enucleation when Cannot be determined. CAP synoptic form item: Specify Length of optic nerve of specimen size For Enucleation when Cannot be determined.
UVEAL_MELANOMA,SP_SZ_NCLT_ND_OND,N,13,NUMERIC,No,CAP synoptic form item: Specify Diameter of optic nerve of specimen size For Enucleation when Cannot be determined. CAP synoptic form item: Specify Diameter of optic nerve of specimen size For Enucleation when Cannot be determined.
UVEAL_MELANOMA,SP_SZ_XTRT_GDS,N,14,NUMERIC,No,CAP synoptic form item: Specify the greatest dimension of specimen size for exenteration. CAP synoptic form item: Specify the greatest dimension of specimen size for exenteration.
UVEAL_MELANOMA,SP_SZ_XNTR_GDAD,N,15,NUMERIC,No,CAP synoptic form item: Specify additional dimension for the greatest dimension of specimen size for exenteration. CAP synoptic form item: Specify additional dimension for the greatest dimension of specimen size for exenteration.
UVEAL_MELANOMA,SP_SZ_XNTR_GDAD2,N,16,NUMERIC,No,CAP synoptic form item: Specify another additional dimension for the greatest dimension of specimen size for exenteration. CAP synoptic form item: Specify another additional dimension for the greatest dimension of specimen size for exenteration.
UVEAL_MELANOMA,SP_SZ_XNTR_NDS,N,17,VARCHAR,No,CAP synoptic form item: Specify details for the specimen size for exenteration that cannot be determined. CAP synoptic form item: Specify details for the specimen size for exenteration that cannot be determined.
UVEAL_MELANOMA,HIST_TP_SPDL_CT_C_NAME,N,18,VARCHAR,No,"CAP synoptic form item: Histologic Type Spindle cell type.
May contain organization-specific values: Yes
Category Entries:
Spindle cell type, spindle A
Spindle cell type, spindle B CAP synoptic form item: Histologic Type Spindle cell type. May contain organization-specific values: Yes Category Entries: Spindle cell type, spindle A Spindle cell type, spindle B"
UVEAL_MELANOMA,ACSR_FND_GRW_PTRN_C_NAME,N,19,VARCHAR,No,"CAP synoptic form item: Accessory Findings Growth Pattern.
May contain organization-specific values: Yes
Category Entries:
Cannot be determined
Solid mass
Diffuse (ciliary body ring)
Diffuse (flat)
Endophytic
Exophytic
Combined exophytic / endophytic
Diffuse CAP synoptic form item: Accessory Findings Growth Pattern. May contain organization-specific values: Yes Category Entries: Cannot be determined Solid mass Diffuse (ciliary body ring) Diffuse (flat) Endophytic Exophytic Combined exophytic / endophytic Diffuse"
UVEAL_MELANOMA,HISTOPATH_TYPE_C_NAME,N,20,VARCHAR,No,"CAP synoptic form item: Histopathologic Type.
May contain organization-specific values: Yes
Category Entries:
Spindle cell melanoma (greater than 90% spindle cells)
Mixed cell melanoma (>10% epithelioid cells and <90% spindle cells)
Epithelioid cell melanoma (greater than 90% epithelioid cells) CAP synoptic form item: Histopathologic Type. May contain organization-specific values: Yes Category Entries: Spindle cell melanoma (greater than 90% spindle cells) Mixed cell melanoma (>10% epithelioid cells and <90% spindle cells) Epithelioid cell melanoma (greater than 90% epithelioid cells)"
UVEAL_MELANOMA,SCLERAL_INVOLVE_C_NAME,N,21,VARCHAR,No,"CAP synoptic form item: Scleral Involvement.
May contain organization-specific values: Yes
Category Entries:
Cannot be determined
None
Extrascleral
Intrascleral CAP synoptic form item: Scleral Involvement. May contain organization-specific values: Yes Category Entries: Cannot be determined None Extrascleral Intrascleral"
UVEAL_MELANOMA,PRMR_TMR_IRIS_C_NAME,N,22,VARCHAR,No,"CAP synoptic form item: Primary Tumor Iris.
May contain organization-specific values: Yes
Category Entries:
pTX: Primary tumor cannot be assessed
pT0: No evidence of primary tumor
pT1a: Tumor limited to the iris not more than 3 clock hours in size
pT1b: Tumor limited to the iris more than 3 clock hours in size
pT1c: Tumor limited to the iris with melanomalytic glaucoma
pT2a: Tumor confluent with or extending into the ciliary body, choroid, or both
pT3a: Tumor confluent with or extending into the ciliary body, choroid, or both
pT4a: Tumor with extrascleral extension less than or equal to 5 mm in diameter
pT4b: Tumor with extrascleral extension more than 5 mm in diameter CAP synoptic form item: Primary Tumor Iris. May contain organization-specific values: Yes Category Entries: pTX: Primary tumor cannot be assessed pT0: No evidence of primary tumor pT1a: Tumor limited to the iris not more than 3 clock hours in size pT1b: Tumor limited to the iris more than 3 clock hours in size pT1c: Tumor limited to the iris with melanomalytic glaucoma pT2a: Tumor confluent with or extending into the ciliary body, choroid, or both pT3a: Tumor confluent with or extending into the ciliary body, choroid, or both pT4a: Tumor with extrascleral extension less than or equal to 5 mm in diameter pT4b: Tumor with extrascleral extension more than 5 mm in diameter"
UVEAL_MELANOMA,PT_CLR_BD_CHRD_C_NAME,N,23,VARCHAR,No,"CAP synoptic form item: Primary Tumor Ciliary Body and Choroid.
May contain organization-specific values: Yes
Category Entries:
pTX: Primary tumor cannot be assessed
pT0: No evidence of primary tumor
pT1a: Tumor size category 1 without ciliary body involvement and extraocular extensio
pT1b: Tumor size category 1 with ciliary body involvement
pT1c: Tumor size category 1 without ciliary body involvement but with extraocular ext
pT1d: Tumor size category 1 with ciliary body involvement and extraocular extension l
pT2a: Tumor size category 2 without ciliary body involvement and extraocular extensio
pT2b: Tumor size category 2 with ciliary body involvement
pT2c: Tumor size category 2 without ciliary body involvement but with extraocular ext
pT2d: Tumor size category 2 with ciliary body involvement and extraocular extension l
pT3a: Tumor size category 3 without ciliary body involvement and extraocular extensio
pT3b: Tumor size category 3 with ciliary body involvement
pT3c: Tumor size category 3 without ciliary body involvement but with extraocular ext
pT3d: Tumor size category 3 with ciliary body involvement and extraocular extension l
pT4a: Tumor size category 4 without ciliary body involvement and extraocular extensio
pT4b: Tumor size category 4 with ciliary body involvement
pT4c: Tumor size category 4 without ciliary body involvement but with extraocular ext
pT4d: Tumor size category 4 with ciliary body involvement and extraocular extension l
pT4e: Any tumor size category with extraocular extension more than 5 mm in diameter CAP synoptic form item: Primary Tumor Ciliary Body and Choroid. May contain organization-specific values: Yes Category Entries: pTX: Primary tumor cannot be assessed pT0: No evidence of primary tumor pT1a: Tumor size category 1 without ciliary body involvement and extraocular extensio pT1b: Tumor size category 1 with ciliary body involvement pT1c: Tumor size category 1 without ciliary body involvement but with extraocular ext pT1d: Tumor size category 1 with ciliary body involvement and extraocular extension l pT2a: Tumor size category 2 without ciliary body involvement and extraocular extensio pT2b: Tumor size category 2 with ciliary body involvement pT2c: Tumor size category 2 without ciliary body involvement but with extraocular ext pT2d: Tumor size category 2 with ciliary body involvement and extraocular extension l pT3a: Tumor size category 3 without ciliary body involvement and extraocular extensio pT3b: Tumor size category 3 with ciliary body involvement pT3c: Tumor size category 3 without ciliary body involvement but with extraocular ext pT3d: Tumor size category 3 with ciliary body involvement and extraocular extension l pT4a: Tumor size category 4 without ciliary body involvement and extraocular extensio pT4b: Tumor size category 4 with ciliary body involvement pT4c: Tumor size category 4 without ciliary body involvement but with extraocular ext pT4d: Tumor size category 4 with ciliary body involvement and extraocular extension l pT4e: Any tumor size category with extraocular extension more than 5 mm in diameter"
UVEAL_MELANOMA,ADTNL_PATH_FND_MTRT,N,24,NUMERIC,No,CAP synoptic form item: Specify Mitotic Rate for Additional Pathologic Findings. CAP synoptic form item: Specify Mitotic Rate for Additional Pathologic Findings.
UVEAL_MELANOMA,OTHER_MARGIN_SPFY,N,25,VARCHAR,No,CAP synoptic form item: Specify other margin. CAP synoptic form item: Specify other margin.
UVEAL_MELANOMA,CAP_COMMENTS,N,26,VARCHAR,No,CAP synoptic form item: General comments. CAP synoptic form item: General comments.
UVEAL_MELANOMA,TUMOR_SITE_SPECIFY,N,27,VARCHAR,No,CAP synoptic form item: Specify tumor site. CAP synoptic form item: Specify tumor site.
UVEAL_MELANOMA,HISTOLOGIC_GRADE_C_NAME,N,28,VARCHAR,No,"CAP synoptic form item: Histologic Grade.
May contain organization-specific values: Yes
Category Entries:
Not applicable
GX: Cannot be assessed
G1: Well differentiated
G2: Moderately differentiated
G3: Poorly differentiated
G4: Undifferentiated
G4: Undifferentiated / anaplastic
WHO grade not assigned
Low-grade (well-differentiated to moderately differentiated)
High-grade (poorly differentiated to undifferentiated)
FIGO Grade 1
FIGO Grade 2
FIGO Grade 3
Favorable (purely epithelial, fetal subtype, mitotically inactive with <=2 mitoses in
Less favorable (all subtypes other than those designated ""Favorable"" or ""Unfavorable""
Unfavorable (small cell undifferentiated or rhabdoid as the predominant or sole histo
Gleason Pattern
Ungraded sarcoma
pGX: Grade cannot be assessed
pG1: Spindle cell melanoma
pG2: Mixed cell melanoma
pG3: Epithelioid cell melanoma
WHO Grade I
WHO Grade II
WHO Grade III
WHO Grade IV
pG1: Well differentiated
pG2: Moderately differentiated
pG3: Poorly differentiated
pG4: Undifferentiated
FNCLCC Grade 1
FNCLCC Grade 2
FNCLCC Grade 3
Grade 1
Grade 2
Grade 3
Cannot be determined
Other CAP synoptic form item: Histologic Grade. May contain organization-specific values: Yes Category Entries: Not applicable GX: Cannot be assessed G1: Well differentiated G2: Moderately differentiated G3: Poorly differentiated G4: Undifferentiated G4: Undifferentiated / anaplastic WHO grade not assigned Low-grade (well-differentiated to moderately differentiated) High-grade (poorly differentiated to undifferentiated) FIGO Grade 1 FIGO Grade 2 FIGO Grade 3 Favorable (purely epithelial, fetal subtype, mitotically inactive with <=2 mitoses in Less favorable (all subtypes other than those designated ""Favorable"" or ""Unfavorable"" Unfavorable (small cell undifferentiated or rhabdoid as the predominant or sole histo Gleason Pattern Ungraded sarcoma pGX: Grade cannot be assessed pG1: Spindle cell melanoma pG2: Mixed cell melanoma pG3: Epithelioid cell melanoma WHO Grade I WHO Grade II WHO Grade III WHO Grade IV pG1: Well differentiated pG2: Moderately differentiated pG3: Poorly differentiated pG4: Undifferentiated FNCLCC Grade 1 FNCLCC Grade 2 FNCLCC Grade 3 Grade 1 Grade 2 Grade 3 Cannot be determined Other"
UVEAL_MELANOMA,REGIONL_LYMPH_ND_C_NAME,N,29,VARCHAR,No,"CAP synoptic form item: Regional Lymph Nodes (pN).
May contain organization-specific values: Yes
Category Entries:
pNX: Cannot be assessed
pN0: No regional lymph node metastasis
pN1: Regional lymph node metastasis
pN1: Metastasis in perirectal lymph nodes
pN1: Metastasis in 1 to 3 regional lymph nodes
pN1a: Metastasis in 1 regional lymph node
pN1b: Metastasis in 2 to 3 regional lymph nodes
pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta
pN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes
pN1: Regional lymph node metastasis involving 1 to 2 nodes
pN1 (IIIC): Regional lymph node metastasis
pN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery
pN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension
pN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes, 
pN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes
pN1a: Clinically occult (microscopic) metastasis
pN1b: Clinically apparent (macroscopic) metastasis
pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension
pN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension
pN1: Metastasis in 1 to 2 perigastric lymph nodes
pN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension,
pN1a: Nodal metastases to Level VI lymph nodes
pN1b: Metastases to unilateral, bilateral or contralateral cervical 
pN1: Single regional lymph node metastasis in the true pelvis 
pN1 (IVB): Pelvic or inguinal lymph node metastasis
pN1: Metastasis in regional lymph node or nodes
pN1: Regional lymph node involvement (preauricular, cervical, submandibular)
pN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s)
pN2: Metastasis in 4 or more regional lymph nodes
pN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd
pN2a: Metastasis in 4 to 6 regional lymph nodes
pN2b: Metastasis in 7 or more regional lymph nodes
pN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho
pN2: 3 to 6 nodes involved
pN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than
pN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension
pN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension
pN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen.
pN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s)
pN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes 
pN2a: Clinically occult (microscopic) metastasis
pN2b: Clinically apparent (macroscopic) metastasis
pN2c: Satellite or in-transit metastasis without nodal metastasis
pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension
pN2: Metastasis in a single regional lymph node, more than 2 cm but not more than
pN2: Metastasis in 3 to 6 perigastric lymph nodes
pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm 
pN2: Multiple regional lymph node metastasis in the true pelvis 
pN2: Distant lymph node involvement
pN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il
pN3: 7 or more nodes involved
pN3: Metastasis in a lymph node more than 6 cm in greatest dimension
pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or
pN3: Metastases in the contralateral mediastinal, contralateral internal mammary,
pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or
pN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa
pN3a: Greater than 6 cm in dimension
pN3b: Extension to the supraclavicular fossa
pN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension
pN3: Metastasis in 7 or more perigastric lymph nodes
pN3a: Metastasis in 7 to 15 perigastric lymph nodes
pN3b: Metastasis in 16 or more perigastric lymph nodes
pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension
pN3: Lymph node metastasis to the common iliac lymph nodes
pN1: One or two regional lymph nodes with the following features
pN2 (FIGO IIIB): Regional lymph node metastasis with the following features
pN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis CAP synoptic form item: Regional Lymph Nodes (pN). May contain organization-specific values: Yes Category Entries: pNX: Cannot be assessed pN0: No regional lymph node metastasis pN1: Regional lymph node metastasis pN1: Metastasis in perirectal lymph nodes pN1: Metastasis in 1 to 3 regional lymph nodes pN1a: Metastasis in 1 regional lymph node pN1b: Metastasis in 2 to 3 regional lymph nodes pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta pN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes pN1: Regional lymph node metastasis involving 1 to 2 nodes pN1 (IIIC): Regional lymph node metastasis pN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery pN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension pN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes, pN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes pN1a: Clinically occult (microscopic) metastasis pN1b: Clinically apparent (macroscopic) metastasis pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension pN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension pN1: Metastasis in 1 to 2 perigastric lymph nodes pN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension, pN1a: Nodal metastases to Level VI lymph nodes pN1b: Metastases to unilateral, bilateral or contralateral cervical pN1: Single regional lymph node metastasis in the true pelvis pN1 (IVB): Pelvic or inguinal lymph node metastasis pN1: Metastasis in regional lymph node or nodes pN1: Regional lymph node involvement (preauricular, cervical, submandibular) pN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s) pN2: Metastasis in 4 or more regional lymph nodes pN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd pN2a: Metastasis in 4 to 6 regional lymph nodes pN2b: Metastasis in 7 or more regional lymph nodes pN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho pN2: 3 to 6 nodes involved pN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than pN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension pN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension pN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen. pN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s) pN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes pN2a: Clinically occult (microscopic) metastasis pN2b: Clinically apparent (macroscopic) metastasis pN2c: Satellite or in-transit metastasis without nodal metastasis pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension pN2: Metastasis in a single regional lymph node, more than 2 cm but not more than pN2: Metastasis in 3 to 6 perigastric lymph nodes pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm pN2: Multiple regional lymph node metastasis in the true pelvis pN2: Distant lymph node involvement pN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il pN3: 7 or more nodes involved pN3: Metastasis in a lymph node more than 6 cm in greatest dimension pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or pN3: Metastases in the contralateral mediastinal, contralateral internal mammary, pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or pN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa pN3a: Greater than 6 cm in dimension pN3b: Extension to the supraclavicular fossa pN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension pN3: Metastasis in 7 or more perigastric lymph nodes pN3a: Metastasis in 7 to 15 perigastric lymph nodes pN3b: Metastasis in 16 or more perigastric lymph nodes pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension pN3: Lymph node metastasis to the common iliac lymph nodes pN1: One or two regional lymph nodes with the following features pN2 (FIGO IIIB): Regional lymph node metastasis with the following features pN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis"
UVEAL_MELANOMA,PRIMARY_TUMOR_C_NAME,N,30,VARCHAR,No,"CAP synoptic form item: Primary Tumor (pT).
May contain organization-specific values: Yes
Category Entries:
pTX: Cannot be determined
pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or
pTX: Cannot be assessed
pT0: No evidence of primary tumor
pTis: Carcinoma in situ
pTis (DCIS): Ductal carcinoma in situ
pTis (LCIS): Lobular carcinoma in situ
pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and
pTis: Carcinoma in situ, intraepithelial (no invasion)
pTis: Carcinoma in situ, invasion of lamina propria
pTis: High-grade dysplasia / carcinoma in situ
pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa)
pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I)
Encapsulated
Extracapsular extension without adjacent organ involvement
Extension into adjacent organs
Extension into spinal canal
pTa: Papillary noninvasive carcinoma
pTa: Noninvasive papillary carcinoma
pTis: Intratubular germ cell neoplasia only (carcinoma in situ)
pTis: Flat carcinoma in situ
pTis: Carcinoma in situ: flat tumor
Iris
Ciliary Body and Choroid
pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion
pT1: Tumor limited to ampulla of Vater or sphincter of Oddi
pT1: Tumor 2 cm or less in greatest dimension
pT1: Tumor invades submucosa
pT1: Tumor confined to the bile duct histologically
pT1: Solitary tumor without vascular invasion
pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue
pT1: Tumor 8 cm or less in greatest dimension
pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion)
pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension
pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension
pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension
pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium
pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium
pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa
pT1a: Tumor invades lamina propria or muscularis mucosae
pT1a: Tumor invades lamina propria
pT1 (I): Tumor limited to fallopian tube(s)
pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites
pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites
pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa
pT1b: Tumor invades submucosa
pT1b: Tumor invades muscle layer
pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney
pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney
pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to  kidney
pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura
pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by 
pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I)
pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or
pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or
pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm
pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm
pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N
pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface
pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule 
pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension
pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen
pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal
pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen
pT1: Tumor invades subepithelial connective tissue (lamina propria)
pT1: Tumor confined to the eye with no optic nerve or choroidal invasion
pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor
pT1b: Tumor 5 cm or less in greatest dimension, deep tumor
pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features
pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion
pT1: Tumor size 2 cm or less, limited to thyroid
pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid
pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid
pT1 (I): Tumor confined to uterus
pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically
pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less
pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth
pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2
pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension
pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension
pT1 (I): Tumor confined to vaginal wall
pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum
pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more
pT2: Tumor greater than 5 cm, no extra-adrenal invasion
pT2: Tumor invades duodenal wall
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension
pT2: Tumor invades muscularis propria
pT2: Tumor invades beyond the wall of the bile duct
pT2a: Solitary tumor with vascular invasion
pT2b: Multiple tumors, with or without vascular invasion
pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue
pT2b: Tumor invades adjacent hepatic parenchyma
pT2: Tumor more than 8 cm in greatest dimension
pT2: Tumor > 20 mm but <= 50 mm in greatest dimension
pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend 
pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension
pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries
pT2b (IIB): Extension to other pelvic structures
pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites
pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney
pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney
pT2b: Tumor more than 10 cm, limited to the kidney
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension
pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l
pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension
pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension)
pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, 
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration
pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell
pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or
pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 
pT2: Tumor with parapharyngeal extension
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or
pT2: Organ confined
pT2a: Unilateral, involving one-half of 1 side or less
pT2b: Unilateral, involving more than one-half of 1 side but not both sides
pT2c: Bilateral disease
pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion
pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor
pT2: Tumor greater than 2 cm in greatest dimension with or without one additional
pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion
pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid 
pT2 (II): Tumor extends outside of the uterus but is limited to genital structures
pT2a: Tumor invades superficial muscularis propria (inner half)
pT2b: Tumor invades deep muscularis propria (outer half)
pT2a (IIA): Tumor without parametrial invasion
pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen
pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension
pT2b (IIB): Tumor with parametrial invasion
pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall
pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures 
pT3: Tumor of any size with local invasion, but not invading adjacent organs
pT3: Tumor invades pancreas
pT3: Tumor more than 5 cm in greatest dimension
pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix
pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of
pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas
pT3: Tumor invades unilateral branches of the portal vein or hepatic artery
pT3: Discontinuous tumors in primary bone site (not including skip metastases)
pT3: Tumor > 50 mm in greatest dimension
pT3: Tumor invades through the muscularis propria into pericolorectal tissues
pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis)
pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve
pT3: Tumor invades adventitia
pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis
pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis
pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen
pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen
pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver
pT3a: Multiple tumors more than 5 cm
pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins
pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal
pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) 
pT3b: Tumor grossly extends into the vena cava below the diaphragm
pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava
pT3: Mucosal disease
pT3: Tumor more than 4 cm in greatest dimension
pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that
pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I)
pT3: Locally advanced but potentially resectable tumor that involves all of the
pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration
pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration
pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor)
pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen
pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or 
pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis
pT3: Tumor invades bony structures of skull base and / or paranasal sinuses
pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary
pT3a: Extraprostatic extension or microscopic invasion of bladder neck
pT3b: Seminal vesicle invasion
pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma
pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion
pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion
pT3: Tumor invades through the muscularis propria into the subserosa or into the
pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone
pT3: Tumor invades subserosal connective tissue, without involvement of
pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion
pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension
pT3: Tumor invades beyond muscularis propria into periureteric fat
pT3a: Microscopically
pT3b: Macroscopically (extravesicular mass)
pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall
pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney
pT3 (III): Tumor extends to pelvic wall
pT3 (FIGO IVA): Tumor of any size with extension to any of the following
pT4: Tumor of any size with invasion of adjacent organs
pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures
pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder
pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within
pT4: Tumor involves the celiac axis or the superior mesenteric artery
pT4: Tumor with periductal invasion
pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati
pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa 
pT4: Tumor invades adjacent structures 
pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic
pT4: Tmr w/ direct invasion of adj. organs other than gallbladder 
pT4: Tmr invades beyond Gerota’s fascia
pT4: Tumor of any size that invades any of the following: mediastinum, heart, great
pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral
pT4: Tumor with intracranial extension and / or involvement of cranial nerves,
pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J)
pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat
pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified
pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified
pT4: Tumor with direct or perineural invasion of skull base or axial skeleton
pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure
pT4: Tumor invades scrotum with or without vascular / lymphatic invasion
pT4: Tumor invades adjacent organs
pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis
pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis
pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi
pT4a: Tumor penetrates the visceral peritoneum
pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas
pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria
pT4c: Both T4a and T4b
pT4d: Inflammatory carcinoma
pT4b: Tumor directly invades other organs or structures
pT4b: Tumor directly invades or is adherent to other organs or structures
pT4a: Resectable tumor invading pleura, pericardium, or diaphragm
pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body
Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells
Primary Tumor (pT): Supraglottis
Primary Tumor (pT): Glottis
Primary Tumor (pT): Subglottis
pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone,
pT4b: Very advanced disease. Tumor involving brain, dura, skull base,
pT4a: Moderately advanced local disease.
pT4b: Very advanced local disease. 
pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal,
pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates
pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration
pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration
Primary Tumor (pT): Maxillary Sinus
Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus
pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic
pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid 
pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage,
pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases
pT4a: Tumor involves visceral peritoneum (serosal surface)
pT4b: Tumor directly invades adjacent structures
pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid
pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid
pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable
pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable
pT4a: Tumor invades prostatic stroma or uterus or vagina
pT4b: Tumor invades pelvic wall or abdominal wall
Not identified CAP synoptic form item: Primary Tumor (pT). May contain organization-specific values: Yes Category Entries: pTX: Cannot be determined pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or pTX: Cannot be assessed pT0: No evidence of primary tumor pTis: Carcinoma in situ pTis (DCIS): Ductal carcinoma in situ pTis (LCIS): Lobular carcinoma in situ pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and pTis: Carcinoma in situ, intraepithelial (no invasion) pTis: Carcinoma in situ, invasion of lamina propria pTis: High-grade dysplasia / carcinoma in situ pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa) pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I) Encapsulated Extracapsular extension without adjacent organ involvement Extension into adjacent organs Extension into spinal canal pTa: Papillary noninvasive carcinoma pTa: Noninvasive papillary carcinoma pTis: Intratubular germ cell neoplasia only (carcinoma in situ) pTis: Flat carcinoma in situ pTis: Carcinoma in situ: flat tumor Iris Ciliary Body and Choroid pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion pT1: Tumor limited to ampulla of Vater or sphincter of Oddi pT1: Tumor 2 cm or less in greatest dimension pT1: Tumor invades submucosa pT1: Tumor confined to the bile duct histologically pT1: Solitary tumor without vascular invasion pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue pT1: Tumor 8 cm or less in greatest dimension pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion) pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa pT1a: Tumor invades lamina propria or muscularis mucosae pT1a: Tumor invades lamina propria pT1 (I): Tumor limited to fallopian tube(s) pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa pT1b: Tumor invades submucosa pT1b: Tumor invades muscle layer pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to  kidney pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I) pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen pT1: Tumor invades subepithelial connective tissue (lamina propria) pT1: Tumor confined to the eye with no optic nerve or choroidal invasion pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor pT1b: Tumor 5 cm or less in greatest dimension, deep tumor pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion pT1: Tumor size 2 cm or less, limited to thyroid pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid pT1 (I): Tumor confined to uterus pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2 pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension pT1 (I): Tumor confined to vaginal wall pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more pT2: Tumor greater than 5 cm, no extra-adrenal invasion pT2: Tumor invades duodenal wall pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension pT2: Tumor invades muscularis propria pT2: Tumor invades beyond the wall of the bile duct pT2a: Solitary tumor with vascular invasion pT2b: Multiple tumors, with or without vascular invasion pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue pT2b: Tumor invades adjacent hepatic parenchyma pT2: Tumor more than 8 cm in greatest dimension pT2: Tumor > 20 mm but <= 50 mm in greatest dimension pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries pT2b (IIB): Extension to other pelvic structures pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney pT2b: Tumor more than 10 cm, limited to the kidney pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension) pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than pT2: Tumor with parapharyngeal extension pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or pT2: Organ confined pT2a: Unilateral, involving one-half of 1 side or less pT2b: Unilateral, involving more than one-half of 1 side but not both sides pT2c: Bilateral disease pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor pT2b: Tumor more than 5 cm in greatest dimension, deep tumor pT2: Tumor greater than 2 cm in greatest dimension with or without one additional pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid pT2 (II): Tumor extends outside of the uterus but is limited to genital structures pT2a: Tumor invades superficial muscularis propria (inner half) pT2b: Tumor invades deep muscularis propria (outer half) pT2a (IIA): Tumor without parametrial invasion pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension pT2b (IIB): Tumor with parametrial invasion pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures pT3: Tumor of any size with local invasion, but not invading adjacent organs pT3: Tumor invades pancreas pT3: Tumor more than 5 cm in greatest dimension pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas pT3: Tumor invades unilateral branches of the portal vein or hepatic artery pT3: Discontinuous tumors in primary bone site (not including skip metastases) pT3: Tumor > 50 mm in greatest dimension pT3: Tumor invades through the muscularis propria into pericolorectal tissues pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis) pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve pT3: Tumor invades adventitia pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver pT3a: Multiple tumors more than 5 cm pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) pT3b: Tumor grossly extends into the vena cava below the diaphragm pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava pT3: Mucosal disease pT3: Tumor more than 4 cm in greatest dimension pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I) pT3: Locally advanced but potentially resectable tumor that involves all of the pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis pT3: Tumor invades bony structures of skull base and / or paranasal sinuses pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary pT3a: Extraprostatic extension or microscopic invasion of bladder neck pT3b: Seminal vesicle invasion pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion pT3: Tumor invades through the muscularis propria into the subserosa or into the pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone pT3: Tumor invades subserosal connective tissue, without involvement of pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension pT3: Tumor invades beyond muscularis propria into periureteric fat pT3a: Microscopically pT3b: Macroscopically (extravesicular mass) pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney pT3 (III): Tumor extends to pelvic wall pT3 (FIGO IVA): Tumor of any size with extension to any of the following pT4: Tumor of any size with invasion of adjacent organs pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within pT4: Tumor involves the celiac axis or the superior mesenteric artery pT4: Tumor with periductal invasion pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa pT4: Tumor invades adjacent structures pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic pT4: Tmr w/ direct invasion of adj. organs other than gallbladder pT4: Tmr invades beyond Gerota’s fascia pT4: Tumor of any size that invades any of the following: mediastinum, heart, great pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral pT4: Tumor with intracranial extension and / or involvement of cranial nerves, pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J) pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified pT4: Tumor with direct or perineural invasion of skull base or axial skeleton pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure pT4: Tumor invades scrotum with or without vascular / lymphatic invasion pT4: Tumor invades adjacent organs pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi pT4a: Tumor penetrates the visceral peritoneum pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria pT4c: Both T4a and T4b pT4d: Inflammatory carcinoma pT4b: Tumor directly invades other organs or structures pT4b: Tumor directly invades or is adherent to other organs or structures pT4a: Resectable tumor invading pleura, pericardium, or diaphragm pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells Primary Tumor (pT): Supraglottis Primary Tumor (pT): Glottis Primary Tumor (pT): Subglottis pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, pT4b: Very advanced disease. Tumor involving brain, dura, skull base, pT4a: Moderately advanced local disease. pT4b: Very advanced local disease. pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal, pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration Primary Tumor (pT): Maxillary Sinus Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage, pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases pT4a: Tumor involves visceral peritoneum (serosal surface) pT4b: Tumor directly invades adjacent structures pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable pT4a: Tumor invades prostatic stroma or uterus or vagina pT4b: Tumor invades pelvic wall or abdominal wall Not identified"
UVEAL_MELANOMA,DISTNT_METASTASIS_C_NAME,N,31,VARCHAR,No,"CAP synoptic form item: Distant Metastasis.
May contain organization-specific values: Yes
Category Entries:
Not applicable
cM0 (i+): No clinical or radiographic evidence of distant metastasis
pM0: No distant metastasis
pM1: Distant metastasis
pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx
pM1b: Nonperitoneal metastasis
pM1: Distant detectable metastasis as determined by classic clinical
pM1 (IVB): Distant metastasis
pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or
pM1b: Distant metastases outside the lung / pleura
pM1: Distant metastasis (documented in this specimen)
pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes
pM1b: Metastasis to lung
pM1c: Metastasis to all other visceral sites or distant metastasis at any site
pM1a: Nonregional lymph node(s)
pM1b: Bone(s)
pM1c: Other site(s) with or without bone disease
pM1: Metastasis to sites other than CNS
pM1a: Single lesion
pM1b: Multiple lesions
pM1c: CNS metastasis
pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement
pM1e: Leptomeningeal and / or CSF involvement
pM1a: Non-regional lymph nodes or pulmonary metastasis
pM1b: Distant metastasis other than to nonregional lymph nodes and lungs
pM1a (III): Tumor extends to the lungs with or without genital tract involvement
pM1b (IV): Tumor involves other metastatic sites
pM1a: Largest diameter of the largest metastasis 3 cm or less
pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm
pM1c: Largest diameter of the largest metastasis 8 cm or more
pM1a: Lung
pM1b: Metastasis involving distant sites other than lung (including skip metastases)
Distant Metastasis present (includes metastasis to lymph nodes) CAP synoptic form item: Distant Metastasis. May contain organization-specific values: Yes Category Entries: Not applicable cM0 (i+): No clinical or radiographic evidence of distant metastasis pM0: No distant metastasis pM1: Distant metastasis pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx pM1b: Nonperitoneal metastasis pM1: Distant detectable metastasis as determined by classic clinical pM1 (IVB): Distant metastasis pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or pM1b: Distant metastases outside the lung / pleura pM1: Distant metastasis (documented in this specimen) pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes pM1b: Metastasis to lung pM1c: Metastasis to all other visceral sites or distant metastasis at any site pM1a: Nonregional lymph node(s) pM1b: Bone(s) pM1c: Other site(s) with or without bone disease pM1: Metastasis to sites other than CNS pM1a: Single lesion pM1b: Multiple lesions pM1c: CNS metastasis pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement pM1e: Leptomeningeal and / or CSF involvement pM1a: Non-regional lymph nodes or pulmonary metastasis pM1b: Distant metastasis other than to nonregional lymph nodes and lungs pM1a (III): Tumor extends to the lungs with or without genital tract involvement pM1b (IV): Tumor involves other metastatic sites pM1a: Largest diameter of the largest metastasis 3 cm or less pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm pM1c: Largest diameter of the largest metastasis 8 cm or more pM1a: Lung pM1b: Metastasis involving distant sites other than lung (including skip metastases) Distant Metastasis present (includes metastasis to lymph nodes)"
UVEAL_MELANOMA,ADDL_PATH_FIND_SPFY,N,32,VARCHAR,No,CAP synoptic form item: Specify additional pathologic findings. CAP synoptic form item: Specify additional pathologic findings.
UVEAL_MELANOMA,TUMOR_BASE_CUT_EDGE,N,33,NUMERIC,No,CAP synoptic form item: Tumor Size After Sectioning Base at Cut Edge. CAP synoptic form item: Tumor Size After Sectioning Base at Cut Edge.
UVEAL_MELANOMA,TUMOR_HT_CUT_EDGE,N,34,NUMERIC,No,CAP synoptic form item: Tumor Size After Sectioning Height at Cut Edge. CAP synoptic form item: Tumor Size After Sectioning Height at Cut Edge.
UVEAL_MELANOMA,TUMOR_GREAT_CUT_ED,N,35,NUMERIC,No,CAP synoptic form item: Tumor Size After Sectioning Greatest Height. CAP synoptic form item: Tumor Size After Sectioning Greatest Height.
UVEAL_MELANOMA,SPEC_PROC_SPECIFY,N,36,VARCHAR,No,CAP synoptic form item: Specify the Specimen Procedure. CAP synoptic form item: Specify the Specimen Procedure.
